
<html lang="en"     class="pb-page"  data-request-id="d6328c7d-39d8-4d61-aaf6-58832a68f1d5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c00361;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-11"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Potent, Selective, and State-Dependent NaV1.7 Inhibitors with Robust Oral Efficacy in Pain Models: Structure–Activity Relationship and Optimization of Chroman and Indane Aryl Sulfonamides" /></meta><meta name="dc.Creator" content="Vidya  Ramdas" /></meta><meta name="dc.Creator" content="Rashmi  Talwar" /></meta><meta name="dc.Creator" content="Vijay  Kanoje" /></meta><meta name="dc.Creator" content="Rajesh M.  Loriya" /></meta><meta name="dc.Creator" content="Moloy  Banerjee" /></meta><meta name="dc.Creator" content="Pradeep  Patil" /></meta><meta name="dc.Creator" content="Advait Arun  Joshi" /></meta><meta name="dc.Creator" content="Laxmikant  Datrange" /></meta><meta name="dc.Creator" content="Amit Kumar  Das" /></meta><meta name="dc.Creator" content="Deepak Sahebrao  Walke" /></meta><meta name="dc.Creator" content="Vaibhav  Kalhapure" /></meta><meta name="dc.Creator" content="Talha  Khan" /></meta><meta name="dc.Creator" content="Ganesh  Gote" /></meta><meta name="dc.Creator" content="Usha  Dhayagude" /></meta><meta name="dc.Creator" content="Shreyas  Deshpande" /></meta><meta name="dc.Creator" content="Javed  Shaikh" /></meta><meta name="dc.Creator" content="Ganesh  Chaure" /></meta><meta name="dc.Creator" content="Ravindra R.  Pal" /></meta><meta name="dc.Creator" content="Santosh  Parkale" /></meta><meta name="dc.Creator" content="Sachin  Suravase" /></meta><meta name="dc.Creator" content="Smita  Bhoskar" /></meta><meta name="dc.Creator" content="Rajesh V.  Gupta" /></meta><meta name="dc.Creator" content="Anil  Kalia" /></meta><meta name="dc.Creator" content="Rajesh  Yeshodharan" /></meta><meta name="dc.Creator" content="Mahammad  Azhar" /></meta><meta name="dc.Creator" content="Jagadeesh  Daler" /></meta><meta name="dc.Creator" content="Vinod  Mali" /></meta><meta name="dc.Creator" content="Geetika  Sharma" /></meta><meta name="dc.Creator" content="Amitesh  Kishore" /></meta><meta name="dc.Creator" content="Rupali  Vyawahare" /></meta><meta name="dc.Creator" content="Gautam  Agarwal" /></meta><meta name="dc.Creator" content="Himani  Pareek" /></meta><meta name="dc.Creator" content="Sagar  Budhe" /></meta><meta name="dc.Creator" content="Arun  Nayak" /></meta><meta name="dc.Creator" content="Dnyaneshwar  Warude" /></meta><meta name="dc.Creator" content="Praveen Kumar  Gupta" /></meta><meta name="dc.Creator" content="Parag  Joshi" /></meta><meta name="dc.Creator" content="Sneha  Joshi" /></meta><meta name="dc.Creator" content="Sagar  Darekar" /></meta><meta name="dc.Creator" content="Dilip  Pandey" /></meta><meta name="dc.Creator" content="Akshaya  Wagh" /></meta><meta name="dc.Creator" content="Prashant B.  Nigade" /></meta><meta name="dc.Creator" content="Maneesh  Mehta" /></meta><meta name="dc.Creator" content="Vinod  Patil" /></meta><meta name="dc.Creator" content="Dipak  Modi" /></meta><meta name="dc.Creator" content="Shashikant  Pawar" /></meta><meta name="dc.Creator" content="Mahip  Verma" /></meta><meta name="dc.Creator" content="Minakshi  Singh" /></meta><meta name="dc.Creator" content="Sudipto  Das" /></meta><meta name="dc.Creator" content="Jayasagar  Gundu" /></meta><meta name="dc.Creator" content="Kumar  Nemmani" /></meta><meta name="dc.Creator" content="Mark G.  Bock" /></meta><meta name="dc.Creator" content="Sharad  Sharma" /></meta><meta name="dc.Creator" content="Dhananjay  Bakhle" /></meta><meta name="dc.Creator" content="Rajender Kumar  Kamboj" /></meta><meta name="dc.Creator" content="Venkata P.  Palle" /></meta><meta name="dc.Description" content="Voltage-gated sodium channel NaV1.7 is a genetically validated target for pain. Identification of NaV1.7 inhibitors with all of the desired properties to develop as an oral therapeutic for pain has..." /></meta><meta name="Description" content="Voltage-gated sodium channel NaV1.7 is a genetically validated target for pain. Identification of NaV1.7 inhibitors with all of the desired properties to develop as an oral therapeutic for pain has..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 5, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00361" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00361" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00361" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00361" /></link>
        
    
    

<title>Discovery of Potent, Selective, and State-Dependent NaV1.7 Inhibitors with Robust Oral Efficacy in Pain Models: Structure–Activity Relationship and Optimization of Chroman and Indane Aryl Sulfonamides | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00361" /></meta><meta property="og:title" content="Discovery of Potent, Selective, and State-Dependent NaV1.7 Inhibitors with Robust Oral Efficacy in Pain Models: Structure–Activity Relationship and Optimization of Chroman and Indane Aryl Sulfonamides" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0020.jpeg" /></meta><meta property="og:description" content="Voltage-gated sodium channel NaV1.7 is a genetically validated target for pain. Identification of NaV1.7 inhibitors with all of the desired properties to develop as an oral therapeutic for pain has been a major challenge. Herein, we report systematic structure–activity relationship (SAR) studies carried out to identify novel sulfonamide derivatives as potent, selective, and state-dependent NaV1.7 inhibitors for pain. Scaffold hopping from benzoxazine to chroman and indane bicyclic system followed by thiazole replacement on sulfonamide led to identification of lead molecules with significant improvement in solubility, selectivity over NaV1.5, and CYP2C9 inhibition. The lead molecules 13, 29, 32, 43, and 51 showed a favorable pharmacokinetics (PK) profile across different species and robust efficacy in veratridine and formalin-induced inflammatory pain models in mice. Compound 51 also showed significant effects on the CCI-induced neuropathic pain model. The profile of 51 indicated that it has the potential for further evaluation as a therapeutic for pain." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00361"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00361">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00361&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00361&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00361&amp;href=/doi/10.1021/acs.jmedchem.0c00361" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 6107-6133</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00343" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00266" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Potent, Selective, and State-Dependent Na<sub>V</sub>1.7 Inhibitors with Robust Oral Efficacy in Pain Models: Structure–Activity Relationship and Optimization of Chroman and Indane Aryl Sulfonamides</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Vidya Ramdas</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vidya Ramdas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#3b4d525f425a495a565a5f5a487b574e4b525515585456"><span class="__cf_email__" data-cfemail="0c7a6568756d7e6d616d686d7f4c60797c6562226f6361">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vidya++Ramdas">Vidya Ramdas</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3965-6731" title="Orcid link">http://orcid.org/0000-0002-3965-6731</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rashmi Talwar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rashmi Talwar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rashmi++Talwar">Rashmi Talwar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vijay Kanoje</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vijay Kanoje</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vijay++Kanoje">Vijay Kanoje</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rajesh M. Loriya</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rajesh M. Loriya</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rajesh+M.++Loriya">Rajesh M. Loriya</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Moloy Banerjee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Moloy Banerjee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Moloy++Banerjee">Moloy Banerjee</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pradeep Patil</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pradeep Patil</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pradeep++Patil">Pradeep Patil</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Advait Arun Joshi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Advait Arun Joshi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Advait+Arun++Joshi">Advait Arun Joshi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laxmikant Datrange</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laxmikant Datrange</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laxmikant++Datrange">Laxmikant Datrange</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Amit Kumar Das</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Amit Kumar Das</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Amit+Kumar++Das">Amit Kumar Das</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Deepak Sahebrao Walke</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Deepak Sahebrao Walke</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Deepak+Sahebrao++Walke">Deepak Sahebrao Walke</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vaibhav Kalhapure</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vaibhav Kalhapure</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vaibhav++Kalhapure">Vaibhav Kalhapure</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Talha Khan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Talha Khan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Talha++Khan">Talha Khan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ganesh Gote</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ganesh Gote</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ganesh++Gote">Ganesh Gote</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Usha Dhayagude</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Usha Dhayagude</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Usha++Dhayagude">Usha Dhayagude</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shreyas Deshpande</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shreyas Deshpande</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shreyas++Deshpande">Shreyas Deshpande</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Javed Shaikh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Javed Shaikh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Javed++Shaikh">Javed Shaikh</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ganesh Chaure</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ganesh Chaure</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ganesh++Chaure">Ganesh Chaure</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ravindra R. Pal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ravindra R. Pal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ravindra+R.++Pal">Ravindra R. Pal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Santosh Parkale</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Santosh Parkale</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Santosh++Parkale">Santosh Parkale</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sachin Suravase</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sachin Suravase</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sachin++Suravase">Sachin Suravase</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Smita Bhoskar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Smita Bhoskar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Smita++Bhoskar">Smita Bhoskar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rajesh V. Gupta</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rajesh V. Gupta</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rajesh+V.++Gupta">Rajesh V. Gupta</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anil Kalia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anil Kalia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anil++Kalia">Anil Kalia</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rajesh Yeshodharan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rajesh Yeshodharan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rajesh++Yeshodharan">Rajesh Yeshodharan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mahammad Azhar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mahammad Azhar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mahammad++Azhar">Mahammad Azhar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jagadeesh Daler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jagadeesh Daler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jagadeesh++Daler">Jagadeesh Daler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vinod Mali</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vinod Mali</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vinod++Mali">Vinod Mali</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Geetika Sharma</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Geetika Sharma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Geetika++Sharma">Geetika Sharma</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Amitesh Kishore</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Amitesh Kishore</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Amitesh++Kishore">Amitesh Kishore</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rupali Vyawahare</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rupali Vyawahare</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rupali++Vyawahare">Rupali Vyawahare</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gautam Agarwal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gautam Agarwal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gautam++Agarwal">Gautam Agarwal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Himani Pareek</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Himani Pareek</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Himani++Pareek">Himani Pareek</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sagar Budhe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sagar Budhe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sagar++Budhe">Sagar Budhe</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Arun Nayak</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Arun Nayak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Arun++Nayak">Arun Nayak</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dnyaneshwar Warude</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dnyaneshwar Warude</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dnyaneshwar++Warude">Dnyaneshwar Warude</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Praveen Kumar Gupta</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Praveen Kumar Gupta</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Praveen+Kumar++Gupta">Praveen Kumar Gupta</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Parag Joshi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Parag Joshi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Parag++Joshi">Parag Joshi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sneha Joshi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sneha Joshi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sneha++Joshi">Sneha Joshi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sagar Darekar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sagar Darekar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sagar++Darekar">Sagar Darekar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dilip Pandey</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dilip Pandey</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dilip++Pandey">Dilip Pandey</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Akshaya Wagh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Akshaya Wagh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Akshaya++Wagh">Akshaya Wagh</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Prashant B. Nigade</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Prashant B. Nigade</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Prashant+B.++Nigade">Prashant B. Nigade</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maneesh Mehta</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maneesh Mehta</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maneesh++Mehta">Maneesh Mehta</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vinod Patil</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vinod Patil</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vinod++Patil">Vinod Patil</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dipak Modi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dipak Modi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dipak++Modi">Dipak Modi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shashikant Pawar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shashikant Pawar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shashikant++Pawar">Shashikant Pawar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mahip Verma</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mahip Verma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mahip++Verma">Mahip Verma</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Minakshi Singh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Minakshi Singh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Minakshi++Singh">Minakshi Singh</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sudipto Das</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sudipto Das</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sudipto++Das">Sudipto Das</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jayasagar Gundu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jayasagar Gundu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jayasagar++Gundu">Jayasagar Gundu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kumar Nemmani</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kumar Nemmani</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kumar++Nemmani">Kumar Nemmani</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mark G. Bock</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mark G. Bock</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mark+G.++Bock">Mark G. Bock</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sharad Sharma</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sharad Sharma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sharad++Sharma">Sharad Sharma</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dhananjay Bakhle</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dhananjay Bakhle</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dhananjay++Bakhle">Dhananjay Bakhle</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rajender Kumar Kamboj</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rajender Kumar Kamboj</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rajender+Kumar++Kamboj">Rajender Kumar Kamboj</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Venkata P. Palle</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Venkata P. Palle</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novel Drug Discovery & Development, Lupin Ltd., Lupin Research Park, Survey No. 46 A/47 A, Village Nande, Taluka Mulshi, Pune 412115, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Venkata+P.++Palle">Venkata P. Palle</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00361&amp;href=/doi/10.1021%2Facs.jmedchem.0c00361" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 6107–6133</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 5, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 February 2020</li><li><span class="item_label"><b>Published</b> online</span>5 May 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 June 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00361" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00361</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6107%26pageCount%3D27%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DVidya%2BRamdas%252C%2BRashmi%2BTalwar%252C%2BVijay%2BKanoje%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D11%26contentID%3Dacs.jmedchem.0c00361%26title%3DDiscovery%2Bof%2BPotent%252C%2BSelective%252C%2Band%2BState-Dependent%2BNaV1.7%2BInhibitors%2Bwith%2BRobust%2BOral%2BEfficacy%2Bin%2BPain%2BModels%253A%2BStructure%25E2%2580%2593Activity%2BRelationship%2Band%2BOptimization%2Bof%2BChroman%2Band%2BIndane%2BAryl%2BSulfonamides%26numPages%3D27%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6133%26publicationDate%3DJune%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00361"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1877</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00361" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Potent, Selective, and State-Dependent NaV1.7 Inhibitors with Robust Oral Efficacy in Pain Models: Structure–Activity Relationship and Optimization of Chroman and Indane Aryl Sulfonamides&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Vidya&quot;,&quot;last_name&quot;:&quot;Ramdas&quot;},{&quot;first_name&quot;:&quot;Rashmi&quot;,&quot;last_name&quot;:&quot;Talwar&quot;},{&quot;first_name&quot;:&quot;Vijay&quot;,&quot;last_name&quot;:&quot;Kanoje&quot;},{&quot;first_name&quot;:&quot;Rajesh&quot;,&quot;last_name&quot;:&quot;M. Loriya&quot;},{&quot;first_name&quot;:&quot;Moloy&quot;,&quot;last_name&quot;:&quot;Banerjee&quot;},{&quot;first_name&quot;:&quot;Pradeep&quot;,&quot;last_name&quot;:&quot;Patil&quot;},{&quot;first_name&quot;:&quot;Advait&quot;,&quot;last_name&quot;:&quot;Arun Joshi&quot;},{&quot;first_name&quot;:&quot;Laxmikant&quot;,&quot;last_name&quot;:&quot;Datrange&quot;},{&quot;first_name&quot;:&quot;Amit&quot;,&quot;last_name&quot;:&quot;Kumar Das&quot;},{&quot;first_name&quot;:&quot;Deepak&quot;,&quot;last_name&quot;:&quot;Sahebrao Walke&quot;},{&quot;first_name&quot;:&quot;Vaibhav&quot;,&quot;last_name&quot;:&quot;Kalhapure&quot;},{&quot;first_name&quot;:&quot;Talha&quot;,&quot;last_name&quot;:&quot;Khan&quot;},{&quot;first_name&quot;:&quot;Ganesh&quot;,&quot;last_name&quot;:&quot;Gote&quot;},{&quot;first_name&quot;:&quot;Usha&quot;,&quot;last_name&quot;:&quot;Dhayagude&quot;},{&quot;first_name&quot;:&quot;Shreyas&quot;,&quot;last_name&quot;:&quot;Deshpande&quot;},{&quot;first_name&quot;:&quot;Javed&quot;,&quot;last_name&quot;:&quot;Shaikh&quot;},{&quot;first_name&quot;:&quot;Ganesh&quot;,&quot;last_name&quot;:&quot;Chaure&quot;},{&quot;first_name&quot;:&quot;Ravindra&quot;,&quot;last_name&quot;:&quot;R. Pal&quot;},{&quot;first_name&quot;:&quot;Santosh&quot;,&quot;last_name&quot;:&quot;Parkale&quot;},{&quot;first_name&quot;:&quot;Sachin&quot;,&quot;last_name&quot;:&quot;Suravase&quot;},{&quot;first_name&quot;:&quot;Smita&quot;,&quot;last_name&quot;:&quot;Bhoskar&quot;},{&quot;first_name&quot;:&quot;Rajesh&quot;,&quot;last_name&quot;:&quot;V. Gupta&quot;},{&quot;first_name&quot;:&quot;Anil&quot;,&quot;last_name&quot;:&quot;Kalia&quot;},{&quot;first_name&quot;:&quot;Rajesh&quot;,&quot;last_name&quot;:&quot;Yeshodharan&quot;},{&quot;first_name&quot;:&quot;Mahammad&quot;,&quot;last_name&quot;:&quot;Azhar&quot;},{&quot;first_name&quot;:&quot;Jagadeesh&quot;,&quot;last_name&quot;:&quot;Daler&quot;},{&quot;first_name&quot;:&quot;Vinod&quot;,&quot;last_name&quot;:&quot;Mali&quot;},{&quot;first_name&quot;:&quot;Geetika&quot;,&quot;last_name&quot;:&quot;Sharma&quot;},{&quot;first_name&quot;:&quot;Amitesh&quot;,&quot;last_name&quot;:&quot;Kishore&quot;},{&quot;first_name&quot;:&quot;Rupali&quot;,&quot;last_name&quot;:&quot;Vyawahare&quot;},{&quot;first_name&quot;:&quot;Gautam&quot;,&quot;last_name&quot;:&quot;Agarwal&quot;},{&quot;first_name&quot;:&quot;Himani&quot;,&quot;last_name&quot;:&quot;Pareek&quot;},{&quot;first_name&quot;:&quot;Sagar&quot;,&quot;last_name&quot;:&quot;Budhe&quot;},{&quot;first_name&quot;:&quot;Arun&quot;,&quot;last_name&quot;:&quot;Nayak&quot;},{&quot;first_name&quot;:&quot;Dnyaneshwar&quot;,&quot;last_name&quot;:&quot;Warude&quot;},{&quot;first_name&quot;:&quot;Praveen&quot;,&quot;last_name&quot;:&quot;Kumar Gupta&quot;},{&quot;first_name&quot;:&quot;Parag&quot;,&quot;last_name&quot;:&quot;Joshi&quot;},{&quot;first_name&quot;:&quot;Sneha&quot;,&quot;last_name&quot;:&quot;Joshi&quot;},{&quot;first_name&quot;:&quot;Sagar&quot;,&quot;last_name&quot;:&quot;Darekar&quot;},{&quot;first_name&quot;:&quot;Dilip&quot;,&quot;last_name&quot;:&quot;Pandey&quot;},{&quot;first_name&quot;:&quot;Akshaya&quot;,&quot;last_name&quot;:&quot;Wagh&quot;},{&quot;first_name&quot;:&quot;Prashant&quot;,&quot;last_name&quot;:&quot;B. Nigade&quot;},{&quot;first_name&quot;:&quot;Maneesh&quot;,&quot;last_name&quot;:&quot;Mehta&quot;},{&quot;first_name&quot;:&quot;Vinod&quot;,&quot;last_name&quot;:&quot;Patil&quot;},{&quot;first_name&quot;:&quot;Dipak&quot;,&quot;last_name&quot;:&quot;Modi&quot;},{&quot;first_name&quot;:&quot;Shashikant&quot;,&quot;last_name&quot;:&quot;Pawar&quot;},{&quot;first_name&quot;:&quot;Mahip&quot;,&quot;last_name&quot;:&quot;Verma&quot;},{&quot;first_name&quot;:&quot;Minakshi&quot;,&quot;last_name&quot;:&quot;Singh&quot;},{&quot;first_name&quot;:&quot;Sudipto&quot;,&quot;last_name&quot;:&quot;Das&quot;},{&quot;first_name&quot;:&quot;Jayasagar&quot;,&quot;last_name&quot;:&quot;Gundu&quot;},{&quot;first_name&quot;:&quot;Kumar&quot;,&quot;last_name&quot;:&quot;Nemmani&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;G. Bock&quot;},{&quot;first_name&quot;:&quot;Sharad&quot;,&quot;last_name&quot;:&quot;Sharma&quot;},{&quot;first_name&quot;:&quot;Dhananjay&quot;,&quot;last_name&quot;:&quot;Bakhle&quot;},{&quot;first_name&quot;:&quot;Rajender&quot;,&quot;last_name&quot;:&quot;Kumar Kamboj&quot;},{&quot;first_name&quot;:&quot;Venkata&quot;,&quot;last_name&quot;:&quot;P. Palle&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;6107-6133&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00361&quot;},&quot;abstract&quot;:&quot;Voltage-gated sodium channel NaV1.7 is a genetically validated target for pain. Identification of NaV1.7 inhibitors with all of the desired properties to develop as an oral therapeutic for pain has been a major challenge. Herein, we report systematic structure–activity relationship (SAR) studies carried out to identify novel sulfonamide derivatives as potent, selective, and state-dependent NaV1.7 inhibitors for pain. Scaffold hopping from benzoxazine to chroman and indane bicyclic system followed by thiazole replacement on sulfonamide led to identification of lead molecules with significant improvement in solubility, selectivity over NaV1.5, and CYP2C9 inhibition. The lead molecules 13, 29, 32, 43, and 51 showed a favorable pharmacokinetics (PK) profile across different species and robust efficacy in veratridine and formalin-induced inflammatory pain models in mice. Compound 51 also showed significant effects on the CCI-induced neuropathic pain model. The profile of 51 indicated that it has the potential for &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00361&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00361" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00361&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00361" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00361&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00361" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00361&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00361&amp;href=/doi/10.1021/acs.jmedchem.0c00361" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00361" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00361" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00361%26sid%3Dliteratum%253Aachs%26pmid%3D32368909%26genre%3Darticle%26aulast%3DRamdas%26date%3D2020%26atitle%3DDiscovery%2Bof%2BPotent%252C%2BSelective%252C%2Band%2BState-Dependent%2BNaV1.7%2BInhibitors%2Bwith%2BRobust%2BOral%2BEfficacy%2Bin%2BPain%2BModels%253A%2BStructure%25E2%2580%2593Activity%2BRelationship%2Band%2BOptimization%2Bof%2BChroman%2Band%2BIndane%2BAryl%2BSulfonamides%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D11%26spage%3D6107%26epage%3D6133%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=290716" title="Sulfones">Sulfones</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/jmcmar.2020.63.issue-11/20200611/jmcmar.2020.63.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Voltage-gated sodium channel Na<sub>V</sub>1.7 is a genetically validated target for pain. Identification of Na<sub>V</sub>1.7 inhibitors with all of the desired properties to develop as an oral therapeutic for pain has been a major challenge. Herein, we report systematic structure–activity relationship (SAR) studies carried out to identify novel sulfonamide derivatives as potent, selective, and state-dependent Na<sub>V</sub>1.7 inhibitors for pain. Scaffold hopping from benzoxazine to chroman and indane bicyclic system followed by thiazole replacement on sulfonamide led to identification of lead molecules with significant improvement in solubility, selectivity over Na<sub>V</sub>1.5, and CYP2C9 inhibition. The lead molecules <b>13</b>, <b>29</b>, <b>32</b>, <b>43</b>, and <b>51</b> showed a favorable pharmacokinetics (PK) profile across different species and robust efficacy in veratridine and formalin-induced inflammatory pain models in mice. Compound <b>51</b> also showed significant effects on the CCI-induced neuropathic pain model. The profile of <b>51</b> indicated that it has the potential for further evaluation as a therapeutic for pain.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15653" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15653" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Pain is a major health problem, which greatly reduces the quality of life and imparts huge health costs and economic loss to society. One-fourth of the world’s population suffers from chronic pain. Pain sensations originate in peripheral neurons such as nociceptors. Increased pain sensations can result from altered electrical excitability of neurons in both peripheral and central neurons. As a therapeutic class, sodium channel blockers such as lidocaine, amitriptyline, and lamotrigine have been widely used to treat disorders where the chosen therapeutic approach is designed to decrease neuronal excitability. Such disorders involving hyperexcitability or increased neuronal sensitivity to stimulation include pain as well.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">Voltage-gated sodium channels (VGSCs) are key elements of excitable cells responsible for the generation and transmission of electrical activity in the central and peripheral nervous system.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> VGSCs consist of a pore-forming α subunit and a stabilizing β subunit. Nine isoforms of the α subunit have been identified to date (Na<sub>V</sub>1.1–Na<sub>V</sub>1.9) and are encoded by SCN genes.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> All of these nine members of the VGSC family have high homology of the amino acid sequence in the extracellular and transmembrane domains. The sodium channels have also been further classified based on their sensitivity to the puffer fish toxin (tetrodotoxin, TTX). Channels Na<sub>V</sub>1.8, Na<sub>V</sub>1.9, and Na<sub>V</sub>1.5 are TTX resistant (TTX-R), whereas the remaining channels are sensitive to TTX and classified as TTX sensitive (TTX-S). VGSCs mediate the influx of sodium ions into the cell in response to membrane depolarization, leading to generation of the action potential to relay information of stimuli from the periphery to the central nervous system. Thus, voltage-gated ion channels play a major role in determining excitability of neurons.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a></div><div class="NLM_p">Na<sub>V</sub>1.7 is one of the highly expressed TTX-sensitive sodium channels in dorsal root ganglion cells and is believed to be an important contributor to signaling in both nociceptive and non-nociceptive neurons. There is strong genetic evidence linking Na<sub>V</sub>1.7 and the pain-processing pathway, and the evidence comes mostly in the form of mutations in human SCN9A, the gene encoding Na<sub>V</sub>1.7. The gain-of-function mutations in human Na<sub>V</sub>1.7 cause spontaneous pain syndromes such as inherited erythromelalgia,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> paroxysmal extreme pain disorder,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and small fiber neuropathy.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> In contrast, the loss-of-function mutations in human Na<sub>V</sub>1.7 lead to a rare condition known as congenital insensitivity to pain (CIP), which manifests in the form of inability of individuals to sense pain while not significantly impacting motor or cognitive function.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Patients with CIP experience no pain following a wide variety of stimuli.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">Similarly, deletion of Na<sub>V</sub>1.7 in sensory and sympathetic neurons of mice leads to a pain-free congenital insensitivity to pain (CIP) phenotype similar to that described in humans. Human and mouse Na<sub>V</sub>1.7-null mutants are apparently normal, suggesting that this channel is an excellent analgesic drug target for acute, inflammatory, and neuropathic pain.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Nonselective Na<sub>V</sub> blockers such as mexiletine and carbamazepine have long been used clinically for the treatment of neuropathic pain. Limitations with these therapies are marginal response and adverse effects seen in patients, and these are due to marginal potency and nonselectivity against other sodium channels or resting-state blockade of channels.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The ion channel moves from the closed state to open through concerted movements and then to an inactivated state, where the channel stops conducting ions. Disease states are characterized by the activated state of high-frequency firing channels; however, the normal somatosensory system is characterized by low-frequency firing channels. Hence, identification of Na<sub>V</sub>1.7 inhibitors that exhibit a different affinity for each of these states and show increased affinity for a slow-inactivated channel state vs. a fast-inactivated one may lead to functional selectivity and exhibit a better safety window. Thus, a potent, selective, and state-dependent Na<sub>V</sub>1.7 blocker can be rationalized as an effective and safe therapeutic option for treatment of chronic pain in humans.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> One of the primary challenges associated with these efforts has been the identification of isoform-selective inhibitors, in particular those that demonstrate suitable levels of selectivity over Na<sub>V</sub>1.5, which is expressed in cardiac myocytes and plays a key role in cardiovascular function.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">Many aryl and acyl sulfonamide derivatives have been reported as potent and selective Na<sub>V</sub>1.7 inhibitors.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> They have been shown to bind to the voltage-sensing domain 4 of Na<sub>V</sub>1.7 and block the channel by locking it into the inactivated state.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, identification of a selective Na<sub>V</sub>1.7 inhibitor, which shows robust efficacy in rodent pain models without any metabolic liability to develop as an oral therapeutic for pain, has been a major challenge for a long time since the structure–activity relationship (SAR) on sulfonamide derivatives was found to be nonadditive for multiparameter optimization.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Most of the initial lead molecules reported by Pfizer,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Amgen,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Merck,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Xenon,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and BMS<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> contained either 1,2,4-thiadiazole or thiazole-substituted aryl sulfonamide analogs, A–F, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. Most of these compounds suffer from high CYP3A4 and/or CYP2C9 inhibition.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20 ref21">(16−21)</a> In addition, many of these sulfonamide derivatives lack a good pharmacokinetics (PK) profile across rodent and nonrodent species suitable for development as an oral therapeutic for pain.<a onclick="showRef(event, 'ref13 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref15">(13,15)</a> From our own internal SAR studies and also from the literature reports that appeared while we were working on the project, it was clear that CYP3A4 inhibition could be overcome by replacement of 1,2,4-thiadiazole with other heteroaryl substitutions on sulfonamide, compounds A, F, and G–I, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>.<a onclick="showRef(event, 'cit16b cit17d cit19a cit20b'); return false;" href="javascript:void(0);" class="ref cit16b cit17d cit19a cit20b">(16b,17d,19a,20b)</a> However, CYP2C9 inhibition was still a challenge, and in addition, heteroaryl modification on sulfonamide led to new challenges such as decrease in potency and selectivity although the extent of compromise on potency and selectivity was dependent on the overall scaffold.<a onclick="showRef(event, 'ref17 cit18b cit19a'); return false;" href="javascript:void(0);" class="ref ref17 cit18b cit19a">(17,18b,19a)</a> Herein, we report systematic SAR studies carried out to identify potent, selective, and orally bioavailable chroman and indane sulfonamide derivatives as state-dependent Na<sub>V</sub>1.7 blockers without any significant CYP liabilities (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). In addition, we report complete characterization of lead molecules <b>13</b>, <b>29</b>, <b>32</b>, <b>43</b>, and <b>51</b>, including detailed pharmacokinetic properties across the species and in vivo efficacy of selected lead molecules in mouse models of veratridine-induced pain, formalin-induced inflammatory pain, and CCI-induced neuropathic pain.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of selected aryl sulfonamide Na<sub>V</sub>1.7 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Central bicyclic core switch from benzoxazine to chroman for multiparameter optimization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30281" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30281" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The objective was to identify a potent, selective, and state-dependent Na<sub>V</sub>1.7 blocker, which will serve as a safe oral therapeutic for chronic pain. To meet this objective, we set out a target product profile with the criteria as Na<sub>V</sub>1.7 potency: IC<sub>50</sub> ≤ 10 nM; Na<sub>V</sub>1.5 selectivity: IC<sub>50</sub> > 10 μM; no significant CYP inhibition (<50% at 10 μM); no significant hERG inhibition; state-dependent block of target; acceptable oral bioavailability; significant efficacy in veratridine- and formalin-induced nociception and/or CCI-induced pain model; and ED<sub>50</sub> that allows a good therapeutic window. Initially, the SAR study was carried out on a benzoxazine core substituted with thiazole sulfonamide. Various analogs were prepared with different aryl, heteroaryl, and heterocyclyl groups as pendant substitution on the terminal phenyl ring (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Most of these compounds showed very good potency (1–10 nM) and moderate selectivity over Na<sub>V</sub>1.5. However, these compounds suffer from high CYP2C9 inhibition, poor solubility, and poor pharmacokinetic profile in spite of their good microsomal stability. Replacement of the thiazole group with different 5–6-membered heteroaryl substitutions on sulfonamide was not tolerated on this core.<a onclick="showRef(event, 'cit17e'); return false;" href="javascript:void(0);" class="ref cit17e">(17e)</a></div><div class="NLM_p">Hence, it was decided to alter the central bicyclic core. By considering multiparameter optimization such as physchem and absorption, distribution, metabolism, and excretion (ADME) properties, it was decided to explore other bicyclic systems such as chroman as the central bicyclic core, since substituted chroman analogs are expected to possess an altered conformation compared to the corresponding substituted benzoxazine analogs. We were interested to explore the role of additional sp<sup>3</sup> carbon on solubility and other ADME properties, the effect of conformational change on potency and selectivity, and the CYP inhibition profile. Herein, we report the outcome of a systematic and elaborate SAR study on multiparameter optimization of this series.</div><div class="NLM_p">First, to check the translation of potency and selectivity, a series of chroman compounds were prepared by keeping the thiazole substitution constant on sulfonamide. A range of heteroaryl, heterocyclyl, aryl, and substituted alkyl groups was tried as the pendant R group substitution on the terminal phenyl ring. The absence of the pendant R group or substitution such as −Cl, alkyl, or branched alkyl as the pendant group led to very less potent compounds. Alkoxy alkyl and fluoro alkyl of different chain lengths were found to be very potent for Na<sub>V</sub>1.7, although less selective over Na<sub>V</sub>1.5 (data not shown). Various compounds (<b>1</b>–<b>12</b>) having heteroaryl, heterocyclyl, or substituted aryl as the pendant R group were prepared and tested for their activity against Na<sub>V</sub>1.7 and Na<sub>V</sub>1.5. Since most of these compounds were prepared as racemic and then the isomers were separated by chiral column chromatography at the final stage, the potencies of both the enantiomers were tested for many compounds with different R groups, and it was consistently found that one of the isomers was significantly more potent than the other isomer. As a representation, for some of the R groups, activities of both the isomers are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The absolute stereochemistries of compounds <b>1a</b> and <b>1b</b> were determined to be “<i>S</i>” and “<i>R</i>” configurations, respectively, using vibrational circular dichroism (VCD). Determination of the absolute configuration of a few additional pairs of isomers using VCD has shown that the more potent isomer consistently possesses an α orientation (below the plane in drawn structures) of the terminal phenyl group with respect to the bicyclic central core (chroman). This finding was further confirmed without any ambiguity through a single-crystal X-ray of the sulfonamide intermediate and its conversion to the lead compounds (refer to the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00361/suppl_file/jm0c00361_si_002.pdf" class="ext-link">Supporting Information</a> for the structure and scheme).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Profile of Chroman Compounds Substituted with Thiazole Sulfonamide</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0011.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">FLIPR membrane potential assay.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Inactive refers to <10% inhibition at 10 μM.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">% Inhibition at 10 μM; NT, not tested.</p></div></div><div></div></div><div class="NLM_p">Most of the compounds showed very good potency (IC<sub>50</sub> < 10 nM) for Na<sub>V</sub>1.7; however, the selectivity over Na<sub>V</sub>1.5 was not along the expected lines (IC<sub>50</sub> > 10μM) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>)</a>. Only a few compounds with R groups such as triazole (<b>4b</b>), morpholinone <b>8</b>, and oxazolinone <b>9</b> showed very good selectivity over Na<sub>V</sub>1.5. Also, for the less active isomer, similar rightward shift of activity for the Na<sub>V</sub>1.5 subtype was observed.</div><div class="NLM_p">Very good potency and the preference of one stereoisomer over the other for activity encouraged us to explore this scaffold in depth for optimization of other properties. When we tested the solubility of these compounds, as expected, these compounds with the chiral sp<sup>3</sup> carbon showed improved solubility over the corresponding benzoxazine analogs. Then, we tested these compounds for the inhibition profile of two important CYP enzymes (3A4 and 2C9). Again, most of these thiazole compounds, in spite of the central core modification with a wide range of R group variants, showed high CYP2C9 inhibition, while CYP3A4 inhibition was not significant at 10 μM (except for compound <b>2b</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). To our disappointment, both isomers showed a similar CYP inhibition profile. The conformational difference between the isomers did not lead to any difference in the CYP inhibition profile. These trends were consistent throughout this series of compounds, where one of the isomers was found to be several fold more potent than the other isomer, but both isomers had a similar CYP inhibition profile. Next, we were interested in looking at the pharmacokinetic profile of chroman-based analogs as it was one of the challenges observed in earlier benzoxazine series. A few best compounds were tested for their pharmacokinetic profile, and to our delight, remarkable improvement in the overall PK profile was observed for chroman analogs (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Compound <b>4b</b> showed low <i>t</i><sub>1/2</sub> due to the high clearance; however, all of the three compounds <b>1b</b>, <b>4b</b>, and <b>5b</b> showed very good exposures and oral bioavailability. Modification of the central bicyclic core from benzoxazine to chroman helped in improving the solubility and pharmacokinetic profile. The SAR outcome clearly indicates that we still have two major challenges at hand, which are selectivity over Na<sub>V</sub>1.5 and CYP2C9 inhibition. For optimizing these two liabilities, we decided to modify the substitution on sulfonamide. First, we kept the pendant R group, <i>N-</i>methyl pyrazole, as a constant and tried various substituted or unsubstituted five- and six-membered heteroaryls as we attempted in the case of the benzoxazine core. The data for six-membered heteroaryl sulfonamide derivatives, <b>13</b>–<b>20</b>, is shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. To our delight, compounds <b>13</b>–<b>15</b> and <b>18</b> having 2-aminopyrimidine, 4-F-2-aminopyrimidine, 4-aminopyrimidine, and 6-F-2-aminopyridine, respectively, showed good potency and very good selectivity over Na<sub>V</sub>1.5. In addition, compounds <b>13</b> and <b>14</b> showed low levels of CYP2C9 inhibition at 10 μM (<40%) (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The potency for Na<sub>V</sub>1.7 was on the lower side for pyridazine (<b>16</b>) and pyrazine (<b>17</b>) compounds. Compounds <b>18</b>–<b>20</b>, having F-pyridines as substitution on sulfonamide, showed better selectivity over compound <b>1b</b>; however, they did not show improvement in CYP2C9 inhibition. Overall, this SAR outcome delineated a way forward to overcome both selectivity and CYP2C9 inhibition challenges while retaining the potency for Na<sub>V</sub>1.7 through modification of substitution on aryl sulfonamide of the chroman scaffold. Hence, it was decided to prepare a focused library of compounds with the best pendant R groups and four different heteroaryl substitutions on sulfonamide. The substitutions were chosen based on Na<sub>V</sub>1.7 potency, selectivity, and low CYP inhibition profile. The resultant matrix of compounds <b>21</b>–<b>50</b> showed that the SAR is not additive. The tolerability of sulfonamide substitution varies with respect to the pendant R group. In the entire matrix, most of the compounds having a heteroaryl group as the pendant group were found to be potent and selective except for compounds <b>21</b> (2-methyl oxazole is a pendant R group) and <b>25</b>–<b>27</b> (triazole is a pendant R group), with a strikingly low potency for Na<sub>V</sub>1.7 (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Compounds with p-F phenyl <b>39</b>–<b>42</b> showed a significant decrease in potency. Except for morpholine, compounds <b>43</b>–<b>46</b>, many saturated heterocyclic groups such as morpholinone (data not shown), oxazolinone (data not shown), and thiamorpholine (<b>47</b>–<b>50</b>) were not tolerated as pendant R groups for modification of thiazole on sulfonamide; a significant decrease in potency was observed like in triazole compounds. Selected potent compounds were tested for their solubility and the CYP inhibition profile. All of the compounds except for 6-fluoropyridyl sulfonamide derivatives showed very good solubility (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Most of the compounds with 6-fluoropyridyl and 4-aminopyrimidinyl substitution on the sulfonamide showed high CYP2C9 inhibition at least at 10 μM (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Poor solubility and high CYP inhibition of most of the 6-fluoropyridyl sulfonamide compounds indicate that 6-fluoropyridyl behaves the same way as thiazole on sulfonamide. Compounds with 4-F-2-aminopyrimidine substitution on the sulfonamide showed moderate to high CYP2C9 inhibition at 10 μM depending on the pendant R group. However, 2-aminopyrimidinyl sulfonamide compounds did not show significant CYP2C9 inhibition even at 10 μM, except for compound <b>43</b>, where it was found to be moderate, 54% inhibition at 10 μM (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Metabolic Rate and Pharmacokinetic Profile of Chroman Compounds in Male BALB/c Mice<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">metabolic rate (nmol/min/mg)</th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">PK IV (1 mpk)</th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">PK PO (10 mpk)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">MLM</th><th class="colsep0 rowsep0" align="center" char=".">RLM</th><th class="colsep0 rowsep0" align="center" char=".">HLM</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub><sub>last</sub></sub> (h*μM)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub><sub>1/2</sub></sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">CL (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub><sub>ss</sub></sub> (l/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub><sub>last</sub></sub> (h*μM)</th><th class="colsep0 rowsep0" align="center" char=".">%<i>F</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">95</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Vehicle: IV: DMA (10%): PEG300 (20%): 20% Captisol in NS (QS); PO: Tween80 (1%): 0.5% CMC solution (QS).</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Profile of Chroman Compounds Substituted with Different Heteroaryl Sulfonamides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0012.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0013.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">FLIPR membrane potential assay.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Inactive refers to <10% inhibition at 10 μM.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">34% inhibition at 10 μM.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Potency and Selectivity of the Focused Library of Chroman Sulfonamide Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0014.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0015.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Inactive refers to <10% inhibition at 10 μM.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">% Inhibition at 10 μM.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Solubility and CYP Profile of the Focused Library of Chroman Sulfonamide Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0016.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0017.gif" alt="" id="fx8" /></img><div></div></div><div class="NLM_p">While gaining knowledge from SAR studies on chroman series, the best combination of pendant groups and heteroaryl sulfonamide was also tried simultaneously on the indane core to understand the effect of the terminal phenyl ring trajectory on Na<sub>V</sub>1.7 inhibition. Out of these, selected examples are shown in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>. We observed good translation of SAR from chroman series to indane, except for compound <b>54</b>, wherein morpholine was a pendant R group.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Profile of Indane Compounds Substituted with Pyrimidine Sulfonamide</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0018.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0019.gif" alt="" id="fx10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">FLIPR membrane potential assay.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Inactive refers to <10% inhibition at 10 μM.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">% Inhibition at 10 μM.</p></div></div><div></div></div><div class="NLM_p">The best compounds with respect to potency for Na<sub>V</sub>1.7, selectivity over Na<sub>V</sub>1.5, good solubility, and no significant CYP inhibition at 10 μM were chosen for assessing the state-dependent blockage of Na<sub>V</sub>1.7 and Na<sub>V</sub>1.5 and the detailed in vitro ADMET profile. Data are shown for selected compounds in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Tables <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>. In the manual patch-clamp electrophysiology assay, all of the tested compounds showed state-dependent inhibition of Na<sub>V</sub>1.7; however, they did not show any use-dependent effect, which is true with known sulfonamide derivatives.<a onclick="showRef(event, 'cit17a'); return false;" href="javascript:void(0);" class="ref cit17a">(17a)</a> Compound <b>29</b> showed a resting-state block with IC<sub>50</sub> of 2.3 μM, and compound <b>43</b> showed a moderate resting-state block of 57% inhibition at 10 μM. The other three lead molecules <b>13</b>, <b>32</b>, and <b>51</b> did not show significant resting-state inhibition (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). These lead molecules exhibited low potency for the fast inactivated state of hNa<sub>V</sub>1.5 with an inhibition of <50% for the first pulse, and these values shifted up to 80% for the tenth pulse at 10 μM (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). All of the five lead molecules showed very good metabolic stability in liver microsomes across the species except for compound <b>43</b> in mice liver microsomes (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>). The chroman and indane compounds showed good permeability in the Caco-2 assay and moderate to high plasma protein binding across the species (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>). All of these compounds did not show any cytotoxicity or hERG inhibition (no to very low (<10%) inhibition) at 10 μM (data not shown).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. State-Dependent Properties of Lead Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">Na<sub>V</sub>1.7 IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" align="center">Na<sub>V</sub>1.7<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">Na<sub>V</sub>1.5 (% <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="2f664147464d465b4640416f1e1f">[email protected]</a> μM)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">slow inactivation</th><th class="colsep0 rowsep0" align="center" char="±">fast inactivation (1p)</th><th class="colsep0 rowsep0" align="center" char="±">use-dependent inhibition (25p)</th><th class="colsep0 rowsep0" align="center">resting IC<sub>50</sub> (μM) or % <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="eb8285838289829f828485abdadb">[email protected]</a> μM</th><th class="colsep0 rowsep0" align="center" char="±">fast inactivation (1p)</th><th class="colsep0 rowsep0" align="center" char="±">fast inactivation (10p)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char="±">15.9 ± 0.9</td><td class="colsep0 rowsep0" align="char" char="±">45.3 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">29.8 ± 1.23</td><td class="colsep0 rowsep0" align="left">9.5 ± 0.43 μM</td><td class="colsep0 rowsep0" align="char" char="±">34 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">64 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char="±">15.9 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">44.4 ± 2.2</td><td class="colsep0 rowsep0" align="char" char="±">34.3 ± 1.5</td><td class="colsep0 rowsep0" align="left">2.28 ± 0.28 μM</td><td class="colsep0 rowsep0" align="char" char="±">46 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">80 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char="±">39.6 ± 3.9</td><td class="colsep0 rowsep0" align="char" char="±">134 ± 8.4</td><td class="colsep0 rowsep0" align="char" char="±">108 ± 4.6</td><td class="colsep0 rowsep0" align="left">38 ± 2% @10 μM</td><td class="colsep0 rowsep0" align="char" char="±">29 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">57 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="char" char="±">35.1 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">67.4 ± 3.2</td><td class="colsep0 rowsep0" align="char" char="±">52.1 ± 2.8</td><td class="colsep0 rowsep0" align="left">57 ± 2% @10 μM</td><td class="colsep0 rowsep0" align="char" char="±">19 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">71 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="char" char="±">33 ± 2.4</td><td class="colsep0 rowsep0" align="char" char="±">99.7 ± 5.8</td><td class="colsep0 rowsep0" align="char" char="±">71 ± 4.9</td><td class="colsep0 rowsep0" align="left">∼8.1 ± 0.58 μM</td><td class="colsep0 rowsep0" align="char" char="±">40 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">65 ± 1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Manual patch-clamp EP assay; IC<sub>50</sub> values are at <i>V</i><sub>1/2</sub> of slow inactivation and fast inactivation.</p></div></div></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Metabolic Stability, Permeability, and Plasma Protein Binding of Lead Molecules</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">metabolic rate (nmol/min/mg)</th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">permeability Caco-2 Papp (nm/sec)</th><th class="rowsep1 colsep0" colspan="3" align="center">% PPB</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">MLM</th><th class="colsep0 rowsep0" align="center" char=".">RLM</th><th class="colsep0 rowsep0" align="center" char=".">DLM</th><th class="colsep0 rowsep0" align="center" char=".">MoLM</th><th class="colsep0 rowsep0" align="center" char=".">HLM</th><th class="colsep0 rowsep0" align="center" char=".">A–B</th><th class="colsep0 rowsep0" align="center" char=".">B-A</th><th class="colsep0 rowsep0" align="center">ER</th><th class="colsep0 rowsep0" align="center">mice</th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center" char=".">human</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.01</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">280</td><td class="colsep0 rowsep0" align="char" char=".">268</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">88.5</td><td class="colsep0 rowsep0" align="left">91</td><td class="colsep0 rowsep0" align="char" char=".">95.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.01</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">418</td><td class="colsep0 rowsep0" align="char" char=".">334</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">95.4</td><td class="colsep0 rowsep0" align="left">93.4</td><td class="colsep0 rowsep0" align="char" char=".">97.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">395</td><td class="colsep0 rowsep0" align="char" char=".">368</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">98</td><td class="colsep0 rowsep0" align="left">99.2</td><td class="colsep0 rowsep0" align="char" char=".">98.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">43</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">376</td><td class="colsep0 rowsep0" align="char" char=".">254</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">94.1</td><td class="colsep0 rowsep0" align="left">92.8</td><td class="colsep0 rowsep0" align="char" char=".">97.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">51</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">315</td><td class="colsep0 rowsep0" align="char" char=".">367</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">92.9</td><td class="colsep0 rowsep0" align="left">99.3</td><td class="colsep0 rowsep0" align="char" char=".">99.7</td></tr></tbody></table></div></div><div class="NLM_p">These five lead compounds were also subjected to detailed in vivo pharmacokinetic profiling in rodent and nonrodent species. All of the compounds showed very good oral bioavailability with low clearance and good <i>t</i><sub>1/2</sub> in mice, rats, and dogs (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>). These compounds showed emesis in dogs post iv and/or po dosing. This could be a species-specific phenomenon. To ensure this, the pharmacokinetic profile of compound <b>51</b> was determined following oral gavage to cynomolgus monkeys at a higher dose of 150 mg/kg to a group of six animals (3 male and 3 female). No emesis was observed. The mean <i>T</i><sub>max</sub> values were found to be 2.0 and 1.5 h in males and females, respectively. The mean <i>C</i><sub>max</sub> and AUC<sub>last</sub> were found to be similar in males (66 ± 8 μM and 684 ± 122 h* μM) and females (69 ± 5 μM and 601 ± 12 h* μM), suggesting no gender difference.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Pharmacokinetic Profile of Lead Molecules<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">IV (1 mpk)</th><th class="rowsep1 colsep0" colspan="3" align="center">PO (10 mpk)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center">AUC<sub><sub>last</sub></sub> (h*μM)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub><sub>1/2</sub></sub> (h)</th><th class="colsep0 rowsep0" align="center">CL (mL/min/kg)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub><sub>ss</sub></sub> (l/kg)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center">AUC<sub><sub>last</sub></sub> (h*μM)</th><th class="colsep0 rowsep0" align="center">%<i>F</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">13</td><td class="colsep0 rowsep0" align="left">mice</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">4.2</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">107</td><td class="colsep0 rowsep0" align="left">89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">2.2 ± 0.2</td><td class="colsep0 rowsep0" align="left">11 ± 3</td><td class="colsep0 rowsep0" align="left">4.2 ± 1</td><td class="colsep0 rowsep0" align="left">3 ± 0.8</td><td class="colsep0 rowsep0" align="left">0.9 ± 0.1</td><td class="colsep0 rowsep0" align="left">13 ± 6</td><td class="colsep0 rowsep0" align="left">114 ± 45</td><td class="colsep0 rowsep0" align="left">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog*</td><td class="colsep0 rowsep0" align="left">6.9 ± 1</td><td class="colsep0 rowsep0" align="left">59 ± 20</td><td class="colsep0 rowsep0" align="left">7.8 ± 3.8</td><td class="colsep0 rowsep0" align="left">0.5 ± 0.3</td><td class="colsep0 rowsep0" align="left">0.3 ± 0</td><td class="colsep0 rowsep0" align="left">10 ± 1.7</td><td class="colsep0 rowsep0" align="left">117 ± 41</td><td class="colsep0 rowsep0" align="left">40 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">29</td><td class="colsep0 rowsep0" align="left">mice</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">3.2</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">171</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">1.7 ± 0.5</td><td class="colsep0 rowsep0" align="left">15 ± 2</td><td class="colsep0 rowsep0" align="left">9.8 ± 5</td><td class="colsep0 rowsep0" align="left">2 ± 0</td><td class="colsep0 rowsep0" align="left">1.2 ± 0.4</td><td class="colsep0 rowsep0" align="left">6.6 ± 1.8</td><td class="colsep0 rowsep0" align="left">111 ± 29</td><td class="colsep0 rowsep0" align="left">74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog*</td><td class="colsep0 rowsep0" align="left">5.7 ± 0.7</td><td class="colsep0 rowsep0" align="left">70 ± 13</td><td class="colsep0 rowsep0" align="left">24 ± 4</td><td class="colsep0 rowsep0" align="left">0.3 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.5 ± 0</td><td class="colsep0 rowsep0" align="left">14 ± 2</td><td class="colsep0 rowsep0" align="left">218 ± 87</td><td class="colsep0 rowsep0" align="left">78 ± 22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">32</td><td class="colsep0 rowsep0" align="left">mice</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">7.6</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">63</td><td class="colsep0 rowsep0" align="left">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">2.6 ± 0.2</td><td class="colsep0 rowsep0" align="left">5.5 ± 0.8</td><td class="colsep0 rowsep0" align="left">1.9 ± 0.3</td><td class="colsep0 rowsep0" align="left">5.5 ± 0.9</td><td class="colsep0 rowsep0" align="left">0.8 ± 0.1</td><td class="colsep0 rowsep0" align="left">19 ± 6</td><td class="colsep0 rowsep0" align="left">112 ± 11</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog*</td><td class="colsep0 rowsep0" align="left">6.5 ± 1</td><td class="colsep0 rowsep0" align="left">19 ± 10</td><td class="colsep0 rowsep0" align="left">2.5 ± 0.6</td><td class="colsep0 rowsep0" align="left">2 ± 1</td><td class="colsep0 rowsep0" align="left">0.4 ± 0.1</td><td class="colsep0 rowsep0" align="left">8.5 ± 3</td><td class="colsep0 rowsep0" align="left">50 ± 30</td><td class="colsep0 rowsep0" align="left">51 ± 16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="3" align="left">43</td><td class="colsep0 rowsep0" align="left">mice</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">0.81</td><td class="colsep0 rowsep0" align="left">9.6</td><td class="colsep0 rowsep0" align="left">62</td><td class="colsep0 rowsep0" align="left">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.2</td><td class="colsep0 rowsep0" align="left">5.9 ± 0.6</td><td class="colsep0 rowsep0" align="left">2.8 ± 0.2</td><td class="colsep0 rowsep0" align="left">5.1 ± 0.4</td><td class="colsep0 rowsep0" align="left">1.2 ± 0.1</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.5</td><td class="colsep0 rowsep0" align="left">19 ± 3</td><td class="colsep0 rowsep0" align="left">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">4.9 ± 1</td><td class="colsep0 rowsep0" align="left">48 ± 1</td><td class="colsep0 rowsep0" align="left">11 ± 2</td><td class="colsep0 rowsep0" align="left">0.5 ± 0</td><td class="colsep0 rowsep0" align="left">0.5 ± 0</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">51</td><td class="colsep0 rowsep0" align="left">mice</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">8.5</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left">99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">2.5 ± 0.5</td><td class="colsep0 rowsep0" align="left">7.9 ± 5</td><td class="colsep0 rowsep0" align="left">2.7 ± 0.3</td><td class="colsep0 rowsep0" align="left">4.9 ± 2.6</td><td class="colsep0 rowsep0" align="left">1.0 ± 0.3</td><td class="colsep0 rowsep0" align="left">10.9 ± 0.7</td><td class="colsep0 rowsep0" align="left">46 ± 7</td><td class="colsep0 rowsep0" align="left">58</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last">Vehicle (mouse, rat, and dog): IV: DMA (10%): PEG300 (20%): 20% Captisol in NS (q.s.); PO: Tween80 (1%): 0.5% CMC solution (QS) *PO at 5 mpk and emesis observed in all cases; nd, not done.</p></div></div></div><div class="NLM_p">Taken together, systematic SAR studies on chroman series for parallel optimization of several parameters (as summarized in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) led to the identification of many novel, potent, and selective Na<sub>V</sub>1.7 inhibitors with good solubility and good pharmacokinetic profile in rodent and nonrodent species devoid of any significant CYP inhibition, which is a major liability observed in many known Na<sub>V</sub>1.7 inhibitors. Based on the overall profile of lead molecules, all of the lead molecules <b>13</b>, <b>29</b>, <b>32</b>, <b>43</b>, and <b>51</b> were tested for efficacy at 30 mpk p.o. dose to understand the translation of in vitro potency to in vivo efficacy in different pain models of mice. We used the in-house-developed veratridine-induced pain model in mice as a primary model to assess the target engagement of Na<sub>V</sub>1.7. Veratridine acts as a neurotoxin and binds to voltage-gated sodium channels, leading to persistent activation, and inhibits transitioning into the inactivated state, thus stimulating a pain response.<a onclick="showRef(event, 'cit9a'); return false;" href="javascript:void(0);" class="ref cit9a">(9a)</a> Compounds were administered orally 30 min prior to subplanter injection of veratridine. All of these compounds demonstrated statistically significant reduction in time spent in nociceptive behavior (time spent in licking and/or flinching) post veratridine injection at 30 mpk po dose, compared to the vehicle. Second, the formalin-induced inflammatory pain model was used as an efficacy model. In this model, formalin generates a biphasic pain response, an acute phase (or phase I) reflective of direct activation of nociceptors and a tonic phase (or phase II) related to inflammatory responses.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Lead compounds were administered orally at 30 mpk dose 30 min prior to formalin challenge. The total time spent in nociceptive behavior at 0–5 min (phase I) and 10–40 min intervals (phase II) for each mouse was measured, and it was found that all of the tested compounds showed a profound effect on decrease in nociceptive behavior in phase II. The brain exposures of compounds <b>13</b>, <b>29</b>, <b>32</b>, and <b>43</b> were measured from the PK-PD study at 30 mpk dose (at 75 min post dose of compounds) and found to be minimal (<1 μM) with 0.5, 1.8, 0.7, and 4.5%, respectively, of the plasma exposure, whereas for compound <b>51</b>, the brain exposure was estimated to be 2.1 μM, which is 7% of the plasma exposure. When these lead molecules were assessed at 30 mpk oral dose in the CCI-induced neuropathic pain model in mice,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> to our surprise, only compounds <b>29</b> and <b>51</b> showed the effect on the paw-withdrawal threshold (mechanical allodynia) using von Frey filaments (data not shown). However, compounds <b>29</b>, <b>32</b>, and <b>43</b> were not chosen for further profiling due to the resting-state block of compounds <b>29</b> and <b>43</b> and the relatively inferior PK (low <i>t</i><sub>1/2</sub> in both rodent and nonrodent) profile of compound <b>32</b>. The two best compounds <b>13</b> and <b>51</b> based on the overall profile were chosen for dose-response studies. Compound <b>13</b> showed a flat dose-response in the veratridine-induced pain model at 3, 10, and 30 mpk p.o. doses. However, in the formalin-induced inflammatory pain model, compound <b>13</b> demonstrated a very good dose-dependent reversal of nociceptive effects in the acute phase of the experiment (phase I) and the tonic phase of the experiment (phase II) at 3, 10, and 30 mpk p.o. doses, compared to vehicle-treated animals, with statistically significant reversal of nociceptive pain at all of the doses in the tonic phase (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Plasma concentrations were measured at the end of the study, and the unbound drug concentration was determined to be 0.728 μM at 3 mpk dose, which is 22-fold higher than the mNa<sub>V</sub>1.7 IC<sub>50</sub> (32.6 ± 1.6 nM). Compound <b>13</b> did not show any effect even at 100 mpk dose in the CCI-induced neuropathic pain model. However, compound <b>51</b> demonstrated a dose-dependent reduction in nociceptive effects in both the veratridine-induced pain model and the formalin-induced inflammatory pain model at 3, 10, and 30 mpk, p.o. doses, compared to vehicle-treated animals (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Plasma concentrations were measured at the end of the formalin study, and the unbound drug concentration was determined to be 0.343 μM at 3 mpk dose, which is 10-fold above the mNa<sub>V</sub>1.7 IC<sub>50</sub> (33 ± 1.8 nM). Compound <b>51</b> also showed a significant effect on the CCI-induced neuropathic pain model at 100 mpk p.o. dose (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overall SAR summary of the chroman series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of compound <b>13</b> in different pain models in mice; (a) dose-response effect at 3, 10, and 30 mpk, p.o. on veratridine-induced nociceptive behaviors; (b) dose-response effect at 3, 10, and 30 mpk, p.o. on phases I and II of formalin-induced nociceptive behaviors. Results are presented as the mean ± standard error of the mean (SEM) response (<i>n</i> = 8–10/group) and were analyzed by one-way analysis of variance (ANOVA) followed by Dunnett’s post hoc tests; **<i>P</i> < 0.01, ***<i>P</i> < 0.001, compared to the respective vehicle group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of compound <b>51</b> in different pain models in mice; (a) dose-response effect at 3, 10, and 30 mpk, p.o. on veratridine-induced nociceptive behaviors; (b) dose-response effect at 3, 10, and 30 mpk, p.o. on phases I and II of formalin-induced nociceptive behaviors; (c) response of compound <b>51</b> at 100 mpk, p.o. in CCI-induced allodynia. Gabapentine (60 mpk, ip) was used as the positive control. Results are presented as the mean ± SEM response (<i>n</i> = 10–13/group) and were analyzed by one-way ANOVA followed by Dunnett’s post hoc tests; **<i>P</i> < 0.01, ***<i>P</i> < 0.001, compared to the respective vehicle group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Having identified compound <b>51</b> as a highly desirable lead compound over compound <b>13</b> due to its efficacy in both inflammatory and neuropathic pain models, compound <b>51</b> was chosen for testing potency across rodent and nonrodent species and for extensive selectivity profiling across human Na<sub>V</sub> channel subtypes. In the manual patch-clamp electrophysiology assay, compound <b>51</b> exhibited state-dependent block of human, monkey, and mouse Na<sub>V</sub>1.7 with a similar potency range (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>). Pleasingly, it also showed good selectivity against other Na<sub>V</sub> isoforms and minimal inhibition at 10 μM for the resting state across different Na<sub>V</sub> isoforms (<a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a></a>). Further, no significant inhibition was observed at 10 μM in the Eurofins CEREP ExpresS panel of 55 targets including GPCRs, other ion channels, and transporters.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. State-Dependent Block of Compound <b>51</b> across Species for Na<sub>V</sub>1.7</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">IC<sub>50</sub> (nM)/% inhibition<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">state</th><th class="colsep0 rowsep0" align="center" char="±">human</th><th class="colsep0 rowsep0" align="center" char="±">monkey</th><th class="colsep0 rowsep0" align="center" char="±">mouse</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">slow inactivation</td><td class="colsep0 rowsep0" align="char" char="±">33 ± 2.4</td><td class="colsep0 rowsep0" align="char" char="±">60 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">33 ± 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">fast inactivation (1P)</td><td class="colsep0 rowsep0" align="char" char="±">99.7 ± 5.8</td><td class="colsep0 rowsep0" align="char" char="±">195 ± 11</td><td class="colsep0 rowsep0" align="char" char="±">118 ± 12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">use dependence (25P)</td><td class="colsep0 rowsep0" align="char" char="±">71 ± 4.9</td><td class="colsep0 rowsep0" align="char" char="±">145 ± 13</td><td class="colsep0 rowsep0" align="char" char="±">89 ± 4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">resting</td><td class="colsep0 rowsep0" align="char" char="±">∼8.1 ± 0.58 μM</td><td class="colsep0 rowsep0" align="char" char="±">31 ± 3% @10 μM</td><td class="colsep0 rowsep0" align="char" char="±">36 ± 1% @10 μM</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup><sup>a</sup></sup><p class="last">Manual patch-clamp EP assay; IC<sub>50</sub> values are at <i>V</i><sub>1/2</sub> of slow inactivation and fast inactivation.</p></div></div></div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Selectivity of Compound <b>51</b> over Other Na<sub>V</sub> Isoforms</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="8" align="center">% inhibition at 10 μM<a class="ref internalNav" href="#t11fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">hNa<sub>V</sub>1.1</th><th class="colsep0 rowsep0" align="center" char="±">hNa<sub>V</sub>1.2</th><th class="colsep0 rowsep0" align="center" char="±">hNa<sub>V</sub>1.3</th><th class="colsep0 rowsep0" align="center" char="±">hNa<sub>V</sub>1.4</th><th class="colsep0 rowsep0" align="center" char="±">hNa<sub>V</sub>1.5</th><th class="colsep0 rowsep0" align="center" char="±">hNa<sub>V</sub>1.6</th><th class="colsep0 rowsep0" align="center" char="±">hNa<sub>V</sub>1.8</th><th class="colsep0 rowsep0" align="center">hNa<sub>V</sub>1.9</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">resting state (1st pulse)</td><td class="colsep0 rowsep0" align="left">8 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">13 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">6 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">7.7 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">10 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">32 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">3 ± 1</td><td class="colsep0 rowsep0" align="left">6 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">inactivated state (2nd pulse)</td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="char" char="±">7.1 ± 1.1 μM (IC<sub>50</sub>)</td><td class="colsep0 rowsep0" align="char" char="±">51 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">8.1 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="±">40 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">59 ± 2</td><td class="colsep0 rowsep0" align="char" char="±">27 ± 2</td><td class="colsep0 rowsep0" align="left">Not done</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t11fn1"><div class="footnote" id="t11fn1"><sup><sup>a</sup></sup><p class="last">Manual patch-clamp EP assay; second pulse at <i>V</i><sub>1/2</sub> of inactivation.</p></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10058" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10058" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Synthesis of chroman sulfonamide derivatives started with 7-bromochroman-4-one <b>55</b>. A palladium-catalyzed thiolation<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> converted <b>55</b> to 7-(benzylthio)chroman-4-one <b>56</b>. The palladium-catalyzed Barluenga reaction<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> was used for the elaboration of the chroman ring at the 4-position with various substituted phenyl groups (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). To convert the 7-(benzylthio)chroman-4-one <b>56</b> to a suitable substrate for the Barluenga reaction,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> tosylhydrazide <b>57</b> was prepared from <b>56</b> and then coupled with 2-substituted 1-bromo-4-(trifluoromethyl)benzene <b>58a,b</b> to get 7-(benzylthio)-4-substituted-2<i>H</i>-chromene <b>59a,b</b>. The thiobenzyl group was then oxidized in situ to the sulfonyl chloride using sulfuryl chloride and then converted to the stable 2<i>H</i>-chromene-7-sulfonates <b>60a,b</b>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1</b>, <b>4</b>, <b>13</b>–<b>20</b>, and <b>25</b>–<b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) BnSH, Pd<sub>2</sub>(dba)<sub>3</sub>, (<i><sup>i</sup></i>Pr)<sub>2</sub>NEt, 80 °C, 1 h, 60%; (b) tosylhydrazide, MeOH, 80 °C, 16 h, 94%; (c) Na<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub>(dppf)·DCM, dioxane-H<sub>2</sub>O (85:15), 100 °C, 5–8 h 47–76%; (d) (i) SO<sub>2</sub>Cl<sub>2</sub>, AcOH, cat. H<sub>2</sub>O, dichloromethane (DCM), −5 °C, 1 h; (ii) pentafluorophenol, Et<sub>3</sub>N, DCM, 0 °C, 1 h, 60–71%; (e) H<sub>2</sub> (3 atm), 10% Pd-C, EtOAc, 4–6 h, room temperature (rt), 83–94%; (f) (i) HetArNH<sub>2</sub>, LiHMDS (1 M in tetrahydrofuran (THF)), 0 °C to rt, 1–2 h; (ii) chiral separation, 9–44%.</p></p></figure><div class="NLM_p">The double bond was then reduced to generate the chiral center of the 4-substituted chroman ring <b>61a,b</b> using hydrogen in the presence of 10% Pd-C. The racemic compounds <b>61a,b</b> were then reacted with various heteroaryl amines in the presence of LiHMDS to give the final sulfonamide derivatives. At this stage, the enantiomers of the individual compounds were separated by preparative chiral HPLC to obtain chirally pure active isomers of chroman compounds <b>1, 4, 13</b>–<b>20</b>, and <b>25</b>–<b>28</b>.</div><div class="NLM_p">Alternatively, intermediate <b>56</b> was first oxidized in situ to the corresponding sulfonyl chloride with <i>N</i>-chlorosuccinimide and then converted to the stable pentafluoroester <b>62</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). This ester was converted to the tosylhydrazide <b>63</b> and then coupled with various 2-substituted 1-bromo-4-(trifluoromethyl)benzene <b>58c–m</b> to give the 2H-chromene-7-sulfonates <b>60c–m</b>. The double bond was reduced to get the racemic 4-substituted chroman compounds <b>61c–m</b> using hydrogen in the presence of 10% Pd-C (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Either the enantiomers were separated at this step and the purified enantiomers were separately reacted with various heteroaryl amines in the presence of LiHMDS to give the final sulfonamide compounds or the amine addition reactions were done on the racemic <b>61c–m</b> and then the enantiomers of the final compounds were separated by preparative chiral HPLC.</div><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>2–3</b>, <b>5–12</b>, <b>21–24</b>, <b>29</b>–<b>31</b>, and <b>36</b>–<b>50</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NCS, AcOH-H<sub>2</sub>O (4:1), 0 °C to rt, 45 min; (ii) pentafluorophenol, Et<sub>3</sub>N, DCM, 0 °C, 45 min, 65%; (b) tosylhydrazide, MeOH, 80 °C, 16 h, 94%; (c) Na<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub>(dppf)·DCM, dioxane-H<sub>2</sub>O (85:15), 100 °C, 1–2 h, 38–61%; (d) H<sub>2</sub> (3 atm), 10% Pd-C, EtOAc, 4–6 h, rt, 50–90%; (e) (i) HetArNH<sub>2</sub>, LiHMDS (1 M in THF), 0 °C to rt, 1–2 h, 9–69%; (ii) chiral separation; (f) HCHO, AcOH cat., NaBH(OAc)<sub>3</sub>, 16 h, 79%.</p></p></figure><div class="NLM_p">Compounds <b>32</b>–<b>35</b> were synthesized from (<i>S</i>)-enantiomer of <b>61l</b> (obtained by separation of the enantiomers of racemic <b>61l</b> using the chiral column) following the reaction sequence as shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Suzuki coupling of <b>61l</b>(<i>S</i>) with 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine gave the pentafluoro intermediate <b>61n</b>, which was then converted to the final sulfonamide compounds <b>32</b>–<b>35</b> using different heteroaryl amines as described in an earlier scheme.</div><figure id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of Compounds <b>32</b>–<b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) [(<i>t</i>-Bu)<sub>3</sub>PH]BF<sub>4</sub>, PdCl<sub>2</sub>(dppf)·DCM, 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, dioxane, 100 °C, 2 h, 91%; (b) HetArNH<sub>2</sub>, LiHMDS (1 M in THF), 0 °C to rt, 1–2 h, 9–78%.</p></p></figure><div class="NLM_p"><a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> depicts the reaction sequence for the synthesis of the indane sulfonamide derivatives, and the transformations were carried out following the same chemistry already described for the chroman sulfonamide compounds in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The starting material in this case was 5-(benzylthio)-2,3-dihydro-1<i>H</i>-inden-1-one <b>64</b>. The keto compound was first converted to the tosylhydrazide <b>65</b> followed by coupling with either 1-bromo-2-chloro-4-(trifluoromethyl)benzene <b>58l</b> or 4-(2-bromo-5-(trifluoromethyl)phenyl) morpholine <b>58m</b> to give the substituted 1<i>H</i>-indene compounds <b>66a</b> and <b>66b</b>, respectively. The thiobenzyl group of <b>66a,b</b> was then oxidized in situ to the sulfonyl chloride with <i>N</i>-chlorosuccinimide and then converted to the stable 1<i>H</i>-indene pentafluoroester <b>67a,b</b> which on reduction provided the racemic indane derivatives <b>68a,b</b>. The pentafluoroester derivative <b>68a</b> was then reacted with <i>N</i>-(2,4-dimethoxybenzyl)pyrimidin-2-amine in the presence of LiHMDS to give the sulfonamide derivative <b>69</b>. The racemic compound <b>69</b> was converted to the final compounds <b>51</b>–<b>53</b> by Suzuki coupling with the respective boronic acids or esters, followed by deprotection of the dimethoxybenzyl group on the sulfonamide and separation of the racemic compounds into the required enantiomers by preparative chiral high-performance liquid chromatography (HPLC). Compound <b>54</b> with the morpholine side chain was obtained from <b>68b</b> by the base-mediated reaction with pyrimidin-2-amine and subsequent separation of the (<i>S</i>)-enantiomer by preparative chiral HPLC.</div><figure id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Compounds <b>51</b>–<b>54</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) tosylhydrazide, MeOH, 80 °C, 16 h, 90%; (b) Na<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub>(dppf)·DCM, dioxane-H<sub>2</sub>O (85:15), 100 °C, 4–6 h, 51–58%; (c) (i) NCS, AcOH-H<sub>2</sub>O (4:1), 0 °C to rt, 45 min; (ii) pentafluorophenol, Et<sub>3</sub>N, DCM, 0 °C, 45 min, 53–55%; (d) H<sub>2</sub> (1 atm), 10% Pd-C, EtOAc, rt, 16 h, 87–91%; (e) <i>N</i>-(2,4-dimethoxybenzyl)pyrimidin-2-amine (for <b>68a</b>) or pyrimidin-2-amine (for <b>68b</b>) LiHMDS (1 M in THF), 0 °C to rt, 1–2 h, 35–55%; chiral separation for <b>54</b>; (f) (i) [(<i>t</i>-Bu)<sub>3</sub>PH]BF<sub>4</sub>, PdCl<sub>2</sub>(dppf)·DCM, heteroarylboronic acid, dioxane, 100 °C, 1–2 h; (ii) trifluoroacetic acid (TFA), DCM, rt; (iii) chiral separation, 23–39%.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25737" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25737" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Chroman-based sulfonamide derivatives have been identified as potent, selective, and state-dependent Na<sub>V</sub>1.7 inhibitors with very good PK and a low CYP inhibition profile through systematic SAR studies and a parallel optimization approach. Switching from the benzoxazine scaffold to a chroman bicyclic system with an sp<sup>3</sup> chiral carbon led to significant improvement in solubility and the overall pharmacokinetic profile. Replacement of thiazole with other heteroaryl substitutions on sulfonamide was tolerated on the chroman core with many pendant groups and also resulted in significant improvement in selectivity over Na<sub>V</sub>1.5 and lowered CYP2C9 inhibition. It is important to note that the modification of heteroaryl substitution on sulfonamide led to a steep decrease in activity on many other scaffolds.<a onclick="showRef(event, 'cit17b cit18b cit19a'); return false;" href="javascript:void(0);" class="ref cit17b cit18b cit19a">(17b,18b,19a)</a> Two major challenges were addressed with this one modification on sulfonamide; however, extensive SAR studies with synthesis of a large number of NCEs in a library fashion were conducted to identify lead molecules with a defined target product profile since the SAR was not additive. Also, good translation of SAR was observed on a similar bicyclic system such as the indane core. More importantly, the lead molecules <b>13</b>, <b>29</b>, <b>32</b>, <b>43</b>, and <b>51</b> showed favorable PK profiles in both rodent and nonrodent species and robust efficacy of translation in veratridine-induced pain and formalin-induced inflammatory pain models in mice. However, to our surprise, only selected leads showed efficacy in the CCI-induced neuropathic pain model in mice. Finally, the detailed characterization of compound <b>51</b> indicated that it has the desired properties for further evaluation as a therapeutic agent for pain.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35218" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35218" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Chemistry</h3><div class="NLM_p">All reagents were purchased from commercial suppliers and used without purification unless otherwise noted. All anhydrous reactions were performed under a nitrogen atmosphere using dry solvents. Silica gel column chromatography was carried out on ISCO CombiFlash Companion with prepacked columns. Nuclear magnetic resonance (<sup>1</sup>H & <sup>13</sup>C NMR) spectra were recorded on a Bruker AvanceV-III 400 MHz spectrometer. All spectra were determined in the solvents indicated, and chemical shifts are reported in δ units downfield from the internal standard tetramethylsilane (TMS) with interproton coupling constants reported in hertz (Hz). All NMR spectra were analyzed using MestReNova 10.0 program software. Liquid chromatography–mass spectrometry (LCMS) analyses were performed either on an Agilent 1200 Series LC instrument coupled to an Agilent Iontrap MS instrument or on a Thermo Scientific Accela LC instrument coupled to a Thermo Scientific MSQ Plus instrument. Preparative HPLC was performed on a Gilson GX 281 series using a YMC ODS-A column or a YMC Triat column (50 mm × 250 mm, 10 μm) using either acid-modified (0.1% formic acid) or base-modified (0.1% NH<sub>4</sub>OH) MeCN-H<sub>2</sub>O gradients. Most of the final compounds were prepared as a racemic mixture and separated using preparative chiral HPLC at the final or prefinal stage. Preparative chiral separations and enantiomeric purity determination were carried out using the Knauer Azura 2.1L purification system with different columns and mobile phases. Methods and conditions for chiral separation of all of the relevant compounds are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00361/suppl_file/jm0c00361_si_002.pdf" class="ext-link">Supporting Information</a>. Compound purity was determined by reverse-phase HPLC performed on an Agilent 1290 Infinity equipped with either a Zorbax Eclipse Plus C18, 50 mm × 2.1 mm, 1.8 μm column or an Acquity Beh C18, 50 mm × 2.1 mm, 1.7 μm column using either acid-modified (0.1% formic acid) or base-modified (0.1% NH<sub>4</sub>OH) MeCN-H<sub>2</sub>O gradients. Purity of the final compounds was determined by HPLC and was greater than 95% for all of the compounds except for compounds <b>23</b> (94%), <b>42</b> (94%), and <b>45</b> (93%). The synthetic procedures and the analytical data for the intermediates <b>58a–m</b> are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00361/suppl_file/jm0c00361_si_002.pdf" class="ext-link">Supporting Information</a>.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>S</i> & <i>R</i>)-4-(2-(1-Methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(thiazol-2-yl)chromane-7-sulfonamide (<b>1a</b> and <b>1b</b>)</h4><div class="NLM_p last">Thiazol-2-amine (25.5 g, 255 mmol) was dissolved in 2 L of THF, the solution was cooled to 0 °C, and a 1 M solution of LiHMDS (242 mL, 242 mmol) was added to it slowly. After the addition, the solution was stirred for 20 min, after which a solution of perfluorophenyl 4-(2-(1-methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)chroman-7-sulfonate (77 g, 127 mmol) (<b>61a</b>) in THF was added; the reaction mixture was then allowed to stir for 1.5 h, after which it was quenched by the addition of 2 N HCl solution, and the reaction mixture was finally extracted with ethyl acetate. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated, and the crude was purified on an 800 g Sepaflash column to obtain the racemic product (46 g, 70%). The racemic product was purified on chiral prep HPLC to obtain the <i>R</i> and <i>S</i> enantiomers (19 g each, 29%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.77 (s, 1H), 7.78 (d, <i>J</i> = 8.4 Hz, 1H), 7.75 (s, 1H), 7.55 (d, <i>J</i> = 1.8 Hz, 1H), 7.32–7.25 (m, 2H), 7.22–7.15 (m, 2H), 6.92–6.78 (m, 2H), 6.47 (d, <i>J</i> = 1.9 Hz, 1H), 4.28–4.19 (m, 1H), 4.19–4.06 (m, 2H), 3.70 (s, 3H), 2.19–2.05 (m, 1H), 2.05–1.89 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 520.88 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>S</i> & <i>R</i>)-<i>N</i>-(Thiazol-2-yl)-4-(2-(thiazol-2-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonamide (<b>2a</b> and <b>2b</b>)</h4><div class="NLM_p last">They were synthesized from perfluorophenyl 4-(2-(thiazol-2-yl)-4-(trifluoromethyl)phenyl)chroman-7-sulfonate (<b>61d</b>) by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomers (yield = 23%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.77 (s, 1H), 8.10–7.93 (m, 3H), 7.80 (d, <i>J</i> = 8.3 Hz, 1H), 7.35–7.27 (m, 2H), 7.23–7.16 (m, 2H), 6.93–6.80 (m, 2H), 5.05 (t, <i>J</i> = 7.1 Hz, 1H), 4.31–4.11 (m, 2H), 2.29–2.21 (m, 1H), 2.15–2.04 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 523.95 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>S</i> & <i>R</i>)-4-(2-(2-Methyloxazol-4-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(thiazol-2-yl)chromane-7-sulfonamide (<b>3a</b> and <b>3b</b>)</h4><div class="NLM_p last">They were synthesized from perfluorophenyl 4-(2-(2-methyloxazol-4-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61c</b>) by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomers (yield = 30%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.78 (s, 1H), 8.44 (s, 1H), 8.00 (d, <i>J</i> = 2.1 Hz, 1H), 7.64 (dd, <i>J</i> = 8.2, 2.1 Hz, 1H), 7.33–7.23 (m, 1H), 7.23–7.18 (m, 2H), 7.15 (d, <i>J</i> = 8.3 Hz, 1H), 6.83 (d, <i>J</i> = 6.7 Hz, 2H), 4.88 (t, <i>J</i> = 6.7 Hz, 1H), 4.30–4.10 (m, 2H), 2.52 (s, 3H), 2.40–2.24 (m, 1H), 2.09–1.94 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 521.82 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>S</i> & <i>R</i>)-4-(2-(1<i>H</i>-1,2,3-Triazol-1-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(thiazol-2-yl)chromane-7-sulfonamide (<b>4a</b> and <b>4b</b>)</h4><div class="NLM_p last">They were synthesized from perfluorophenyl 4-(2-(1<i>H</i>-1,2,3-triazol-1-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61b</b>) by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomers (yield = 24%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.77 (s, 1H), 8.68 (s, 1H), 8.03 (s, 1H), 7.98 (d, <i>J</i> = 2.0 Hz, 1H), 7.91 (d, <i>J</i> = 7.3 Hz, 1H), 7.41 (d, <i>J</i> = 8.3 Hz, 1H), 7.27 (d, <i>J</i> = 4.7 Hz, 1H), 7.23–7.15 (m, 2H), 6.90 (d, <i>J</i> = 8.0 Hz, 1H), 6.84 (d, <i>J</i> = 4.6 Hz, 1H), 4.29–4.17 (m, 1H), 4.18–4.07 (m, 1H), 3.99 (t, <i>J</i> = 7.1 Hz, 1H), 2.23–2.13 (m, 1H), 2.09–1.97 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 508.06 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>S</i> & <i>R</i>)-4-(2-(6-Fluoropyridin-3-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(thiazol-2-yl)chromane-7-sulfonamide (<b>5a</b> and <b>5b</b>)</h4><div class="NLM_p last">They were synthesized from perfluorophenyl 4-(2-(6-fluoropyridin-3-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61e</b>) by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomers (yield = 45%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.77 (s, 1H), 8.38 (d, <i>J</i> = 2.5 Hz, 1H), 8.15 (td, <i>J</i> = 8.2, 2.5 Hz, 1H), 7.74 (d, <i>J</i> = 8.3 Hz, 1H), 7.68 (s, 1H), 7.32 (dd, <i>J</i> = 8.5, 2.7 Hz, 1H), 7.30–7.23 (m, 2H), 7.22–7.14 (m, 2H), 6.91 (d, <i>J</i> = 8.0 Hz, 1H), 6.84 (d, <i>J</i> = 4.6 Hz, 1H), 4.29–4.16 (m, 2H), 4.11 (t, <i>J</i> = 9.9 Hz, 1H), 2.18–2.08 (m, 1H), 2.05–1.95 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 536.01 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>R</i>)-4-(2-(5-Fluoropyridin-2-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(thiazol-2-yl)chromane-7-sulfonamide (<b>6</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(5-fluoropyridin-2-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61f</b>) by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 42%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.76 (s, 1H), 8.70 (d, <i>J</i> = 2.9 Hz, 1H), 7.97–7.85 (m, 1H), 7.84–7.63 (m, 3H), 7.30–7.23 (m, 2H), 7.22–7.14 (m, 2H), 6.91–6.77 (m, 2H), 4.63–4.48 (m, 1H), 4.33–4.18 (m, 1H), 4.16–4.03 (m, 1H), 2.22–2.10 (m, 1H), 2.08–1.94 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 536.07 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>S</i> & <i>R</i>)-4-(4′-Fluoro-5-(trifluoromethyl)-[1,1′-biphenyl]-2-yl)-<i>N</i>-(thiazol-2-yl)chromane-7-sulfonamide (<b>7a</b> and <b>7b</b>)</h4><div class="NLM_p last">They were synthesized from perfluorophenyl 4-(4′-fluoro-5-(trifluoromethyl)-[1,1′-biphenyl]-2-yl)chromane-7-sulfonate (<b>61g</b>) by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomers (yield = 35%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.76 (s, 1H), 7.68 (d, <i>J</i> = 8.3 Hz, 1H), 7.58–7.49 (m, 3H), 7.32 (t, <i>J</i> = 8.7 Hz, 2H), 7.26–7.13 (m, 4H), 6.85 (d, <i>J</i> = 8.0 Hz, 1H), 6.77 (d, <i>J</i> = 4.5 Hz, 1H), 4.35–4.13 (m, 2H), 4.07 (t, <i>J</i> = 10.8 Hz, 1H), 2.14–2.05 (m, 1H), 2.05–1.94 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 534.94 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>R</i>)-4-(2-(3-Oxomorpholino)-4-(trifluoromethyl)phenyl)-<i>N</i>-(thiazol-2-yl)chroman-7-sulfonamide (<b>8</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl (<i>R</i>)-4-(2-(3-oxomorpholino)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61h</b>) by following an analogous procedure described for <b>1a</b> and <b>1b</b> (yield = 41%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.77 (s, 1H), 7.87 (s, 1H), 7.66 (t, <i>J</i> = 7.0 Hz, 1H), 7.27 (d, <i>J</i> = 4.5 Hz, 1H), 7.19 (dt, <i>J</i> = 16.3, 8.9 Hz, 3H), 6.97–6.75 (m, 2H), 4.43–4.21 (m, 5H), 4.04 (q, <i>J</i> = 4.7, 3.7 Hz, 2H), 3.89 (d, <i>J</i> = 9.1 Hz, 1H), 3.58 (dd, <i>J</i> = 27.7, 11.7 Hz, 1H), 2.30–2.16 (m, 1H), 2.06–1.96 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 624.21 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>R</i>)-4-(2-(2-Oxooxazolidin-3-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(thiazol-2-yl)chromane-7-sulfonamide (<b>9</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(2-oxooxazolidin-3-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61i</b>) by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 23%).<sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.77 (s, 1H), 7.99 (s, 1H), 7.67 (d, <i>J</i> = 8.3 Hz, 1H), 7.34–7.10 (m, 4H), 6.84 (t, <i>J</i> = 5.9 Hz, 2H), 4.66–4.42 (m, 3H), 4.27 (t, <i>J</i> = 4.9 Hz, 2H), 4.13–3.87 (m, 2H), 2.26 (d, <i>J</i> = 13.8 Hz, 1H), 2.02 (d, <i>J</i> = 7.2 Hz, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 526.07 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>R</i>)-4-(2-(1,1-Dioxidothiomorpholino)-4-(trifluoromethyl)phenyl)-<i>N</i>-(thiazol-2-yl)chroman-7-sulfonamide (<b>10</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(1,1-dioxidothiomorpholino)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61j</b>) by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 23%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.75 (s, 1H), 7.71 (s, 1H), 7.46 (d, <i>J</i> = 8.2 Hz, 1H), 7.27 (d, <i>J</i> = 4.6 Hz, 1H), 7.23–7.16 (m, 2H), 7.11 (d, <i>J</i> = 8.3 Hz, 1H), 6.84 (d, <i>J</i> = 4.6 Hz, 1H), 6.79 (d, <i>J</i> = 8.0 Hz, 1H), 4.83 (t, 1H), 4.33 (t, <i>J</i> = 9.9 Hz, 1H), 4.29–4.18 (m, 1H), 3.53–3.40 (m, 2H), 3.34–3.19 (m, 6H), 2.31–2.21 (m, 1H), 2.11–1.99 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 573.82 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>R</i>)-4-(2-(Piperazin-1-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(thiazol-2-yl)chromane-7-sulfonamide hydrochloride Salt (<b>11</b>)</h4><div class="NLM_p last">It was synthesized from <i>tert</i>-butyl 4-(2-(7-((perfluorophenoxy)sulfonyl)chroman-4-yl)-5-(trifluoromethyl)phenyl)piperazine-1-carboxylate (<b>61k</b>) by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomers. The enantiomer obtained from the later eluting peak in chiral HPLC was deprotected by 4N dioxane in HCl, whereby the Boc group is deprotected and the compound was converted to its hydrochloride salt (yield = 23%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.78 (s, 1H), 8.85 (s, 2H), 7.52 (s, 1H), 7.47 (d, <i>J</i> = 8.1 Hz, 1H), 7.27 (d, <i>J</i> = 4.6 Hz, 1H), 7.23–7.11 (m, 3H), 6.84 (d, <i>J</i> = 4.6 Hz, 1H), 6.76 (d, <i>J</i> = 8.1 Hz, 1H), 4.77 (t, <i>J</i> = 7.4 Hz, 1H), 4.37–4.19 (m, 2H), 3.32–3.13 (m, 6H), 3.14–3.01 (m, 2H), 2.28–2.17 (m, 1H), 2.07 (t, <i>J</i> = 10.6 Hz, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 525.03 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>R</i>)-4-(2-(4-Methylpiperazin-1-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(thiazol-2-yl)chromane-7-sulfonamide hydrochloride Salt (<b>12</b>)</h4><div class="NLM_p last">To a stirred solution of (<i>R</i>)-4-(2-(piperazin-1-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(thiazol-2-yl)chromane-7-sulfonamide hydrochloride salt (<b>11</b>) (0.22 g, 0.40 mmol) in 10 mL of 1,2-dichloroethane (DCE) was added 37% solution of formaldehyde (0.30 mL, 4.0 mmol) followed by acetic acid (0.11 mL, 2.0 mmol), and the reaction mixture was stirred for 1 h. Sodium triacetoxyborohydride (0.424 g, 2.0 mmol) was added, and the reaction mixture was stirred overnight at room temperature. The reaction mixture was quenched by the addition of a saturated solution of NaHCO<sub>3</sub> and extracted with 10% MeOH in DCM. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to obtain the product, which was converted to its hydrochloride salt by stirring with 2 N ethereal HCl and then filtered. (0.17 g, 79%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.81 (brs, 1H), 10.94 (brs, 1H), 7.54 (d, <i>J</i> = 1.9 Hz, 1H), 7.48 (dd, <i>J</i> = 8.1, 1.9 Hz, 1H), 7.27 (d, <i>J</i> = 4.6 Hz, 1H), 7.22–7.12 (m, 3H), 6.85 (d, <i>J</i> = 4.6 Hz, 1H), 6.76 (d, <i>J</i> = 8.1 Hz, 1H), 4.77 (dd, <i>J</i> = 8.8, 5.9 Hz, 1H), 4.34–4.22 (m, 2H), 3.47 (d, <i>J</i> = 9.2 Hz, 3H), 3.32–3.15 (m, 5H), 2.81 (s, 3H), 2.25 (d, <i>J</i> = 13.3 Hz, 1H), 2.14–2.02 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 539.45 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>R</i>)-4-(2-(1-Methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-2-yl) chromane-7-sulfonamide (<b>13</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(1-methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61a</b>) and pyrimidin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 44%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.80 (s, 1H), 8.53 (d, <i>J</i> = 4.8 Hz, 2H), 7.85–7.72 (m, 2H), 7.52 (s, 1H), 7.45–7.34 (m, 2H), 7.28 (d, <i>J</i> = 8.2 Hz, 1H), 7.08 (t, <i>J</i> = 5.0 Hz, 1H), 6.89 (d, <i>J</i> = 8.1 Hz, 1H), 6.44 (s, 1H), 4.30-4.19 (m, 1H), 4.19–4.03 (m, 2H), 3.70 (s, 3H), 2.18–2.07 (m, 1H), 2.03–1.91 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.84, 157.38, 155.11, 149.09, 140.55, 139.44, 138.54, 131.99, 131.09, 130.62, 130.08, 128.13 (q, <i>J</i><sub>C–F</sub> = 32 Hz), 127.88 (q, <i>J</i><sub>C–F</sub> = 4 Hz), 126.85 (q, <i>J</i><sub>C–F</sub> = 4 Hz), 124.32 (q, <i>J</i><sub>C–F</sub> = 273 Hz), 119.43, 116.29, 116.13, 107.82, 65.00, 37.85, 37.26, 30.01. HRMS <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>20</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub>S [M + H]<sup>+</sup>: 516.1312, observed: 516.1311; [α]<sub>D</sub>: −88.98° (<i>c</i> 1.01, CHCl<sub>3</sub>).</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>R</i>)-<i>N</i>-(5-Fluoropyrimidin-2-yl)-4-(2-(1-methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl) phenyl) Chroman-7-sulfonamide (<b>14</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(1-methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61a</b>) and 5-fluoropyrimidin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 34%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.89 (s, 1H), 8.66 (s, 2H), 7.83–7.73 (m, 2H), 7.53 (d, <i>J</i> = 1.8 Hz, 1H), 7.36 (d, <i>J</i> = 7.2 Hz, 2H), 7.28 (d, <i>J</i> = 8.2 Hz, 1H), 6.90 (d, <i>J</i> = 8.1 Hz, 1H), 6.45 (s, 1H), 4.29–4.20 (m, 1H), 4.20–4.10 (m, 2H), 3.70 (s, 3H), 2.20–2.07 (m, 1H), 2.07–1.91 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 534.07 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>R</i>)-4-(2-(1-Methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-4-yl) Chroman-7-sulfonamide (<b>15</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(1-methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61a</b>) and pyrimidin-4-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 28%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.65 (s, 1H), 8.36 (s, 1H), 7.82–7.74 (m, 2H), 7.53 (d, <i>J</i> = 1.9 Hz, 1H), 7.36–7.24 (m, 3H), 7.05 (d, <i>J</i> = 6.2 Hz, 1H), 6.89 (d, <i>J</i> = 8.5 Hz, 1H), 6.45 (s, 1H), 4.27–4.20 (m, 1H), 4.18–4.09 (m, 2H), 3.70 (s, 3H), 2.18–2.08 (m, 1H), 2.03–1.93 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 516.06 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>R</i>)-4-(2-(1-Methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyridazin-3-yl) chromane-7-sulfonamide (<b>16</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(1-methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61a</b>) and pyridazin-3-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 23%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.34 (s, 1H), 7.83–7.70 (m, 3H), 7.66–7.58 (m, 1H), 7.54 (d, <i>J</i> = 2.0 Hz, 1H), 7.28 (d, <i>J</i> = 8.3 Hz, 1H), 7.23 (t, <i>J</i> = 3.6 Hz, 2H), 6.83 (d, <i>J</i> = 8.3 Hz, 1H), 6.46 (s, 1H), 4.22 (s, 1H), 4.11 (q, <i>J</i> = 10.8, 9.1 Hz, 2H), 3.70 (s, 3H), 2.19–2.06 (m, 1H), 1.99–1.91 (m, 1H). LCMS: <i>m</i>/<i>z</i> 516.19 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>R</i>)-4-(2-(1-Methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrazin-2-yl) Chromane-7-sulfonamide (<b>17</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(1-methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61a</b>) and pyrazin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 12%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.59 (s, 1H), 8.33 (s, 1H), 8.22 (q, <i>J</i> = 2.8 Hz, 2H), 7.81–7.73 (m, 2H), 7.52 (d, <i>J</i> = 1.8 Hz, 1H), 7.33 (d, <i>J</i> = 7.6 Hz, 2H), 7.27 (d, <i>J</i> = 8.2 Hz, 1H), 6.89 (d, <i>J</i> = 8.0 Hz, 1H), 6.43 (s, 1H), 4.23 (dt, <i>J</i> = 9.6, 4.2 Hz, 1H), 4.18–4.11 (m, 2H), 3.69 (s, 3H), 2.17–2.08 (m, 1H), 2.00–1.92 (m, 1H). LCMS: <i>m</i>/<i>z</i> 516.04 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>R</i>)-<i>N</i>-(6-Fluoropyridin-2-yl)-4-(2-(1-methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl) phenyl) Chroman-7-sulfonamide (<b>18</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(1-methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61a</b>) and 6-fluoropyridin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 28%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.39 (s, 1H), 7.87 (q, <i>J</i> = 8.5 Hz, 1H), 7.81–7.71 (m, 2H), 7.52 (s, 1H), 7.40–7.31 (m, 2H), 7.27 (d, <i>J</i> = 8.2 Hz, 1H), 6.97 (d, <i>J</i> = 8.0 Hz, 1H), 6.92 (d, <i>J</i> = 8.0 Hz, 1H), 6.76 (d, <i>J</i> = 8.0 Hz, 1H), 6.42 (s, 1H), 4.29–4.20 (m, 1H), 4.20–4.08 (m, 2H), 3.69 (s, 3H), 2.20–2.07 (m, 1H), 2.04–1.91 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 533.07 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>R</i>)-<i>N</i>-(5-Fluoropyridin-2-yl)-4-(2-(1-methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl) Chroman-7-sulfonamide (<b>19</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(1-methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61a</b>) and 5-fluoropyridin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 20%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.13 (s, 1H), 8.21 (d, <i>J</i> = 3.0 Hz, 1H), 7.82–7.73 (m, 2H), 7.68 (dt, <i>J</i> = 8.6, 5.1 Hz, 1H), 7.52 (d, <i>J</i> = 1.8 Hz, 1H), 7.32–7.23 (m, 3H), 7.13 (dd, <i>J</i> = 9.2, 3.8 Hz, 1H), 6.88 (d, <i>J</i> = 8.1 Hz, 1H), 6.42 (s, 1H), 4.30–4.19 (m, 1H), 4.19–4.09 (m, 2H), 3.69 (s, 3H), 2.19–2.07 (m, 1H), 2.03–1.91 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 533.06 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (<i>R</i>)-<i>N</i>-(4-Fluoropyridin-2-yl)-4-(2-(1-methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl) Chroman-7-sulfonamide (<b>20</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(1-methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61a</b>) and 4-fluoropyridin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 23%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.07 (dd, <i>J</i> = 8.8, 6.3 Hz, 1H), 7.81–7.73 (m, 2H), 7.53 (d, <i>J</i> = 1.8 Hz, 1H), 7.30–7.22 (m, 3H), 6.86–6.77 (m, 2H), 6.74 (s, 1H), 6.44 (s, 1H), 4.25–4.18 (m, 1H), 4.16–4.08 (m, 2H), 3.69 (s, 3H), 2.11 (dd, <i>J</i> = 12.6, 6.4 Hz, 1H), 1.98–1.90 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 533.07 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (<i>R</i>)-4-(2-(2-Methyloxazol-4-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-2-yl)chroman-7-sulfonamide (<b>21</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(2-methyloxazol-4-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61c</b>) and pyrimidin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 10%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) 8.54 (d, <i>J</i> = 4.9 Hz, 2H), 8.43 (s, 1H), 8.01 (d, <i>J</i> = 2.1 Hz, 1H), 7.64 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 7.42 (d, <i>J</i> = 1.9 Hz, 1H), 7.38 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 7.14 (s, 1H), 7.12–7.04 (m, 1H), 6.89 (d, <i>J</i> = 8.1 Hz, 1H), 4.91 (t, <i>J</i> = 6.6 Hz, 1H), 4.31–4.14 (m, 2H), 2.49 (s, 3H), 2.37–2.27 (m, 1H), 2.05–1.94 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 517.04 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (<i>R</i>)-<i>N</i>-(5-Fluoropyrimidin-2-yl)-4-(2-(2-methyloxazol-4-yl)-4-(trifluoromethyl) phenyl) Chroman-7-sulfonamide (<b>22</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(2-methyloxazol-4-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61c</b>) and 5-fluoropyrimidin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 23%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.89 (s, 1H), 8.66 (s, 2H), 8.43 (s, 1H), 8.01 (s, 1H), 7.64 (d, <i>J</i> = 8.2 Hz, 1H), 7.41 (d, <i>J</i> = 1.9 Hz, 1H), 7.39–7.31 (m, 1H), 7.14 (d, <i>J</i> = 8.2 Hz, 1H), 6.90 (d, <i>J</i> = 8.1 Hz, 1H), 4.91 (t, <i>J</i> = 6.7 Hz, 1H), 4.30–4.15 (m, 2H), 2.33–2.24 (m, 1H), 2.03–1.98 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 534.82 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (<i>R</i>)-4-(2-(2-Methyloxazol-4-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-4-yl)chroman-7-sulfonamide (<b>23</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(2-methyloxazol-4-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61c</b>) and pyrimidin-4-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 9%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.66 (s, 1H), 8.44 (s, 1H), 8.37 (s, 1H), 8.00 (d, <i>J</i> = 2.0 Hz, 1H), 7.64 (d, <i>J</i> = 8.3 Hz, 1H), 7.35 (s, 1H), 7.32 (d, <i>J</i> = 7.9 Hz, 1H), 7.14 (d, <i>J</i> = 8.2 Hz, 1H), 7.06 (s, 1H), 6.88 (d, <i>J</i> = 8.1 Hz, 1H), 4.90 (t, <i>J</i> = 6.8 Hz, 1H), 4.28–4.10 (m, 2H), 2.32–2.25 (m, 1H), 2.06–1.94 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 516.82 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (<i>R</i>)-<i>N</i>-(6-Fluoropyridin-2-yl)-4-(2-(2-methyloxazol-4-yl)-4-(trifluoromethyl)phenyl) Chroman-7-sulfonamide (<b>24</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(2-methyloxazol-4-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61c</b>) and 6-fluoropyridin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 11%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.79 (d, <i>J</i> = 7.4 Hz, 1H), 7.78–7.69 (m, 2H), 7.61–7.49 (m, 1H), 7.44 (d, <i>J</i> = 2.0 Hz, 1H), 7.31 (s, 2H), 7.05 (d, <i>J</i> = 8.2 Hz, 1H), 6.89 (d, <i>J</i> = 8.2 Hz, 1H), 6.64 (dd, <i>J</i> = 8.1, 2.3 Hz, 1H), 4.89 (t, <i>J</i> = 6.9 Hz, 1H), 4.33–4.19 (m, 2H), 2.55 (s, 3H), 2.38–2.27 (m, 1H), 2.14–2.05 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 534.07 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (<i>R</i>)-4-(2-(1<i>H</i>-1,2,3-Triazol-1-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-2-yl)chromane-7-sulfonamide (<b>25</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(1<i>H</i>-1,2,3-triazol-1-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61b</b>) and pyrimidin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 9%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.69 (s, 1H), 8.34 (s, 1H), 8.02 (s, 1H), 7.98 (d, <i>J</i> = 1.9 Hz, 1H), 7.95–7.84 (m, 2H), 7.70 (dd, <i>J</i> = 9.6, 4.1 Hz, 1H), 7.40 (d, <i>J</i> = 8.3 Hz, 1H), 7.25 (d, <i>J</i> = 8.5 Hz, 2H), 6.90 (d, <i>J</i> = 7.9 Hz, 1H), 4.26–4.17 (m, 1H), 4.11 (ddd, <i>J</i> = 11.4, 8.8, 2.7 Hz, 1H), 4.00 (t, <i>J</i> = 7.1 Hz, 1H), 2.23–2.13 (m, 1H), 2.09–1.98 (m, 1H). LCMS: <i>m</i>/<i>z</i> 502.98 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (<i>R</i>)-4-(2-(1<i>H</i>-1,2,3-Triazol-1-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(5-fluoro pyrimidin-2-yl) Chromane-7-sulfonamide (<b>26</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(1<i>H</i>-1,2,3-triazol-1-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61b</b>) and 5-fluoropyrimidin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 21%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.89 (s, 1H), 8.67 (d, <i>J</i> = 5.8 Hz, 3H), 8.00 (d, <i>J</i> = 7.4 Hz, 2H), 7.91 (d, <i>J</i> = 8.3 Hz, 1H), 7.50–7.32 (m, 3H), 6.96 (d, <i>J</i> = 8.4 Hz, 1H), 4.30–4.20 (m, 1H), 4.13 (t, <i>J</i> = 10.2 Hz, 1H), 4.02 (t, <i>J</i> = 7.3 Hz, 1H), 2.25–2.14 (m, 1H), 2.13–1.99 (m, 1H). LCMS: <i>m</i>/<i>z</i> 520.98 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (<i>R</i>)-4-(2-(1<i>H</i>-1,2,3-Triazol-1-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin -4-yl)chromane-7-sulfonamide (<b>27</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(1<i>H</i>-1,2,3-triazol-1-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61b</b>) and pyrimidin-4-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 11%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.66–8.58 (m, 2H), 8.30 (s, 1H), 7.97 (d, <i>J</i> = 11.7 Hz, 2H), 7.91 (dd, <i>J</i> = 8.3, 1.9 Hz, 1H), 7.40 (d, <i>J</i> = 8.3 Hz, 1H), 7.34–7.26 (m, 2H), 7.01 (s, 1H), 6.91 (d, <i>J</i> = 8.0 Hz, 1H), 4.27–4.19 (m, 1H), 4.10 (t, <i>J</i> = 9.9 Hz, 1H), 3.99 (t, <i>J</i> = 7.4 Hz, 1H), 2.18–2.14 (m, 1H), 2.10–1.96 (m, 1H). LCMS: <i>m</i>/<i>z</i> 502.94 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (<i>R</i>)-4-(2-(1<i>H</i>-1,2,3-Triazol-1-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(6-fluoropyridin-2-yl) Chromane-7-sulfonamide (<b>28</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(1<i>H</i>-1,2,3-triazol-1-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61b</b>) and 6-fluoropyridin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 17%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.40 (s, 1H), 8.66 (s, 1H), 7.99 (d, <i>J</i> = 4.2 Hz, 2H), 7.96–7.83 (m, 2H), 7.40 (d, <i>J</i> = 8.3 Hz, 1H), 7.34 (d, <i>J</i> = 7.1 Hz, 2H), 6.97 (d, <i>J</i> = 8.1 Hz, 2H), 6.77 (dd, <i>J</i> = 8.1, 2.4 Hz, 1H), 4.32–4.20 (m, 1H), 4.13 (t, <i>J</i> = 10.0 Hz, 1H), 4.02 (t, <i>J</i> = 7.3 Hz, 1H), 2.24–2.13 (m, 1H), 2.13–2.02 (m, 1H). LCMS: <i>m</i>/<i>z</i> 520.02 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (<i>R</i>)-4-(2-(6-Fluoropyridin-3-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-2-yl)chromane-7-sulfonamide (<b>29</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(6-fluoropyridin-3-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61e</b>) and pyrimidin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 34%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.78 (s, 1H), 8.52 (d, <i>J</i> = 4.9 Hz, 2H), 8.38 (d, <i>J</i> = 2.4 Hz, 1H), 8.23–8.08 (m, 1H), 7.73 (d, <i>J</i> = 8.3 Hz, 1H), 7.69 (s, 1H), 7.41–7.29 (m, 3H), 7.24 (d, <i>J</i> = 8.3 Hz, 1H), 7.07 (t, <i>J</i> = 4.9 Hz, 1H), 6.96 (d, <i>J</i> = 8.1 Hz, 1H), 4.29–4.18 (m, 2H), 4.19–4.07 (m, 1H), 2.20–2.08 (m, 1H), 2.07–1.91 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 164.31, 161.96, 158.83, 157.42, 155.14, 147.76 (d, <i>J</i><sub>C–F</sub> = 15 Hz), 147.64, 143.23 (d, <i>J</i><sub>C–F</sub> = 8 Hz), 139.63 (d, <i>J</i><sub>C–F</sub> = 179 Hz), 133.70 (d, <i>J</i><sub>C–F</sub> = 4 Hz), 131.26, 130.42 (d, <i>J</i><sub>C–F</sub> = 4 Hz), 127.93 (q, <i>J</i><sub>C–F</sub> = 31 Hz), 127.45 (q, <i>J</i><sub>C–F</sub> = 4 Hz), 125.96 (q, <i>J</i><sub>C–F</sub> = 4 Hz), 124.44 (q, <i>J</i><sub>C–F</sub> = 272 Hz), 119.34, 116.27, 116.04, 109.88 (d, <i>J</i><sub>C–F</sub> = 40 Hz), 65.02, 37.30, 30.06. HRMS <i>m</i>/<i>z</i> calculated for C<sub>25</sub>H<sub>18</sub>F<sub>4</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup>: 531.1109, observed: 531.1108; [α]<sub>D</sub>: −97.88° (<i>c</i> 1.04, MeOH).</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>R</i>)-4-(2-(6-Fluoropyridin-3-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(5-fluoropyrimidin-2-yl) Chromane-7-sulfonamide (<b>30</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(6-fluoropyridin-3-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61e</b>) and 5-fluoropyrimidin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 32%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.88 (s, 1H), 8.65 (s, 2H), 8.38 (d, <i>J</i> = 2.4 Hz, 1H), 8.15 (td, <i>J</i> = 8.2, 2.5 Hz, 1H), 7.74 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 7.69 (d, <i>J</i> = 2.0 Hz, 1H), 7.37–7.29 (m, 3H), 7.24 (d, <i>J</i> = 8.2 Hz, 1H), 6.97 (d, <i>J</i> = 8.2 Hz, 1H), 4.29–4.19 (m, 2H), 4.17–4.09 (m, 1H), 2.19–2.10 (m, 1H), 2.02–1.98 (m, 1H). LCMS: <i>m</i>/<i>z</i> 549.08 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (<i>R</i>)-4-(2-(6-Fluoropyridin-3-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-4-yl)chromane-7-sulfonamide (<b>31</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(6-fluoropyridin-3-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61e</b>) and pyrimidin-4-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 17%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.65 (s, 1H), 8.38 (d, <i>J</i> = 2.5 Hz, 2H), 8.15 (td, <i>J</i> = 8.3, 2.6 Hz, 1H), 7.73 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 7.69 (s, 1H), 7.40–7.21 (m, 4H), 7.08 (brs, 1H), 6.96 (d, <i>J</i> = 8.3 Hz, 1H), 4.23 (q, <i>J</i> = 6.6, 5.8 Hz, 2H), 4.13 (t, <i>J</i> = 10.0 Hz, 1H), 2.18–2.08 (m, 1H), 2.04–1.90 (m, 1H). LCMS: <i>m</i>/<i>z</i> 530.82 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (<i>R</i>)-4-(2-(6-Methylpyridin-3-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-2-yl)chromane-7-sulfonamide (<b>32</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl (<i>R</i>)-4-(2-(6-methylpyridin-3-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61n</b>) and pyrimidin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> (yield = 78%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.80 (s, 1H), 8.59–8.46 (m, 3H), 7.82 (d, <i>J</i> = 8.0 Hz, 1H), 7.70 (d, <i>J</i> = 8.4 Hz, 1H), 7.62 (s, 1H), 7.36 (d, <i>J</i> = 6.6 Hz, 3H), 7.23 (d, <i>J</i> = 8.3 Hz, 1H), 7.07 (d, <i>J</i> = 4.7 Hz, 1H), 6.93 (d, <i>J</i> = 8.1 Hz, 1H), 4.32–4.18 (m, 2H), 4.11 (t, <i>J</i> = 10.4 Hz, 1H), 2.22–2.08 (m, 1H), 2.08–1.95 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.84, 157.86, 157.38, 155.11, 148.66, 147.44, 140.47, 139.93, 137.51, 132.53, 131.20, 130.51, 130.40, 127.94 (q, <i>J</i><sub>C–F</sub> = 32 Hz), 127.26 (q, <i>J</i><sub>C–F</sub> = 4 Hz), 125.66 (q, <i>J</i><sub>C–F</sub> = 4 Hz), 124.46 (q, <i>J</i><sub>C–F</sub> = 274 Hz), 123.40, 119.39, 116.30, 116.05, 65.09, 37.33, 30.12, 24.13. HRMS <i>m</i>/<i>z</i> calculated for C<sub>26</sub>H<sub>21</sub>F<sub>3</sub>N<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup>: 527.1359, observed: 527.1356; [α]<sub>D</sub>: −89.90° (<i>c</i> 0.51, MeOH).</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (<i>R</i>)-<i>N</i>-(5-Fluoropyrimidin-2-yl)-4-(2-(6-methylpyridin-3-yl)-4-(trifluoromethyl)phenyl)chroman-7-sulfonamide (<b>33</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl (<i>R</i>)-4-(2-(6-methylpyridin-3-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61n</b>) and 5-fluoropyrimidin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> (yield = 26%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.88 (s, 1H), 8.65 (s, 2H), 8.58 (s, 1H), 7.87 (d, <i>J</i> = 7.9 Hz, 1H), 7.71 (d, <i>J</i> = 8.3 Hz, 1H), 7.63 (s, 1H), 7.41 (d, <i>J</i> = 8.0 Hz, 1H), 7.35 (d, <i>J</i> = 6.3 Hz, 2H), 7.24 (d, <i>J</i> = 8.2 Hz, 1H), 6.94 (d, <i>J</i> = 8.6 Hz, 1H), 4.31–4.21 (m, 2H), 4.12 (t, <i>J</i> = 10.2 Hz, 1H), 2.55 (s, 3H), 2.21–2.10 (m, 1H), 2.07–1.98 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 545.09 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (<i>R</i>)-4-(2-(6-Methylpyridin-3-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-4-yl)chroman-7-sulfonamide (<b>34</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl (<i>R</i>)-4-(2-(6-methylpyridin-3-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61n</b>) and pyrimidin-4-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> (yield = 9%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.65 (s, 1H), 8.56 (s, 1H), 8.40 (s, 1H), 7.83 (d, <i>J</i> = 8.0 Hz, 1H), 7.71 (d, <i>J</i> = 8.5 Hz, 1H), 7.62 (s, 1H), 7.38 (d, <i>J</i> = 8.0 Hz, 1H), 7.30 (s, 2H), 7.24 (d, <i>J</i> = 8.5 Hz, 1H), 7.18–7.03 (m, 1H), 7.00–6.87 (m, 1H), 4.34–4.17 (m, 2H), 4.18–4.06 (m, 1H), 2.21–2.08 (m, 1H), 2.08–1.95 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 527.04 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (<i>R</i>)-<i>N</i>-(6-Fluoropyridin-2-yl)-4-(2-(6-methylpyridin-3-yl)-4-(trifluoromethyl)phenyl)chroman-7-sulfonamide (<b>35</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl (<i>R</i>)-4-(2-(6-methylpyridin-3-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61n</b>) and 6-fluoropyridin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> (yield = 22%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.37 (s, 1H), 8.55 (d, <i>J</i> = 2.3 Hz, 1H), 7.90–7.77 (m, 2H), 7.70 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 7.62 (s, 1H), 7.40–7.27 (m, 3H), 7.22 (d, <i>J</i> = 8.2 Hz, 1H), 6.95 (d, <i>J</i> = 8.0 Hz, 2H), 6.73 (d, <i>J</i> = 8.1 Hz, 1H), 4.32–4.19 (m, 2H), 4.12 (t, <i>J</i> = 10.2 Hz, 1H), 2.16–2.10 (m, 1H), 2.05–1.99 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 544.03 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> (<i>R</i>)-4-(2-(5-Fluoropyridin-2-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-2-yl)chroman-7-sulfonamide (<b>36</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(5-fluoropyridin-2-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61f</b>) and pyrimidin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 31%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.79 (s, 1H), 8.69 (d, <i>J</i> = 2.9 Hz, 1H), 8.53 (d, <i>J</i> = 4.9 Hz, 2H), 7.89 (td, <i>J</i> = 8.7, 3.0 Hz, 1H), 7.79 (dd, <i>J</i> = 8.7, 4.5 Hz, 1H), 7.73 (d, <i>J</i> = 7.8 Hz, 2H), 7.37 (d, <i>J</i> = 7.0 Hz, 2H), 7.24 (d, <i>J</i> = 8.1 Hz, 1H), 7.07 (t, <i>J</i> = 4.9 Hz, 1H), 6.91 (d, <i>J</i> = 8.2 Hz, 1H), 4.57 (dd, <i>J</i> = 8.8, 6.1 Hz, 1H), 4.25 (dt, <i>J</i> = 11.4, 4.1 Hz, 1H), 4.16–4.09 (m, 1H), 2.21–2.15 (m, 1H), 2.11–2.03 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 531.02 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> (<i>R</i>)-4-(2-(5-Fluoropyridin-2-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(5-fluoropyrimidin-2-yl)chroman-7-sulfonamide (<b>37</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(5-fluoropyridin-2-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61f</b>) and 5-fluoropyrimidin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 33%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.88 (s, 1H), 8.69 (d, <i>J</i> = 2.8 Hz, 1H), 8.61 (s, 2H), 7.89 (dd, <i>J</i> = 10.2, 7.4 Hz, 1H), 7.85–7.70 (m, 3H), 7.33 (d, <i>J</i> = 7.4 Hz, 2H), 7.24 (d, <i>J</i> = 8.3 Hz, 1H), 6.90 (d, <i>J</i> = 8.3 Hz, 1H), 4.56 (t, <i>J</i> = 7.6 Hz, 1H), 4.32–4.21 (m, 1H), 4.11 (t, <i>J</i> = 10.1 Hz, 1H), 2.24–2.13 (m, 1H), 2.13–1.99 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 548.70 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (<i>R</i>)-4-(2-(5-Fluoropyridin-2-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-4-yl)chroman-7-sulfonamide (<b>38</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(5-fluoropyridin-2-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61f</b>) and pyrimidin-4-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 14%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 14.52 (s, 1H), 8.70 (d, <i>J</i> = 2.9 Hz, 1H), 8.30 (s, 1H), 7.97–7.86 (m, 2H), 7.79 (dd, <i>J</i> = 8.7, 4.5 Hz, 1H), 7.77–7.66 (m, 3H), 7.34–7.19 (m, 3H), 6.87 (d, <i>J</i> = 7.9 Hz, 1H), 4.59–4.53 (m, 1H), 4.27–4.21 (m, 1H), 4.10 (t, <i>J</i> = 10.3 Hz, 1H), 2.23–2.14 (m, 1H), 2.08–2.02 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> = 531.22 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (<i>R</i>)-4-(4′-Fluoro-5-(trifluoromethyl)-[1,1′-biphenyl]-2-yl)-<i>N</i>-(pyrimidin-2-yl)chromane-7-sulfonamide (<b>39</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(4′-fluoro-5-(trifluoromethyl)-[1,1′-biphenyl]-2-yl)chromane-7-sulfonate (<b>61g</b>) and pyrimidin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 40%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.74 (s, 1H), 8.53 (d, <i>J</i> = 4.9 Hz, 2H), 7.68 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 7.61–7.49 (m, 3H), 7.41–7.29 (m, 4H), 7.21 (d, <i>J</i> = 8.2 Hz, 1H), 7.08 (t, <i>J</i> = 5.0 Hz, 1H), 6.93 (d, <i>J</i> = 8.5 Hz, 1H), 4.34–4.19 (m, 2H), 4.16–4.06 (m, 1H), 2.15–2.08 (m, 1H), 2.05–1.98 (m, 1H). LCMS: <i>m</i>/<i>z</i> 530.19 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> (<i>R</i>)-4-(4′-Fluoro-5-(trifluoromethyl)-[1,1′-biphenyl]-2-yl)-<i>N</i>-(5-fluoropyrimidin-2-yl) Chromane-7-sulfonamide (<b>40</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(4′-fluoro-5-(trifluoromethyl)-[1,1′-biphenyl]-2-yl)chromane-7-sulfonate (<b>61g</b>) and 5-fluoropyrimidin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 23%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.88 (s, 1H), 8.65 (s, 2H), 7.69 (d, <i>J</i> = 8.3 Hz, 1H), 7.61–7.47 (m, 3H), 7.43–7.28 (m, 4H), 7.21 (d, <i>J</i> = 8.3 Hz, 1H), 6.93 (d, <i>J</i> = 8.5 Hz, 1H), 4.35–4.21 (m, 2H), 4.10 (t, <i>J</i> = 9.9 Hz, 1H), 2.13–2.06 (m, 1H), 2.06–1.97 (m, 1H). LCMS: <i>m</i>/<i>z</i> 547.99 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> (<i>R</i>)-4-(4′-Fluoro-5-(trifluoromethyl)-[1,1′-biphenyl]-2-yl)-<i>N</i>-(pyrimidin-4-yl)chromane-7-sulfonamide (<b>41</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(4′-fluoro-5-(trifluoromethyl)-[1,1′-biphenyl]-2-yl)chromane-7-sulfonate (<b>61g</b>) and pyrimidin-4-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 21%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.65 (s, 1H), 8.37 (s, 1H), 7.69 (d, <i>J</i> = 8.3 Hz, 1H), 7.62–7.48 (m, 3H), 7.43–7.26 (m, 4H), 7.22 (d, <i>J</i> = 8.3 Hz, 1H), 7.05 (s, 1H), 6.92 (d, <i>J</i> = 8.3 Hz, 1H), 4.35–4.17 (m, 2H), 4.11 (d, <i>J</i> = 9.6 Hz, 1H), 2.13–2.06 (m, 1H), 2.08–1.94 (m, 1H). LCMS: <i>m</i>/<i>z</i> 529.97 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (<i>R</i>)-4-(4′-Fluoro-5-(trifluoromethyl)-[1,1′-biphenyl]-2-yl)-<i>N</i>-(6-fluoropyridin-2-yl) Chromane-7-sulfonamide (<b>42</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(4′-fluoro-5-(trifluoromethyl)-[1,1′-biphenyl]-2-yl)chromane-7-sulfonate (<b>61g</b>) and 6-fluoropyridin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 15%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.38 (s, 1H), 7.87 (q, <i>J</i> = 8.2 Hz, 1H), 7.68 (d, <i>J</i> = 8.3 Hz, 1H), 7.57 (s, 1H), 7.53 (dd, <i>J</i> = 8.3, 5.3 Hz, 2H), 7.32 (d, <i>J</i> = 8.6 Hz, 4H), 7.20 (d, <i>J</i> = 8.2 Hz, 1H), 7.02–6.92 (m, 2H), 6.76 (dd, <i>J</i> = 8.1, 2.4 Hz, 1H), 4.35–4.19 (m, 2H), 4.10 (t, <i>J</i> = 10.1 Hz, 1H), 2.15–2.07 (m, 1H), 2.07–1.96 (m, 1H). LCMS: <i>m</i>/<i>z</i> 547.00 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> (<i>R</i>)-4-(2-Morpholino-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-2-yl)chroman-7-sulfonamide (<b>43</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-morpholino-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61m</b>) and pyrimidin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 32%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.74 (s, 1H), 8.54 (d, <i>J</i> = 4.9 Hz, 2H), 7.58 (d, <i>J</i> = 1.9 Hz, 1H), 7.43 (dd, <i>J</i> = 8.2, 1.9 Hz, 1H), 7.40 (d, <i>J</i> = 1.9 Hz, 1H), 7.36 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 7.12 (d, <i>J</i> = 8.2 Hz, 1H), 7.08 (t, <i>J</i> = 4.9 Hz, 1H), 6.80 (d, <i>J</i> = 8.1 Hz, 1H), 4.79 (t, <i>J</i> = 7.6 Hz, 1H), 4.39–4.10 (m, 2H), 3.78–3.48 (m, 4H), 3.04–2.89 (m, 2H), 2.89–2.71 (m, 2H), 2.30–2.17 (m, 1H), 2.17–2.05 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.85, 157.40, 155.25, 152.65, 145.75, 140.07, 131.27, 131.19, 130.82, 128.94 (q, <i>J</i><sub>C–F</sub> = 31 Hz), 124.52 (q, <i>J</i><sub>C–F</sub> = 273 Hz), 122.05 (q, <i>J</i><sub>C–F</sub> = 4 Hz), 119.39, 118.96 (q, <i>J</i><sub>C–F</sub> = 4 Hz), 116.32, 115.99, 66.97, 65.57, 53.58, 35.68, 29.90. HRMS <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>23</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub>S [M + H]<sup>+</sup>: 521.1465, observed: 521.1464; [α]<sub>D</sub>: −46.27° (<i>c</i> 1.01, CHCl<sub>3</sub>).</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (<i>R</i>)-<i>N</i>-(5-Fluoropyrimidin-2-yl)-4-(2-morpholino-4-(trifluoromethyl)phenyl) Chroman-7-sulfonamide (<b>44</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl (<i>R</i>)-4-(2-morpholino-4-(trifluoromethyl)phenyl)chromane-7-sulfonate <b>[61m(</b><i><b>R</b></i><b>)]</b> and 5-fluoropyrimidin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> (yield = 28%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.86 (s, 1H), 8.66 (s, 2H), 7.58 (s, 1H), 7.43 (d, <i>J</i> = 8.2 Hz, 1H), 7.39 (s, 1H), 7.34 (d, <i>J</i> = 8.2 Hz, 1H), 7.12 (d, <i>J</i> = 8.1 Hz, 1H), 6.81 (d, <i>J</i> = 8.1 Hz, 1H), 4.80 (d, <i>J</i> = 7.7 Hz, 1H), 4.28 (t, <i>J</i> = 5.0 Hz, 2H), 3.75–3.54 (m, 4H), 3.05–2.91 (m, 2H), 2.91–2.73 (m, 2H), 2.30–2.17 (m, 1H), 2.17–2.05 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 539.07(M + H)<sup>+</sup>.</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (<i>R</i>)-4-(2-Morpholino-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-4-yl) Chroman-7-sulfonamide (<b>45</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl (<i>R</i>)-4-(2-morpholino-4-(trifluoromethyl)phenyl)chromane-7-sulfonate <b>[61m(</b><i><b>R</b></i><b>)]</b> and pyrimidin-4-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> (yield = 30%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.66 (s, 1H), 8.37 (s, 1H), 7.58 (d, <i>J</i> = 1.8 Hz, 1H), 7.43 (d, <i>J</i> = 8.3 Hz, 1H), 7.33 (d, <i>J</i> = 1.9 Hz, 1H), 7.32–7.26 (m, 1H), 7.12 (d, <i>J</i> = 8.3 Hz, 1H), 7.09–7.02 (m, 1H), 6.79 (d, <i>J</i> = 8.1 Hz, 1H), 4.79 (t, <i>J</i> = 7.5 Hz, 1H), 4.28 (t, <i>J</i> = 5.2 Hz, 2H), 3.75–3.56 (m, 4H), 3.02–2.91 (m, 2H), 2.89–2.75 (m, 2H), 2.27–2.18 (m, 1H), 2.16–2.05 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 521.06 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> (<i>R</i>)-<i>N</i>-(6-Fluoropyridin-2-yl)-4-(2-morpholino-4-(trifluoromethyl)phenyl) Chroman-7-sulfonamide (<b>46</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl (<i>R</i>)-4-(2-morpholino-4-(trifluoromethyl)phenyl)chromane-7-sulfonate <b>[61m(</b><i><b>R</b></i><b>)]</b> and 6-fluoropyridin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> (yield = 59%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.36 (s, 1H), 7.87 (q, <i>J</i> = 8.2 Hz, 1H), 7.58 (s, 1H), 7.43 (d, <i>J</i> = 8.2 Hz, 1H), 7.36 (d, <i>J</i> = 1.9 Hz, 1H), 7.31 (dd, <i>J</i> = 8.2, 2.0 Hz, 1H), 7.12 (d, <i>J</i> = 8.1 Hz, 1H), 6.98 (dd, <i>J</i> = 7.9, 2.1 Hz, 1H), 6.82 (d, <i>J</i> = 8.2 Hz, 1H), 6.77 (dd, <i>J</i> = 8.0, 2.4 Hz, 1H), 4.78 (t, <i>J</i> = 7.4 Hz, 1H), 4.41–4.20 (m, 2H), 3.80–3.50 (m, 4H), 3.02–2.88 (m, 2H), 2.88–2.73 (m, 2H), 2.28–2.18 (m, 1H), 2.18–2.07 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 538.06 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> (<i>R</i>)-4-(2-(1,1-Dioxidothiomorpholino)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-2-yl)chroman-7-sulfonamide (<b>47</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(1,1-dioxidothiomorpholino)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61j</b>) and pyrimidin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> followed by separation of the enantiomer (yield = 38%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.74 (s, 1H), 8.54 (d, <i>J</i> = 4.9 Hz, 2H), 7.71 (d, <i>J</i> = 1.9 Hz, 1H), 7.46 (d, <i>J</i> = 8.2 Hz, 1H), 7.41 (d, <i>J</i> = 1.9 Hz, 1H), 7.35 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 7.13–7.04 (m, 2H), 6.85 (d, <i>J</i> = 8.2 Hz, 1H), 4.89–4.78 (m, 1H), 4.34 (t, <i>J</i> = 10.1 Hz, 1H), 4.30–4.20 (m, 1H), 3.44–3.37 (m, 4H), 3.35–3.22 (m, 4H), 2.33–2.23 (m, 1H), 2.11–2.01 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 569.07 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> (<i>R</i>)-4-(2-(1,1-Dioxidothiomorpholino)-4-(trifluoromethyl)phenyl)-<i>N</i>-(5-fluoropyrimidin-2-yl)chroman-7-sulfonamide (<b>48</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl (<i>R</i>)-4-(2-(1,1-dioxidothiomorpholino)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate <b>[61j(</b><i><b>R</b></i><b>)]</b> and 5-fluoropyrimidin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> (yield = 37%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.86 (s, 1H), 8.66 (s, 2H), 7.72 (d, <i>J</i> = 1.9 Hz, 1H), 7.46 (d, <i>J</i> = 8.2 Hz, 1H), 7.40 (d, <i>J</i> = 1.9 Hz, 1H), 7.34 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 7.09 (d, <i>J</i> = 8.1 Hz, 1H), 6.86 (d, <i>J</i> = 8.2 Hz, 1H), 4.90–4.79 (m, 1H), 4.34 (t, <i>J</i> = 9.9 Hz, 1H), 4.31–4.22 (m, 1H), 3.51–3.35 (m, 4H), 3.33–3.17 (m, 4H), 2.32–2.21 (m, 1H), 2.09–2.00 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 586.83 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> (<i>R</i>)-4-(2-(1,1-Dioxidothiomorpholino)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-4-yl)chromane-7-sulfonamide (<b>49</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl (<i>R</i>)-4-(2-(1,1-dioxidothiomorpholino)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate <b>[61j(</b><i><b>R</b></i><b>)]</b> and pyrimidin-4-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> (yield = 69%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.66 (s, 1H), 8.41 (s, 1H), 7.72 (s, 1H), 7.46 (d, <i>J</i> = 8.2 Hz, 1H), 7.41–7.25 (m, 2H), 7.09 (d, <i>J</i> = 8.0 Hz, 2H), 6.84 (d, <i>J</i> = 8.1 Hz, 1H), 4.90–4.78 (m, 1H), 4.34 (t, <i>J</i> = 9.5 Hz, 1H), 4.29–4.19 (m, 1H), 3.54–3.35 (m, 4H), 3.32–3.17 (m, 4H), 2.32–2.19 (m, 1H), 2.14–2.01 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 568.95 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> (<i>R</i>)-4-(2-(1,1-Dioxidothiomorpholino)-4-(trifluoromethyl)phenyl)-<i>N</i>-(6-fluoropyridin-2-yl)chroman-7-sulfonamide (<b>50</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl (<i>R</i>)-4-(2-(1,1-dioxidothiomorpholino)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate <b>[61j(</b><i><b>R</b></i><b>)]</b> and 6-fluoropyridin-2-amine by following an analogous procedure described for <b>1a</b> and <b>1b</b> (yield = 37%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.37 (s, 1H), 7.87 (q, <i>J</i> = 8.2 Hz, 1H), 7.71 (s, 1H), 7.45 (d, <i>J</i> = 8.2 Hz, 1H), 7.37 (d, <i>J</i> = 2.0 Hz, 1H), 7.31 (dd, <i>J</i> = 8.2, 2.0 Hz, 1H), 7.08 (s, 1H), 6.98 (dd, <i>J</i> = 8.0, 2.1 Hz, 1H), 6.86 (d, <i>J</i> = 8.2 Hz, 1H), 6.77 (dd, <i>J</i> = 8.0, 2.4 Hz, 1H), 4.90–4.79 (m, 1H), 4.39–4.21 (m, 2H), 3.50–3.21 (m, 8H), 2.33–2.21 (m, 1H), 2.11–2.00 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 585.95 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> (<i>S</i>)-1-(2-(1-Methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-2-yl)-2,3-dihydro-1<i>H</i>-indene-5-sulfonamide (<b>51</b>)</h4><div id="sec5_1_51_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> Step 1: (<i>R</i> and <i>S</i>)-<i>N</i>-(2,4-Dimethoxybenzyl)-1-(2-(1-methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-2-yl)-2,3-dihydro-1<i>H</i>-indene-5-sulfonamide</h5><div class="NLM_p last">To a nitrogen-purged solution of 1-(2-chloro-4-(trifluoromethyl)phenyl)-<i>N</i>-(2,4-dimethoxybenzyl)-<i>N</i>-(pyrimidin-2-yl)-2,3-dihydro-1<i>H</i>-indene-5-sulfonamide (<b>69</b>) (0.25 g, 0.41 mmol) in 10 mL of 1,4-dioxane were added 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (0.086 g, 0.41 mmol), PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct (0.084 g, 0.10 mmol), K<sub>3</sub>PO<sub>4</sub>.3H<sub>2</sub>O (0.345 g, 1.24 mmol), and tritertbutylphosphin tetrafluoroborate (0.012 g, 0.1 mmol). The reaction mixture was heated at 120 °C for 2 h, after which it was poured into water and extracted with EtOAc. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, evaporated, and purified by column chromatography to obtain the product as a colorless mass (yield = 204 mg, 76%). LCMS (ESI): <i>m</i>/<i>z</i> 650.37(M + H)<sup>+</sup>.</div></div><div id="sec5_1_51_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> Step 2: (<i>S</i>)-1-(2-(1-Methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-2-yl)-2,3-dihydro-1<i>H</i>-indene-5-sulfonamide</h5><div class="NLM_p last">To a stirred solution of the product from Step 1 (0.19 g, 0.29 mmol) in DCM (5 mL) at 0–10 °C was added TFA (0.45 mL, 5.85 mmol) and stirred at 10 °C for 30 min. The contents were evaporated completely and diluted with MeOH (2 mL). This was evaporated again up to dryness under reduced pressure. The pink residue was taken up in MeOH and filtered through a membrane filter to get a sticky mass. This was dissolved in EtOAc, and pentane was added to get an off-white solid precipitate followed by separation of the enantiomer. (Yield = 75 mg, 52%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.77 (s, 1H), 8.51 (d, <i>J</i> = 4.9 Hz, 2H), 7.89 (d, <i>J</i> = 1.8 Hz, 1H), 7.81–7.75 (m, 2H), 7.73 (d, <i>J</i> = 2.0 Hz, 1H), 7.53 (d, <i>J</i> = 1.9 Hz, 1H), 7.29 (d, <i>J</i> = 8.2 Hz, 1H), 7.09–7.00 (m, 2H), 6.43 (d, <i>J</i> = 1.9 Hz, 1H), 4.24 (t, <i>J</i> = 8.6 Hz, 1H), 3.67 (s, 3H), 3.13–3.02 (m, 1H), 3.02–2.86 (m, 1H), 2.49–2.43 (m, 1H), 2.09–1.96 (m, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.81, 157.42, 151.54, 149.25, 149.24, 145.41, 139.81, 138.51, 131.84, 129.69, 127.89 (q, <i>J</i><sub>C–F</sub> = 32 Hz), 127.51 (q, <i>J</i><sub>C–F</sub> = 4 Hz), 127.00 (q, <i>J</i><sub>C–F</sub> = 4 Hz), 126.95, 125.08, 124.37 (q, <i>J</i><sub>C–F</sub> = 274 Hz), 123.92, 116.26, 107.93, 47.74, 37.18, 36.22, 31.53. HRMS <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>20</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup>: 500.1363, observed: 500.1360; [α]<sub>D</sub>: −69.20° (<i>c</i> 0.97, DCM).</div></div></div><div id="sec5_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> (<i>S</i>)-1-(2-(6-Fluoropyridin-3-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-2-yl)-2,3-dihydro-1<i>H</i>-indene-5-sulfonamide (<b>52</b>)</h4><div class="NLM_p last">The title compound was prepared by following a similar procedure as described for <b>51</b> (Steps 1 and 2) using 1-(2-chloro-4-(trifluoromethyl)phenyl)-<i>N</i>-(2,4-dimethoxybenzyl)-<i>N</i>-(pyrimidin-2-yl)-2,3-dihydro-1<i>H</i>-indene-5-sulfonamide (<b>69</b>) and 2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine followed by separation of the enantiomer (yield = 23%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.72 (brs, 1H), 8.51 (d, <i>J</i> = 4.8 Hz, 2H), 8.34 (d, <i>J</i> = 2.5 Hz, 1H), 8.11 (td, <i>J</i> = 8.1, 2.5 Hz, 1H), 7.88 (d, <i>J</i> = 1.8 Hz, 1H), 7.75 (ddd, <i>J</i> = 12.9, 8.1, 1.9 Hz, 2H), 7.68 (d, <i>J</i> = 2.0 Hz, 1H), 7.31 (dd, <i>J</i> = 8.4, 2.7 Hz, 1H), 7.26 (d, <i>J</i> = 8.2 Hz, 1H), 7.13–7.02 (m, 2H), 4.35 (t, <i>J</i> = 8.7 Hz, 1H), 3.16–3.02 (m, 1H), 2.99–2.85 (m, 1H), 2.49–2.42 (m, 1H), 2.06 (dq, <i>J</i> = 12.6, 9.2 Hz, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 514.99 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> (<i>S</i>)-1-(2-(6-Methylpyridin-3-yl)-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-2-yl)-2,3-dihydro-1<i>H</i>-indene-5-sulfonamide (<b>53</b>)</h4><div class="NLM_p last">The title compound was prepared by following a similar procedure as described for <b>51</b> (Steps 1 and 2) using 1-(2-chloro-4-(trifluoromethyl)phenyl)-<i>N</i>-(2,4-dimethoxybenzyl)-<i>N</i>-(pyrimidin-2-yl)-2,3-dihydro-1<i>H</i>-indene-5-sulfonamide (<b>69</b>) and 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine followed by separation of the enantiomer (yield = 27%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.79 (s, 1H), 8.53 (s, 1H), 8.49 (d, <i>J</i> = 4.7 Hz, 2H), 7.87 (s, 1H), 7.82–7.66 (m, 3H), 7.63 (s, 1H), 7.37 (d, <i>J</i> = 7.9 Hz, 1H), 7.27 (d, <i>J</i> = 8.3 Hz, 1H), 7.02 (d, <i>J</i> = 7.5 Hz, 2H), 4.37 (t, <i>J</i> = 8.7 Hz, 1H), 3.15–3.03 (m, 1H), 2.99–2.86 (m, 1H), 2.15–2.00 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 511.25 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> (<i>S</i>)-1-(2-Morpholino-4-(trifluoromethyl)phenyl)-<i>N</i>-(pyrimidin-2-yl)-2,3-dihydro-1<i>H</i>-indene-5-sulfonamide (<b>54</b>)</h4><div class="NLM_p last">The title compound was prepared by following a similar procedure as described for <b>1a</b> and <b>1b</b> using perfluorophenyl 1-(2-morpholino-4-(trifluoromethyl)phenyl)-2,3-dihydro-1<i>H</i>-indene-5-sulfonate (<b>68b</b>) and pyrimidin-2-amine followed by separation of the enantiomer (yield = 35%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.72 (s, 1H), 8.52 (d, <i>J</i> = 4.9 Hz, 2H), 7.91 (s, 1H), 7.75 (d, <i>J</i> = 8.0 Hz, 1H), 7.50 (s, 1H), 7.40 (d, <i>J</i> = 8.2 Hz, 1H), 7.13 (d, <i>J</i> = 8.1 Hz, 1H), 7.07 (t, <i>J</i> = 4.9 Hz, 1H), 6.91 (d, <i>J</i> = 8.0 Hz, 1H), 4.96 (t, <i>J</i> = 8.7 Hz, 1H), 3.77–3.57 (m, 4H), 3.20–3.11 (m, 1H), 3.06 (q, <i>J</i> = 8.2 Hz, 1H), 2.97–2.86 (m, 4H), 2.71–2.57 (m, 1H), 2.11–1.95 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 505.00 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 7-(Benzylthio)chroman-4-one (<b>56</b>)</h4><div class="NLM_p last">7-Bromochroman-4-one (<b>55</b>) (390 g, 1.72 mol) was dissolved in 1, 4-dioxane (4.5 L) and the solution was purged with nitrogen and Pd<sub>2</sub>(dba)<sub>3</sub> (39.3 g, 0.043 mol); Hunig’s Base (600 mL, 3.44 mol) and benzyl mercaptan (193 mL, 1.63 mol) were added. The reaction mixture was heated to 80 °C for 1 h. After completion of the reaction as indicated by thin-layer chromatography (TLC), the compound was extracted with ethyl acetate and washed with water. The ethyl acetate layer was then dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The crude product was purified by column chromatography to obtain the title compound as a pale-yellow solid (279 g, 60%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.78 (d, <i>J</i> = 8.3 Hz, 1H), 7.49–7.23 (m, 5H), 6.90 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 6.85–6.75 (m, 1H), 4.52 (m, 2H), 4.20 (s, 2H), 2.78 (m, 2H).</div></div><div id="sec5_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> <i>N</i>′-(7-(Benzylthio)chroman-4-ylidene)-4-methylbenzenesulfonohydrazide (<b>57</b>)</h4><div class="NLM_p last">7-(Benzylthio)chroman-4-one (<b>56</b>) (100 g, 0.37 mol) and 4-methylbenzenesulfonohydrazide (76 g, 0.41 mol) were added into 2.5 L of MeOH, and the mixture was heated at 70 °C overnight. The reaction mixture was then cooled in an ice salt bath for 1 h, and the precipitated pale-yellow solid was filtered and washed with ethanol. The solid product was then triturated with hexane and dried under vacuum to obtain the title compound (153 g, 94%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.91 (d, <i>J</i> = 8.1 Hz, 2H), 7.82 (d, <i>J</i> = 8.4 Hz, 1H), 7.38–7.29 (m, 7H), 6.86 (dd, <i>J</i> = 8.4, 1.9 Hz, 1H), 6.77 (d, <i>J</i> = 1.8 Hz, 1H), 4.25–4.18 (m, 2H), 4.16 (s, 2H), 2.75 (t, <i>J</i> = 6.1 Hz, 2H), 2.44 (s, 3H). LCMS (ESI): <i>m</i>/<i>z</i> 439.09 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Perfluorophenyl 4-Oxochroman-7-sulfonate (<b>62</b>)</h4><div class="NLM_p last">To a suspension of 7-(benzylthio) chroman-4-one (<b>56</b>) (37 g, 137 mmol) in 200 mL of acetic acid and 50 mL of water was added <i>N</i>-chlorosuccinimide (54.8 g, 411 mmol) in two portions and stirred for 45 min. The reaction mixture was diluted with a mixture of ether and water and extracted with ether. The combined organic layer was washed with water followed by brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated to dryness under reduced pressure. The sulfonyl chloride intermediate was dissolved in DCM and slowly added into a stirred solution of 2,3,4,5,6-pentafluorophenol (35.3 g, 192 mmol) and triethylamine (114 mL, 821 mmol) in 200 mL of DCM at 0 °C. After the completion of addition, the reaction mixture was stirred for 45 min and then quenched with water and extracted with DCM. The combined organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The crude product was purified by column chromatography to obtain the pentafluoroester as an off-white solid (35g, 65%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.06 (d, <i>J</i> = 8.2 Hz, 1H), 7.71 (d, <i>J</i> = 1.8 Hz, 1H), 7.65 (dd, <i>J</i> = 8.2, 1.9 Hz, 1H), 4.70 (t, <i>J</i> = 6.5 Hz, 2H), 2.95 (t, <i>J</i> = 6.4 Hz, 2H).</div></div><div id="sec5_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> Perfluorophenyl 4-(2-Tosylhydrazono)chroman-7-sulfonate (<b>63</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-oxochroman-7-sulfonate (<b>62</b>) by following an analogous procedure described for <b>57</b> (yield = 72%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.08 (s, 1H), 8.03 (d, <i>J</i> = 8.4 Hz, 1H), 7.85 (d, 2H), 7.55 (dd, <i>J</i> = 8.5, 2.0 Hz, 1H), 7.49 (d, <i>J</i> = 2.0 Hz, 1H), 7.43 (d, <i>J</i> = 8.1 Hz, 2H), 4.32 (t, <i>J</i> = 6.2 Hz, 2H), 2.82 (t, <i>J</i> = 6.2 Hz, 2H), 2.39 (s, 3H).</div></div><div id="sec5_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 5-(2-(7-(Benzylthio)-2<i>H</i>-chromen-4-yl)-5-(trifluoromethyl)phenyl)-1-methyl-1<i>H</i>-pyrazole (<b>59a</b>)</h4><div class="NLM_p last">A mixture of 2.4 L of 1,4-dioxane and 400 mL of water was degassed for 30 min with N<sub>2</sub>, after which 5-(2-bromo-5-(trifluoromethyl)phenyl)-1-methyl-1<i>H</i>-pyrazole (<b>58a</b>) (84 g, 0.275 mol), <i>N</i>′-(7-(benzylthio)chroman-4-ylidene)-4-methylbenzenesulfonohydrazide (<b>57</b>) (121 g, 0.27 mol), sodium carbonate (73 g, 0.69 mol), and PdCl<sub>2</sub>(dppf)-DCM adduct (22.48 g, 0.028 mol) were added and the reaction mixture was refluxed for 5 h. After completion of the reaction as indicated by TLC, the compound was extracted with ethyl acetate and washed with water. The ethyl acetate layer was then dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The crude was purified by column chromatography to obtain the title compound as an off-white solid (100 g, 76%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.74 (d, <i>J</i> = 8.0 Hz, 1H), 7.67 (s, 1H), 7.51 (d, <i>J</i> = 8.1 Hz, 1H), 7.40 (d, <i>J</i> = 1.9 Hz, 1H), 7.36–7.30 (m, 4H), 7.28 (s, 1H), 6.79 (d, <i>J</i> = 1.8 Hz, 1H), 6.70 (dd, <i>J</i> = 8.1, 1.9 Hz, 1H), 6.56 (d, <i>J</i> = 8.1 Hz, 1H), 6.16 (d, <i>J</i> = 1.9 Hz, 1H), 5.50 (t, <i>J</i> = 3.9 Hz, 1H), 4.71 (d, <i>J</i> = 3.9 Hz, 2H), 4.13 (s, 2H), 3.65 (s, 3H). LCMS (ESI): <i>m</i>/<i>z</i> 479.09 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 1-(2-(7-(Benzylthio)-2<i>H</i>-chromen-4-yl)-5-(trifluoromethyl)phenyl)-1<i>H</i>-1,2,3-triazole (<b>59b</b>)</h4><div class="NLM_p last">It was synthesized from <i>N</i>′-(7-(benzylthio)chroman-4-ylidene)-4-methylbenzenesulfonohydrazide (<b>57</b>) and 1-(2-iodo-5-(trifluoromethyl)phenyl)-1<i>H</i>-1,2,3-triazole (<b>58b</b>) by following an analogous procedure described for <b>59a</b> (yield = 47%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.06 (d, <i>J</i> = 1.8 Hz, 1H), 7.83 (dd, <i>J</i> = 8.1, 1.8 Hz, 1H), 7.70 (d, <i>J</i> = 1.1 Hz, 1H), 7.67–7.56 (m, 2H), 7.34 (d, <i>J</i> = 4.3 Hz, 5H), 6.77 (d, <i>J</i> = 1.8 Hz, 1H), 6.64 (dd, <i>J</i> = 8.0, 1.9 Hz, 1H), 6.43 (d, <i>J</i> = 8.0 Hz, 1H), 5.72 (t, <i>J</i> = 3.9 Hz, 1H), 4.82–4.72 (m, 2H), 4.11 (s, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 466.17 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Perfluorophenyl 4-(2-(1-Methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60a</b>)</h4><div class="NLM_p last">5-(2-(7-(Benzylthio)-2<i>H</i>-chromen-4-yl)-5-(trifluoromethyl)phenyl)-1-methyl-1<i>H</i>-pyrazole (<b>59a</b>) (100 g, 199 mmol) was dissolved in 1500 mL of DCM and 45.5 mL of acetic acid followed by 14.31 mL of water; the solution was cooled to −5 °C, and sulfuryl chloride (48.4 mL, 0.60 mol) was added dropwise. After the addition, the reaction was stirred for 1 h; TLC showed formation of sulfonyl chloride. The reaction mixture was washed with water, and the DCM layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The crude sulfonyl chloride product was diluted with 500 mL of DCM and added slowly to a stirred solution of 2,3,4,5,6-pentafluorophenol (54.8 g, 0.30 mol) and triethylamine (138 mL, 0.99 mol) in DCM at −5 °C. The reaction mixture was stirred for 1 h, after which it was washed with water, and the DCM layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The crude product was purified by column chromatography to obtain the title compound as a pale-yellow solid (85 g, 71%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.82 (dd, <i>J</i> = 8.1, 1.9 Hz, 1H), 7.72 (d, <i>J</i> = 1.9 Hz, 1H), 7.56 (d, <i>J</i> = 8.0 Hz, 1H), 7.44–7.31 (m, 3H), 6.83 (d, <i>J</i> = 8.1 Hz, 1H), 6.13 (d, <i>J</i> = 1.9 Hz, 1H), 5.84 (t, <i>J</i> = 3.8 Hz, 1H), 4.92 (d, <i>J</i> = 3.8 Hz, 2H), 3.70 (s, 3H). LCMS (ESI): <i>m</i>/<i>z</i> 603.03 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> Perfluorophenyl 4-(2-(1<i>H</i>-1,2,3-Triazol-1-yl)-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60b</b>)</h4><div class="NLM_p last">It was synthesized from 1-(2-(7-(benzylthio)-2<i>H</i>-chromen-4-yl)-5-(trifluoromethyl)phenyl)-1<i>H</i>-1,2,3-triazole (<b>59b</b>) by following an analogous procedure described for <b>60a</b> (yield = 60%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.03 (d, <i>J</i> = 1.8 Hz, 1H), 7.91 (dd, <i>J</i> = 8.7, 1.7 Hz, 1H), 7.72 (d, <i>J</i> = 1.1 Hz, 1H), 7.70 – 7.64 (m, 2H), 7.38 (d, <i>J</i> = 1.9 Hz, 1H), 7.31 (d, <i>J</i> = 1.9 Hz, 1H), 6.73 (d, <i>J</i> = 8.1 Hz, 1H), 6.05 (t, <i>J</i> = 3.8 Hz, 1H), 4.97 (d, <i>J</i> = 3.8 Hz, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 589.83 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> Perfluorophenyl 4-(2-(2-Methyloxazol-4-yl)-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60c</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-tosylhydrazono)chroman-7-sulfonate (<b>63</b>) and 4-(2-bromo-5-(trifluoromethyl)phenyl)-2-methyloxazole (<b>58c</b>) by following an analogous procedure described for <b>59a</b> (yield = 38%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.36 (s, 1H), 7.68 (d, <i>J</i> = 8.0 Hz, 1H), 7.57 (s, 1H), 7.52–7.41 (m, 2H), 7.25 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 6.69 (d, <i>J</i> = 8.1 Hz, 1H), 6.10 (t, <i>J</i> = 3.7 Hz, 1H), 5.10 (dd, <i>J</i> = 6.3, 3.7 Hz, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 603.88 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Perfluorophenyl 4-(2-(Thiazol-2-yl)-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60d</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-tosylhydrazono)chroman-7-sulfonate (<b>63</b>) and 2-(2-bromo-5-(trifluoromethyl)phenyl)thiazole (<b>58d</b>) by following an analogous procedure described for <b>59a</b> (yield = 44%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.45 (d, <i>J</i> = 1.9 Hz, 1H), 7.84 (d, <i>J</i> = 3.2 Hz, 1H), 7.79 (d, <i>J</i> = 8.0 Hz, 1H), 7.52 (d, <i>J</i> = 8.0 Hz, 1H), 7.40 (d, <i>J</i> = 1.8 Hz, 1H), 7.36 (d, <i>J</i> = 3.2 Hz, 1H), 7.21 (dd, <i>J</i> = 8.1, 1.9 Hz, 1H), 6.68 (d, <i>J</i> = 8.1 Hz, 1H), 6.14 (t, <i>J</i> = 3.7 Hz, 1H), 5.12 (t, <i>J</i> = 4.1 Hz, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 606.03 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Perfluorophenyl 4-(2-(6-Fluoropyridin-3-yl)-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60e</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-tosylhydrazono)chroman-7-sulfonate (<b>63</b>) and 5-(2-bromo-5-(trifluoromethyl)phenyl)-2-fluoropyridine (<b>58e</b>) by following an analogous procedure described for <b>59a</b> (yield = 52%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.22 (d, <i>J</i> = 2.5 Hz, 1H), 7.80 (dd, <i>J</i> = 7.9, 1.8 Hz, 1H), 7.76–7.66 (m, 2H), 7.55 (d, <i>J</i> = 7.9 Hz, 1H), 7.32 (dd, <i>J</i> = 13.2, 1.9 Hz, 2H), 6.89 (dd, <i>J</i> = 8.5, 2.9 Hz, 1H), 6.75 (d, <i>J</i> = 8.1 Hz, 1H), 5.95 (t, <i>J</i> = 3.7 Hz, 1H), 4.98–4.92 (m, 2H). LCMS: <i>m</i>/<i>z</i> 618.03 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 5-Fluoro-2-(2-(7-((perfluorophenoxy)sulfonyl)-2<i>H</i>-chromen-4-yl)-5-(trifluoromethyl)phenyl)pyridine 1-Oxide (<b>60f</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-tosylhydrazono)chroman-7-sulfonate (<b>63</b>) and 2-(2-bromo-5-(trifluoromethyl)phenyl)-5-fluoropyridine 1-oxide (<b>58f</b>) by following an analogous procedure described for <b>59a</b> (yield = 59%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.17 (s, 1H), 7.83 (d, <i>J</i> = 8.7 Hz, 2H), 7.54 (d, <i>J</i> = 7.9 Hz, 1H), 7.44–7.33 (m, 3H), 7.04 (dd, <i>J</i> = 12.2, 4.8 Hz, 2H), 5.97 (s, 1H), 5.02–4.77 (m, 2H). LCMS: <i>m</i>/<i>z</i> 634.01 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Perfluorophenyl 4-(4′-Fluoro-5-(trifluoromethyl)-[1,1′-biphenyl]-2-yl)-2<i>H</i>-chromene-7-sulfonate (<b>60g</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-tosylhydrazono)chroman-7-sulfonate (<b>63</b>) and 4′-fluoro-2-iodo-5-(trifluoromethyl)-1,1′-biphenyl (<b>58g</b>) by following an analogous procedure described for <b>59a</b> (yield = 52%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.72 (d, <i>J</i> = 9.7 Hz, 2H), 7.49 (d, <i>J</i> = 7.9 Hz, 1H), 7.38–7.21 (m, 4H), 7.00 (t, <i>J</i> = 8.4 Hz, 2H), 6.77 (d, <i>J</i> = 8.1 Hz, 1H), 5.92 (t, <i>J</i> = 3.8 Hz, 1H), 4.92 (brs, 2H).</div></div><div id="sec5_1_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Perfluorophenyl 4-(2-(3-Oxomorpholino)-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60h</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-tosylhydrazono)chroman-7-sulfonate (<b>63</b>) and 4-(2-bromo-5-(trifluoromethyl)phenyl)morpholin-3-one (<b>58h</b>) by following an analogous procedure described for <b>59a</b> (yield = 42%). LCMS: <i>m</i>/<i>z</i> 621.71 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> Perfluorophenyl 4-(2-(2-Oxooxazolidin-3-yl)-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60i</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-tosylhydrazono)chroman-7-sulfonate (<b>63</b>) and 3-(2-iodo-5-(trifluoromethyl)phenyl)oxazolidin-2-one (<b>58i</b>) by following an analogous procedure described for <b>59a</b> (yield = 41%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.77 (s, 1H), 7.72 (d, <i>J</i> = 8.1 Hz, 1H), 7.55–7.47 (m, 2H), 7.42 (d, <i>J</i> = 8.2 Hz, 1H), 6.90 (d, <i>J</i> = 8.1 Hz, 1H), 6.16 (t, <i>J</i> = 3.8 Hz, 1H), 5.17–4.98 (m, 2H), 4.34–4.16 (m, 2H), 3.98–3.85 (m, 1H), 3.78–3.61 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 630.01 (M + Na)<sup>+</sup>.</div></div><div id="sec5_1_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> Perfluorophenyl 4-(2-(1,1-Dioxidothiomorpholino)-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60j</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-tosylhydrazono)chroman-7-sulfonate (<b>63</b>) and 4-(2-bromo-5-(trifluoromethyl)phenyl)thiomorpholine 1,1-dioxide (<b>58j</b>) by following an analogous procedure described for <b>59a</b> (yield = 32%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.60–7.49 (m, 2H), 7.50–7.38 (m, 3H), 6.81 (d, <i>J</i> = 8.2 Hz, 1H), 6.15 (t, <i>J</i> = 3.7 Hz, 1H), 5.12–4.92 (m, 2H), 3.96–3.85 (m, 1H), 3.67–3.56 (m, 2H), 3.44–3.29 (m, 2H), 3.22–3.12 (m, 1H), 2.88–2.72 (m, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 656.05 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> <i>tert</i>-Butyl 4-(2-(7-((perfluorophenoxy)sulfonyl)-2<i>H</i>-chromen-4-yl)-5-(trifluoromethyl)phenyl)piperazine-1-carboxylate (<b>60k</b>)</h4><div class="NLM_p">It was synthesized from perfluorophenyl 4-(2-tosylhydrazono)chroman-7-sulfonate (<b>63</b>).</div><div class="NLM_p last">and <i>tert</i>-butyl 4-(2-bromo-5-(trifluoromethyl)phenyl)piperazine-1-carboxylate (<b>58k</b>) by following an analogous procedure described for <b>59a</b> (yield = 43%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.48 (d, <i>J</i> = 1.9 Hz, 1H), 7.45–7.36 (m, 3H), 7.28–7.27 (m, 1H), 6.85 (d, <i>J</i> = 8.2 Hz, 1H), 6.15 (t, <i>J</i> = 3.8 Hz, 1H), 5.01 (dd, <i>J</i> = 15.6, 3.8 Hz, 2H), 3.25–3.03 (m, 6H), 2.84–2.62 (m, 2H), 1.44 (s, 9H). LCMS (ESI): <i>m</i>/<i>z</i> 729.20 (M + Na)<sup>+</sup>.</div></div><div id="sec5_1_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> Perfluorophenyl 4-(2-Chloro-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60l</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-tosylhydrazono)chroman-7-sulfonate (<b>63</b>) and 1-bromo-2-chloro-4-(trifluoromethyl)benzene (<b>58l</b>) by following an analogous procedure described for <b>59a</b> (yield = 61%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.81–7.76 (bs, 1H), 7.66 (dd, <i>J</i> = 7.9, 1.8 Hz, 1H), 7.52–7.45 (m, 2H), 7.38 (dd, <i>J</i> = 8.1, 1.9 Hz, 1H), 6.75 (d, <i>J</i> = 8.1 Hz, 1H), 6.02 (t, <i>J</i> = 3.7 Hz, 1H), 5.12 (dd, <i>J</i> = 13.6, 3.7 Hz, 2H), 1.34–1.19 (m, 1H).</div></div><div id="sec5_1_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> Perfluorophenyl 4-(2-Morpholino-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60m</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-tosylhydrazono)chroman-7-sulfonate (<b>63</b>) and 4-(2-bromo-5-(trifluoromethyl)phenyl)morpholine (<b>58m</b>) by following an analogous procedure described for <b>59a</b> (yield = 44%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.51 (d, <i>J</i> = 1.9 Hz, 1H), 7.45–7.36 (m, 3H), 6.88 (d, <i>J</i> = 8.2 Hz,1H), 6.16 (t, <i>J</i> = 3.8 Hz, 1H), 5.00 (m, 2H), 3.40 (m, 4H), 3.17 (bs, 2H), 2.79 (bs, 2H). LCMS(ESI): <i>m</i>/<i>z</i> 607.99 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> Perfluorophenyl 4-(2-(1-Methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61a</b>)</h4><div class="NLM_p last">Perfluorophenyl 4-(2-(1-methyl-1<i>H</i>-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60a</b>) (85 g, 0.141mol) was dissolved in 1 L of degassed ethyl acetate. The solution was put in a Parr shaker, 10% Pd-C (67.6 g, 0.0635 mol) was added, and the mixture was hydrogenated at 50 psi for 4 h. After completion of the reaction, the mixture was filtered through a pad of celite and the pad was washed with ethyl acetate. The filtrate was concentrated, and the crude was purified by column chromatography to obtain the product as a pale-yellow solid (80 g, 94%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.69 (dd, <i>J</i> = 8.3, 2.0 Hz, 1H), 7.63 (dd, <i>J</i> = 5.1, 1.9 Hz, 2H), 7.50 (d, <i>J</i> = 2.0 Hz, 1H), 7.38 (dd, <i>J</i> = 8.2, 2.0 Hz, 1H), 7.16 (d, <i>J</i> = 8.2 Hz, 1H), 6.96–6.88 (m, 1H), 6.36 (d, <i>J</i> = 1.9 Hz, 1H), 4.39–4.30 (m, 1H), 4.27 (t, <i>J</i> = 7.5 Hz, 1H), 4.21–4.16 (m, 1H), 3.81 (s, 3H), 2.24–2.14 (m, 1H), 2.07–1.98 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 604.08 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> Perfluorophenyl 4-(2-(1<i>H</i>-1,2,3-Triazol-1-yl)-4-(trifluoromethyl) phenyl) Chromane-7-sulfonate (<b>61b</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(1<i>H</i>-1,2,3-triazol-1-yl)-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60b</b>) by following an analogous procedure described for <b>61a</b> (yield = 83%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.97 (d, <i>J</i> = 15.9 Hz, 2H), 7.77 (d, <i>J</i> = 8.3 Hz, 1H), 7.68 (s, 1H), 7.51 (d, <i>J</i> = 2.0 Hz, 1H), 7.38 (dd, <i>J</i> = 8.2, 2.0 Hz, 1H), 7.26 (d, <i>J</i> = 8.2 Hz, 1H), 7.00 (d, <i>J</i> = 8.2 Hz, 1H), 4.40–4.25 (m, 2H), 4.25–4.17 (m, 1H), 2.50–2.37 (m, 1H), 2.23–2.09 (m, 1H). LCMS: <i>m</i>/<i>z</i> 592.20 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> Perfluorophenyl 4-(2-(2-Methyloxazol-4-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61c</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(2-methyloxazol-4-yl)-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60c</b>) by following an analogous procedure described for <b>61a</b> (yield = 76%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.82 (s, 1H), 7.77 (s, 1H), 7.55 (dd, <i>J</i> = 8.3, 2.0 Hz, 1H), 7.51 (d, <i>J</i> = 2.0 Hz, 1H), 7.36 (dd, <i>J</i> = 8.2, 2.0 Hz, 1H), 7.09–7.00 (m, 2H), 5.02 (t, <i>J</i> = 6.8 Hz, 1H), 4.37–4.22 (m, 2H), 2.57 (s, 3H), 2.47–2.37 (m, 1H), 2.22–2.09 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 605.91 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> Perfluorophenyl 4-(2-(Thiazol-2-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61d</b>)</h4><div class="NLM_p last">It was synthesized from 4-(2-(thiazol-2-yl)-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60d</b>) by following an analogous procedure described for <b>61a</b> (yield = 52%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.99 (d, <i>J</i> = 3.3 Hz, 1H), 7.96–7.92 (m, 1H), 7.63 (dd, <i>J</i> = 8.3, 1.9 Hz, 1H), 7.55 (d, <i>J</i> = 3.3 Hz, 1H), 7.51 (d, <i>J</i> = 2.0 Hz, 1H), 7.40–7.34 (m, 1H), 7.13 (d, <i>J</i> = 8.2 Hz, 1H), 7.05 (d, <i>J</i> = 8.2 Hz, 1H), 5.39–5.24 (m, 1H), 4.39–4.31 (m, 1H), 4.33–4.22 (m, 1H), 2.57–2.42 (m, 1H), 2.27–2.11 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 608.00 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> Perfluorophenyl 4-(2-(6-Fluoropyridin-3-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61e</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(6-fluoropyridin-3-yl)-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60e</b>) by following an analogous procedure described for <b>61a</b> (yield = 74%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.30 (d, <i>J</i> = 2.5 Hz, 1H), 7.85 (td, <i>J</i> = 7.9, 2.5 Hz, 1H), 7.66 (dd, <i>J</i> = 8.2, 2.0 Hz, 1H), 7.58 (d, <i>J</i> = 2.0 Hz, 1H), 7.50 (d, <i>J</i> = 2.0 Hz, 1H), 7.38 (dd, <i>J</i> = 8.2, 2.0 Hz, 1H), 7.18–7.09 (m, 2H), 6.94 (dd, <i>J</i> = 8.1, 1.0 Hz, 1H), 4.42–4.28 (m, 2H), 4.20–4.10 (m, 1H), 2.25–2.07 (m, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 620.02 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> Perfluorophenyl 4-(2-(5-Fluoropyridin-2-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61f</b>)</h4><div class="NLM_p last">It was synthesized from 5-fluoro-2-(2-(7-((perfluorophenoxy)sulfonyl)-2<i>H</i>-chromen-4-yl)-5-(trifluoromethyl)phenyl)pyridine 1-oxide (<b>60f</b>) by following an analogous procedure described for <b>61a</b> (yield = 90%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.30 (d, <i>J</i> = 2.5 Hz, 1H), 7.85 (td, <i>J</i> = 7.9, 2.5 Hz, 1H), 7.66 (dd, <i>J</i> = 8.2, 2.0 Hz, 1H), 7.58 (d, <i>J</i> = 2.0 Hz, 1H), 7.50 (d, <i>J</i> = 2.0 Hz, 1H), 7.38 (dd, <i>J</i> = 8.2, 2.0 Hz, 1H), 7.18–7.09 (m, 2H), 6.94 (dd, <i>J</i> = 8.1, 1.0 Hz, 1H), 4.42–4.28 (m, 2H), 4.20–4.10 (m, 1H), 2.25–2.07 (m, 2H). LCMS: <i>m</i>/<i>z</i> 620.10 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> Perfluorophenyl 4-(4′-Fluoro-5-(trifluoromethyl)-[1,1′-biphenyl]-2-yl)chromane-7-sulfonate (<b>61g</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(4′-fluoro-5-(trifluoromethyl)-[1,1′-biphenyl]-2-yl)-2<i>H</i>-chromene-7-sulfonate (<b>60g</b>) by following an analogous procedure described for <b>61a</b> (yield = 90%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.61–7.55 (m, 2H), 7.49 (d, <i>J</i> = 2.0 Hz, 1H), 7.39–7.34 (m, 3H), 7.21 (t, <i>J</i> = 8.4 Hz, 2H), 7.08 (d, <i>J</i> = 8.1 Hz, 1H), 6.96 (d, <i>J</i> = 8.2 Hz, 1H), 4.45–4.40 (m, 1H), 4.39–4.31 (m, 1H), 4.18–4.14 (m, 1H), 2.20–2.07 (m, 2H).</div></div><div id="sec5_1_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> Perfluorophenyl (<i>R</i>)-4-(2-(3-Oxomorpholino)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61h</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl perfluorophenyl 4-(2-(3-oxomorpholino)-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60h</b>) by following an analogous procedure described for <b>61a</b> (yield = 85%). LCMS (ESI): <i>m</i>/<i>z</i> 624.06(M + H)<sup>+</sup>. The required enantiomer was separated by chiral preparative HPLC.</div></div><div id="sec5_1_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> Perfluorophenyl 4-(2-(2-Oxooxazolidin-3-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61i</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(2-oxooxazolidin-3-yl)-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60i</b>) by following an analogous procedure described for <b>61a</b> (yield = 75%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.04 (s, 1H), 7.68 (d, <i>J</i> = 8.3 Hz, 1H), 7.45 (s, 1H), 7.40 (d, <i>J</i> = 8.3 Hz, 1H), 7.17 (d, <i>J</i> = 8.2 Hz, 1H), 7.08 (d, <i>J</i> = 8.2 Hz, 1H), 4.75 (t, <i>J</i> = 7.4 Hz, 1H), 4.54 (t, <i>J</i> = 8.2 Hz, 2H), 4.34 (t, <i>J</i> = 5.2 Hz, 2H), 4.14 (q, <i>J</i> = 7.9 Hz, 1H), 4.03 (p, <i>J</i> = 7.7, 6.5 Hz, 1H), 2.38–2.29 (m, 1H), 2.13–2.02 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 610.10(M + H)<sup>+</sup>.</div></div><div id="sec5_1_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> Perfluorophenyl 4-(2-(1,1-Dioxidothiomorpholino)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61j</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-(1,1-dioxidothiomorpholino)-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60j</b>) by following an analogous procedure described for <b>61a</b> (yield = 84%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.59 (s, 1H), 7.55 (d, <i>J</i> = 1.9 Hz, 1H), 7.50–7.44 (m, 1H), 7.37 (dd, <i>J</i> = 8.2, 1.9 Hz, 1H), 7.08 (d, <i>J</i> = 8.2 Hz, 1H), 6.87 (d, <i>J</i> = 8.2 Hz, 1H), 4.77 (d, <i>J</i> = 7.6 Hz, 1H), 4.46–4.26 (m, 2H), 3.65–3.34 (m, 4H), 3.31–3.08 (m, 4H), 2.41–2.12 (m, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 657.84 (M + H)<sup>+</sup>. The <i>R</i> enantiomer <b>[61j(<i>R</i>)]</b> was separated from the racemic compound by chiral preparative HPLC.</div></div><div id="sec5_1_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> <i>tert-</i>Butyl 4-(2-(7-((Perfluorophenoxy)sulfonyl)chroman-4-yl)-5-(trifluoromethyl)phenyl)piperazine-1-carboxylate (<b>61k</b>)</h4><div class="NLM_p last">It was synthesized from <i>tert</i>-butyl 4-(2-(7-((perfluorophenoxy)sulfonyl)-2<i>H</i>-chromen-4-yl)-5-(trifluoromethyl)phenyl)piperazine-1-carboxylate (<b>60k</b>) by following an analogous procedure described for <b>61a</b> (yield = 81%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.51 (d, <i>J</i> = 9.5 Hz, 2H), 7.37 (dd, <i>J</i> = 14.3, 8.1 Hz, 2H), 7.01 (d, <i>J</i> = 8.1 Hz, 1H), 6.89 (d, <i>J</i> = 8.2 Hz, 1H), 4.91 (s, 1H), 4.33 (dd, <i>J</i> = 20.5, 11.2 Hz, 2H), 3.87–3.37 (m, 4H), 3.14–2.96 (m, 2H), 2.96–2.80 (m, 2H), 2.42–2.29 (m, 1H), 2.29–2.11 (m, 1H), 1.51 (s, 9H). LCMS (ESI): <i>m</i>/<i>z</i> 709.23 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_85" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> Perfluorophenyl (<i>S</i>)-4-(2-Chloro-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61l</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-chloro-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60l</b>) by following an analogous procedure described for <b>61a</b> (yield = 50%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.77–7.74 (m, 1H), 7.55 (d, <i>J</i> = 2.0 Hz, 1H), 7.48 (dt, <i>J</i> = 8.1, 1.2 Hz, 1H), 7.42 (dd, <i>J</i> = 8.2, 2.0 Hz, 1H), 7.06 (dd, <i>J</i> = 8.1, 0.9 Hz, 1H), 6.96 (d, <i>J</i> = 8.1 Hz, 1H), 4.82 (t, <i>J</i> = 6.1 Hz, 1H), 4.37–4.20 (m, 2H), 2.49–2.38 (m, 1H), 2.25–2.14 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 580.95 (M + Na)<sup>+</sup>. The enantiomers were separated using chiral preparative HPLC.</div></div><div id="sec5_1_86" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> Perfluorophenyl 4-(2-Morpholino-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61m</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 4-(2-morpholino-4-(trifluoromethyl)phenyl)-2<i>H</i>-chromene-7-sulfonate (<b>60m</b>) by following an analogous procedure described for <b>61a</b> (yield = 72%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.52 (t, <i>J</i> = 2.2 Hz, 2H), 7.38 (d, <i>J</i> = 8.1 Hz, 1H), 7.35 (dd, <i>J</i> = 8.2, 2.0 Hz, 1H), 7.01(d, <i>J</i> = 8.2 Hz, 1H), 6.88 (dd, <i>J</i> = 8.2, 1.0 Hz, 1H), 4.91 (t, <i>J</i> = 7.3 Hz, 1H), 4.43–4.27 (m, 2H), 3.90 (q, <i>J</i> = 7.2, 6.5 Hz, 4H), 3.14–3.01 (m, 2H), 2.92 (s, 2H), 2.34 (m, 1H), 2.19 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 610.0(M + H)<sup>+</sup>. The <i>R</i> enantiomer <b>[61m(<i>R</i>)]</b> was separated from the racemic compound by chiral preparative HPLC.</div></div><div id="sec5_1_87" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> Perfluorophenyl (<i>R</i>)-4-(2-(6-Methylpyridin-3-yl)-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61n</b>)</h4><div class="NLM_p last">A stirred suspension of perfluorophenyl (<i>S</i>)-4-(2-chloro-4-(trifluoromethyl)phenyl)chromane-7-sulfonate (<b>61l</b>) (0.70 g, 1.16 mmol), 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine (0.64 g, 2.90 mmol), and Na<sub>2</sub>CO<sub>3</sub> (0.25 g, 2.32 mmol) in a solvent mixture of 10 mL of 1,4-dioxane and 1.0 mL of water was degassed for 15 min using nitrogen; then, PdCl<sub>2</sub>(dppf)-CH<sub>2</sub>Cl<sub>2</sub> adduct (0.095 g, 0.12 mmol) was added and heated at 100 °C for 2 h. After completion of the reaction as indicated by TLC, the reaction mixture was poured into water and extracted with ethyl acetate. The combined organic layer was washed with water, followed by brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under vacuum. The crude product was purified by column chromatography to obtain the title compound (0.65 g, 91%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.57 (d, <i>J</i> = 2.3 Hz, 1H), 7.63 (m, 2H), 7.58 (d, <i>J</i> = 1.9 Hz, 1H), 7.49 (d, <i>J</i> = 2.0 Hz, 1H), 7.39–7.31 (m, 2H), 7.12 (d, <i>J</i> = 8.2 Hz, 1H), 6.95 (d, <i>J</i> = 8.2 Hz, 1H), 4.44–4.29 (m, 2H), 4.19–4.14 (m, 1H), 2.68 (s, 3H), 2.25–2.08 (m, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 516.11 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_88" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> <i>N</i>′-(5-(Benzylthio)-2,3-dihydro-1<i>H</i>-inden-1-ylidene)-4-methylbenzene Sulfonohydrazide (<b>65</b>)</h4><div class="NLM_p last">It was synthesized from 5-(benzylthio)-2,3-dihydro-1<i>H</i>-inden-1-one (<b>64</b>) [synthesized as described in Howbert et al., <i>Synth. Commun</i>., 1990, 20(20), 3193–3200] by following an analogous procedure described for <b>57</b> (yield = 90%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>), δ 10.31 (s, 1H), 7.81 (d, <i>J</i> = 7.9 Hz, 2H), 7.43–7.34 (m, 5H), 7.33–7.27 (m, 3H), 7.26–7.19 (m, 2H), 4.28 (s, 2H), 2.99–2.92 (m, 2H), 2.76–2.67 (m, 2H), 2.37 (s, 3H). LCMS (ESI): <i>m</i>/<i>z</i> 423.01 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_89" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> Benzyl(3-(2-chloro-4-(trifluoromethyl)phenyl)-1<i>H</i>-inden-6-yl)sulfane (<b>66a</b>)</h4><div class="NLM_p last">It was synthesized from <i>N</i>′-(5-(benzylthio)-2,3-dihydro-1<i>H</i>-inden-1-ylidene)-4-methylbenzene sulfonohydrazide (<b>65</b>) and 1-bromo-2-chloro-4-(trifluoromethyl)benzene (<b>58l</b>) by following an analogous procedure described for <b>59a</b> (yield = 51%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.80 (s, 1H), 7.61 (d, <i>J</i> = 8.1 Hz, 1H), 7.54 (s, 2H), 7.38–7.28 (m, 6H), 7.15–7.04 (m, 1H), 6.65 (d, <i>J</i> = 3.0 Hz, 1H), 4.17 (s, 2H), 3.58 (s, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 417.18 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_90" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> 4-(2-(6-(Benzylthio)-1<i>H</i>-inden-3-yl)-5-(trifluoromethyl)phenyl)morpholine (<b>66b</b>)</h4><div class="NLM_p last">It was synthesized from <i>N</i>′-(5-(benzylthio)-2,3-dihydro-1<i>H</i>-inden-1-ylidene)-4-methylbenzene sulfonohydrazide (<b>65</b>) and 4-(2-bromo-5-(trifluoromethyl)phenyl)morpholine (<b>58m</b>) by following an analogous procedure described for <b>59a</b> (yield = 58%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.54 (s, 1H), 7.49 (d, <i>J</i> = 7.9 Hz, 1H), 7.40 (d, <i>J</i> = 8.1 Hz, 1H), 7.34–7.28 (m, 4H), 7.27–7.19 (m, 4H), 6.74 (d, <i>J</i> = 2.2 Hz, 1H), 4.23 (s, 2H), 3.34 (s, 2H), 3.29 (d, <i>J</i> = 5.2 Hz, 4H), 2.90 (t, <i>J</i> = 4.3 Hz, 4H). LCMS (ESI): <i>m</i>/<i>z</i> 468.03 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_91" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> Perfluorophenyl 1-(2-Chloro-4-(trifluoromethyl)phenyl)-2,3-dihydro-1<i>H</i>-indene-5-sulfonate (<b>67a</b>)</h4><div class="NLM_p last">To a cold suspension (5 °C) of benzyl(3-(2-chloro-4-(trifluoromethyl)phenyl)-1<i>H</i>-inden-6-yl)sulfane (<b>66a</b>) (1 g, 1.9 mmol) in acetic acid (10 mL) and water (1 mL) was added NCS (0.73 g, 5.4 mmol) in two portions. After completion of the reaction as indicated by TLC, the reaction mixture was diluted with DCM. The organic layer was washed with water, followed by brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated to dryness under vacuum. This crude sulfonyl chloride was taken in DCM (10 mL) and added into a stirred solution of 2,3,4,5,6-pentafluorophenol (0.54 g, 2.9 mmol) and triethylamine (1.9 mL, 13.6 mmol) in 10 mL of DCM at 0 °C. The reaction mixture was gradually warmed to room temperature and stirred for 45 min. The reaction mixture was quenched with water, followed by extraction with DCM. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and purified by column chromatography to obtain a brown sticky mass (yield = 700 mg, 55%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.24 (s, 1H), 8.10 (s, 1H), 7.93 (d, <i>J</i> = 8.3 Hz, 1H), 7.88 (d, <i>J</i> = 8.1 Hz, 1H), 7.76 (d, <i>J</i> = 8.0 Hz, 1H), 7.43 (d, <i>J</i> = 8.4 Hz, 1H), 7.23 (s, 1H), 3.96–3.83 (m, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 562.95 (M + Na)<sup>+</sup>.</div></div><div id="sec5_1_92" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116"> Perfluorophenyl 3-(2-Morpholino-4-(trifluoromethyl)phenyl)-1<i>H</i>-indene-6-sulfonate (<b>67b</b>)</h4><div class="NLM_p last">It was synthesized from 4-(2-(6-(benzylthio)-1<i>H</i>-inden-3-yl)-5-(trifluoromethyl)phenyl)morpholine (<b>66b</b>) by following an analogous procedure described for <b>67a</b> (yield = 53%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.19 (s, 1H), 7.86 (d, <i>J</i> = 8.3 Hz, 1H), 7.60–7.51 (m, 3H), 7.47 (d, <i>J</i> = 8.4 Hz, 1H), 7.18 (s, 1H), 3.81 (s, 2H), 3.26 (br s, 4H), 2.91 (br s, 4H). LCMS (ESI): <i>m</i>/<i>z</i> 592.03 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_93" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117"> Perfluorophenyl 1-(2-Chloro-4-(trifluoromethyl)phenyl)-2,3-dihydro-1<i>H</i>-indene-5-sulfonate (<b>68a</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 1-(2-chloro-4-(trifluoromethyl)phenyl)-2,3-dihydro-1<i>H</i>-indene-5-sulfonate (<b>67a</b>) by following an analogous procedure described for <b>61a</b> (yield = 91%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.03 (s, 1H), 7.96 (s, 1H), 7.81 (d, <i>J</i> = 8.1 Hz, 1H), 7.68 (d, <i>J</i> = 8.2 Hz, 1H), 7.30 (d, <i>J</i> = 8.1 Hz, 1H), 7.24 (d, <i>J</i> = 8.2 Hz, 1H), 5.02 (t, <i>J</i> = 8.3 Hz, 1H), 3.23–3.07 (m, 2H), 2.77–2.69 (m, 1H), 2.17–2.08 (m, 1H).</div></div><div id="sec5_1_94" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118"> Perfluorophenyl 1-(2-Morpholino-4-(trifluoromethyl)phenyl)-2,3-dihydro-1<i>H</i>-indene-5-sulfonate (<b>68b</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 3-(2-morpholino-4-(trifluoromethyl)phenyl)-1<i>H</i>-indene-6-sulfonate (<b>67b</b>) by following an analogous procedure described for <b>61a</b> (yield = 87%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 7.95 (s, 1H), 7.75 (d, <i>J</i> = 8.1 Hz, 1H), 7.48 (s, 1H), 7.37 (d, <i>J</i> = 8.2 Hz, 1H), 7.03 (t, <i>J</i> = 7.5 Hz, 2H), 5.15 (t, <i>J</i> = 8.9 Hz, 1H), 3.90 (d, <i>J</i> = 5.0 Hz, 4H), 3.30–3.20 (m, 1H), 3.20–2.96 (m, 5H), 2.79–2.72 (m, 1H), 2.19–2.05 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 594.00 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_95" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119"> 1-(2-Chloro-4-(trifluoromethyl)phenyl)-<i>N</i>-(2,4-dimethoxybenzyl)-<i>N</i>-(pyrimidin-2-yl)-2,3-dihydro-1<i>H</i>-indene-5-sulfonamide (<b>69</b>)</h4><div class="NLM_p last">It was synthesized from perfluorophenyl 1-(2-chloro-4-(trifluoromethyl)phenyl)-2,3-dihydro-1<i>H</i>-indene-5-sulfonate (<b>68a</b>) and <i>N</i>-(2,4-dimethoxybenzyl)pyrimidin-2-amine (synthesized as described in Sun et al.,<a onclick="showRef(event, 'cit19a'); return false;" href="javascript:void(0);" class="ref cit19a">(19a)</a>) by following an analogous procedure described for <b>1a</b> and <b>1b</b> (yield = 55%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.60 (d, <i>J</i> = 4.8 Hz, 2H), 7.94 (s, 1H), 7.84 (d, <i>J</i> = 8.5 Hz, 1H), 7.73 (s, 1H), 7.67 (d, <i>J</i> = 8.1 Hz, 1H), 7.22–7.12 (m, 2H), 7.08 (d, <i>J</i> = 8.1 Hz, 1H), 6.99 (d, <i>J</i> = 8.3 Hz, 1H), 6.50 (d, <i>J</i> = 2.3 Hz, 1H), 6.48–6.42 (m, 1H), 5.31 (s, 2H), 4.90 (t, <i>J</i> = 8.2 Hz, 1H), 3.73 (s, 3H), 3.59 (s, 3H), 3.12–2.91 (m, 2H), 2.69–2.60 (m, 1H), 2.09–1.99 (m, 1H). LCMS (ESI): <i>m</i>/<i>z</i> 604.12 (M + H)<sup>+</sup>.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i120" class="anchor-spacer"></div><h3 class="article-section__title" id="_i120"> Sodium Channel Inhibition Using the FLIPR Membrane Potential Assay</h3><div class="NLM_p last">HEK-293 cells overexpressing the channel of interest were seeded in a 96-well plate at a density of 30000 cells/well and incubated at 37 °C/5% CO<sub>2</sub> for 48 h. The assay was carried out using the red membrane potential dye (Molecular Devices) following the manufacturer’s instructions. Briefly, the cells were incubated with 1X red membrane potential dye for 1.5 h. The cells were then treated with various concentrations of the test compounds for 15–20 min followed by depolarization with 10–30 μM Veratridine. The fluorescence was read following excitation at 510–545 nm and emission at 565–625 nm in FLIPR. The “max-min” fluorescence values were used to calculate the % inhibition. IC<sub>50</sub> values were calculated by plotting % inhibition against concentration and curve-fitting into a sigmoidal dose response.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i121" class="anchor-spacer"></div><h3 class="article-section__title" id="_i121"> Manual Patch-Clamp Electrophysiology Assay</h3><div class="NLM_p">HEK-293 cells stably expressed with the hNa<sub>V</sub>1.7 or hNa<sub>V</sub>1.5 ion channel were held at −120 mV. Inhibition of sodium current due to the test article was measured using a voltage step protocol. Cells were cultured in DMEM/F-12 media containing 10% FBS with 400 μg/ml G418. The cells plated (20000–30000 cells/ml) on PDL-coated coverslips were placed in a recording chamber on the stage of an inverted microscope and continuously perfused (∼1–2 mL/min) with a bath solution at room temperature. When filled with the pipette solution, patch electrodes had a tip resistance of approximately 1–3 MΩ. After a tight gigaseal had been achieved between the patch electrode and a cell, the membrane across the electrode tip was ruptured to establish the whole-cell patch-clamp configuration. Once a stable patch status was achieved, the recordings in the voltage clamp mode, with a holding voltage of −120 mV, were noted. After control currents were recorded, solutions with set concentrations of 1, 10, 100, 1000, 2500, and 10000 nM for Na<sub>V</sub>1.7 and 1000 and 10 000 nM for Na<sub>V</sub>1.5 test articles were perfused through the bath. Sodium current changes in the presence of the test article at each concentration were recorded until a stable point was reached. The sodium current amplitudes were measured at the pretreatment control and steady-state blockade for the desired concentration. Each recording ended with a final application of the reference standard (Propafenone, 100 μM) to assess the contribution of endogenous currents. The remaining uninhibited current was subtracted to determine the potency of the test article for sodium current inhibition.</div><div class="NLM_p">The holding potential was kept at −120 mV. Resting, fast, and slow inactivation voltage protocols were used to study the effect of the test article on hNa<sub>V</sub>1.7 and hNa<sub>V</sub>1.5 currents. Single-pulse voltage was used from the holding potential to peak for the individual cell in the resting-state protocol.</div><div class="NLM_p">The 10 Hz 25 pulse protocol was used for fast inactivation and use-dependent phenomenon of hNa<sub>V</sub>1.7. A prepulse of 500 ms was given, and cells were held at <i>V</i><sub>1/2</sub> of inactivation (approx. 40–50%) with repeated pulse (25 pulses) given at 10 Hz. The slow inactivation protocol was given as a single-pulse protocol with prepulse of 10 s at <i>V</i><sub>1/2</sub> of inactivation. The single pulse was repeated every 15 s.</div><div class="NLM_p last">The 3 Hz 10 pulse protocol was used for fast inactivation and use-dependent phenomenon of hNa<sub>V</sub>1.5. A prepulse of 500 ms was given, and cells were held at <i>V</i><sub>1/2</sub> of inactivation (approx. 40–50%) with repeated pulse (10 pulses) given at 3 Hz. The single pulse was repeated every 20 and 15 s for fast inactivated and resting-state protocols for Na<sub>V</sub>1.5.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i122" class="anchor-spacer"></div><h3 class="article-section__title" id="_i122"> Pharmacokinetic Assessment</h3><div class="NLM_p last">The studies were conducted at the DMPK Laboratory of Lupin Limited, Pune, India, and approved by the Institutional Animal Care and Use Committee. Male BALB/c mice supplied by the Research Animal Facility, Lupin Ltd (Pune, India), were randomly assigned to two treatment groups (<i>n</i> = 9 per group). On the dosing day, mice received a single intravenous (IV) dose (1 mg/kg) or oral (PO) dose (10 mg/kg) of the compound. The dosing volume was 5 mL/kg for IV and 10 mL/kg for oral administration. The blood samples were collected at 0.083 (only for IV), 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h after dosing in microcentrifuge tubes containing K<sub>2</sub>EDTA as the anticoagulant. Blood samples were collected from a set of three mice per time-point alternating between three sets. Plasma samples were harvested by centrifugation of whole blood at 7000 rpm and 4 ± 2 °C for 5 min. All of the samples were stored below −20 °C until analysis. All samples were processed for analysis by the precipitation method using an internal standard and analyzed with the fit-for-purpose LCMS/MS method (LLOQ was 0.01 μM). The plasma concentration–time data was subjected to noncompartmental analysis using Phoenix WinNonlin (version: 8.0) to assess the pharmacokinetic parameters. For PK assessment in rats, male Sprague Dawley rats were randomly assigned to two treatment groups (<i>n</i> = 4 per group). On the dosing day, rats received a single intravenous (IV) dose (1 mg/kg) or oral (PO) dose (10 mg/kg) of the test compound, and ∼200 μL of blood samples was collected under light isoflurane anesthesia (Surgivet) at 0.083 (only for IV), 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h after dosing. Blood samples were collected from each rat per time-point. For dog PK, three male beagle dogs were used in two period cross-over study designs. In the first period, dogs received a single intravenous 15 min infusion dose (1 mg/kg), and after washout in the second period, dogs were administered the test compound orally (5 mg/kg). Blood samples were collected at 0.083 (only for IV), 0.25, 0.5, 1, 1.5, 2, 3, 4, 6, 8, and 24 h after dosing. Blood samples were collected from the cephalic vein of each dog per time-point.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i123" class="anchor-spacer"></div><h3 class="article-section__title" id="_i123"> In Vitro Metabolic Stability Assay</h3><div class="NLM_p last">Stock solutions of test compounds were spiked at 1 μM concentration into 0.25 mg/mL liver microsomes (rat and human) and preincubated for 5 min at 37 °C. The reaction was initiated by adding NADPH in potassium phosphate buffer (50 mM, pH 7.4). The reaction was quenched with 100 μL of the quenching solvent at 0, 10, 20, and 30 min. A positive control reaction was performed similarly with Nicardipine (1 μM) at 0.25 mg/mL microsomal protein concentration. An NADPH negative-control was performed in a similar manner, except that in this case NADPH was withheld from the incubation mixture and the samples were collected at 0 and 30 min. All of the samples were analyzed by LCMS/MS. The percentage of parent remaining at 10, 20, and 30 min was quantified. Log-transformed % parent remaining was plotted as a function of time, and the slope of the regression line was used to calculate the metabolic rate.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i124" class="anchor-spacer"></div><h3 class="article-section__title" id="_i124"> CYP Inhibition Assay</h3><div class="NLM_p">The inhibitory potencies of test compounds on CYP3A4 and CYP2C9 were evaluated by incubating in pooled human liver microsomes containing isozyme-specific substrates, using cofactors, and by monitoring the production of selective metabolites using ultrahigh-pressure liquid chromatography (UPLC)-MS/MS. The incubation mixtures were prepared by taking pooled human liver microsomes (0.15 mg/mL) and 2 mM NADPH, diluting the mixture with 50 mM pH 7.4 potassium phosphate buffer to a final volume of 1 mL. Test compounds (1 and 10 μM) or positive inhibitors like ketoconazole and sulfaphenazole at IC<sub>50</sub> concentrations (0.017, 0.685 μM) for CYP3A4 and 2C9 were taken. The CYP3A4 and 2C9 substrates were used at concentrations approximating their respective <i>K</i><sub>m</sub> values, i.e., 58 μM testosterone and 11 μM diclofenac sodium. After a 5 min preincubation at 37 °C, the reactions were initiated by addition of NADPH (80 μL/mL), and incubation was continued for 10 min at 37 °C in a shaking bath. The reaction was stopped by placing the tubes on ice and adding 75 μL of ice-cold methanol containing internal standards. For each isozyme, the mean area ratio in samples from control incubations containing no inhibitor was set to 100%, and areas or ratios for all other samples were expressed as % inhibition.<span class="NLM_disp-formula" id="ueqn1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_m001.gif" alt="" id="_i125" /></img></span></div><div class="NLM_p">All of the procedures conducted on animals were in accordance with the provisions of the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) and was approved by the Institutional Animal Ethics Committee (IAEC) of Lupin Research Park.</div><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i126" class="anchor-spacer"></div><h4 class="article-section__title" id="_i126"> Veratridine Pain Model<a onclick="showRef(event, 'cit9a'); return false;" href="javascript:void(0);" class="ref cit9a">(9a)</a></h4><div class="NLM_p last">In the veratridine pain model, pain was induced by subplanter injection of veratridine (20 μL, 50 μM in 0.1% V/V DMSO in PBS) in C57BL6 male mice. The animals were observed for nociceptive behavior (time spent in licking and/or flinching and/or guarding) for 20 min post veratridine injection. All studied compounds were administered orally 30 min prior to veratridine injection.</div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127"> Formalin Pain Model<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></h4><div class="NLM_p last">In the formalin pain model, formalin was injected into the planter region (20 μL, 1% v/v formaldehyde in normal saline) of C57BL6 male mice. The nociceptive behavior of each mouse (time spent in licking and/or flinching of the injected paw) was recorded for consecutive 5 min intervals and for total 40 min duration. Total time spent in nociceptive behavior at 0–5 and 10–40 min intervals was classified as phases I and II for each mouse, respectively. All studied compounds were administered orally 30 min prior to formalin injection.</div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i128" class="anchor-spacer"></div><h4 class="article-section__title" id="_i128"> Chronic Constriction Injury</h4><div class="NLM_p last">The chronic constriction injury (CCI)-induced neuropathic pain model<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> was developed in male ICR-CD1 mice by placing three loose loops of 6-0 chromic catgut around the sciatic nerve keeping ∼1 mm distance between them. The pain behavior was assessed by measuring paw-withdrawal response (measure of mechanical allodynia) by presenting a series of von Fray filaments. All studied compounds were administered orally 30 min, whereas gabapentin was administered 45 min prior to assessment of pain behavior.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i129"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00361" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22377" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22377" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00361?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00361</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">SMILES strrings for the compounds that are the subject of this publication (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00361/suppl_file/jm0c00361_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Confirmation of absolute configuration of active isomer; synthesis of intermediates <b>58a–m</b> and analytical data; methods and conditions for separation of enantiomers by preparative chiral HPLC (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00361/suppl_file/jm0c00361_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00361/suppl_file/jm0c00361_si_001.csv">jm0c00361_si_001.csv (5.71 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00361/suppl_file/jm0c00361_si_002.pdf">jm0c00361_si_002.pdf (3.33 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00361" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23202" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23202" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vidya Ramdas</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3965-6731" title="Orcid link">http://orcid.org/0000-0002-3965-6731</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ea9c838e938b988b878b8e8b99aa869f9a8384c4898587"><span class="__cf_email__" data-cfemail="2b5d424f524a594a464a4f4a586b475e5b424505484446">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rashmi Talwar</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vijay Kanoje</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajesh M. Loriya</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Moloy Banerjee</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pradeep Patil</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Advait Arun Joshi</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laxmikant Datrange</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amit Kumar Das</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deepak Sahebrao Walke</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vaibhav Kalhapure</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Talha Khan</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ganesh Gote</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Usha Dhayagude</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shreyas Deshpande</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Javed Shaikh</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ganesh Chaure</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ravindra R. Pal</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Santosh Parkale</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sachin Suravase</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Smita Bhoskar</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajesh V. Gupta</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anil Kalia</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajesh Yeshodharan</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mahammad Azhar</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jagadeesh Daler</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vinod Mali</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Geetika Sharma</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amitesh Kishore</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rupali Vyawahare</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gautam Agarwal</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Himani Pareek</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sagar Budhe</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><sup>†</sup><span class="hlFld-ContribAuthor strong">Arun Nayak</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dnyaneshwar Warude</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Praveen Kumar Gupta</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Parag Joshi</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sneha Joshi</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sagar Darekar</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dilip Pandey</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Akshaya Wagh</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Prashant B. Nigade</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maneesh Mehta</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vinod Patil</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dipak Modi</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shashikant Pawar</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mahip Verma</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Minakshi Singh</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sudipto Das</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jayasagar Gundu</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kumar Nemmani</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark G. Bock</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sharad Sharma</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dhananjay Bakhle</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajender Kumar Kamboj</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Venkata P. Palle</span> - <span class="hlFld-Affiliation affiliation">Novel Drug Discovery &
Development, Lupin Ltd., Lupin Research
Park, Survey No. 46 A/47
A, Village Nande, Taluka Mulshi, Pune 412115, India</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><sup>†</sup>Deceased, March 11, 2019.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e9830-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i131">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22845" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22845" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the analytical team for their support in purification, characterization, and isomer separation of compounds. We would also like to acknowledge all of the support received from various functional groups such as intellectual property management, process chemistry, and molecular modeling.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">AUC<sub>last</sub></td><td class="NLM_def"><p class="first last">area under the curve from time zero to the last measurable concentration</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum plasma concentration</p></td></tr><tr><td class="NLM_term">CCI</td><td class="NLM_def"><p class="first last">chronic constriction injury</p></td></tr><tr><td class="NLM_term">Compd</td><td class="NLM_def"><p class="first last">compound</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">systemic clearance</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">DCE</td><td class="NLM_def"><p class="first last">1,2-dichloroethane</p></td></tr><tr><td class="NLM_term">dppf</td><td class="NLM_def"><p class="first last">1,1′-bis(diphenylphosphino)ferrocene</p></td></tr><tr><td class="NLM_term">EP</td><td class="NLM_def"><p class="first last">electrophysiology</p></td></tr><tr><td class="NLM_term">%<i>F</i></td><td class="NLM_def"><p class="first last">oral bioavailability</p></td></tr><tr><td class="NLM_term">IV</td><td class="NLM_def"><p class="first last">intravenous delivery</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney 293 cells</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">LiHMDS</td><td class="NLM_def"><p class="first last">lithium bis(trimethylsilyl)amide</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mice liver microsomes</p></td></tr><tr><td class="NLM_term">MoLM</td><td class="NLM_def"><p class="first last">monkey liver microsomes</p></td></tr><tr><td class="NLM_term">mpk</td><td class="NLM_def"><p class="first last">milligram per kilogram</p></td></tr><tr><td class="NLM_term">Na<sub>V</sub>1.5</td><td class="NLM_def"><p class="first last">voltage-gated sodium channel 1.5</p></td></tr><tr><td class="NLM_term">Na<sub>V</sub>1.7</td><td class="NLM_def"><p class="first last">voltage-gated sodium channel 1.7</p></td></tr><tr><td class="NLM_term">NCS</td><td class="NLM_def"><p class="first last"><i>N</i>-chlorosuccinimide</p></td></tr><tr><td class="NLM_term">nd</td><td class="NLM_def"><p class="first last">not done</p></td></tr><tr><td class="NLM_term">NT</td><td class="NLM_def"><p class="first last">not tested</p></td></tr><tr><td class="NLM_term">nM</td><td class="NLM_def"><p class="first last">nanomolar</p></td></tr><tr><td class="NLM_term">Pfp</td><td class="NLM_def"><p class="first last">pentafluorophenyl</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PO</td><td class="NLM_def"><p class="first last">per oral delivery</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i133">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 26 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ragsdale, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPhee, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheuer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catterall, W. A.</span></span> <span> </span><span class="NLM_article-title">Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na<sup>+</sup> channels</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">9270</span>– <span class="NLM_lpage">9275</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.17.9270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1073%2Fpnas.93.17.9270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=8799190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADyaK28Xlt1Cnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=9270-9275&author=D.+S.+Ragsdaleauthor=J.+C.+McPheeauthor=T.+Scheuerauthor=W.+A.+Catterall&title=Common+molecular+determinants+of+local+anesthetic%2C+antiarrhythmic%2C+and+anticonvulsant+block+of+voltage-gated+Na%2B+channels&doi=10.1073%2Fpnas.93.17.9270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels</span></div><div class="casAuthors">Ragsdale, David S.; McPhee, Jancy C.; Scheuer, Todd; Catterall, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9270-9275</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Voltage-gated Na+ channels are the mol. targets of local anesthetics, class I antiarrhythmic drugs, and some anticonvulsants.  These chem. diverse drugs inhibit Na+ channels with complex voltage- and frequency-dependent properties that reflect preferential drug binding to open and inactivated channel states.  The site-directed mutations F1764A and Y1771A in transmembrane segment IVS6 of type IIA Na+ channel α subunits dramatically reduce the affinity of inactivated channels for the local anesthetic etidocaine.  In this study, we show that these mutations also greatly reduce the sensitivity of Na+ channels to state-dependent block by the class Ib antiarrhythmic drug lidocaine and the anticonvulsant phenytoin and, to a lesser extent, reduce the sensitivity to block by the class Ia and Ic antiarrhythmic drugs quinidine and flecainide.  For lidocaine and phenytoin, which bind preferentially to inactivated Na+ channels, the mutation F1764A reduced the affinity for binding to the inactivated state 24.5-fold and 8.3-fold, resp., while Y1771A had smaller effects.  For quinidine and flecainide, which bind preferentially to the open Na+ channels, the mutations F1764A and Y1771A reduced the affinity for binding to the open state 2- to 3-fold.  Thus, F1764 and Y1771 are common mol. determinants of state-dependent binding of diverse drugs including lidocaine, phenytoin, flecainide, and quinidine, suggesting that these drugs interact with a common receptor site.  However, the different magnitude of the effects of these mutations on binding of the individual drugs indicates that they interact in an overlapping, but nonidentical, manner with a common receptor site.  These results further define the contributions of F1764 and Y1771 to a complex drug receptor site in the pore of Na+ channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRIXUvm8DEQLVg90H21EOLACvtfcHk0liZ3Oy4b8B2fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xlt1Cnur0%253D&md5=6df1987234a739a47ed5e3b12059245d</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.17.9270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.17.9270%26sid%3Dliteratum%253Aachs%26aulast%3DRagsdale%26aufirst%3DD.%2BS.%26aulast%3DMcPhee%26aufirst%3DJ.%2BC.%26aulast%3DScheuer%26aufirst%3DT.%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26atitle%3DCommon%2520molecular%2520determinants%2520of%2520local%2520anesthetic%252C%2520antiarrhythmic%252C%2520and%2520anticonvulsant%2520block%2520of%2520voltage-gated%2520Na%252B%2520channels%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D9270%26epage%3D9275%26doi%3D10.1073%2Fpnas.93.17.9270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lampert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberhardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">Altered sodium channel gating as molecular basis for pain: contribution of activation, inactivation, and resurgent currents</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>221</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1007%2F978-3-642-41588-3_5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=24737233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFOiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=2014&pages=91-110&author=A.+Lampertauthor=M.+Eberhardtauthor=S.+G.+Waxman&title=Altered+sodium+channel+gating+as+molecular+basis+for+pain%3A+contribution+of+activation%2C+inactivation%2C+and+resurgent+currents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Altered sodium channel gating as molecular basis for pain: Contribution of activation, inactivation, and resurgent currents</span></div><div class="casAuthors">Lampert, Angelika; Eberhardt, Mirjam; Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue">Voltage Gated Sodium Channels</span>),
    <span class="NLM_cas:pages">91-110</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Mutations in voltage-gated sodium channels, esp. Nav1.7, can cause the genetic pain syndromes inherited erythromelalgia, small fiber neuropathy, paroxysmal extreme pain disorder, and chronic insensitivity to pain.  Functional anal. of these mutations offers the possibility of understanding the potential pathomechanisms of these disease patterns and also may help to explicate the mol. mechanisms underlying pain in normal conditions.  The mutations are distributed over the whole channel protein, but nevertheless induce similar changes for each pain syndrome.  In this review we focus on their impact on sodium channel gating, which may be conferred via modulation of (1) conformation (affecting all gating characteristics); (2) the amt. of voltage-sensing charges (affecting mainly activation); (3) interaction within the protein (e.g., binding of the inactivation linker); and (4) interaction with other proteins (e.g., for generation of resurgent currents).  Understanding the mol. basis for each gating mode and its impact on cellular excitability and nociception in each disease type may provide a basis for development of more specific and effective therapeutic tools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5dw1Yz0s5Y7Vg90H21EOLACvtfcHk0liZ3Oy4b8B2fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFOiurw%253D&md5=ba7b1e27b05d13a6d47ace1a80f5483b</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-41588-3_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-41588-3_5%26sid%3Dliteratum%253Aachs%26aulast%3DLampert%26aufirst%3DA.%26aulast%3DEberhardt%26aufirst%3DM.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DAltered%2520sodium%2520channel%2520gating%2520as%2520molecular%2520basis%2520for%2520pain%253A%2520contribution%2520of%2520activation%252C%2520inactivation%252C%2520and%2520resurgent%2520currents%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2014%26volume%3D221%26spage%3D91%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">England, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D.</span></span> <span> </span><span class="NLM_article-title">Isoform-selective voltage-gated Na<sup>+</sup> channel modulators as next-generation analgesics</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.4155/fmc.10.26</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.4155%2Ffmc.10.26" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=21426202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslamtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=775-790&author=S.+Englandauthor=D.+Rawson&title=Isoform-selective+voltage-gated+Na%2B+channel+modulators+as+next-generation+analgesics&doi=10.4155%2Ffmc.10.26"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform-selective voltage-gated Na+ channel modulators as next-generation analgesics</span></div><div class="casAuthors">England, Steve; Rawson, David</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">775-790</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  For many patients the current therapies for controlling chronic pain are inadequate.  This has driven the search for analgesics with improved efficacy and side effect profiles.  Some anticonvulsants have voltage-gated Na+ channels (VGSCs) as their mol. targets and are used to treat pain, but the efficacy seen is marginal and the drugs are generally poorly tolerated.  The clin. used VGSC-modulating analgesics show no isoform selectivity, which probably limits their use.  Thus, focus has fallen on VGSCs expressed selectively by primary afferent neurons and the search for isoform-selective drugs.  In this review, we describe developments in our understanding of the biol. of VGSCs, screening technologies and the pharmacol. properties of VGSC modulators with promise as analgesics.  Also highlighted are the challenges assocd. with targeting isoform-selective VGSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHZcFRT0qRdbVg90H21EOLACvtfcHk0li4XQe3XK2Sog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslamtLo%253D&md5=06b147bfe9141a4742ff4dcd2642b86c</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.4155%2Ffmc.10.26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.10.26%26sid%3Dliteratum%253Aachs%26aulast%3DEngland%26aufirst%3DS.%26aulast%3DRawson%26aufirst%3DD.%26atitle%3DIsoform-selective%2520voltage-gated%2520Na%252B%2520channel%2520modulators%2520as%2520next-generation%2520analgesics%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2010%26volume%3D2%26spage%3D775%26epage%3D790%26doi%3D10.4155%2Ffmc.10.26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ogata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span> <span> </span><span class="NLM_article-title">New perspectives on the structure and function of the Na<sup>+</sup> channel multigene family</span>. <i>Curr. Med. Chem.: Cent. Nerv. Syst. Agents</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.2174/1568015024606637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.2174%2F1568015024606637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Oltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=59-81&author=N.+Ogataauthor=S.+Yoshida&title=New+perspectives+on+the+structure+and+function+of+the+Na%2B+channel+multigene+family&doi=10.2174%2F1568015024606637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">New perspectives on the structure and function of the Na+ channel multigene family</span></div><div class="casAuthors">Ogata, Nobukuni; Yoshida, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Central Nervous System Agents</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-81</span>CODEN:
                <span class="NLM_cas:coden">CMCCCO</span>;
        ISSN:<span class="NLM_cas:issn">1568-0150</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent studies on the voltage-gated Na+ channel (VGSC) have revealed several excellent discoveries regarding its structure and function.  This article summarizes recent findings on VGSCs, and presents our views on the subject.  Based on the multi-pore 3D model of the VGSC, we propose a "twist-sprinkler" model: (i) twisting and untwisting of the central cavity corresponds to the closed and open states of the channel, and (ii) cytoplasmic outlet pores sprinkle Na+ ions laterally over the inner surface of the plasma membrane to effect a rapid depolarization.  VGSCs can be classified into two major categories.  Category-I isoforms currently comprise nine highly homologous clones (Nav1.1-Nav1.9), most of which have been functionally expressed.  In contrast, the category-II isoform consists of one clone (Nax), which has not been successfully expressed in an exogenous system.  It is considerably different from the category-I isoforms, esp. in the S4 segment, and shows little voltage dependence.  The main function of the category-I isoforms is to form an action potential upstroke.  However, Nav1.6 can also influence subthreshold elec. activity in neurons through the "persistent" and "resurgent" Na+ currents, indicating that the VGSC itself can modulate overall neuronal firing behavior.  Nav1.8 and Nav1.9 are preferentially expressed in peripheral nociceptive neurons and contain a structure common to tetrodotoxin (TTX)-resistant Na+ channels.  Both Nav1.8 and Nav1.9 play a pivotal role in pain sensation.  The category-II isoform Nax (x = unknown function) is a "concn.-sensitive" but not "voltage-sensitive" Na+ channel.  It is involved in regulation of salt intake behavior by sensing an increase in [Na+]o, and it should be renamed as Nac (c = concn.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmFQ0MDmvtlLVg90H21EOLACvtfcHk0li4XQe3XK2Sog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Oltrg%253D&md5=7aa71ed0cbe1d0478a7eebd85f055d16</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.2174%2F1568015024606637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568015024606637%26sid%3Dliteratum%253Aachs%26aulast%3DOgata%26aufirst%3DN.%26aulast%3DYoshida%26aufirst%3DS.%26atitle%3DNew%2520perspectives%2520on%2520the%2520structure%2520and%2520function%2520of%2520the%2520Na%252B%2520channel%2520multigene%2520family%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Cent.%2520Nerv.%2520Syst.%2520Agents%26date%3D2002%26volume%3D2%26spage%3D59%26epage%3D81%26doi%3D10.2174%2F1568015024606637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boorman, J.</span></span> <span> </span><span class="NLM_article-title">Voltage-gated sodium channel blockers; target validation and therapeutic potential</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.2174/1568026054367584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.2174%2F1568026054367584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=16022675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVKltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=529-537&author=J.+N.+Woodauthor=J.+Boorman&title=Voltage-gated+sodium+channel+blockers%3B+target+validation+and+therapeutic+potential&doi=10.2174%2F1568026054367584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-gated sodium channel blockers; target validation and therapeutic potential</span></div><div class="casAuthors">Wood, John N.; Boorman, James</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">529-537</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium channels are encoded by a family of 10 structurally-related genes that are expressed in spatially and temporally distinct patterns, mainly in excitable tissues.  They underlie elec. signalling in nerve and muscle.  It has long been known that sodium channel blockers are anesthetics as well as powerful analgesics when delivered at low concns.  In addn., cardiac arrhythmias and epileptic activity can be treated with sodium channel blockers.  As we have learned more about the subtypes of sodium channels and their distribution, new therapeutic opportunities have suggested themselves.  There are indications that sodium channel blockers may also be useful in affective disorders and schizophrenia.  The prodn. of tissue-specific and eventually inducible knock out mice as well as genetic studies has proved useful in understanding the specialized role of individual types of sodium channels.  The development of subtype-specific blockers has proved slower than anticipated, although the properties of naturally occurring toxin blockers suggest that subtype-specific blockers of sodium channels could be very useful clin. in the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro0_4sFMQybrVg90H21EOLACvtfcHk0li4XQe3XK2Sog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVKltro%253D&md5=1ed688405bc9f975b23d61fc2ada387c</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.2174%2F1568026054367584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054367584%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DBoorman%26aufirst%3DJ.%26atitle%3DVoltage-gated%2520sodium%2520channel%2520blockers%253B%2520target%2520validation%2520and%2520therapeutic%2520potential%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D529%26epage%3D537%26doi%3D10.2174%2F1568026054367584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eijkelkamp, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minett, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cregg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werdehausen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rugiero, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span> <span> </span><span class="NLM_article-title">Neurological perspectives on voltage-gated sodium channels</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">2585</span>– <span class="NLM_lpage">2612</span>, <span class="refDoi"> DOI: 10.1093/brain/aws225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1093%2Fbrain%2Faws225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=22961543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A280%3ADC%252BC38bltlymug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2012&pages=2585-2612&author=N.+Eijkelkampauthor=J.+E.+Linleyauthor=M.+D.+Bakerauthor=M.+S.+Minettauthor=R.+Creggauthor=R.+Werdehausenauthor=F.+Rugieroauthor=J.+N.+Wood&title=Neurological+perspectives+on+voltage-gated+sodium+channels&doi=10.1093%2Fbrain%2Faws225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Neurological perspectives on voltage-gated sodium channels</span></div><div class="casAuthors">Eijkelkamp Niels; Linley John E; Baker Mark D; Minett Michael S; Cregg Roman; Werdehausen Robert; Rugiero Francois; Wood John N</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">Pt 9</span>),
    <span class="NLM_cas:pages">2585-612</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The activity of voltage-gated sodium channels has long been linked to disorders of neuronal excitability such as epilepsy and chronic pain.  Recent genetic studies have now expanded the role of sodium channels in health and disease, to include autism, migraine, multiple sclerosis, cancer as well as muscle and immune system disorders.  Transgenic mouse models have proved useful in understanding the physiological role of individual sodium channels, and there has been significant progress in the development of subtype selective inhibitors of sodium channels.  This review will outline the functions and roles of specific sodium channels in electrical signalling and disease, focusing on neurological aspects.  We also discuss recent advances in the development of selective sodium channel inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMaWmHsTCoQ3l8icjszYl0fW6udTcc2ebAgE3W8SaNkbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bltlymug%253D%253D&md5=6f9b33df722a3c5831b8860d3fad1af2</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Faws225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Faws225%26sid%3Dliteratum%253Aachs%26aulast%3DEijkelkamp%26aufirst%3DN.%26aulast%3DLinley%26aufirst%3DJ.%2BE.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DMinett%26aufirst%3DM.%2BS.%26aulast%3DCregg%26aufirst%3DR.%26aulast%3DWerdehausen%26aufirst%3DR.%26aulast%3DRugiero%26aufirst%3DF.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26atitle%3DNeurological%2520perspectives%2520on%2520voltage-gated%2520sodium%2520channels%26jtitle%3DBrain%26date%3D2012%26volume%3D135%26spage%3D2585%26epage%3D2612%26doi%3D10.1093%2Fbrain%2Faws225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">de Lera Ruiz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span> <span> </span><span class="NLM_article-title">Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7093</span>– <span class="NLM_lpage">7118</span>, <span class="refDoi"> DOI: 10.1021/jm501981g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501981g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7093-7118&author=M.+de+Lera+Ruizauthor=R.+L.+Kraus&title=Voltage-gated+sodium+channels%3A+structure%2C+function%2C+pharmacology%2C+and+clinical+indications&doi=10.1021%2Fjm501981g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications</span></div><div class="casAuthors">de Lera Ruiz, Manuel; Kraus, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7093-7118</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The tremendous therapeutic potential of voltage-gated sodium channels (Navs) has been the subject of many studies in the past and is of intense interest today.  Nav1.7 channels in particular have received much attention recently because of strong genetic validation of their involvement in nociception.  Here we summarize the current status of research in the Nav field and present the most relevant recent developments with respect to the mol. structure, general physiol., and pharmacol. of distinct Nav channel subtypes.  We discuss Nav channel ligands such as small mols., toxins isolated from animal venoms, and the recently identified Nav1.7-selective antibody.  Furthermore, we review eight characterized ligand binding sites on the Nav channel α subunit.  Finally, we examine possible therapeutic applications of Nav ligands and provide an update on current clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn2idyYye8oLVg90H21EOLACvtfcHk0ljUhd6QZqNMkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D&md5=a816fdf5b46e2e5727669bf17e2e4fd4</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1021%2Fjm501981g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501981g%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLera%2BRuiz%26aufirst%3DM.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26atitle%3DVoltage-gated%2520sodium%2520channels%253A%2520structure%252C%2520function%252C%2520pharmacology%252C%2520and%2520clinical%2520indications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7093%26epage%3D7118%26doi%3D10.1021%2Fjm501981g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">The Na(V)1.7 sodium channel: from molecule to man</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1038/nrn3404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1038%2Fnrn3404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=23232607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=49-62&author=S.+D.+Dib-Hajjauthor=Y.+Yangauthor=J.+A.+Blackauthor=S.+G.+Waxman&title=The+Na%28V%291.7+sodium+channel%3A+from+molecule+to+man&doi=10.1038%2Fnrn3404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">The NaV1.7 sodium channel: from molecule to man</span></div><div class="casAuthors">Dib-Hajj, Sulayman D.; Yang, Yang; Black, Joel A.; Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-62</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The voltage-gated sodium channel NaV1.7 is preferentially expressed in peripheral somatic and visceral sensory neurons, olfactory sensory neurons and sympathetic ganglion neurons.  NaV1.7 accumulates at nerve fiber endings and amplifies small subthreshold depolarizations, poising it to act as a threshold channel that regulates excitability.  Genetic and functional studies have added to the evidence that NaV1.7 is a major contributor to pain signaling in humans, and homol. modeling based on crystal structures of ion channels suggests an at.-level structural basis for the altered gating of mutant NaV1.7 that causes pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC4lZH1L7XWLVg90H21EOLACvtfcHk0ljUhd6QZqNMkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ&md5=0e075d2c82d98774da1d316f4409d3eb</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1038%2Fnrn3404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3404%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DThe%2520Na%2528V%25291.7%2520sodium%2520channel%253A%2520from%2520molecule%2520to%2520man%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D49%26epage%3D62%26doi%3D10.1038%2Fnrn3404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rush, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisama, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrrell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">Gain-of-function mutation in Na<sub>V</sub>1.7 in familial erythromelalgia induces bursting of sensory neurons</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">1847</span>– <span class="NLM_lpage">1854</span>, <span class="refDoi"> DOI: 10.1093/brain/awh514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1093%2Fbrain%2Fawh514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=15958509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A280%3ADC%252BD2MzntF2mtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2005&pages=1847-1854&author=S.+D.+Dib-Hajjauthor=A.+M.+Rushauthor=T.+R.+Cumminsauthor=F.+M.+Hisamaauthor=S.+Novellaauthor=L.+Tyrrellauthor=L.+Marshallauthor=S.+G.+Waxman&title=Gain-of-function+mutation+in+NaV1.7+in+familial+erythromelalgia+induces+bursting+of+sensory+neurons&doi=10.1093%2Fbrain%2Fawh514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons</span></div><div class="casAuthors">Dib-Hajj S D; Rush A M; Cummins T R; Hisama F M; Novella S; Tyrrell L; Marshall L; Waxman S G</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">Pt 8</span>),
    <span class="NLM_cas:pages">1847-54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Erythromelalgia is an autosomal dominant disorder characterized by burning pain in response to warm stimuli or moderate exercise.  We describe a novel mutation in a family with erythromelalgia in SCN9A, the gene that encodes the Na(v)1.7 sodium channel.  Na(v)1.7 produces threshold currents and is selectively expressed within sensory neurons including nociceptors.  We demonstrate that this mutation, which produces a hyperpolarizing shift in activation and a depolarizing shift in steady-state inactivation, lowers thresholds for single action potentials and high frequency firing in dorsal root ganglion neurons.  Erythromelalgia is the first inherited pain disorder in which it is possible to link a mutation with an abnormality in ion channel function and with altered firing of pain signalling neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7l6KFKSfqfGPgL4LrC-0VfW6udTcc2ebTXU2h8nnNNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzntF2mtw%253D%253D&md5=6befcde7de47dd574901a333c2f14909</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawh514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawh514%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DRush%26aufirst%3DA.%2BM.%26aulast%3DCummins%26aufirst%3DT.%2BR.%26aulast%3DHisama%26aufirst%3DF.%2BM.%26aulast%3DNovella%26aufirst%3DS.%26aulast%3DTyrrell%26aufirst%3DL.%26aulast%3DMarshall%26aufirst%3DL.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DGain-of-function%2520mutation%2520in%2520NaV1.7%2520in%2520familial%2520erythromelalgia%2520induces%2520bursting%2520of%2520sensory%2520neurons%26jtitle%3DBrain%26date%3D2005%26volume%3D128%26spage%3D1847%26epage%3D1854%26doi%3D10.1093%2Fbrain%2Fawh514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rush, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">Mutation in the sodium channel Na<sub>V</sub>1.7 underlie inherited erythromelalgia</span>. <i>Drug Discovery Today: Dis. Mech.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1016/j.ddmec.2006.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.ddmec.2006.09.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=343-350&author=S.+D.+Dib-Hajjauthor=A.+M.+Rushauthor=T.+R.+Cumminsauthor=S.+G.+Waxman&title=Mutation+in+the+sodium+channel+NaV1.7+underlie+inherited+erythromelalgia&doi=10.1016%2Fj.ddmec.2006.09.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2Fj.ddmec.2006.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddmec.2006.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DRush%26aufirst%3DA.%2BM.%26aulast%3DCummins%26aufirst%3DT.%2BR.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DMutation%2520in%2520the%2520sodium%2520channel%2520NaV1.7%2520underlie%2520inherited%2520erythromelalgia%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Dis.%2520Mech.%26date%3D2006%26volume%3D3%26spage%3D343%26epage%3D350%26doi%3D10.1016%2Fj.ddmec.2006.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fertleman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffatt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmslie, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrahamsen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klugbauer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, M.</span></span> <span> </span><span class="NLM_article-title">SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2006.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.neuron.2006.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=17145499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCgu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2006&pages=767-774&author=C.+R.+Fertlemanauthor=M.+D.+Bakerauthor=K.+A.+Parkerauthor=S.+Moffattauthor=F.+V.+Elmslieauthor=B.+Abrahamsenauthor=J.+Ostmanauthor=N.+Klugbauerauthor=J.+N.+Woodauthor=R.+M.+Gardinerauthor=M.+Rees&title=SCN9A+mutations+in+paroxysmal+extreme+pain+disorder%3A+allelic+variants+underlie+distinct+channel+defects+and+phenotypes&doi=10.1016%2Fj.neuron.2006.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">SCN9A mutations in paroxysmal clinical study extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes</span></div><div class="casAuthors">Fertleman, Caroline R.; Baker, Mark D.; Parker, Keith A.; Moffatt, Sarah; Elmslie, Frances V.; Abrahamsen, Bjarke; Ostman, Johan; Klugbauer, Norbert; Wood, John N.; Gardiner, R. Mark; Rees, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">767-774</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Paroxysmal extreme pain disorder (PEPD), previously known as familial rectal pain (FRP, or OMIM 167400), is an inherited condition characterized by paroxysms of rectal, ocular, or submandibular pain with flushing.  A genome-wide linkage search followed by mutational anal. of the candidate gene SCN9A, which encodes hNav1.7, identified eight missense mutations in 11 families and 2 sporadic cases.  Functional anal. in vitro of three of these mutant Nav1.7 channels revealed a redn. in fast inactivation, leading to persistent sodium current.  Other mutations in SCN9A assocd. with more neg. activation thresholds are known to cause primary erythermalgia (PE).  Carbamazepine, a drug that is effective in PEPD, but not PE, showed selective block of persistent current assocd. with PEPD mutants, but did not affect the neg. activation threshold of a PE mutant.  PEPD and PE are allelic variants with distinct underlying biophys. mechanisms and represent a sep. class of peripheral neuronal sodium channelopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi2qhSqNNAvLVg90H21EOLACvtfcHk0lhF7TFJSDQFzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCgu7fJ&md5=2f52e4722b3046d2bb0dc7af0901e952</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2006.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2006.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DFertleman%26aufirst%3DC.%2BR.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DParker%26aufirst%3DK.%2BA.%26aulast%3DMoffatt%26aufirst%3DS.%26aulast%3DElmslie%26aufirst%3DF.%2BV.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DOstman%26aufirst%3DJ.%26aulast%3DKlugbauer%26aufirst%3DN.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DGardiner%26aufirst%3DR.%2BM.%26aulast%3DRees%26aufirst%3DM.%26atitle%3DSCN9A%2520mutations%2520in%2520paroxysmal%2520extreme%2520pain%2520disorder%253A%2520allelic%2520variants%2520underlie%2520distinct%2520channel%2520defects%2520and%2520phenotypes%26jtitle%3DNeuron%26date%3D2006%26volume%3D52%26spage%3D767%26epage%3D774%26doi%3D10.1016%2Fj.neuron.2006.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faber, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoeijmakers, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estacion, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauria, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoutte, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerrits, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drenth, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merkies, I. S.</span></span> <span> </span><span class="NLM_article-title">Gain of function Na<sub>V</sub>1.7 mutations in idiopathic small fiber neuropathy</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1002/ana.22485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1002%2Fana.22485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=21698661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=26-39&author=C.+G.+Faberauthor=J.+G.+Hoeijmakersauthor=H.+S.+Ahnauthor=X.+Chengauthor=C.+Hanauthor=J.+S.+Choiauthor=M.+Estacionauthor=G.+Lauriaauthor=E.+K.+Vanhoutteauthor=M.+M.+Gerritsauthor=S.+Dib-Hajjauthor=J.+P.+Drenthauthor=S.+G.+Waxmanauthor=I.+S.+Merkies&title=Gain+of+function+NaV1.7+mutations+in+idiopathic+small+fiber+neuropathy&doi=10.1002%2Fana.22485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy</span></div><div class="casAuthors">Faber, Catharina G.; Hoeijmakers, Janneke G. J.; Ahn, Hye-Sook; Cheng, Xiaoyang; Han, Chongyang; Choi, Jin-Sung; Estacion, Mark; Lauria, Giuseppe; Vanhoutte, Els K.; Gerrits, Monique M.; Dib-Hajj, Sulayman; Drenth, Joost P. H.; Waxman, Stephen G.; Merkies, Ingemar S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-39</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective: : Small nerve fiber neuropathy (SFN) often occurs without apparent cause, but no systematic genetic studies have been performed in patients with idiopathic SFN (I-SFN).  We sought to identify a genetic basis for I-SFN by screening patients with biopsy-confirmed idiopathic SFN for mutations in the SCN9A gene, encoding voltage-gated sodium channel NaV1.7, which is preferentially expressed in small diam. peripheral axons.  Methods: : Patients referred with possible I-SFN, who met the criteria of ≥2 SFN-related symptoms, normal strength, tendon reflexes, vibration sense, and nerve conduction studies, and reduced intraepidermal nerve fiber d. (IENFD) plus abnormal quant. sensory testing (QST) and no underlying etiol. for SFN, were assessed clin. and by screening of SCN9A for mutations and functional analyses.  Results: : Twenty-eight patients who met stringent criteria for I-SFN including abnormal IENFD and QST underwent SCN9A gene analyses.  Of these 28 patients with biopsy-confirmed I-SFN, 8 were found to carry novel mutations in SCN9A.  Functional anal. revealed multiple gain of function changes in the mutant channels; each of the mutations rendered dorsal root ganglion neurons hyperexcitable.  Interpretation: : We show for the first time that gain of function mutations in sodium channel NaV1.7, which render dorsal root ganglion neurons hyperexcitable, are present in a substantial proportion (28.6%; 8 of 28) of patients meeting strict criteria for I-SFN.  These results point to a broader role of NaV1.7 mutations in neurol. disease than previously considered from studies on rare genetic syndromes, and suggest an etiol. basis for I-SFN, whereby expression of gain of function mutant sodium channels in small diam. peripheral axons may cause these fibers to degenerate.  ANN NEUROL 2012;71:26-39.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI5yt6a_BN-rVg90H21EOLACvtfcHk0lgqMtEG5skWRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCqtr4%253D&md5=ea551234a6635b3fd70e3ea4bd68f96c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fana.22485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22485%26sid%3Dliteratum%253Aachs%26aulast%3DFaber%26aufirst%3DC.%2BG.%26aulast%3DHoeijmakers%26aufirst%3DJ.%2BG.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DC.%26aulast%3DChoi%26aufirst%3DJ.%2BS.%26aulast%3DEstacion%26aufirst%3DM.%26aulast%3DLauria%26aufirst%3DG.%26aulast%3DVanhoutte%26aufirst%3DE.%2BK.%26aulast%3DGerrits%26aufirst%3DM.%2BM.%26aulast%3DDib-Hajj%26aufirst%3DS.%26aulast%3DDrenth%26aufirst%3DJ.%2BP.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26aulast%3DMerkies%26aufirst%3DI.%2BS.%26atitle%3DGain%2520of%2520function%2520NaV1.7%2520mutations%2520in%2520idiopathic%2520small%2520fiber%2520neuropathy%26jtitle%3DAnn.%2520Neurol.%26date%3D2012%26volume%3D71%26spage%3D26%26epage%3D39%26doi%3D10.1002%2Fana.22485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karbani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jafri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raashid, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gazali, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamamy, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHale, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C. G.</span></span> <span> </span><span class="NLM_article-title">An SCN9A channelopathy causes congenital inability to experience pain</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>444</i></span>,  <span class="NLM_fpage">894</span>– <span class="NLM_lpage">898</span>, <span class="refDoi"> DOI: 10.1038/nature05413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1038%2Fnature05413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=17167479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2006&pages=894-898&author=J.+J.+Coxauthor=F.+Reimannauthor=A.+K.+Nicolasauthor=G.+Thorntonauthor=E.+Robertsauthor=K.+Springellauthor=G.+Karbaniauthor=H.+Jafriauthor=J.+Mannanauthor=Y.+Raashidauthor=L.+Al-Gazaliauthor=H.+Hamamyauthor=E.+M.+Valenteauthor=S.+Gormanauthor=R.+Williamsauthor=D.+P.+McHaleauthor=J.+N.+Woodauthor=F.+M.+Gribbleauthor=C.+G.+Woods&title=An+SCN9A+channelopathy+causes+congenital+inability+to+experience+pain&doi=10.1038%2Fnature05413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">An SCN9A channelopathy causes congenital inability to experience pain</span></div><div class="casAuthors">Cox, James J.; Reimann, Frank; Nicholas, Adeline K.; Thornton, Gemma; Roberts, Emma; Springell, Kelly; Karbani, Gulshan; Jafri, Hussain; Mannan, Jovaria; Raashid, Yasmin; Al-Gazali, Lihadh; Hamamy, Henan; Valente, Enza Maria; Gorman, Shaun; Williams, Richard; McHale, Duncan P.; Wood, John N.; Gribble, Fiona M.; Woods, C. Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">444</span>
        (<span class="NLM_cas:issue">7121</span>),
    <span class="NLM_cas:pages">894-898</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The complete inability to sense pain in an otherwise healthy individual is a very rare phenotype.  In three consanguineous families from northern Pakistan, we mapped the condition as an autosomal-recessive trait to chromosome 2q24.3.  This region contains the gene SCN9A, encoding the α-subunit of the voltage-gated sodium channel, Nav1.7, which is strongly expressed in nociceptive neurons.  Sequence anal. of SCN9A in affected individuals revealed three distinct homozygous nonsense mutations (S459X, I767X and W897X).  We show that these mutations cause loss of function of Nav1.7 by co-expression of wild-type or mutant human Nav1.7 with sodium channel β1 and β2 subunits in HEK293 cells.  In cells expressing mutant Nav1.7, the currents were no greater than background.  Our data suggest that SCN9A is an essential and non-redundant requirement for nociception in humans.  These findings should stimulate the search for novel analgesics that selectively target this sodium channel subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWD3rCKSQEurVg90H21EOLACvtfcHk0lgqMtEG5skWRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM&md5=461e3a6abd6d3f4f8f7d896d8f62d882</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature05413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05413%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DJ.%2BJ.%26aulast%3DReimann%26aufirst%3DF.%26aulast%3DNicolas%26aufirst%3DA.%2BK.%26aulast%3DThornton%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DSpringell%26aufirst%3DK.%26aulast%3DKarbani%26aufirst%3DG.%26aulast%3DJafri%26aufirst%3DH.%26aulast%3DMannan%26aufirst%3DJ.%26aulast%3DRaashid%26aufirst%3DY.%26aulast%3DAl-Gazali%26aufirst%3DL.%26aulast%3DHamamy%26aufirst%3DH.%26aulast%3DValente%26aufirst%3DE.%2BM.%26aulast%3DGorman%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DMcHale%26aufirst%3DD.%2BP.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26aulast%3DWoods%26aufirst%3DC.%2BG.%26atitle%3DAn%2520SCN9A%2520channelopathy%2520causes%2520congenital%2520inability%2520to%2520experience%2520pain%26jtitle%3DNature%26date%3D2006%26volume%3D444%26spage%3D894%26epage%3D898%26doi%3D10.1038%2Fnature05413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFarlane, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattice, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pape, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radomski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donaldson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oves, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younghusband, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boltshauser, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinspan, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andria, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toscano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerdraon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowsher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pimstone, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuels, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherrington, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, M. R.</span></span> <span> </span><span class="NLM_article-title">Loss-of-function mutations in the Na<sub>V</sub>1.7 gene underlie congenital indifference to pain in multiple human populations</span>. <i>Clin. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">319</span>, <span class="refDoi"> DOI: 10.1111/j.1399-0004.2007.00790.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1111%2Fj.1399-0004.2007.00790.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=17470132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=311-319&author=Y.+P.+Goldbergauthor=J.+MacFarlaneauthor=M.+L.+MacDonaldauthor=J.+Thompsonauthor=M.-P.+Dubeauthor=M.+Matticeauthor=R.+Fraserauthor=C.+Youngauthor=S.+Hossainauthor=T.+Papeauthor=B.+Payneauthor=C.+Radomskiauthor=G.+Donaldsonauthor=E.+Ovesauthor=J.+Coxauthor=H.+B.+Younghusbandauthor=R.+Greenauthor=A.+Duffauthor=E.+Boltshauserauthor=G.+A.+Grinspanauthor=J.+H.+Dimonauthor=B.+G.+Sibleyauthor=G.+Andriaauthor=E.+Toscanoauthor=J.+Kerdraonauthor=D.+Bowsherauthor=S.+N.+Pimstoneauthor=M.+E.+Samuelsauthor=R.+Sherringtonauthor=M.+R.+Hayden&title=Loss-of-function+mutations+in+the+NaV1.7+gene+underlie+congenital+indifference+to+pain+in+multiple+human+populations&doi=10.1111%2Fj.1399-0004.2007.00790.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations</span></div><div class="casAuthors">Goldberg Y P; MacFarlane J; MacDonald M L; Thompson J; Dube M-P; Mattice M; Fraser R; Young C; Hossain S; Pape T; Payne B; Radomski C; Donaldson G; Ives E; Cox J; Younghusband H B; Green R; Duff A; Boltshauser E; Grinspan G A; Dimon J H; Sibley B G; Andria G; Toscano E; Kerdraon J; Bowsher D; Pimstone S N; Samuels M E; Sherrington R; Hayden M R</div><div class="citationInfo"><span class="NLM_cas:title">Clinical genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-9</span>
        ISSN:<span class="NLM_cas:issn">0009-9163</span>.
    </div><div class="casAbstract">Congenital indifference to pain (CIP) is a rare condition in which patients have severely impaired pain perception, but are otherwise essentially normal.  We identified and collected DNA from individuals from nine families of seven different nationalities in which the affected individuals meet the diagnostic criteria for CIP.  Using homozygosity mapping and haplotype sharing methods, we narrowed the CIP locus to chromosome 2q24-q31, a region known to contain a cluster of voltage-gated sodium channel genes.  From these prioritized candidate sodium channels, we identified 10 mutations in the SCN9A gene encoding the sodium channel protein Nav1.7.  The mutations completely co-segregated with the disease phenotype, and nine of these SCN9A mutations resulted in truncation and loss-of-function of the Nav1.7 channel.  These genetic data further support the evidence that Nav1.7 plays an essential role in mediating pain in humans, and that SCN9A mutations identified in multiple different populations underlie CIP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgEhjb_1oWGHqj_yg7twvpfW6udTcc2eb5NRjPQsewdrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D&md5=02ae3943bc678b3407d492e4a6298b74</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-0004.2007.00790.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-0004.2007.00790.x%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DY.%2BP.%26aulast%3DMacFarlane%26aufirst%3DJ.%26aulast%3DMacDonald%26aufirst%3DM.%2BL.%26aulast%3DThompson%26aufirst%3DJ.%26aulast%3DDube%26aufirst%3DM.-P.%26aulast%3DMattice%26aufirst%3DM.%26aulast%3DFraser%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DHossain%26aufirst%3DS.%26aulast%3DPape%26aufirst%3DT.%26aulast%3DPayne%26aufirst%3DB.%26aulast%3DRadomski%26aufirst%3DC.%26aulast%3DDonaldson%26aufirst%3DG.%26aulast%3DOves%26aufirst%3DE.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DYounghusband%26aufirst%3DH.%2BB.%26aulast%3DGreen%26aufirst%3DR.%26aulast%3DDuff%26aufirst%3DA.%26aulast%3DBoltshauser%26aufirst%3DE.%26aulast%3DGrinspan%26aufirst%3DG.%2BA.%26aulast%3DDimon%26aufirst%3DJ.%2BH.%26aulast%3DSibley%26aufirst%3DB.%2BG.%26aulast%3DAndria%26aufirst%3DG.%26aulast%3DToscano%26aufirst%3DE.%26aulast%3DKerdraon%26aufirst%3DJ.%26aulast%3DBowsher%26aufirst%3DD.%26aulast%3DPimstone%26aufirst%3DS.%2BN.%26aulast%3DSamuels%26aufirst%3DM.%2BE.%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26atitle%3DLoss-of-function%2520mutations%2520in%2520the%2520NaV1.7%2520gene%2520underlie%2520congenital%2520indifference%2520to%2520pain%2520in%2520multiple%2520human%2520populations%26jtitle%3DClin.%2520Genet.%26date%3D2007%26volume%3D71%26spage%3D311%26epage%3D319%26doi%3D10.1111%2Fj.1399-0004.2007.00790.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gingras, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nye, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couture, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feric, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottman, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beiler, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmberg, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, S. I.</span></span> <span> </span><span class="NLM_article-title">Global Na<sub>V</sub>1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e105895</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0105895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1371%2Fjournal.pone.0105895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=25188265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslaqt73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=J.+Gingrasauthor=S.+Smithauthor=D.+J.+Matsonauthor=D.+Johnsonauthor=K.+Nyeauthor=L.+Coutureauthor=E.+Fericauthor=R.+Yinauthor=B.+D.+Moyerauthor=M.+L.+Petersonauthor=J.+B.+Rottmanauthor=R.+J.+Beilerauthor=A.+B.+Malmbergauthor=S.+I.+McDonough&title=Global+NaV1.7+knockout+mice+recapitulate+the+phenotype+of+human+congenital+indifference+to+pain&doi=10.1371%2Fjournal.pone.0105895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain</span></div><div class="casAuthors">Gingras, Jacinthe; Smith, Sarah; Matson, David J.; Johnson, Danielle; Nye, Kim; Couture, Lauren; Feric, Elma; Yin, Ruoyuan; Moyer, Bryan D.; Peterson, Matthew L.; Rottman, James B.; Beiler, Rudolph J.; Malmberg, Annika B.; McDonough, Stefan I.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e105895/1-e105895/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Clin. genetic studies have shown that loss of Nav1.7 function leads to the complete loss of acute pain perception.  The global deletion is reported lethal in mice, however, and studies of mice with promoter-specific deletions of Nav1.7 have suggested that the role of Nav1.7 in pain transduction depends on the precise form of pain.  We developed genetic and animal husbandry strategies that overcame the neonatal-lethal phenotype and enabled construction of a global Nav1.7 knockout mouse.  Knockouts were anatomically normal, reached adulthood, and had phenotype wholly analogous to human congenital indifference to pain (CIP): compared to littermates, knockouts showed no defects in mech. sensitivity or overall movement yet were completely insensitive to painful tactile, thermal, and chem. stimuli and were anosmic.  Knockouts also showed no painful behaviors resulting from peripheral injection of nonselective sodium channel activators, did not develop complete Freund's adjuvant-induced thermal hyperalgesia, and were insensitive to intra-dermal histamine injection.  Tetrodotoxin-sensitive sodium current recorded from cell bodies of isolated sensory neurons and the mech.-evoked spiking of C-fibers in a skin-nerve prepn. each were reduced but not eliminated in tissue from knockouts compared to littermates.  Results support a role for Nav1.7 that is conserved between rodents and humans and suggest several possibly translatable biomarkers for the study of Nav1.7-targeted therapeutics.  Results further suggest that Nav1.7 may retain its key role in persistent as well as acute forms of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAzxB508dD1LVg90H21EOLACvtfcHk0ljfdZY5pIeVfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslaqt73O&md5=6a1acb0c6e4e38ac89b1ab38d67b538e</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0105895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0105895%26sid%3Dliteratum%253Aachs%26aulast%3DGingras%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DMatson%26aufirst%3DD.%2BJ.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DNye%26aufirst%3DK.%26aulast%3DCouture%26aufirst%3DL.%26aulast%3DFeric%26aufirst%3DE.%26aulast%3DYin%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26aulast%3DRottman%26aufirst%3DJ.%2BB.%26aulast%3DBeiler%26aufirst%3DR.%2BJ.%26aulast%3DMalmberg%26aufirst%3DA.%2BB.%26aulast%3DMcDonough%26aufirst%3DS.%2BI.%26atitle%3DGlobal%2520NaV1.7%2520knockout%2520mice%2520recapitulate%2520the%2520phenotype%2520of%2520human%2520congenital%2520indifference%2520to%2520pain%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0105895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Gingras, J.</span>; <span class="NLM_string-name">McDonough, S. I.</span></span> <span> </span><span class="NLM_article-title">Na<sub>V</sub>1.7 Knockout Mouse and Uses Thereof</span>. <span class="NLM_patent">WO2012/099983A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+Gingras&author=S.+I.+McDonough&title=NaV1.7+Knockout+Mouse+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGingras%26aufirst%3DJ.%26atitle%3DNaV1.7%2520Knockout%2520Mouse%2520and%2520Uses%2520Thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Theile, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, T. R.</span></span> <span> </span><span class="NLM_article-title">Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes</span>. <i>Front Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.3389/fphar.2011.00054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.3389%2Ffphar.2011.00054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=21779246" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=1-14&author=J.+W.+Theileauthor=T.+R.+Cummins&title=Recent+developments+regarding+voltage-gated+sodium+channel+blockers+for+the+treatment+of+inherited+and+acquired+neuropathic+pain+syndromes&doi=10.3389%2Ffphar.2011.00054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2011.00054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2011.00054%26sid%3Dliteratum%253Aachs%26aulast%3DTheile%26aufirst%3DJ.%2BW.%26aulast%3DCummins%26aufirst%3DT.%2BR.%26atitle%3DRecent%2520developments%2520regarding%2520voltage-gated%2520sodium%2520channel%2520blockers%2520for%2520the%2520treatment%2520of%2520inherited%2520and%2520acquired%2520neuropathic%2520pain%2520syndromes%26jtitle%3DFront%2520Pharmacol.%26date%3D2011%26volume%3D2%26spage%3D1%26epage%3D14%26doi%3D10.3389%2Ffphar.2011.00054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandrou, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mis, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilbrey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutteridge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castle, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krafte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estacion, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hounshell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randall, A.</span></span> <span> </span><span class="NLM_article-title">Subtype-selective small molecule inhibitors reveal a fundamental role for Na<sub>V</sub>1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e0152405</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0152405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1371%2Fjournal.pone.0152405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=27050761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1KqtL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&author=A.+J.+Alexandrouauthor=A.+R.+Brownauthor=J.+Turnerauthor=M.+A.+Misauthor=A.+Wilbreyauthor=E.+C.+Payneauthor=A.+Gutteridgeauthor=P.+J.+Coxauthor=R.+P.+Buttauthor=E.+B.+Stevensauthor=M.+L.+Chapmanauthor=D.+Printzenhoffauthor=Z.+Linauthor=B.+E.+Marronauthor=C.+Westauthor=N.+A.+Castleauthor=D.+Krafteauthor=M.+Estacionauthor=S.+D.+Dib-Hajjauthor=S.+G.+Waxmanauthor=R.+Doyleauthor=N.+A.+Swainauthor=R.+I.+Storerauthor=P.+A.+Stuppleauthor=J.+A.+Hounshellauthor=M.+Rivaraauthor=M.+K.+Patelauthor=A.+Randall&title=Subtype-selective+small+molecule+inhibitors+reveal+a+fundamental+role+for+NaV1.7+in+nociceptor+electrogenesis%2C+axonal+conduction+and+presynaptic+release&doi=10.1371%2Fjournal.pone.0152405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">Subtype-selective small molecule inhibitors reveal a fundamental role for Nav1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release</span></div><div class="casAuthors">Alexandrou, Aristos J.; Brown, Adam R.; Chapman, Mark L.; Estacion, Mark; Turner, Jamie; Mis, Malgorzata A.; Wilbrey, Anna; Payne, Elizabeth C.; Gutteridge, Alex; Cox, Peter J.; Doyle, Rachel; Printzenhoff, David; Lin, Zhixin; Marron, Brian E.; West, Christopher; Swain, Nigel A.; Storer, R. Ian; Stupple, Paul A.; Castle, Neil A.; Hounshell, James A.; Rivara, Mirko; Randall, Andrew; Dib-Hajj, Sulayman D.; Krafte, Douglas; Waxman, Stephen G.; Patel, Manoj K.; Butt, Richard P.; Stevens, Edward B.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e0152405/1-e0152405/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Human genetic studies show that the voltage gated sodium channel 1.7 (Nav1.7) is a key mol. determinant of pain sensation.  However, defining the Nav1.7 contribution to nociceptive signalling has been hampered by a lack of selective inhibitors.  Here we report two potent and selective arylsulfonamide Nav1.7 inhibitors; PF-05198007 and PF-05089771, which we have used to directly interrogate Nav1.7's role in nociceptor physiol.  We report that Nav1.7 is the predominant functional TTX-sensitive Nav in mouse and human nociceptors and contributes to the initiation and the upstroke phase of the nociceptor action potential.  Moreover, we confirm a role for Nav1.7 in influencing synaptic transmission in the dorsal horn of the spinal cord as well as peripheral neuropeptide release in the skin.  These findings demonstrate multiple contributions of Nav1.7 to nociceptor signalling and shed new light on the relative functional contribution of this channel to peripheral and central noxious signal transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx6L5QNhpEg7Vg90H21EOLACvtfcHk0libBKKo8UnCbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1KqtL3M&md5=41505ac1108ad830dec78c052655f6b0</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0152405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0152405%26sid%3Dliteratum%253Aachs%26aulast%3DAlexandrou%26aufirst%3DA.%2BJ.%26aulast%3DBrown%26aufirst%3DA.%2BR.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DMis%26aufirst%3DM.%2BA.%26aulast%3DWilbrey%26aufirst%3DA.%26aulast%3DPayne%26aufirst%3DE.%2BC.%26aulast%3DGutteridge%26aufirst%3DA.%26aulast%3DCox%26aufirst%3DP.%2BJ.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DStevens%26aufirst%3DE.%2BB.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DWest%26aufirst%3DC.%26aulast%3DCastle%26aufirst%3DN.%2BA.%26aulast%3DKrafte%26aufirst%3DD.%26aulast%3DEstacion%26aufirst%3DM.%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26aulast%3DDoyle%26aufirst%3DR.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DHounshell%26aufirst%3DJ.%2BA.%26aulast%3DRivara%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DM.%2BK.%26aulast%3DRandall%26aufirst%3DA.%26atitle%3DSubtype-selective%2520small%2520molecule%2520inhibitors%2520reveal%2520a%2520fundamental%2520role%2520for%2520NaV1.7%2520in%2520nociceptor%2520electrogenesis%252C%2520axonal%2520conduction%2520and%2520presynaptic%2520release%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26doi%3D10.1371%2Fjournal.pone.0152405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mulroy, M. F.</span></span> <span> </span><span class="NLM_article-title">Systemic toxicity and cardiotoxicity from local anesthetics: incidence and preventive measures</span>. <i>Reg. Anesth. Pain Med.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">556</span>– <span class="NLM_lpage">561</span>, <span class="refDoi"> DOI: 10.1097/00115550-200211000-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1097%2F00115550-200211000-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=12430104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1Kns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=556-561&author=M.+F.+Mulroy&title=Systemic+toxicity+and+cardiotoxicity+from+local+anesthetics%3A+incidence+and+preventive+measures&doi=10.1097%2F00115550-200211000-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic toxicity and cardiotoxicity from local anesthetics: incidence and preventive measures</span></div><div class="casAuthors">Mulroy, Michael F.</div><div class="citationInfo"><span class="NLM_cas:title">Regional Anesthesia and Pain Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">556-561</span>CODEN:
                <span class="NLM_cas:coden">RAPMFX</span>;
        ISSN:<span class="NLM_cas:issn">1098-7339</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">A review.  Central nervous system toxicity from unintentionally high blood levels has been a significant concern and risk with local anesthetics since their discovery.  Cardiotoxicity assocd. with toxic blood levels of long-acting local anesthetics has heightened concern about systemic blood levels in the last 20 yr.  This review will discuss the apparent incidence of systemic toxicity, the situations in which it occurs, some of the other risks of regional anesthesia, and appropriate safety steps to reduce the frequency of both systemic reactions and cardiotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoMkLHgF6vjrVg90H21EOLACvtfcHk0libBKKo8UnCbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1Kns7o%253D&md5=6ddb4d2bbba7485049e85a3f8df71038</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1097%2F00115550-200211000-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00115550-200211000-00003%26sid%3Dliteratum%253Aachs%26aulast%3DMulroy%26aufirst%3DM.%2BF.%26atitle%3DSystemic%2520toxicity%2520and%2520cardiotoxicity%2520from%2520local%2520anesthetics%253A%2520incidence%2520and%2520preventive%2520measures%26jtitle%3DReg.%2520Anesth.%2520Pain%2520Med.%26date%3D2002%26volume%3D27%26spage%3D556%26epage%3D561%26doi%3D10.1097%2F00115550-200211000-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Walia, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raza, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, Y. N.</span></span> <span> </span><span class="NLM_article-title">Side effects of antiepileptics-a review</span>. <i>Pain Pract.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1111/j.1533-2500.2004.04304.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1111%2Fj.1533-2500.2004.04304.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=17173601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A280%3ADC%252BD28jjs1Gkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=194-203&author=K.+S.+Waliaauthor=E.+A.+Khanauthor=D.+H.+Koauthor=S.+S.+Razaauthor=Y.+N.+Khan&title=Side+effects+of+antiepileptics-a+review&doi=10.1111%2Fj.1533-2500.2004.04304.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Side effects of antiepileptics--a review</span></div><div class="casAuthors">Walia Kulbir S; Khan Elizabeth A; Ko Dong H; Raza Shariq S; Khan Yasin N</div><div class="citationInfo"><span class="NLM_cas:title">Pain practice : the official journal of World Institute of Pain</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">194-203</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Older generation antiepileptic drugs like Phenobarbital (Luminal), carbamazepine (Tegretol), phenytoin (Dilantin), and valproic acid (Depakote) have several shortcomings such as suboptimal response rates, significant adverse effects, several drug interactions, and a narrow therapeutic index.  New antiepileptic drugs have been developed in the last decade to overcome some of these problems.  These newer generation antiepileptics like felbamate (Felbatol), gabapentin (Neurontin), lamotrigine (Lamictal), levetiracetam (Keppra), oxcarbazepine (Trileptal), tiagabine (Gabitril), topiramate (Topamax), and zonisamide (Zonegran) have better tolerability profiles, low interaction potential, and significantly less enzyme inducing or inhibiting properties.  As the use of antiepileptic drugs has expanded to include treatment of neuropathic pain, newer side effects have been reported.  In addition to the common side effects of antiepileptic drugs, like dizziness, drowsiness, and mental slowing; other side effects like weight gain, metabolic acidosis, nephrolithiasis, angle closure glaucoma, skin rash, hepatotoxicity, colitis, and movement and behavioral disorders, to name a few, have been brought to our attention.  This review is an attempt to highlight the features and incidences of some of these side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSq8w-gtiU7_bYtC3U5jeOifW6udTcc2eYxXbq0Weu6Nrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jjs1Gkug%253D%253D&md5=0bd5221a573a26194b0ea14116d9ce7c</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1111%2Fj.1533-2500.2004.04304.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1533-2500.2004.04304.x%26sid%3Dliteratum%253Aachs%26aulast%3DWalia%26aufirst%3DK.%2BS.%26aulast%3DKhan%26aufirst%3DE.%2BA.%26aulast%3DKo%26aufirst%3DD.%2BH.%26aulast%3DRaza%26aufirst%3DS.%2BS.%26aulast%3DKhan%26aufirst%3DY.%2BN.%26atitle%3DSide%2520effects%2520of%2520antiepileptics-a%2520review%26jtitle%3DPain%2520Pract.%26date%3D2004%26volume%3D4%26spage%3D194%26epage%3D203%26doi%3D10.1111%2Fj.1533-2500.2004.04304.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dworkin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backonja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrar, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finnerup, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalso, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeser, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miaskowski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nurmikko, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portenoy, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stacey, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treede, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, M. S.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic management of neuropathic pain: evidence-based recommendations</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">251</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2007.08.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.pain.2007.08.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=17920770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1yls7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2007&pages=237-251&author=R.+H.+Dworkinauthor=A.+B.+O%E2%80%99Connorauthor=M.+Backonjaauthor=J.+T.+Farrarauthor=N.+B.+Finnerupauthor=T.+S.+Jensenauthor=E.+A.+Kalsoauthor=J.+D.+Loeserauthor=C.+Miaskowskiauthor=T.+J.+Nurmikkoauthor=R.+K.+Portenoyauthor=A.+S.+Riceauthor=B.+R.+Staceyauthor=R.+D.+Treedeauthor=D.+C.+Turkauthor=M.+S.+Wallace&title=Pharmacologic+management+of+neuropathic+pain%3A+evidence-based+recommendations&doi=10.1016%2Fj.pain.2007.08.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic management of neuropathic pain: Evidence-based recommendations</span></div><div class="casAuthors">Dworkin, Robert H.; O'Connor, Alec B.; Backonja, Miroslav; Farrar, John T.; Finnerup, Nanna B.; Jensen, Troels S.; Kalso, Eija A.; Loeser, John D.; Miaskowski, Christine; Nurmikko, Turo J.; Portenoy, Russell K.; Rice, Andrew S. C.; Stacey, Brett R.; Treede, Rolf-Detlef; Turk, Dennis C.; Wallace, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-251</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Patients with neuropathic pain (NP) are challenging to manage and evidence-based clin. recommendations for pharmacol. management are needed.  Systematic literature reviews, randomized clin. trials, and existing guidelines were evaluated at a consensus meeting.  Medications were considered for recommendation if their efficacy was supported by at least one methodol.-sound, randomized clin. trial (RCT) demonstrating superiority to placebo or a relevant comparison treatment.  Recommendations were based on the amt. and consistency of evidence, degree of efficacy, safety, and clin. experience of the authors.  Available RCTs typically evaluated chronic NP of moderate to severe intensity.  Recommended first-line treatments include certain antidepressants (i.e., tricyclic antidepressants and dual reuptake inhibitors of both serotonin and norepinephrine), calcium channel α2-δ ligands (i.e., gabapentin and pregabalin), and topical lidocaine.  Opioid analgesics and tramadol are recommended as generally second-line treatments that can be considered for first-line use in select clin. circumstances.  Other medications that would generally be used as third-line treatments but that could also be used as second-line treatments in some circumstances include certain antiepileptic and antidepressant medications, mexiletine, N-methyl-D-aspartate receptor antagonists, and topical capsaicin.  Medication selection should be individualized, considering side effects, potential beneficial or deleterious effects on comorbidities, and whether prompt onset of pain relief is necessary.  To date, no medications have demonstrated efficacy in lumbosacral radiculopathy, which is probably the most common type of NP.  Long-term studies, head-to-head comparisons between medications, studies involving combinations of medications, and RCTs examg. treatment of central NP are lacking and should be a priority for future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNM2xlrhF4ZrVg90H21EOLACvtfcHk0lixcKl1WiXIWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1yls7nN&md5=dfa9749c8bb2a828419a7d0cfd62c9b4</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2007.08.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2007.08.033%26sid%3Dliteratum%253Aachs%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%2BB.%26aulast%3DBackonja%26aufirst%3DM.%26aulast%3DFarrar%26aufirst%3DJ.%2BT.%26aulast%3DFinnerup%26aufirst%3DN.%2BB.%26aulast%3DJensen%26aufirst%3DT.%2BS.%26aulast%3DKalso%26aufirst%3DE.%2BA.%26aulast%3DLoeser%26aufirst%3DJ.%2BD.%26aulast%3DMiaskowski%26aufirst%3DC.%26aulast%3DNurmikko%26aufirst%3DT.%2BJ.%26aulast%3DPortenoy%26aufirst%3DR.%2BK.%26aulast%3DRice%26aufirst%3DA.%2BS.%26aulast%3DStacey%26aufirst%3DB.%2BR.%26aulast%3DTreede%26aufirst%3DR.%2BD.%26aulast%3DTurk%26aufirst%3DD.%2BC.%26aulast%3DWallace%26aufirst%3DM.%2BS.%26atitle%3DPharmacologic%2520management%2520of%2520neuropathic%2520pain%253A%2520evidence-based%2520recommendations%26jtitle%3DPain%26date%3D2007%26volume%3D132%26spage%3D237%26epage%3D251%26doi%3D10.1016%2Fj.pain.2007.08.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertrampf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kless, A.</span></span> <span> </span><span class="NLM_article-title">Advances in targeting voltage-gated sodium channels with small molecules</span>. <i>Chem. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1712</span>– <span class="NLM_lpage">1740</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1002%2Fcmdc.201200298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=22945552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yks7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1712-1740&author=A.+Nardiauthor=N.+Damannauthor=T.+Hertrampfauthor=A.+Kless&title=Advances+in+targeting+voltage-gated+sodium+channels+with+small+molecules&doi=10.1002%2Fcmdc.201200298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in Targeting Voltage-Gated Sodium Channels with Small Molecules</span></div><div class="casAuthors">Nardi, Antonio; Damann, Nils; Hertrampf, Torsten; Kless, Achim</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1712-1740</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Blockade of voltage-gated sodium channels (VGSCs) has been used successfully in the clinic to enable control of pathol. firing patterns that occur in conditions as diverse as chronic pain, epilepsy, and arrhythmias.  Herein we review the state of the art in marketed sodium channel inhibitors, including a brief compendium of their binding sites and of the cellular and mol. biol. of sodium channels.  Despite the preferential action of this drug class toward over-excited cells, which significantly limits potential undesired side effects on other cells, the need to develop a second generation of sodium channel inhibitors to overcome their crit. clin. shortcomings is apparent.  Current approaches in drug discovery to deliver novel and truly innovative sodium channel inhibitors is next presented by surveying the most recent medicinal chem. breakthroughs in the field of small mols. and developments in automated patch-clamp platforms.  Various strategies aimed at identifying small mols. that target either particular isoforms of sodium channels involved in specific diseases or anomalous sodium channel currents, irresp. of the isoform by which they have been generated, are critically discussed and revised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq25xI9xQpdebVg90H21EOLACvtfcHk0lixcKl1WiXIWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yks7nN&md5=a4072539ac2084d994eb4a2143844d3c</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200298%26sid%3Dliteratum%253Aachs%26aulast%3DNardi%26aufirst%3DA.%26aulast%3DDamann%26aufirst%3DN.%26aulast%3DHertrampf%26aufirst%3DT.%26aulast%3DKless%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520targeting%2520voltage-gated%2520sodium%2520channels%2520with%2520small%2520molecules%26jtitle%3DChem.%2520Med.%2520Chem.%26date%3D2012%26volume%3D7%26spage%3D1712%26epage%3D1740%26doi%3D10.1002%2Fcmdc.201200298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prime, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Recent progress in sodium channel modulators for pain</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3690</span>– <span class="NLM_lpage">3699</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.06.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2014.06.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=25060923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Wls7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3690-3699&author=S.+K.+Bagalauthor=M.+L.+Chapmanauthor=B.+E.+Marronauthor=R.+Primeauthor=R.+I.+Storerauthor=N.+A.+Swain&title=Recent+progress+in+sodium+channel+modulators+for+pain&doi=10.1016%2Fj.bmcl.2014.06.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in sodium channel modulators for pain</span></div><div class="casAuthors">Bagal, Sharan K.; Chapman, Mark L.; Marron, Brian E.; Prime, Rebecca; Storer, R. Ian; Swain, Nigel A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3690-3699</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium channels (Navs) are an important family of transmembrane ion channel proteins and Nav drug discovery is an exciting field.  Pharmaceutical investment in Navs for pain therapeutics has expanded exponentially due to genetic data such as SCN10A mutations and an improved ability to establish an effective screen sequence for example IonWorks Barracuda, Synchropatch and Qube.  Moreover, emerging clin. data (AZD-3161, XEN402, CNV1014802, PF-05089771, PF-04531083) combined with recent breakthroughs in Nav structural biol. pave the way for a future of fruitful prospective Nav drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbT6en4xkVxLVg90H21EOLACvtfcHk0lixcKl1WiXIWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Wls7vL&md5=c8bae40b70509e2aa3dce106e2c41677</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.038%26sid%3Dliteratum%253Aachs%26aulast%3DBagal%26aufirst%3DS.%2BK.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DPrime%26aufirst%3DR.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26atitle%3DRecent%2520progress%2520in%2520sodium%2520channel%2520modulators%2520for%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3690%26epage%3D3699%26doi%3D10.1016%2Fj.bmcl.2014.06.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuliani, V.</span></span> <span> </span><span class="NLM_article-title">Novel sodium channel antagonists in the treatment of neuropathic pain</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1517/13543784.2016.1121992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1517%2F13543784.2016.1121992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=26576738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVSrt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=215-226&author=M.+Rivaraauthor=V.+Zuliani&title=Novel+sodium+channel+antagonists+in+the+treatment+of+neuropathic+pain&doi=10.1517%2F13543784.2016.1121992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Novel sodium channel antagonists in the treatment of neuropathic pain</span></div><div class="casAuthors">Rivara, Mirko; Zuliani, Valentina</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-226</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Effective and safe drugs for the treatment of neuropathic pain are still an unmet clin. need.  Neuropathic pain, caused by a lesion or disease that affects the somatosensory system, is a debilitating and hampering condition that has a great economic cost and, above all, a tremendous impact on the quality of life.  Sodium channels are one of the major players in generating and propagating action potentials.  They represent an appealing target for researchers involved in the development of new and safer drugs useful in the treatment of neuropathic pain.  The actual goal for researchers is to target sodium channels selectively to stop the abnormal signaling that characterizes neuropathic pain while leaving normal somatosensory functions intact.: This review covers the most recent publications regarding sodium channel blockers and their development as new treatments for neuropathic pain.  The main areas discussed are the natural sources of new blockers, such as venom exts. and the recent efforts from many pharmaceutical companies in the field.: There have been serious efforts by both the pharmaceutical industry and academia to develop new and safer therapeutic options for neuropathic pain.  A no. of different strategies have been undertaken; the main efforts directed towards the identification of selective blockers starting from both natural products or screening chem. libraries.  At this time, researchers have identified and characterized selective compds. against NaV1.7 or NaV1.8 voltage-gated sodium channels but only time will tell if they reach the market.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl3PzyBSNxFbVg90H21EOLACvtfcHk0lgHv-vEp4Eu_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVSrt7rK&md5=f0280383c1361e07d6c5378b0dda6373</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1517%2F13543784.2016.1121992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2016.1121992%26sid%3Dliteratum%253Aachs%26aulast%3DRivara%26aufirst%3DM.%26aulast%3DZuliani%26aufirst%3DV.%26atitle%3DNovel%2520sodium%2520channel%2520antagonists%2520in%2520the%2520treatment%2520of%2520neuropathic%2520pain%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2016%26volume%3D25%26spage%3D215%26epage%3D226%26doi%3D10.1517%2F13543784.2016.1121992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuis, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starobova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rash, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobli, M.</span></span> <span> </span><span class="NLM_article-title">Na<sub>V</sub>1.7 as a pain target – From gene to pharmacology</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2016.11.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.pharmthera.2016.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=27916648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislClsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2017&pages=73-100&author=I.+Vetterauthor=J.+R.+Deuisauthor=A.+Muellerauthor=M.+R.+Israelauthor=H.+Starobovaauthor=A.+Zhangauthor=L.+D.+Rashauthor=M.+Mobli&title=NaV1.7+as+a+pain+target+%E2%80%93+From+gene+to+pharmacology&doi=10.1016%2Fj.pharmthera.2016.11.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11dR"><div class="casContent"><span class="casTitleNuber">11d</span><div class="casTitle"><span class="NLM_cas:atitle">NaV1.7 as a pain target - From gene to pharmacology</span></div><div class="casAuthors">Vetter, Irina; Deuis, Jennifer R.; Mueller, Alexander; Israel, Mathilde R.; Starobova, Hana; Zhang, Alan; Rash, Lachlan D.; Mobli, Mehdi</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">73-100</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">NaV1.7, a subtype of the voltage-gated sodium channel family that is highly expressed in peripheral sensory neurons, remains one of the most promising targets for the treatment of pain.  However, despite compelling genetic evidence supporting a key role for NaV1.7 in regulating excitability of peripheral sensory neurons, the development of truly subtype-selective inhibitors has been challenging.  Here, we discuss complexities surrounding targeting NaV1.7 pharmacol. for treatment of pain and explore future opportunities for development of effective analgesic NaV1.7 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgpB1bBe31X7Vg90H21EOLACvtfcHk0lgHv-vEp4Eu_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislClsg%253D%253D&md5=78a0e17dfccd84b511491b6c5d83fd94</span></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2016.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2016.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DVetter%26aufirst%3DI.%26aulast%3DDeuis%26aufirst%3DJ.%2BR.%26aulast%3DMueller%26aufirst%3DA.%26aulast%3DIsrael%26aufirst%3DM.%2BR.%26aulast%3DStarobova%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DRash%26aufirst%3DL.%2BD.%26aulast%3DMobli%26aufirst%3DM.%26atitle%3DNaV1.7%2520as%2520a%2520pain%2520target%2520%25E2%2580%2593%2520From%2520gene%2520to%2520pharmacology%26jtitle%3DPharmacol.%2520Ther.%26date%3D2017%26volume%3D172%26spage%3D73%26epage%3D100%26doi%3D10.1016%2Fj.pharmthera.2016.11.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asghari-Roodsari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H. L.</span></span> <span> </span><span class="NLM_article-title">Cardiac sodium channelopathies</span>. <i>Pfluegers Arch. - Eur. J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>460</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1007/s00424-009-0761-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1007%2Fs00424-009-0761-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=20091048" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=460&publication_year=2010&pages=223-237&author=A.+S.+Aminauthor=A.+Asghari-Roodsariauthor=H.+L.+Tan&title=Cardiac+sodium+channelopathies&doi=10.1007%2Fs00424-009-0761-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1007%2Fs00424-009-0761-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00424-009-0761-0%26sid%3Dliteratum%253Aachs%26aulast%3DAmin%26aufirst%3DA.%2BS.%26aulast%3DAsghari-Roodsari%26aufirst%3DA.%26aulast%3DTan%26aufirst%3DH.%2BL.%26atitle%3DCardiac%2520sodium%2520channelopathies%26jtitle%3DPfluegers%2520Arch.%2520-%2520Eur.%2520J.%2520Physiol.%26date%3D2010%26volume%3D460%26spage%3D223%26epage%3D237%26doi%3D10.1007%2Fs00424-009-0761-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Schott, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alshinawi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyndt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Probst, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoorntje, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulsbeek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilde, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escande, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannens, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Marec, H.</span></span> <span> </span><span class="NLM_article-title">Cardiac conduction defects associate with mutations in SCN5A</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1038/12618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1038%2F12618" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10471492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFWhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1999&pages=20-21&author=J.+J.+Schottauthor=C.+Alshinawiauthor=F.+Kyndtauthor=V.+Probstauthor=T.+M.+Hoorntjeauthor=M.+Hulsbeekauthor=A.+A.+Wildeauthor=D.+Escandeauthor=M.+M.+Mannensauthor=H.+Le+Marec&title=Cardiac+conduction+defects+associate+with+mutations+in+SCN5A&doi=10.1038%2F12618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac conduction defects associate with mutations in SCN5A</span></div><div class="casAuthors">Schott, Jean-Jacques; Alshinawi, Connie; Kyndt, Florence; Probst, Vincent; Hoorntje, Theo M.; Hulsbeek, Miriam; Wilde, Arthur A. M.; Escande, Denis; Mannens, Marcel M. A. M.; Le Marec, Herve</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-21</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Progressive cardiac conduction defect (PCCD) also called Lenegre or Lev disease, is one of the most common cardiac conduction disturbances.  Here, the authors report a mutation in the gene encoding the cardiac-specific sodium channel (SCN5A) that segregates with PCCD in an autosomal dominant manner in a large French family.  The authors also studied a Dutch family in which the proband presented after birth with asymptomatic first-degree atrio-ventricular block assocd. with right bundle branch block.  Sequencing the entire SCN5A coding region in the French family identified a T→C substitution in the highly conserved +2 donor splicing site of intron 22.  The abnormal transcript predicts in-frame skipping of exon 22 and an impaired gene product lacking the voltage-sensitive DIIIS4 segment.  SCN5A was directly sequenced in the Dutch family.  A deletion of a single nucleotide (G) at position 5280 resulting in a frameshift predicting a premature stop codon was identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsWjnnnqL4MbVg90H21EOLACvtfcHk0lgHv-vEp4Eu_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFWhs7k%253D&md5=7cb11c78625c8e2fd7f21caa876de2ff</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1038%2F12618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F12618%26sid%3Dliteratum%253Aachs%26aulast%3DSchott%26aufirst%3DJ.%2BJ.%26aulast%3DAlshinawi%26aufirst%3DC.%26aulast%3DKyndt%26aufirst%3DF.%26aulast%3DProbst%26aufirst%3DV.%26aulast%3DHoorntje%26aufirst%3DT.%2BM.%26aulast%3DHulsbeek%26aufirst%3DM.%26aulast%3DWilde%26aufirst%3DA.%2BA.%26aulast%3DEscande%26aufirst%3DD.%26aulast%3DMannens%26aufirst%3DM.%2BM.%26aulast%3DLe%2BMarec%26aufirst%3DH.%26atitle%3DCardiac%2520conduction%2520defects%2520associate%2520with%2520mutations%2520in%2520SCN5A%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D23%26spage%3D20%26epage%3D21%26doi%3D10.1038%2F12618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tfelt-Hansen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkel, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunnet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jespersen, T.</span></span> <span> </span><span class="NLM_article-title">Inherited cardiac diseases caused by mutations in the Na<sub>V</sub>1.5 sodium channel</span>. <i>J. Cardiovasc. Electrophysiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1111/j.1540-8167.2009.01633.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1111%2Fj.1540-8167.2009.01633.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=19845816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A280%3ADC%252BC3czkvVOksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=107-115&author=J.+Tfelt-Hansenauthor=B.+G.+Winkelauthor=M.+Grunnetauthor=T.+Jespersen&title=Inherited+cardiac+diseases+caused+by+mutations+in+the+NaV1.5+sodium+channel&doi=10.1111%2Fj.1540-8167.2009.01633.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">Inherited cardiac diseases caused by mutations in the Nav1.5 sodium channel</span></div><div class="casAuthors">Tfelt-Hansen Jacob; Winkel Bo Gregers; Grunnet Morten; Jespersen Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cardiovascular electrophysiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A prerequisite for a normal cardiac function is a proper generation and propagation of electrical impulses.  Contraction of the heart is obtained through a delicate matched transmission of the electrical impulses.  A pivotal element of the impulse propagation is the depolarizing sodium current, responsible for the initial depolarization of the cardiomyocytes.  Recent research has shown that mutations in the SCN5A gene, encoding the cardiac sodium channel Nav1.5, are associated with both rare forms of ventricular arrhythmia, as well as the most frequent form of arrhythmia, atrial fibrillation (AF).  In this comprehensive review, we describe the functional role of Nav1.5 and its associated proteins in propagation and depolarization both in a normal- and in a pathophysiological setting.  Furthermore, several of the arrhythmogenic diseases, such as long-QT syndrome, Brugada syndrome, and AF, reported to be associated with mutations in SCN5A, are thoroughly described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRQrZacCEoQ64hLSh9fo81bfW6udTcc2eY6PD-4djz3ibntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czkvVOksQ%253D%253D&md5=f232be7a17114e5ef7f275c6cce32c6e</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1111%2Fj.1540-8167.2009.01633.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1540-8167.2009.01633.x%26sid%3Dliteratum%253Aachs%26aulast%3DTfelt-Hansen%26aufirst%3DJ.%26aulast%3DWinkel%26aufirst%3DB.%2BG.%26aulast%3DGrunnet%26aufirst%3DM.%26aulast%3DJespersen%26aufirst%3DT.%26atitle%3DInherited%2520cardiac%2520diseases%2520caused%2520by%2520mutations%2520in%2520the%2520NaV1.5%2520sodium%2520channel%26jtitle%3DJ.%2520Cardiovasc.%2520Electrophysiol.%26date%3D2010%26volume%3D21%26spage%3D107%26epage%3D115%26doi%3D10.1111%2Fj.1540-8167.2009.01633.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Erdemli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penland, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, P. K.</span></span> <span> </span><span class="NLM_article-title">Cardiac safety implications of hNa<sub>V</sub>1.5 blockade and a framework for pre-clinical evaluation</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.3389/fphar.2012.00006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.3389%2Ffphar.2012.00006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=22291651" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1-9&author=G.+Erdemliauthor=A.+M.+Kimauthor=H.+Juauthor=C.+Springerauthor=R.+C.+Penlandauthor=P.+K.+Hoffmann&title=Cardiac+safety+implications+of+hNaV1.5+blockade+and+a+framework+for+pre-clinical+evaluation&doi=10.3389%2Ffphar.2012.00006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2012.00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2012.00006%26sid%3Dliteratum%253Aachs%26aulast%3DErdemli%26aufirst%3DG.%26aulast%3DKim%26aufirst%3DA.%2BM.%26aulast%3DJu%26aufirst%3DH.%26aulast%3DSpringer%26aufirst%3DC.%26aulast%3DPenland%26aufirst%3DR.%2BC.%26aulast%3DHoffmann%26aufirst%3DP.%2BK.%26atitle%3DCardiac%2520safety%2520implications%2520of%2520hNaV1.5%2520blockade%2520and%2520a%2520framework%2520for%2520pre-clinical%2520evaluation%26jtitle%3DFront.%2520Pharmacol.%26date%3D2012%26volume%3D3%26spage%3D1%26epage%3D9%26doi%3D10.3389%2Ffphar.2012.00006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of voltage-gated sodium channel Na<sub>V</sub>1.7: patent applications since 2010</span>. <i>Pharm. Pat. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">509</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.4155/ppa.14.39</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.4155%2Fppa.14.39" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=25374320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVKrs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=509-521&author=S.+Sunauthor=C.+J.+Cohenauthor=C.+M.+Dehnhardt&title=Inhibitors+of+voltage-gated+sodium+channel+NaV1.7%3A+patent+applications+since+2010&doi=10.4155%2Fppa.14.39"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010</span></div><div class="casAuthors">Sun, Shaoyi; Cohen, Charles J.; Dehnhardt, Christoph M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Patent Analyst</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">509-521</span>CODEN:
                <span class="NLM_cas:coden">PPAHCN</span>;
        ISSN:<span class="NLM_cas:issn">2046-8954</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  There has been intense interest in developing inhibitors of the sodium channel Nav1.7 because genetic studies have established very strong validation for the efficacy to alleviate both inflammatory and neuropathic pain.  This review summarizes patent applications targeting Nav1.7 since 2010 until May, 2014.  We have classified the patents into three categories as follows: small mols. with well-defined mol. selectivity among sodium channel isoforms; biologicals with well-defined mol. selectivity; and, small mols. that inhibit Nav1.7 with unknown mol. selectivity.  Most of the review is dedicated to small mol. selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE50bQQ3wiFLVg90H21EOLACvtfcHk0lht5hUmGNIn5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKrs7rL&md5=6986fe156f608706204b483207d2201c</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.4155%2Fppa.14.39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Fppa.14.39%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26atitle%3DInhibitors%2520of%2520voltage-gated%2520sodium%2520channel%2520NaV1.7%253A%2520patent%2520applications%2520since%25202010%26jtitle%3DPharm.%2520Pat.%2520Anal.%26date%3D2014%26volume%3D3%26spage%3D509%26epage%3D521%26doi%3D10.4155%2Fppa.14.39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batchelor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudoin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechle, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galan, S. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulier, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greener, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markworth, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransley, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reister, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate 4-[2-(5-amino-1Hpyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-<i>N</i>-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): design and optimization of diary ether aryl sulfonamides as selective inhibitors of Na<sub>V</sub>1.7</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7029</span>– <span class="NLM_lpage">7042</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFagu7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7029-7042&author=N.+A.+Swainauthor=D.+Batchelorauthor=S.+Beaudoinauthor=B.+M.+Bechleauthor=P.+A.+Bradleyauthor=A.+D.+Brownauthor=B.+Brownauthor=K.+J.+Butcherauthor=R.+P.+Buttauthor=M.+L.+Chapmanauthor=S.+Dentonauthor=D.+Ellisauthor=S.+R.+G.+Galanauthor=S.+M.+Gaulierauthor=B.+S.+Greenerauthor=M.+J.+de+Grootauthor=M.+S.+Glossopauthor=I.+K.+Gurrellauthor=J.+Hannamauthor=M.+S.+Johnsonauthor=Z.+Linauthor=C.+J.+Markworthauthor=B.+E.+Marronauthor=D.+S.+Millanauthor=S.+Nakagawaauthor=A.+Pikeauthor=D.+Printzenhoffauthor=D.+J.+Rawsonauthor=S.+J.+Ransleyauthor=S.+M.+Reisterauthor=K.+Sasakiauthor=R.+I.+Storerauthor=P.+A.+Stuppleauthor=C.+W.+West&title=Discovery+of+clinical+candidate+4-%5B2-%285-amino-1Hpyrazol-4-yl%29-4-chlorophenoxy%5D-5-chloro-2-fluoro-N-1%2C3-thiazol-4-ylbenzenesulfonamide+%28PF-05089771%29%3A+design+and+optimization+of+diary+ether+aryl+sulfonamides+as+selective+inhibitors+of+NaV1.7&doi=10.1021%2Facs.jmedchem.7b00598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7</span></div><div class="casAuthors">Swain, Nigel. A.; Batchelor, Dave; Beaudoin, Serge; Bechle, Bruce M.; Bradley, Paul A.; Brown, Alan D.; Brown, Bruce; Butcher, Ken J.; Butt, Richard P.; Chapman, Mark L.; Denton, Stephen; Ellis, David; Galan, Sebastien R. G.; Gaulier, Steven M.; Greener, Ben S.; de Groot, Marcel J.; Glossop, Mel S.; Gurrell, Ian K.; Hannam, Jo; Johnson, Matthew S.; Lin, Zhixin; Markworth, Christopher J.; Marron, Brian E.; Millan, David S.; Nakagawa, Shoko; Pike, Andy; Printzenhoff, David; Rawson, David J.; Ransley, Sarah J.; Reister, Steven M.; Sasaki, Kosuke; Storer, R. Ian; Stupple, Paul A.; West, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7029-7042</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of acidic diaryl ether heterocyclic sulfonamides that are potent and sub-type selective NaV1.7 inhibitors is described.  Optimization of early lead matter focused on removal of structural alerts, improving metabolic stability and reducing cytochrome P 450 inhibition driven drug-drug interaction concerns to deliver the desired balance of preclin. in vitro properties.  Concerns over non-metabolic routes of clearance, variable clearance in pre-clin. species and subsequent low confidence human pharmacokinetic predictions led to the decision to conduct a human microdose study to det. clin. pharmacokinetics.  The design strategies and results from pre-clin. PK and clin. human microdose PK data are described leading to the discovery of the first sub-type selective NaV1.7 inhibitor clin. candidate PF-05089771 (34) which binds to a site in the voltage sensing domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpST6i8wDUALbVg90H21EOLACvtfcHk0lhgv9lcRSkvNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFagu7jM&md5=93761c8e8e16cea4db2c9cff6e315e57</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00598%26sid%3Dliteratum%253Aachs%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DBatchelor%26aufirst%3DD.%26aulast%3DBeaudoin%26aufirst%3DS.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DBradley%26aufirst%3DP.%2BA.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DButcher%26aufirst%3DK.%2BJ.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DDenton%26aufirst%3DS.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DGalan%26aufirst%3DS.%2BR.%2BG.%26aulast%3DGaulier%26aufirst%3DS.%2BM.%26aulast%3DGreener%26aufirst%3DB.%2BS.%26aulast%3Dde%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DGlossop%26aufirst%3DM.%2BS.%26aulast%3DGurrell%26aufirst%3DI.%2BK.%26aulast%3DHannam%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DRawson%26aufirst%3DD.%2BJ.%26aulast%3DRansley%26aufirst%3DS.%2BJ.%26aulast%3DReister%26aufirst%3DS.%2BM.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWest%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25204-%255B2-%25285-amino-1Hpyrazol-4-yl%2529-4-chlorophenoxy%255D-5-chloro-2-fluoro-N-1%252C3-thiazol-4-ylbenzenesulfonamide%2520%2528PF-05089771%2529%253A%2520design%2520and%2520optimization%2520of%2520diary%2520ether%2520aryl%2520sulfonamides%2520as%2520selective%2520inhibitors%2520of%2520NaV1.7%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7029%26epage%3D7042%26doi%3D10.1021%2Facs.jmedchem.7b00598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojic, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milgram, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescourio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparling, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stellwagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaida, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: Optimizing potency, pharmacokinetics, and metabolic properties to obtain atropisomeric quinolinone (AM-0466) that affords robust in vivo activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5990</span>– <span class="NLM_lpage">6017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5990-6017&author=R.+F.+Graceffaauthor=A.+A.+Boezioauthor=J.+Ableauthor=S.+Altmannauthor=L.+M.+Berryauthor=C.+Boezioauthor=J.+R.+Butlerauthor=M.+Chu-Moyerauthor=M.+Cookeauthor=E.+F.+DiMauroauthor=T.+A.+Dineenauthor=E.+F.+Bojicauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=A.+Guzman-Perezauthor=H.+Gaoauthor=H.+Gunaydinauthor=H.+Huangauthor=L.+Huangauthor=C.+Ilchauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=B.+C.+Milgramauthor=M.+J.+Linauthor=I.+E.+Marxauthor=H.+N.+Nguyenauthor=E.+A.+Petersonauthor=G.+Rescourioauthor=J.+Robertsauthor=L.+Schenkelauthor=R.+Shimanovichauthor=B.+A.+Sparlingauthor=J.+Stellwagenauthor=K.+Tabornauthor=K.+R.+Vaidaauthor=J.+Wangauthor=J.+Yeomanauthor=V.+Yuauthor=D.+Zhuauthor=B.+D.+Moyerauthor=M.+M.+Weiss&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+Optimizing+potency%2C+pharmacokinetics%2C+and+metabolic+properties+to+obtain+atropisomeric+quinolinone+%28AM-0466%29+that+affords+robust+in+vivo+activity&doi=10.1021%2Facs.jmedchem.6b01850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity</span></div><div class="casAuthors">Graceffa, Russell F.; Boezio, Alessandro A.; Able, Jessica; Altmann, Steven; Berry, Loren M.; Boezio, Christiane; Butler, John R.; Chu-Moyer, Margaret; Cooke, Melanie; DiMauro, Erin F.; Dineen, Thomas A.; Feric Bojic, Elma; Foti, Robert S.; Fremeau, Robert T.; Guzman-Perez, Angel; Gao, Hua; Gunaydin, Hakan; Huang, Hongbing; Huang, Liyue; Ilch, Christopher; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Milgram, Benjamin C.; Lin, Min-Hwa Jasmine; Marx, Isaac E.; Nguyen, Hanh N.; Peterson, Emily A.; Rescourio, Gwen; Roberts, John; Schenkel, Laurie; Shimanovich, Roman; Sparling, Brian A.; Stellwagen, John; Taborn, Kristin; Vaida, Karina R.; Wang, Jean; Yeoman, John; Yu, Violeta; Zhu, Dawn; Moyer, Bryan D.; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5990-6017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of its strong genetic validation, NaV1.7 has attracted significant interest as a target for the treatment of pain.  We have previously reported on a no. of structurally distinct bicyclic heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  Herein, we report the discovery and optimization of a series of atropisomeric quinolinone sulfonamide inhibitors [Bicyclic sulfonamide compds. as sodium channel inhibitors and their prepn. WO 2014201206, 2014] of NaV1.7, which demonstrate nanomolar inhibition of NaV1.7 and exhibit high levels of selectivity over other sodium channel isoforms.  After optimization of metabolic and pharmacokinetic properties, including PXR activation, CYP2C9 inhibition, and CYP3A4 TDI, several compds. were advanced into in vivo target engagement and efficacy models.  When tested in mice, compd. 39 (AM-0466) demonstrated robust pharmacodynamic activity in a NaV1.7-dependent model of histamine-induced pruritus (itch) and addnl. in a capsaicin-induced nociception model of pain without any confounding effect in open-field activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ofeMhgMFqbVg90H21EOLACvtfcHk0lhgv9lcRSkvNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D&md5=5b48afe24a97290ea5e44a71deaa0303</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01850%26sid%3Dliteratum%253Aachs%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DBoezio%26aufirst%3DC.%26aulast%3DButler%26aufirst%3DJ.%2BR.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DBojic%26aufirst%3DE.%2BF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DIlch%26aufirst%3DC.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DMilgram%26aufirst%3DB.%2BC.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRescourio%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DSchenkel%26aufirst%3DL.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DSparling%26aufirst%3DB.%2BA.%26aulast%3DStellwagen%26aufirst%3DJ.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DVaida%26aufirst%3DK.%2BR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYeoman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520Optimizing%2520potency%252C%2520pharmacokinetics%252C%2520and%2520metabolic%2520properties%2520to%2520obtain%2520atropisomeric%2520quinolinone%2520%2528AM-0466%2529%2520that%2520affords%2520robust%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5990%26epage%3D6017%26doi%3D10.1021%2Facs.jmedchem.6b01850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shields, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post-Munson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graef, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newberry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivarao, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senapati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linda J. Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of indole- and indazole-acylsulfonamides as potent and selective Na<sub>V</sub>1.7 inhibitors for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">831</span>– <span class="NLM_lpage">856</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01550</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01550" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFyhurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=831-856&author=G.+Luoauthor=L.+Chenauthor=A.+Eastonauthor=A.+Newtonauthor=C.+Bourinauthor=E.+Shieldsauthor=K.+Mosureauthor=M.+G.+Soarsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+L.+Pieschlauthor=D.+J.+Post-Munsonauthor=S.+Wangauthor=J.+Herringtonauthor=J.+Graefauthor=K.+Newberryauthor=D.+V.+Sivaraoauthor=A.+Senapatiauthor=L.+J.+Linda+J.+Bristowauthor=N.+A.+Meanwellauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Discovery+of+indole-+and+indazole-acylsulfonamides+as+potent+and+selective+NaV1.7+inhibitors+for+the+treatment+of+pain&doi=10.1021%2Facs.jmedchem.8b01550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13dR"><div class="casContent"><span class="casTitleNuber">13d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain</span></div><div class="casAuthors">Luo, Guanglin; Chen, Ling; Easton, Amy; Newton, Amy; Bourin, Clotilde; Shields, Eric; Mosure, Kathy; Soars, Matthew G.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick L.; Post-Munson, Debra J.; Wang, Shuya; Herrington, James; Graef, John; Newberry, Kimberly; Sivarao, Digavalli V.; Senapati, Arun; Bristow, Linda J.; Meanwell, Nicholas A.; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">831-856</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Aryl-indole and 3-aryl-indazole derivs. were identified as potent and selective Nav1.7 inhibitors.  Compd. I was shown to be efficacious in the mouse formalin assay and also reduced complete Freund's adjuvant (CFA)-induced thermal hyperalgesia and chronic constriction injury (CCI) induced cold allodynia and models of inflammatory and neuropathic pain, resp., following i.p. (IP) doses of 30 mg/kg.  The obsd. efficacy could be correlated with the mouse dorsal root ganglion exposure and NaV1.7 potency assocd. with I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfhO7JA5f8M7Vg90H21EOLACvtfcHk0lj5NrIx-qij4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFyhurvJ&md5=e9fbe2bca698914994f5f008a918d935</span></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01550%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DEaston%26aufirst%3DA.%26aulast%3DNewton%26aufirst%3DA.%26aulast%3DBourin%26aufirst%3DC.%26aulast%3DShields%26aufirst%3DE.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%2BL.%26aulast%3DPost-Munson%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DGraef%26aufirst%3DJ.%26aulast%3DNewberry%26aufirst%3DK.%26aulast%3DSivarao%26aufirst%3DD.%2BV.%26aulast%3DSenapati%26aufirst%3DA.%26aulast%3DLinda%2BJ.%2BBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520indole-%2520and%2520indazole-acylsulfonamides%2520as%2520potent%2520and%2520selective%2520NaV1.7%2520inhibitors%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D831%26epage%3D856%26doi%3D10.1021%2Facs.jmedchem.8b01550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenova, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrez, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemeon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelkenbrecher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPasquale, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sojo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindgren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldbrook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinette, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span> <span> </span><span class="NLM_article-title">Identification of selective acyl sulfonamide–cycloalkylether inhibitors of the voltage-gated sodium channel (Na<sub>V</sub>) 1.7 with potent analgesic activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">927</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01621</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01621" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlylsLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=908-927&author=S.+Sunauthor=Q.+Jiaauthor=A.+Y.+Zenovaauthor=M.+S.+Wilsonauthor=S.+Chowdhuryauthor=T.+Fockenauthor=J.+Liauthor=S.+Deckerauthor=M.+E.+Grimwoodauthor=J.-C.+Andrezauthor=I.+Hemeonauthor=T.+Shengauthor=C.-A.+Chenauthor=A.+Whiteauthor=D.+H.+Hackosauthor=L.+Dengauthor=G.+Bankarauthor=K.+Khakhauthor=E.+Changauthor=R.+Kwanauthor=S.+Linauthor=K.+Nelkenbrecherauthor=B.+D.+Sellersauthor=A.+G.+DiPasqualeauthor=J.+Changauthor=J.+Pangauthor=L.+Sojoauthor=A.+Lindgrenauthor=M.+Waldbrookauthor=Z.+Xieauthor=C.+Youngauthor=J.+P.+Johnsonauthor=C.+L.+Robinetteauthor=C.+J.+Cohenauthor=B.+S.+Safinaauthor=D.+P.+Sutherlinauthor=D.+F.+Ortwineauthor=C.+M.+Dehnhardt&title=Identification+of+selective+acyl+sulfonamide%E2%80%93cycloalkylether+inhibitors+of+the+voltage-gated+sodium+channel+%28NaV%29+1.7+with+potent+analgesic+activity&doi=10.1021%2Facs.jmedchem.8b01621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13eR"><div class="casContent"><span class="casTitleNuber">13e</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Selective Acyl Sulfonamide-Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (Nav) 1.7 with Potent Analgesic Activity</span></div><div class="casAuthors">Sun, Shaoyi; Jia, Qi; Zenova, Alla Y.; Wilson, Michael S.; Chowdhury, Sultan; Focken, Thilo; Li, Jun; Decker, Shannon; Grimwood, Michael E.; Andrez, Jean-Christophe; Hemeon, Ivan; Sheng, Tao; Chen, Chien-An; White, Andy; Hackos, David H.; Deng, Lunbin; Bankar, Girish; Khakh, Kuldip; Chang, Elaine; Kwan, Rainbow; Lin, Sophia; Nelkenbrecher, Karen; Sellers, Benjamin D.; DiPasquale, Antonio G.; Chang, Jae; Pang, Jodie; Sojo, Luis; Lindgren, Andrea; Waldbrook, Matthew; Xie, Zhiwei; Young, Clint; Johnson, James P.; Robinette, C. Lee; Cohen, Charles J.; Safina, Brian S.; Sutherlin, Daniel P.; Ortwine, Daniel F.; Dehnhardt, Christoph M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">908-927</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, the authors report the discovery and optimization of a series of orally bioavailable acyl sulfonamide Nav1.7 inhibitors that are selective for Nav1.7 over Nav1.5 and highly efficacious in in vivo models of pain and hNav1.7 target engagement.  An anal. of the physicochem. properties of literature Nav1.7 inhibitors suggested that acyl sulfonamides with high fsp3 could overcome some of the pharmacokinetic (PK) and efficacy challenges seen with existing series.  Parallel library syntheses lead to the identification of analog 7, which exhibited moderate potency against Nav1.7 and an acceptable PK profile in rodents, but relatively poor stability in human liver microsomes.  Further, design strategy then focused on the optimization of potency against hNav1.7 and improvement of human metabolic stability, using induced fit docking in the authors' previously disclosed x-ray cocrystal of the Nav1.7 voltage sensing domain.  These studies culminated in the discovery of tool compd. 33(I), one of the most potent and efficacious Nav1.7 inhibitors reported to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ73dSmnXyarVg90H21EOLACvtfcHk0lj5NrIx-qij4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlylsLzF&md5=f098e8182d290e4c1233b7d74887a4d0</span></div><a href="/servlet/linkout?suffix=cit13e&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01621%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DQ.%26aulast%3DZenova%26aufirst%3DA.%2BY.%26aulast%3DWilson%26aufirst%3DM.%2BS.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DDecker%26aufirst%3DS.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DAndrez%26aufirst%3DJ.-C.%26aulast%3DHemeon%26aufirst%3DI.%26aulast%3DSheng%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DC.-A.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DE.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DNelkenbrecher%26aufirst%3DK.%26aulast%3DSellers%26aufirst%3DB.%2BD.%26aulast%3DDiPasquale%26aufirst%3DA.%2BG.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DSojo%26aufirst%3DL.%26aulast%3DLindgren%26aufirst%3DA.%26aulast%3DWaldbrook%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DRobinette%26aufirst%3DC.%2BL.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26atitle%3DIdentification%2520of%2520selective%2520acyl%2520sulfonamide%25E2%2580%2593cycloalkylether%2520inhibitors%2520of%2520the%2520voltage-gated%2520sodium%2520channel%2520%2528NaV%2529%25201.7%2520with%2520potent%2520analgesic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D908%26epage%3D927%26doi%3D10.1021%2Facs.jmedchem.8b01621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit13f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrall, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPasquale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chernov-Rogan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payandeh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proctor, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shields, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span> <span> </span><span class="NLM_article-title">Structure and ligand-based discovery of chromane arylsulfonamide Na<sub>V</sub>1.7 inhibitors for the treatment of chronic pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4091</span>– <span class="NLM_lpage">4109</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00141</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00141" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmslSgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=4091-4109&author=S.+J.+McKerrallauthor=T.+Nguyenauthor=K.+W.+Laiauthor=P.+Bergeronauthor=L.+Dengauthor=A.+DiPasqualeauthor=J.+H.+Changauthor=J.+Chenauthor=T.+Chernov-Roganauthor=D.+H.+Hackosauthor=J.+Maherauthor=D.+F.+Ortwineauthor=J.+Pangauthor=J.+Payandehauthor=W.+R.+Proctorauthor=S.+D.+Shieldsauthor=J.+Vogtauthor=P.+Jiauthor=W.+Liuauthor=E.+Balliniauthor=L.+Schumannauthor=G.+Tarozzoauthor=G.+Bankarauthor=S.+Chowdhuryauthor=A.+Hasanauthor=J.+P.+Johnsonauthor=K.+Khakhauthor=S.+Linauthor=C.+J.+Cohenauthor=C.+M.+Dehnhardtauthor=B.+S.+Safinaauthor=D.+P.+Sutherlin&title=Structure+and+ligand-based+discovery+of+chromane+arylsulfonamide+NaV1.7+inhibitors+for+the+treatment+of+chronic+pain&doi=10.1021%2Facs.jmedchem.9b00141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13fR"><div class="casContent"><span class="casTitleNuber">13f</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Nav1.7 Inhibitors for the Treatment of Chronic Pain</span></div><div class="casAuthors">McKerrall, Steven J.; Nguyen, Teresa; Lai, Kwong Wah; Bergeron, Philippe; Deng, Lunbin; DiPasquale, Antonio; Chang, Jae H.; Chen, Jun; Chernov-Rogan, Tania; Hackos, David H.; Maher, Jonathan; Ortwine, Daniel F.; Pang, Jodie; Payandeh, Jian; Proctor, William R.; Shields, Shannon D.; Vogt, Jennifer; Ji, Pengfei; Liu, Wenfeng; Ballini, Elisa; Schumann, Lilia; Tarozzo, Glauco; Bankar, Girish; Chowdhury, Sultan; Hasan, Abid; Johnson, J. P.; Khakh, Kuldip; Lin, Sophia; Cohen, Charles J.; Dehnhardt, Christoph M.; Safina, Brian S.; Sutherlin, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4091-4109</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using structure- and ligand-based design principles, a novel series of piperidyl chromane arylsulfonamide Nav1.7 inhibitors was discovered.  Early optimization focused on improvement of potency through refinement of the low energy ligand conformation and mitigation of high in vivo clearance.  An in vitro hepatotoxicity hazard was identified and resolved through optimization of lipophilicity and LLE to arrive at GNE-616 (24(I)), a highly potent, metabolically stable, subtype selective inhibitor of Nav1.7.  I showed a robust PK/PD response in a Nav1.7 dependent mouse model and site-directed mutagenesis was used to identify residues crit. for the isoform selectivity profile of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw_A7qQl172bVg90H21EOLACvtfcHk0lg4HSXxqziZzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmslSgsLk%253D&md5=b8bd9e3d9f7debf6e4168e605dd837dc</span></div><a href="/servlet/linkout?suffix=cit13f&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00141%26sid%3Dliteratum%253Aachs%26aulast%3DMcKerrall%26aufirst%3DS.%2BJ.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DLai%26aufirst%3DK.%2BW.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DDiPasquale%26aufirst%3DA.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChernov-Rogan%26aufirst%3DT.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DMaher%26aufirst%3DJ.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPayandeh%26aufirst%3DJ.%26aulast%3DProctor%26aufirst%3DW.%2BR.%26aulast%3DShields%26aufirst%3DS.%2BD.%26aulast%3DVogt%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBallini%26aufirst%3DE.%26aulast%3DSchumann%26aufirst%3DL.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DHasan%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26atitle%3DStructure%2520and%2520ligand-based%2520discovery%2520of%2520chromane%2520arylsulfonamide%2520NaV1.7%2520inhibitors%2520for%2520the%2520treatment%2520of%2520chronic%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D4091%26epage%3D4109%26doi%3D10.1021%2Facs.jmedchem.9b00141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahuja, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukundl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shriverl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brillantes, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estevez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verschoof, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrez, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starovasnik, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koth, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payandeh, J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of Na<sub>V</sub>1.7 inhibition by an isoform-selective small molecule antagonist</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>350</i></span>, <span class="NLM_elocation-id">aac5464</span> <span class="refDoi"> DOI: 10.1126/science.aac5464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1126%2Fscience.aac5464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=26680203" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2015&author=S.+Ahujaauthor=S.+Mukundlauthor=L.+Dengauthor=K.+Khakhauthor=E.+Changauthor=H.+Hoauthor=S.+Shriverlauthor=C.+Youngauthor=S.+Linauthor=J.+P.+Johnsonauthor=P.+Wuauthor=J.+Liauthor=M.+Coonsauthor=C.+Tamauthor=B.+Brillantesauthor=H.+Sampangauthor=K.+Mortaraauthor=K.+K.+Bowmanauthor=K.+R.+Clarkauthor=A.+Estevezauthor=Z.+Xieauthor=H.+Verschoofauthor=M.+Grimwoodauthor=C.+Dehnhardtauthor=J.-C.+Andrezauthor=T.+Fockenauthor=D.+P.+Sutherlinauthor=B.+S.+Safinaauthor=M.+A.+Starovasnikauthor=D.+F.+Ortwineauthor=Y.+Frankeauthor=C.+J.+Cohenauthor=D.+H.+Hackosauthor=C.+M.+Kothauthor=J.+Payandeh&title=Structural+basis+of+NaV1.7+inhibition+by+an+isoform-selective+small+molecule+antagonist&doi=10.1126%2Fscience.aac5464"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscience.aac5464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aac5464%26sid%3Dliteratum%253Aachs%26aulast%3DAhuja%26aufirst%3DS.%26aulast%3DMukundl%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DE.%26aulast%3DHo%26aufirst%3DH.%26aulast%3DShriverl%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCoons%26aufirst%3DM.%26aulast%3DTam%26aufirst%3DC.%26aulast%3DBrillantes%26aufirst%3DB.%26aulast%3DSampang%26aufirst%3DH.%26aulast%3DMortara%26aufirst%3DK.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DClark%26aufirst%3DK.%2BR.%26aulast%3DEstevez%26aufirst%3DA.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DVerschoof%26aufirst%3DH.%26aulast%3DGrimwood%26aufirst%3DM.%26aulast%3DDehnhardt%26aufirst%3DC.%26aulast%3DAndrez%26aufirst%3DJ.-C.%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DStarovasnik%26aufirst%3DM.%2BA.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DFranke%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DKoth%26aufirst%3DC.%2BM.%26aulast%3DPayandeh%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520of%2520NaV1.7%2520inhibition%2520by%2520an%2520isoform-selective%2520small%2520molecule%2520antagonist%26jtitle%3DScience%26date%3D2015%26volume%3D350%26doi%3D10.1126%2Fscience.aac5464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrall, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span> <span> </span><span class="NLM_article-title">Na<sub>V</sub>1.7 inhibitors for the treatment of chronic pain</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3141</span>– <span class="NLM_lpage">3149</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2018.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=30139550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFCrtrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=3141-3149&author=S.+J.+McKerrallauthor=D.+P.+Sutherlin&title=NaV1.7+inhibitors+for+the+treatment+of+chronic+pain&doi=10.1016%2Fj.bmcl.2018.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Nav1.7 inhibitors for the treatment of chronic pain</span></div><div class="casAuthors">McKerrall, Steven J.; Sutherlin, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3141-3149</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage gated sodium channel Nav1.7 plays an essential role in the transmission of pain signals.  Strong human genetic validation has motivated extensive efforts to discover potent, selective, and efficacious Nav1.7 inhibitors for the treatment of chronic pain.  This digest will introduce the structure and function of Nav1.7 and highlight the wealth of recent developments on a diverse array of Nav1.7 inhibitors, including optimization of their potency, selectivity, and PK/PD relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV0q99YDMCULVg90H21EOLACvtfcHk0lgmxm2SczqTFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFCrtrzO&md5=7242d16b121ee8d18f769e220e5a51ef</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DMcKerrall%26aufirst%3DS.%2BJ.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26atitle%3DNaV1.7%2520inhibitors%2520for%2520the%2520treatment%2520of%2520chronic%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D3141%26epage%3D3149%26doi%3D10.1016%2Fj.bmcl.2018.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="note"><p class="first last">and references cited therein.</p></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mulcahy, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajouhesh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckley, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delwig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du Bois, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, J. C.</span></span> <span> </span><span class="NLM_article-title">Challenges and opportunities for therapeutics targeting the voltage-gated sodium channel isoform Na<sub>V</sub>1.7</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">8695</span>– <span class="NLM_lpage">8710</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01906</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01906" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvFCiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8695-8710&author=J.+V.+Mulcahyauthor=H.+Pajouheshauthor=J.+T.+Beckleyauthor=A.+Delwigauthor=J.+Du+Boisauthor=J.+C.+Hunter&title=Challenges+and+opportunities+for+therapeutics+targeting+the+voltage-gated+sodium+channel+isoform+NaV1.7&doi=10.1021%2Facs.jmedchem.8b01906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform NaV1.7</span></div><div class="casAuthors">Mulcahy, John V.; Pajouhesh, Hassan; Beckley, Jacob T.; Delwig, Anton; Du Bois, J.; Hunter, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8695-8710</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium ion channel subtype 1.7 (NaV1.7) is a high interest target for the discovery of non-opioid analgesics.  Compelling evidence from human genetic data, particularly the finding that persons lacking functional NaV1.7 are insensitive to pain, has spurred considerable effort to develop selective inhibitors of this Na+ ion channel target as analgesic medicines.  Recent clin. setbacks and disappointing performance of preclin. compds. in animal pain models, however, have led to skepticism around the potential of selective NaV1.7 inhibitors as human therapeutics.  In this Perspective, we discuss the attributes and limitations of recently disclosed investigational drugs targeting NaV1.7, and review evidence that, by better understanding the requirements for selectivity and target engagement, the opportunity to deliver effective analgesic medicines targeting NaV1.7 endures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLRid0FL5Uk7Vg90H21EOLACvtfcHk0lgmxm2SczqTFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvFCiurw%253D&md5=414a1a2ba5f68684ae8a6fbba812b1f5</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01906%26sid%3Dliteratum%253Aachs%26aulast%3DMulcahy%26aufirst%3DJ.%2BV.%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DBeckley%26aufirst%3DJ.%2BT.%26aulast%3DDelwig%26aufirst%3DA.%26aulast%3DDu%2BBois%26aufirst%3DJ.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26atitle%3DChallenges%2520and%2520opportunities%2520for%2520therapeutics%2520targeting%2520the%2520voltage-gated%2520sodium%2520channel%2520isoform%2520NaV1.7%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D8695%26epage%3D8710%26doi%3D10.1021%2Facs.jmedchem.8b01906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">and reference cited therein.</p></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzygiel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luckwell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phipps, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segelbacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speed, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span> <span> </span><span class="NLM_article-title">Clinical micro-dose studies to explore the human pharmacokinetics of four selective inhibitors of human Na<sub>V</sub>1.7 voltage-dependent sodium channels</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">875</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1007/s40262-015-0365-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1007%2Fs40262-015-0365-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=26895021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=875-887&author=H.+M.+Jonesauthor=R.+P.+Buttauthor=R.+W.+Websterauthor=I.+Gurrellauthor=P.+Dzygielauthor=N.+Flanaganauthor=D.+Fraierauthor=T.+Hayauthor=L.+E.+Iavaroneauthor=J.+Luckwellauthor=H.+Pearceauthor=A.+Phippsauthor=J.+Segelbacherauthor=B.+Speedauthor=K.+Beaumont&title=Clinical+micro-dose+studies+to+explore+the+human+pharmacokinetics+of+four+selective+inhibitors+of+human+NaV1.7+voltage-dependent+sodium+channels&doi=10.1007%2Fs40262-015-0365-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels</span></div><div class="casAuthors">Jones, Hannah M.; Butt, Richard P.; Webster, Rob W.; Gurrell, Ian; Dzygiel, Pawel; Flanagan, Neil; Fraier, Daniela; Hay, Tanya; Iavarone, Laura Else; Luckwell, Jacquelynn; Pearce, Hannah; Phipps, Alex; Segelbacher, Jill; Speed, Bill; Beaumont, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">875-887</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Background: The emergence of genetic data linking Nav1.7 sodium channel over- and under- expression to human pain signalling has led to an interest in the treatment of chronic pain through inhibition of Nav1.7 channels.  Objective: We describe the pharmacokinetic (PK) results of a clin. microdose study performed with four potent and selective Nav1.7 inhibitors and the subsequent modeling resulting in the selection of a single compd. to explore Nav1.7 pharmacol. at higher doses.  Methods: A clin. microdose study to investigate the i.v. and oral PK of four compds. (PF-05089771, PF-05150122, PF-05186462 and PF-05241328) was performed in healthy volunteers.  PK parameters were derived via noncompartmental anal.  A physiol.-based PK (PBPK) model was used to predict exposure and multiples of Nav1.7 50 % inhibitory concn. (IC50) for each compd. at higher doses.  Results: Plasma clearance, vol. of distribution and bioavailability ranged from 45 to 392 mL/min/kg, 13 to 36 L/kg and 38 to 110 %, resp.  The PBPK model for PF-05089771 predicted a 1 g oral dose would be required to achieve exposures of approx. 12× Nav1.7 IC50 at max. concn. (Cmax), and approx. 3× IC50 after 12 h (min. concn. [Cmin] for a twice-daily regimen).  Lower multiples of Nav1.7 IC50 were predicted with the same oral doses of PF-05150122, PF-05186462, and PF-05241328.  In a subsequent single ascending oral dose clin. study, the predictions for PF-05089771 compared well with obsd. data.  Conclusion: Based on the human PK data obtained from the microdose study and subsequent modeling, PF-05089771 provided the best opportunity to explore Nav1.7 blockade for the treatment of acute or chronic pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUEQTEvITzd7Vg90H21EOLACvtfcHk0lgmxm2SczqTFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D&md5=bf8dbccbbbbf25f52bf13f28bc995c18</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1007%2Fs40262-015-0365-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-015-0365-0%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DWebster%26aufirst%3DR.%2BW.%26aulast%3DGurrell%26aufirst%3DI.%26aulast%3DDzygiel%26aufirst%3DP.%26aulast%3DFlanagan%26aufirst%3DN.%26aulast%3DFraier%26aufirst%3DD.%26aulast%3DHay%26aufirst%3DT.%26aulast%3DIavarone%26aufirst%3DL.%2BE.%26aulast%3DLuckwell%26aufirst%3DJ.%26aulast%3DPearce%26aufirst%3DH.%26aulast%3DPhipps%26aufirst%3DA.%26aulast%3DSegelbacher%26aufirst%3DJ.%26aulast%3DSpeed%26aufirst%3DB.%26aulast%3DBeaumont%26aufirst%3DK.%26atitle%3DClinical%2520micro-dose%2520studies%2520to%2520explore%2520the%2520human%2520pharmacokinetics%2520of%2520four%2520selective%2520inhibitors%2520of%2520human%2520NaV1.7%2520voltage-dependent%2520sodium%2520channels%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2016%26volume%3D55%26spage%3D875%26epage%3D887%26doi%3D10.1007%2Fs40262-015-0365-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batchelor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudoin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechle, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galan, S. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulier, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greener, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markworth, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransley, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reister, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate 4-[2-(5-amino-1Hpyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-<i>N</i>-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): design and optimization of diary ether aryl sulfonamides as selective inhibitors of Na<sub>V</sub>1.7</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7029</span>– <span class="NLM_lpage">7042</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFagu7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7029-7042&author=N.+A.+Swainauthor=D.+Batchelorauthor=S.+Beaudoinauthor=B.+M.+Bechleauthor=P.+A.+Bradleyauthor=A.+D.+Brownauthor=B.+Brownauthor=K.+J.+Butcherauthor=R.+P.+Buttauthor=M.+L.+Chapmanauthor=S.+Dentonauthor=D.+Ellisauthor=S.+R.+G.+Galanauthor=S.+M.+Gaulierauthor=B.+S.+Greenerauthor=M.+J.+de+Grootauthor=M.+S.+Glossopauthor=I.+K.+Gurrellauthor=J.+Hannamauthor=M.+S.+Johnsonauthor=Z.+Linauthor=C.+J.+Markworthauthor=B.+E.+Marronauthor=D.+S.+Millanauthor=S.+Nakagawaauthor=A.+Pikeauthor=D.+Printzenhoffauthor=D.+J.+Rawsonauthor=S.+J.+Ransleyauthor=S.+M.+Reisterauthor=K.+Sasakiauthor=R.+I.+Storerauthor=P.+A.+Stuppleauthor=C.+W.+West&title=Discovery+of+clinical+candidate+4-%5B2-%285-amino-1Hpyrazol-4-yl%29-4-chlorophenoxy%5D-5-chloro-2-fluoro-N-1%2C3-thiazol-4-ylbenzenesulfonamide+%28PF-05089771%29%3A+design+and+optimization+of+diary+ether+aryl+sulfonamides+as+selective+inhibitors+of+NaV1.7&doi=10.1021%2Facs.jmedchem.7b00598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7</span></div><div class="casAuthors">Swain, Nigel. A.; Batchelor, Dave; Beaudoin, Serge; Bechle, Bruce M.; Bradley, Paul A.; Brown, Alan D.; Brown, Bruce; Butcher, Ken J.; Butt, Richard P.; Chapman, Mark L.; Denton, Stephen; Ellis, David; Galan, Sebastien R. G.; Gaulier, Steven M.; Greener, Ben S.; de Groot, Marcel J.; Glossop, Mel S.; Gurrell, Ian K.; Hannam, Jo; Johnson, Matthew S.; Lin, Zhixin; Markworth, Christopher J.; Marron, Brian E.; Millan, David S.; Nakagawa, Shoko; Pike, Andy; Printzenhoff, David; Rawson, David J.; Ransley, Sarah J.; Reister, Steven M.; Sasaki, Kosuke; Storer, R. Ian; Stupple, Paul A.; West, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7029-7042</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of acidic diaryl ether heterocyclic sulfonamides that are potent and sub-type selective NaV1.7 inhibitors is described.  Optimization of early lead matter focused on removal of structural alerts, improving metabolic stability and reducing cytochrome P 450 inhibition driven drug-drug interaction concerns to deliver the desired balance of preclin. in vitro properties.  Concerns over non-metabolic routes of clearance, variable clearance in pre-clin. species and subsequent low confidence human pharmacokinetic predictions led to the decision to conduct a human microdose study to det. clin. pharmacokinetics.  The design strategies and results from pre-clin. PK and clin. human microdose PK data are described leading to the discovery of the first sub-type selective NaV1.7 inhibitor clin. candidate PF-05089771 (34) which binds to a site in the voltage sensing domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpST6i8wDUALbVg90H21EOLACvtfcHk0lgknRI4IjBt5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFagu7jM&md5=93761c8e8e16cea4db2c9cff6e315e57</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00598%26sid%3Dliteratum%253Aachs%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DBatchelor%26aufirst%3DD.%26aulast%3DBeaudoin%26aufirst%3DS.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DBradley%26aufirst%3DP.%2BA.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DButcher%26aufirst%3DK.%2BJ.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DDenton%26aufirst%3DS.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DGalan%26aufirst%3DS.%2BR.%2BG.%26aulast%3DGaulier%26aufirst%3DS.%2BM.%26aulast%3DGreener%26aufirst%3DB.%2BS.%26aulast%3Dde%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DGlossop%26aufirst%3DM.%2BS.%26aulast%3DGurrell%26aufirst%3DI.%2BK.%26aulast%3DHannam%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DRawson%26aufirst%3DD.%2BJ.%26aulast%3DRansley%26aufirst%3DS.%2BJ.%26aulast%3DReister%26aufirst%3DS.%2BM.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWest%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25204-%255B2-%25285-amino-1Hpyrazol-4-yl%2529-4-chlorophenoxy%255D-5-chloro-2-fluoro-N-1%252C3-thiazol-4-ylbenzenesulfonamide%2520%2528PF-05089771%2529%253A%2520design%2520and%2520optimization%2520of%2520diary%2520ether%2520aryl%2520sulfonamides%2520as%2520selective%2520inhibitors%2520of%2520NaV1.7%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7029%26epage%3D7042%26doi%3D10.1021%2Facs.jmedchem.7b00598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit16c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandrou, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechle, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakemore, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castle, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fengas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckmans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theile, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torella, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmus, J. S.</span></span> <span> </span><span class="NLM_article-title">Highly potent and selective Na<sub>V</sub>1.7 inhibitors for use as intravenous agents and chemical probes</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">4805</span>– <span class="NLM_lpage">4811</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.09.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2017.09.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=29029933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gmur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4805-4811&author=R.+I.+Storerauthor=A.+Pikeauthor=N.+A.+Swainauthor=A.+J.+Alexandrouauthor=B.+M.+Bechleauthor=D.+C.+Blakemoreauthor=A.+D.+Brownauthor=N.+A.+Castleauthor=M.+S.+Corbettauthor=N.+J.+Flanaganauthor=D.+Fengasauthor=M.+S.+Johnsonauthor=L.+H.+Jonesauthor=B.+E.+Marronauthor=C.+E.+Payneauthor=D.+Printzenhoffauthor=D.+J.+Rawsonauthor=C.+R.+Roseauthor=T.+Ryckmansauthor=J.+Sunauthor=J.+W.+Theileauthor=R.+Torellaauthor=E.+Tsengauthor=J.+S.+Warmus&title=Highly+potent+and+selective+NaV1.7+inhibitors+for+use+as+intravenous+agents+and+chemical+probes&doi=10.1016%2Fj.bmcl.2017.09.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">Highly potent and selective NaV1.7 inhibitors for use as intravenous agents and chemical probes</span></div><div class="casAuthors">Storer, R. Ian; Pike, Andy; Swain, Nigel A.; Alexandrou, Aristos J.; Bechle, Bruce M.; Blakemore, David C.; Brown, Alan D.; Castle, Neil A.; Corbett, Matthew S.; Flanagan, Neil J.; Fengas, David; Johnson, M. Scott; Jones, Lyn H.; Marron, Brian E.; Payne, C. Elizabeth; Printzenhoff, David; Rawson, David J.; Rose, Colin R.; Ryckmans, Thomas; Sun, Jianmin; Theile, Jonathan W.; Torella, Rubben; Tseng, Elaine; Warmus, Joseph S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4805-4811</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and selection of a highly potent and selective NaV1.7 inhibitor PF-06456384, designed specifically for i.v. infusion, is disclosed.  Extensive in vitro pharmacol. and ADME profiling followed by in vivo preclin. PK and efficacy model data are discussed.  A proposed protein-ligand binding mode for this compd. is also provided to rationalize the high levels of potency and selectivity over inhibition of related sodium channels.  To further support the proposed binding mode, potent conjugates are described which illustrate the potential for development of chem. probes to enable further target evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA-67HTehcGLVg90H21EOLACvtfcHk0lgknRI4IjBt5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gmur3L&md5=5be8e615ad061aa7cf06056de8b8682c</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.09.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.09.056%26sid%3Dliteratum%253Aachs%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DAlexandrou%26aufirst%3DA.%2BJ.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DCastle%26aufirst%3DN.%2BA.%26aulast%3DCorbett%26aufirst%3DM.%2BS.%26aulast%3DFlanagan%26aufirst%3DN.%2BJ.%26aulast%3DFengas%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DPayne%26aufirst%3DC.%2BE.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DRawson%26aufirst%3DD.%2BJ.%26aulast%3DRose%26aufirst%3DC.%2BR.%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DTheile%26aufirst%3DJ.%2BW.%26aulast%3DTorella%26aufirst%3DR.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DWarmus%26aufirst%3DJ.%2BS.%26atitle%3DHighly%2520potent%2520and%2520selective%2520NaV1.7%2520inhibitors%2520for%2520use%2520as%2520intravenous%2520agents%2520and%2520chemical%2520probes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D4805%26epage%3D4811%26doi%3D10.1016%2Fj.bmcl.2017.09.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit16d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">McDonnell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surujbally, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span> <span> </span><span class="NLM_article-title">Efficacy of the Na<sub>V</sub>1.7 blocker PF-05089771 in a randomized, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">1465</span>– <span class="NLM_lpage">1476</span>, <span class="refDoi"> DOI: 10.1097/j.pain.0000000000001227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1097%2Fj.pain.0000000000001227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=29578944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlelu7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2018&pages=1465-1476&author=A.+McDonnellauthor=S.+Collinsauthor=Z.+Aliauthor=L.+Iavaroneauthor=R.+Surujballyauthor=S.+Kirbyauthor=R.+P.+Butt&title=Efficacy+of+the+NaV1.7+blocker+PF-05089771+in+a+randomized%2C+placebo-controlled%2C+double-blind+clinical+study+in+subjects+with+painful+diabetic+peripheral+neuropathy&doi=10.1097%2Fj.pain.0000000000001227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16dR"><div class="casContent"><span class="casTitleNuber">16d</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy</span></div><div class="casAuthors">McDonnell, Aoibhinn; Collins, Susie; Ali, Zahid; Iavarone, Laura; Surujbally, Raulin; Kirby, Simon; Butt, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1465-1476</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The effect of PF-05089771, a selective, peripherally restricted Nav1.7 sodium channel blocker on pain due to diabetic peripheral neuropathy was investigated in a randomised, placebo and active-controlled parallel group clin. trial (NCT02215252).  A 1-wk placebo-run in the period was followed by a 4-wk treatment period and a 1-wk placebo run-out/taper-down period.  Single-blind placebo was administered throughout run-in and run-out periods.  Subjects were randomised to receive either PF-05089771 150 mg twice daily, pregabalin 150 mg twice daily, or placebo during the 4-wk treatment period.  One hundred thirty-five subjects were randomised.  The primary endpoint was the av. pain score derived from subjects' Numerical Rating Scale scores over the past 7 days of week 4 of the double-blind treatment period.  Predefined efficacy criteria for the trial were the effect of PF-05089771 being >0.5 units better than placebo at interim anal. after completion of the first part of the study.  Although a trend for a redn. in the weekly av. pain score in the PF-05089771 treatment group was obsd., this was not statistically significant when compared with placebo at week 4, with a mean posterior difference of -0.41 (90% credible interval: -1.00 to 0.17).  The effect of PF-05089771 was smaller than that seen with pregabalin, which was statistically significant when compared with placebo at week 4, with a mean posterior difference of -0.53 (90% credible interval: -0.91 to -0.20).  As predefined efficacy criteria were not met, the study did not proceed to the second part.  PF-05089771 was well tolerated.  Possible reasons for the modest efficacy obsd. with PF-05089771 are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKiEsCT64-q7Vg90H21EOLACvtfcHk0lg2Jb5URHekcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlelu7fM&md5=61d83a34d992b85b828cea56f0a4f7b9</span></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=10.1097%2Fj.pain.0000000000001227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fj.pain.0000000000001227%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonnell%26aufirst%3DA.%26aulast%3DCollins%26aufirst%3DS.%26aulast%3DAli%26aufirst%3DZ.%26aulast%3DIavarone%26aufirst%3DL.%26aulast%3DSurujbally%26aufirst%3DR.%26aulast%3DKirby%26aufirst%3DS.%26aulast%3DButt%26aufirst%3DR.%2BP.%26atitle%3DEfficacy%2520of%2520the%2520NaV1.7%2520blocker%2520PF-05089771%2520in%2520a%2520randomized%252C%2520placebo-controlled%252C%2520double-blind%2520clinical%2520study%2520in%2520subjects%2520with%2520painful%2520diabetic%2520peripheral%2520neuropathy%26jtitle%3DPain%26date%3D2018%26volume%3D159%26spage%3D1465%26epage%3D1476%26doi%3D10.1097%2Fj.pain.0000000000001227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojic, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkel, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Application of a parallel synthetic strategy in the discovery of biaryl acyl sulfonamides as efficient and selective Na<sub>V</sub>1.7 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7818</span>– <span class="NLM_lpage">7839</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00425</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00425" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1SktLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7818-7839&author=E.+F.+DiMauroauthor=S.+Altmannauthor=L.+M.+Berryauthor=H.+Bregmanauthor=N.+Chakkaauthor=M.+Chu-Moyerauthor=E.+F.+Bojicauthor=R.+S.+Fotiauthor=R.+Fremeauauthor=H.+Gaoauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=B.+E.+Hallauthor=H.+Huangauthor=M.+Jaroshauthor=T.+Kornecookauthor=J.+Leeauthor=J.+Liguttiauthor=D.+Liuauthor=B.+D.+Moyerauthor=D.+Ortunoauthor=P.+E.+Roseauthor=L.+B.+Schenkelauthor=K.+Tabornauthor=J.+Wangauthor=Y.+Wangauthor=V.+Yuauthor=M.+M.+Weiss&title=Application+of+a+parallel+synthetic+strategy+in+the+discovery+of+biaryl+acyl+sulfonamides+as+efficient+and+selective+NaV1.7+inhibitors&doi=10.1021%2Facs.jmedchem.6b00425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors</span></div><div class="casAuthors">DiMauro, Erin F.; Altmann, Stephen; Berry, Loren M.; Bregman, Howard; Chakka, Nagasree; Chu-Moyer, Margaret; Bojic, Elma Feric; Foti, Robert S.; Fremeau, Robert; Gao, Hua; Gunaydin, Hakan; Guzman-Perez, Angel; Hall, Brian E.; Huang, Hongbing; Jarosh, Michael; Kornecook, Thomas; Lee, Josie; Ligutti, Joseph; Liu, Dong; Moyer, Bryan D.; Ortuno, Daniel; Rose, Paul E.; Schenkel, Laurie B.; Taborn, Kristin; Wang, Jean; Wang, Yan; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7818-7839</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of potent and selective hNaV1.7 inhibitors possess common pharmacophoric features that include a heteroaryl sulfonamide headgroup and a lipophilic arom. tail group.  Recently, reports of similar arom. tail groups in combination with an acyl sulfonamide headgroup have emerged, with the acyl sulfonamide bestowing levels of selectivity over hNaV1.5 comparable to the heteroaryl sulfonamide.  Beginning with com. available carboxylic acids that met selected pharmacophoric requirements in the lipophilic tail, a parallel synthetic approach was applied to rapidly generate the derived acyl sulfonamides.  A biaryl acyl sulfonamide hit from this library was elaborated, optimizing for potency and selectivity with attention to physicochem. properties.  The resulting novel leads are potent, ligand and lipophilic efficient, and selective over hNaV1.5.  Representative lead I demonstrates selectivity over other human NaV isoforms and good pharmacokinetics in rodents.  The biaryl acyl sulfonamides reported herein may also offer ADME advantages over known heteroaryl sulfonamide inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxffPzH1T1T7Vg90H21EOLACvtfcHk0lg2Jb5URHekcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1SktLjK&md5=8afa7437928f0d43a1327662674978ed</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00425%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DBojic%26aufirst%3DE.%2BF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DHall%26aufirst%3DB.%2BE.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DOrtuno%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DSchenkel%26aufirst%3DL.%2BB.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DApplication%2520of%2520a%2520parallel%2520synthetic%2520strategy%2520in%2520the%2520discovery%2520of%2520biaryl%2520acyl%2520sulfonamides%2520as%2520efficient%2520and%2520selective%2520NaV1.7%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7818%26epage%3D7839%26doi%3D10.1021%2Facs.jmedchem.6b00425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: optimizing potency and pharmacokinetics to enable in vivo target engagement</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1062</span>– <span class="NLM_lpage">1067</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00243</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00243" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFCmsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1062-1067&author=I.+E.+Marxauthor=T.+A.+Dineenauthor=J.+Ableauthor=C.+Bodeauthor=H.+Bregmanauthor=M.+Chu-Moyerauthor=E.+F.+DiMauroauthor=B.+Duauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=H.+Gaoauthor=H.+Gunaydinauthor=B.+E.+Hallauthor=L.+Huangauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=M.+J.+Linauthor=D.+Liuauthor=J.+S.+McDermottauthor=B.+D.+Moyerauthor=E.+A.+Petersonauthor=J.+T.+Robertsauthor=P.+Roseauthor=J.+Wangauthor=B.+D.+Youngbloodauthor=V.+Yuauthor=M.+M.+Weiss&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+optimizing+potency+and+pharmacokinetics+to+enable+in+vivo+target+engagement&doi=10.1021%2Facsmedchemlett.6b00243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement</span></div><div class="casAuthors">Marx, Isaac E.; Dineen, Thomas A.; Able, Jessica; Bode, Christiane; Bregman, Howard; Chu-Moyer, Margaret; DiMauro, Erin F.; Du, Bingfan; Foti, Robert S.; Fremeau, Robert T.; Gao, Hua; Gunaydin, Hakan; Hall, Brian E.; Huang, Liyue; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Lin, Min-Hwa Jasmine; Liu, Dong; McDermott, Jeff S.; Moyer, Bryan D.; Peterson, Emily A.; Roberts, Jonathan T.; Rose, Paul; Wang, Jean; Youngblood, Beth D.; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1062-1067</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human genetic evidence has identified the voltage-gated sodium channel NaV1.7 as an attractive target for the treatment of pain.  The authors initially identified naphthalene sulfonamide 5-(2-(1-methyl-1H-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-N-(1,2,4-thiadiazol-5-yl)naphthalene-2-sulfonamide (compd. 3) as a potent and selective inhibitor of NaV1.7.  Optimization to reduce biliary clearance by balancing hydrophilicity and hydrophobicity (Log D) while maintaining NaV1.7 potency led to the identification of quinazoline 16 (AM-2099).  Compd. 16 demonstrated a favorable pharmacokinetic profile in rat and dog and demonstrated dose-dependent redn. of histamine-induced scratching bouts in a mouse behavioral model following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosNi8X2t0EULVg90H21EOLACvtfcHk0lhHRWaf3qswuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFCmsr%252FE&md5=43c2ae357af90d6c6f56245c3114c016</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00243%26sid%3Dliteratum%253Aachs%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDu%26aufirst%3DB.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHall%26aufirst%3DB.%2BE.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRoberts%26aufirst%3DJ.%2BT.%26aulast%3DRose%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYoungblood%26aufirst%3DB.%2BD.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520optimizing%2520potency%2520and%2520pharmacokinetics%2520to%2520enable%2520in%2520vivo%2520target%2520engagement%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D1062%26epage%3D1067%26doi%3D10.1021%2Facsmedchemlett.6b00243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojic, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: optimizing potency and pharmacokinetics while mitigating metabolic liabilities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5969</span>– <span class="NLM_lpage">5989</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01851</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01851" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFOmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5969-5989&author=M.+M.+Weissauthor=T.+A.+Dineenauthor=I.+E.+Marxauthor=S.+Altmannauthor=A.+A.+Boezioauthor=H.+Bregmanauthor=M.+Chu-Moyerauthor=E.+F.+DiMauroauthor=E.+F.+Bojicauthor=R.+S.+Fotiauthor=H.+Gaoauthor=R.+F.+Graceffaauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=H.+Huangauthor=L.+Huangauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=J.+Liguttiauthor=D.+S.+Laauthor=M.+J.+Linauthor=D.+Liuauthor=B.+D.+Moyerauthor=H.+N.+Nguyenauthor=E.+A.+Petersonauthor=P.+E.+Roseauthor=K.+Tabornauthor=B.+D.+Youngbloodauthor=V.+Yuauthor=R.+T.+Fremeau&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+optimizing+potency+and+pharmacokinetics+while+mitigating+metabolic+liabilities&doi=10.1021%2Facs.jmedchem.6b01851"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17cR"><div class="casContent"><span class="casTitleNuber">17c</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities</span></div><div class="casAuthors">Weiss, Matthew M.; Dineen, Thomas A.; Marx, Isaac E.; Altmann, Steven; Boezio, Alessandro; Bregman, Howard; Chu-Moyer, Margaret; DiMauro, Erin F.; Feric Bojic, Elma; Foti, Robert S.; Gao, Hua; Graceffa, Russell; Gunaydin, Hakan; Guzman-Perez, Angel; Huang, Hongbing; Huang, Liyue; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; Ligutti, Joseph; La, Daniel S.; Lin, Min-Hwa Jasmine; Liu, Dong; Moyer, Bryan D.; Nguyen, Hanh N.; Peterson, Emily A.; Rose, Paul E.; Taborn, Kristin; Youngblood, Beth D.; Yu, Violeta; Fremeau, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5969-5989</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several reports have recently emerged regarding the identification of heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  The optimization of a series of internal NaV1.7 leads that address a no. of metabolic liabilities including bioactivation, PXR activation, as well as CYP3A4 induction and inhibition led to the identification of potent and selective inhibitors that demonstrated favorable pharmacokinetic profiles and were devoid of the aforementioned liabilities.  The key to achieving this within a series prone to transporter-mediated clearance was the identification of a small range of optimal cLogD values and the discovery of subtle PXR SAR that was not lipophilicity dependent.  This enabled the identification of compd. 20, which was advanced into a target engagement pharmacodynamic model where it exhibited robust reversal of histamine-induced scratching bouts in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovsPC2UZpxsbVg90H21EOLACvtfcHk0lhHRWaf3qswuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFOmtbw%253D&md5=6333a6b936e48f9d18cf9df10ea12853</span></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01851%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DBojic%26aufirst%3DE.%2BF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DYoungblood%26aufirst%3DB.%2BD.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520optimizing%2520potency%2520and%2520pharmacokinetics%2520while%2520mitigating%2520metabolic%2520liabilities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5969%26epage%3D5989%26doi%3D10.1021%2Facs.jmedchem.6b01851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit17d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojic, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milgram, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescourio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparling, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stellwagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaida, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: optimizing potency, pharmacokinetics, and metabolic properties to obtain atropisomeric quinolinone (AM-0466) that affords robust in vivo activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5990</span>– <span class="NLM_lpage">6017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5990-6017&author=R.+F.+Graceffaauthor=A.+A.+Boezioauthor=J.+Ableauthor=S.+Altmannauthor=L.+M.+Berryauthor=C.+Boezioauthor=J.+R.+Butlerauthor=M.+Chu-Moyerauthor=M.+Cookeauthor=E.+F.+DiMauroauthor=T.+A.+Dineenauthor=E.+F.+Bojicauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=A.+Guzman-Perezauthor=H.+Gaoauthor=H.+Gunaydinauthor=H.+Huangauthor=L.+Huangauthor=C.+Ilchauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=B.+C.+Milgramauthor=M.+J.+Linauthor=I.+E.+Marxauthor=H.+N.+Nguyenauthor=E.+A.+Petersonauthor=G.+Rescourioauthor=J.+Robertsauthor=L.+Schenkelauthor=R.+Shimanovichauthor=B.+A.+Sparlingauthor=J.+Stellwagenauthor=K.+Tabornauthor=K.+R.+Vaidaauthor=J.+Wangauthor=J.+Yeomanauthor=V.+Yuauthor=D.+Zhuauthor=B.+D.+Moyerauthor=M.+M.+Weiss&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+optimizing+potency%2C+pharmacokinetics%2C+and+metabolic+properties+to+obtain+atropisomeric+quinolinone+%28AM-0466%29+that+affords+robust+in+vivo+activity&doi=10.1021%2Facs.jmedchem.6b01850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17dR"><div class="casContent"><span class="casTitleNuber">17d</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity</span></div><div class="casAuthors">Graceffa, Russell F.; Boezio, Alessandro A.; Able, Jessica; Altmann, Steven; Berry, Loren M.; Boezio, Christiane; Butler, John R.; Chu-Moyer, Margaret; Cooke, Melanie; DiMauro, Erin F.; Dineen, Thomas A.; Feric Bojic, Elma; Foti, Robert S.; Fremeau, Robert T.; Guzman-Perez, Angel; Gao, Hua; Gunaydin, Hakan; Huang, Hongbing; Huang, Liyue; Ilch, Christopher; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Milgram, Benjamin C.; Lin, Min-Hwa Jasmine; Marx, Isaac E.; Nguyen, Hanh N.; Peterson, Emily A.; Rescourio, Gwen; Roberts, John; Schenkel, Laurie; Shimanovich, Roman; Sparling, Brian A.; Stellwagen, John; Taborn, Kristin; Vaida, Karina R.; Wang, Jean; Yeoman, John; Yu, Violeta; Zhu, Dawn; Moyer, Bryan D.; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5990-6017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of its strong genetic validation, NaV1.7 has attracted significant interest as a target for the treatment of pain.  We have previously reported on a no. of structurally distinct bicyclic heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  Herein, we report the discovery and optimization of a series of atropisomeric quinolinone sulfonamide inhibitors [Bicyclic sulfonamide compds. as sodium channel inhibitors and their prepn. WO 2014201206, 2014] of NaV1.7, which demonstrate nanomolar inhibition of NaV1.7 and exhibit high levels of selectivity over other sodium channel isoforms.  After optimization of metabolic and pharmacokinetic properties, including PXR activation, CYP2C9 inhibition, and CYP3A4 TDI, several compds. were advanced into in vivo target engagement and efficacy models.  When tested in mice, compd. 39 (AM-0466) demonstrated robust pharmacodynamic activity in a NaV1.7-dependent model of histamine-induced pruritus (itch) and addnl. in a capsaicin-induced nociception model of pain without any confounding effect in open-field activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ofeMhgMFqbVg90H21EOLACvtfcHk0lheJdUQ-HGVzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D&md5=5b48afe24a97290ea5e44a71deaa0303</span></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01850%26sid%3Dliteratum%253Aachs%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DBoezio%26aufirst%3DC.%26aulast%3DButler%26aufirst%3DJ.%2BR.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DBojic%26aufirst%3DE.%2BF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DIlch%26aufirst%3DC.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DMilgram%26aufirst%3DB.%2BC.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRescourio%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DSchenkel%26aufirst%3DL.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DSparling%26aufirst%3DB.%2BA.%26aulast%3DStellwagen%26aufirst%3DJ.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DVaida%26aufirst%3DK.%2BR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYeoman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520optimizing%2520potency%252C%2520pharmacokinetics%252C%2520and%2520metabolic%2520properties%2520to%2520obtain%2520atropisomeric%2520quinolinone%2520%2528AM-0466%2529%2520that%2520affords%2520robust%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5990%26epage%3D6017%26doi%3D10.1021%2Facs.jmedchem.6b01850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit17e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coats, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">The discovery of benzoxazine sulfonamide inhibitors of Na<sub>V</sub>1.7: tools that bridge efficacy and target engagement</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3477</span>– <span class="NLM_lpage">3485</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.05.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2017.05.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=28629594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVeqsb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=3477-3485&author=D.+S.+Laauthor=E.+A.+Petersonauthor=C.+Bodeauthor=A.+A.+Boezioauthor=H.+Bregmanauthor=M.+Y.+Chu-Moyerauthor=J.+Coatsauthor=E.+F.+DiMauroauthor=T.+A.+Dineenauthor=B.+Duauthor=H.+Gaoauthor=R.+Graceffaauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=R.+Fremeauauthor=X.+Huangauthor=C.+Ilchauthor=T.+J.+Kornecookauthor=C.+Kreimanauthor=J.+Liguttiauthor=M.+J.+Linauthor=J.+S.+McDermottauthor=I.+Marxauthor=D.+J.+Matsonauthor=S.+I.+McDonoughauthor=B.+D.+Moyerauthor=H.+N.+Nguyenauthor=K.+Tabornauthor=V.+Yuauthor=M.+M.+Weiss&title=The+discovery+of+benzoxazine+sulfonamide+inhibitors+of+NaV1.7%3A+tools+that+bridge+efficacy+and+target+engagement&doi=10.1016%2Fj.bmcl.2017.05.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17eR"><div class="casContent"><span class="casTitleNuber">17e</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of benzoxazine sulfonamide inhibitors of NaV1.7: Tools that bridge efficacy and target engagement</span></div><div class="casAuthors">La, Daniel S.; Peterson, Emily A.; Bode, Christiane; Boezio, Alessandro A.; Bregman, Howard; Chu-Moyer, Margaret Y.; Coats, James; Di Mauro, Erin F.; Dineen, Thomas A.; Du, Bingfan; Gao, Hua; Graceffa, Russell; Gunaydin, Hakan; Guzman-Perez, Angel; Fremeau, Robert, Jr.; Huang, Xin; Ilch, Christopher; Kornecook, Thomas J.; Kreiman, Charles; Ligutti, Joseph; Jasmine Lin, Min-Hwa; McDermott, Jeff S.; Marx, Isaac; Matson, David J.; McDonough, Stefan I.; Moyer, Bryan D.; Nho Nguyen, Hanh; Taborn, Kristin; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3477-3485</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage-gated sodium channel NaV1.7 has received much attention from the scientific community due to compelling human genetic data linking gain- and loss-of-function mutations to pain phenotypes.  Despite this genetic validation of NaV1.7 as a target for pain, high quality pharmacol. tools facilitate further understanding of target biol., establishment of target coverage requirements and subsequent progression into the clinic.  Within the sulfonamide class of inhibitors, reduced potency on rat NaV1.7 vs. human NaV1.7 was obsd., rendering in vivo rat pharmacol. studies challenging.  Herein, the authors report the discovery and optimization of novel benzoxazine sulfonamide inhibitors of human, rat and mouse NaV1.7 which enabled pharmacol. assessment in traditional behavioral rodent models of pain and in turn, established a connection between formalin-induced pain and histamine-induced pruritus in mice.  The latter represents a simple and efficient means of measuring target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrephmJ2EoOv7Vg90H21EOLACvtfcHk0lheJdUQ-HGVzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVeqsb7K&md5=680ffa374194c12fd3705a7003bd572e</span></div><a href="/servlet/linkout?suffix=cit17e&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.05.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.05.070%26sid%3Dliteratum%253Aachs%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%2BY.%26aulast%3DCoats%26aufirst%3DJ.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DDu%26aufirst%3DB.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DFremeau%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DIlch%26aufirst%3DC.%26aulast%3DKornecook%26aufirst%3DT.%2BJ.%26aulast%3DKreiman%26aufirst%3DC.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DMarx%26aufirst%3DI.%26aulast%3DMatson%26aufirst%3DD.%2BJ.%26aulast%3DMcDonough%26aufirst%3DS.%2BI.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DThe%2520discovery%2520of%2520benzoxazine%2520sulfonamide%2520inhibitors%2520of%2520NaV1.7%253A%2520tools%2520that%2520bridge%2520efficacy%2520and%2520target%2520engagement%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D3477%26epage%3D3485%26doi%3D10.1016%2Fj.bmcl.2017.05.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Roecker, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egbertson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koser, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majercak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarelli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of selective, orally bioavailable, N-linked arylsulfonamide Na<sub>V</sub>1.7 inhibitors with pain efficacy in mice</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2087</span>– <span class="NLM_lpage">2093</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2017.03.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=28389149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslOgur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2087-2093&author=A.+J.+Roeckerauthor=M.+Egbertsonauthor=K.+L.+G.+Jonesauthor=R.+Gomezauthor=R.+L.+Krausauthor=Y.+Liauthor=A.+J.+Koserauthor=M.+O.+Urbanauthor=R.+Kleinauthor=M.+Clementsauthor=J.+Panigelauthor=C.+Daleyauthor=J.+Wangauthor=E.+N.+Fingerauthor=J.+Majercakauthor=V.+Santarelliauthor=I.+Greganauthor=M.+Catoauthor=T.+Filzenauthor=A.+Jovanovskaauthor=Y.+Wangauthor=D.+Wangauthor=L.+A.+Joyceauthor=E.+C.+Shererauthor=X.+Pengauthor=X.+Wangauthor=H.+Sunauthor=P.+J.+Colemanauthor=A.+K.+Houghtonauthor=M.+E.+Layton&title=Discovery+of+selective%2C+orally+bioavailable%2C+N-linked+arylsulfonamide+NaV1.7+inhibitors+with+pain+efficacy+in+mice&doi=10.1016%2Fj.bmcl.2017.03.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nav1.7 inhibitors with pain efficacy in mice</span></div><div class="casAuthors">Roecker, Anthony J.; Egbertson, Melissa; Jones, Kristen L. G.; Gomez, Robert; Kraus, Richard L.; Li, Yuxing; Koser, Amy Jo; Urban, Mark O.; Klein, Rebecca; Clements, Michelle; Panigel, Jacqueline; Daley, Christopher; Wang, Jixin; Finger, Eleftheria N.; Majercak, John; Santarelli, Vincent; Gregan, Irene; Cato, Matthew; Filzen, Tracey; Jovanovska, Aneta; Wang, Ying-Hong; Wang, Deping; Joyce, Leo A.; Sherer, Edward C.; Peng, Xuanjia; Wang, Xiu; Sun, Haiyan; Coleman, Paul J.; Houghton, Andrea K.; Layton, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2087-2093</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage-gated sodium channel Nav1.7 is a genetically validated target for the treatment of pain with gain-of-function mutations in man eliciting a variety of painful disorders and loss-of-function mutations affording insensitivity to pain.  Unfortunately, drugs thought to garner efficacy via Nav1 inhibition have undesirable side effect profiles due to their lack of selectivity over channel isoforms.  Herein we report the discovery of a novel series of orally bioavailable arylsulfonamide Nav1.7 inhibitors with high levels of selectivity over Nav1.5, the Nav isoform responsible for cardiovascular side effects, through judicious use of parallel medicinal chem. and physicochem. property optimization.  This effort produced inhibitors such as compd. 5 with excellent potency, selectivity, behavioral efficacy in a rodent pain model, and efficacy in a mouse itch model suggestive of target modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNDA0s8NB86LVg90H21EOLACvtfcHk0lj4xxwU8o77kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslOgur0%253D&md5=5729efef8e3df4afe3f89c25472c9268</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.085%26sid%3Dliteratum%253Aachs%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DEgbertson%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DK.%2BL.%2BG.%26aulast%3DGomez%26aufirst%3DR.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKoser%26aufirst%3DA.%2BJ.%26aulast%3DUrban%26aufirst%3DM.%2BO.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DClements%26aufirst%3DM.%26aulast%3DPanigel%26aufirst%3DJ.%26aulast%3DDaley%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DMajercak%26aufirst%3DJ.%26aulast%3DSantarelli%26aufirst%3DV.%26aulast%3DGregan%26aufirst%3DI.%26aulast%3DCato%26aufirst%3DM.%26aulast%3DFilzen%26aufirst%3DT.%26aulast%3DJovanovska%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DJoyce%26aufirst%3DL.%2BA.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DHoughton%26aufirst%3DA.%2BK.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26atitle%3DDiscovery%2520of%2520selective%252C%2520orally%2520bioavailable%252C%2520N-linked%2520arylsulfonamide%2520NaV1.7%2520inhibitors%2520with%2520pain%2520efficacy%2520in%2520mice%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2087%26epage%3D2093%26doi%3D10.1016%2Fj.bmcl.2017.03.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pero, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehman, H. D. G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulhearn, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolkenberg, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henze, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majercak, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span> <span> </span><span class="NLM_article-title">Benzoxazolinone aryl sulfonamides as potent, selective Na<sub>V</sub>1.7 inhibitors with in vivo efficacy in a preclinical pain model</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2683</span>– <span class="NLM_lpage">2688</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.04.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2017.04.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=28465103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFSmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2683-2688&author=J.+E.+Peroauthor=M.+A.+Rossiauthor=H.+D.+G.+F.+Lehmanauthor=M.+J.+Kellyauthor=J.+J.+Mulhearnauthor=S.+E.+Wolkenbergauthor=M.+J.+Catoauthor=M.+K.+Clementsauthor=C.+J.+Daleyauthor=T.+Filzenauthor=E.+N.+Fingerauthor=Y.+Greganauthor=D.+A.+Henzeauthor=A.+Jovanovskaauthor=R.+Kleinauthor=R.+L.+Krausauthor=Y.+Liauthor=A.+Liangauthor=J.+M.+Majercakauthor=J.+Panigelauthor=M.+O.+Urbanauthor=J.+Wangauthor=Y.+Wangauthor=A.+K.+Houghtonauthor=M.+E.+Layton&title=Benzoxazolinone+aryl+sulfonamides+as+potent%2C+selective+NaV1.7+inhibitors+with+in+vivo+efficacy+in+a+preclinical+pain+model&doi=10.1016%2Fj.bmcl.2017.04.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model</span></div><div class="casAuthors">Pero, Joseph E.; Rossi, Michael A.; Lehman, Hannah D. G. F.; Kelly, Michael J., III; Mulhearn, James J.; Wolkenberg, Scott E.; Cato, Matthew J.; Clements, Michelle K.; Daley, Christopher J.; Filzen, Tracey; Finger, Eleftheria N.; Gregan, Yun; Henze, Darrell A.; Jovanovska, Aneta; Klein, Rebecca; Kraus, Richard L.; Li, Yuxing; Liang, Annie; Majercak, John M.; Panigel, Jacqueline; Urban, Mark O.; Wang, Jixin; Wang, Ying-Hong; Houghton, Andrea K.; Layton, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2683-2688</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Studies on human genetics have suggested that inhibitors of the Nav1.7 voltage-gated sodium channel hold considerable promise as therapies for the treatment of chronic pain syndromes.  Herein, we report novel, peripherally-restricted benzoxazolinone aryl sulfonamides as potent Nav1.7 inhibitors with excellent selectivity against the Nav1.5 isoform, which is expressed in the heart muscle.  Elaboration of initial lead compd. 3d afforded exemplar 13, which featured attractive physicochem. properties, outstanding lipophilic ligand efficiency and pharmacol. selectivity against Nav1.5 exceeding 1000-fold.  Key structure-activity relationships assocd. with oral bioavailability were leveraged to discover compd. 17, which exhibited a comparable potency/selectivity profile as well as full efficacy following oral administration in a preclin. model indicative of antinociceptive behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGCg6OCYoM57Vg90H21EOLACvtfcHk0lj4xxwU8o77kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFSmt70%253D&md5=9ea2c021a2c76ffe0bb8c623d1eb7427</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.04.040%26sid%3Dliteratum%253Aachs%26aulast%3DPero%26aufirst%3DJ.%2BE.%26aulast%3DRossi%26aufirst%3DM.%2BA.%26aulast%3DLehman%26aufirst%3DH.%2BD.%2BG.%2BF.%26aulast%3DKelly%26aufirst%3DM.%2BJ.%26aulast%3DMulhearn%26aufirst%3DJ.%2BJ.%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DCato%26aufirst%3DM.%2BJ.%26aulast%3DClements%26aufirst%3DM.%2BK.%26aulast%3DDaley%26aufirst%3DC.%2BJ.%26aulast%3DFilzen%26aufirst%3DT.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DGregan%26aufirst%3DY.%26aulast%3DHenze%26aufirst%3DD.%2BA.%26aulast%3DJovanovska%26aufirst%3DA.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DA.%26aulast%3DMajercak%26aufirst%3DJ.%2BM.%26aulast%3DPanigel%26aufirst%3DJ.%26aulast%3DUrban%26aufirst%3DM.%2BO.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHoughton%26aufirst%3DA.%2BK.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26atitle%3DBenzoxazolinone%2520aryl%2520sulfonamides%2520as%2520potent%252C%2520selective%2520NaV1.7%2520inhibitors%2520with%2520in%2520vivo%2520efficacy%2520in%2520a%2520preclinical%2520pain%2520model%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2683%26epage%3D2688%26doi%3D10.1016%2Fj.bmcl.2017.04.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenova, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chafeev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span> <span> </span><span class="NLM_article-title">The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na<sub>V</sub>1.7</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4397</span>– <span class="NLM_lpage">4401</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2014.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=25176194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWqsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4397-4401&author=S.+Sunauthor=Q.+Jiaauthor=A.+Y.+Zenovaauthor=M.+Chafeevauthor=Z.+Zhangauthor=S.+Linauthor=R.+Kwanauthor=M.+E.+Grimwoodauthor=S.+Chowdhuryauthor=C.+Youngauthor=C.+J.+Cohenauthor=R.+M.+Oballa&title=The+discovery+of+benzenesulfonamide-based+potent+and+selective+inhibitors+of+voltage-gated+sodium+channel+NaV1.7&doi=10.1016%2Fj.bmcl.2014.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Nav1.7</span></div><div class="casAuthors">Sun, Shaoyi; Jia, Qi; Zenova, Alla Y.; Chafeev, Mikhail; Zhang, Zaihui; Lin, Sophia; Kwan, Rainbow; Grimwood, Mike E.; Chowdhury, Sultan; Young, Clint; Cohen, Charles J.; Oballa, Renata M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4397-4401</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage gated sodium channel Nav1.7 represents an interesting target for the treatment of pain.  Human genetic studies have identified the crucial role of Nav1.7 in pain signaling.  Herein, we report the design and synthesis of a novel series of benzenesulfonamide-based Nav1.7 inhibitors.  Structural-activity relationship (SAR) studies were undertaken towards improving Nav1.7 activity and minimizing CYP inhibition.  These efforts resulted in the identification of compd. I, a highly potent Nav1.7 inhibitor with a thousand-fold selectivity over Nav1.5 and negligible CYP inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjReDfVWQ9BbVg90H21EOLACvtfcHk0liAOZ8GXhpazQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWqsrfJ&md5=ac2bc2156d5bce18e8eb6027088edf27</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DQ.%26aulast%3DZenova%26aufirst%3DA.%2BY.%26aulast%3DChafeev%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26atitle%3DThe%2520discovery%2520of%2520benzenesulfonamide-based%2520potent%2520and%2520selective%2520inhibitors%2520of%2520voltage-gated%2520sodium%2520channel%2520NaV1.7%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4397%26epage%3D4401%26doi%3D10.1016%2Fj.bmcl.2014.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chahal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauphinais, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemeon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bichler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogucki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldbrook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sojo, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuart, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinette, C. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of aryl sulfonamides as isoform-selective inhibitors of Na<sub>V</sub>1.7 with efficacy in rodent pain models</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">282</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00447</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00447" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=277-282&author=T.+Fockenauthor=S.+Liuauthor=N.+Chahalauthor=M.+Dauphinaisauthor=M.+E.+Grimwoodauthor=S.+Chowdhuryauthor=I.+Hemeonauthor=P.+Bichlerauthor=D.+Boguckiauthor=M.+Waldbrookauthor=G.+Bankarauthor=L.+E.+Sojoauthor=C.+Youngauthor=S.+Linauthor=N.+Shuartauthor=R.+Kwanauthor=J.+Pangauthor=J.+H.+Changauthor=B.+S.+Safinaauthor=D.+P.+Sutherlinauthor=J.+P.+Johnsonauthor=C.+M.+Dehnhardtauthor=T.+S.+Mansourauthor=R.+M.+Oballaauthor=C.+J.+Cohenauthor=C.+L.+Robinette&title=Discovery+of+aryl+sulfonamides+as+isoform-selective+inhibitors+of+NaV1.7+with+efficacy+in+rodent+pain+models&doi=10.1021%2Facsmedchemlett.5b00447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of NaV1.7 with Efficacy in Rodent Pain Models</span></div><div class="casAuthors">Focken, Thilo; Liu, Shifeng; Chahal, Navjot; Dauphinais, Maxim; Grimwood, Michael E.; Chowdhury, Sultan; Hemeon, Ivan; Bichler, Paul; Bogucki, David; Waldbrook, Matthew; Bankar, Girish; Sojo, Luis E.; Young, Clint; Lin, Sophia; Shuart, Noah; Kwan, Rainbow; Pang, Jodie; Chang, Jae H.; Safina, Brian S.; Sutherlin, Daniel P.; Johnson, J. P., Jr.; Dehnhardt, Christoph M.; Mansour, Tarek S.; Oballa, Renata M.; Cohen, Charles J.; Robinette, C. Lee</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-282</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report on a novel series of aryl sulfonamides that act as nanomolar potent, isoform-selective inhibitors of the human sodium channel hNaV1.7.  The optimization of these inhibitors is described.  The authors aimed to improve potency against hNaV1.7 while minimizing off-target safety concerns and generated compd. I.  This agent displayed significant analgesic effects in rodent models of acute and inflammatory pain and demonstrated that binding to the voltage sensor domain 4 site of NaV1.7 leads to an analgesic effect in vivo.  The findings corroborate the importance of hNaV1.7 as a drug target for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpIxiu3ixqRLVg90H21EOLACvtfcHk0liAOZ8GXhpazQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKksrk%253D&md5=ae05f2c1ef6cf51d69a67a7b1ee7f8fa</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00447%26sid%3Dliteratum%253Aachs%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DChahal%26aufirst%3DN.%26aulast%3DDauphinais%26aufirst%3DM.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DHemeon%26aufirst%3DI.%26aulast%3DBichler%26aufirst%3DP.%26aulast%3DBogucki%26aufirst%3DD.%26aulast%3DWaldbrook%26aufirst%3DM.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DSojo%26aufirst%3DL.%2BE.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DShuart%26aufirst%3DN.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DRobinette%26aufirst%3DC.%2BL.%26atitle%3DDiscovery%2520of%2520aryl%2520sulfonamides%2520as%2520isoform-selective%2520inhibitors%2520of%2520NaV1.7%2520with%2520efficacy%2520in%2520rodent%2520pain%2520models%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D277%26epage%3D282%26doi%3D10.1021%2Facsmedchemlett.5b00447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrall, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPasquale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chernov-Rogan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payandeh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proctor, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shields, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span> <span> </span><span class="NLM_article-title">Structure- and ligand-based discovery of chromane arylsulfonamide Na<sub>V</sub>1.7 inhibitors for the treatment of chronic pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4091</span>– <span class="NLM_lpage">4109</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00141</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00141" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmslSgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=4091-4109&author=S.+J.+McKerrallauthor=T.+Nguyenauthor=K.+W.+Laiauthor=P.+Bergeronauthor=L.+Dengauthor=A.+DiPasqualeauthor=J.+H.+Changauthor=J.+Chenauthor=T.+Chernov-Roganauthor=D.+H.+Hackosauthor=J.+Maherauthor=D.+F.+Ortwineauthor=J.+Pangauthor=J.+Payandehauthor=W.+R.+Proctorauthor=S.+D.+Shieldsauthor=J.+Vogtauthor=P.+Jiauthor=W.+Liuauthor=E.+Balliniauthor=L.+Schumannauthor=G.+Tarozzoauthor=G.+Bankarauthor=S.+Chowdhuryauthor=A.+Hasanauthor=J.+P.+Johnsonauthor=K.+Khakhauthor=S.+Linauthor=C.+J.+Cohenauthor=C.+M.+Dehnhardtauthor=B.+S.+Safinaauthor=D.+P.+Sutherlin&title=Structure-+and+ligand-based+discovery+of+chromane+arylsulfonamide+NaV1.7+inhibitors+for+the+treatment+of+chronic+pain&doi=10.1021%2Facs.jmedchem.9b00141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Nav1.7 Inhibitors for the Treatment of Chronic Pain</span></div><div class="casAuthors">McKerrall, Steven J.; Nguyen, Teresa; Lai, Kwong Wah; Bergeron, Philippe; Deng, Lunbin; DiPasquale, Antonio; Chang, Jae H.; Chen, Jun; Chernov-Rogan, Tania; Hackos, David H.; Maher, Jonathan; Ortwine, Daniel F.; Pang, Jodie; Payandeh, Jian; Proctor, William R.; Shields, Shannon D.; Vogt, Jennifer; Ji, Pengfei; Liu, Wenfeng; Ballini, Elisa; Schumann, Lilia; Tarozzo, Glauco; Bankar, Girish; Chowdhury, Sultan; Hasan, Abid; Johnson, J. P.; Khakh, Kuldip; Lin, Sophia; Cohen, Charles J.; Dehnhardt, Christoph M.; Safina, Brian S.; Sutherlin, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4091-4109</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using structure- and ligand-based design principles, a novel series of piperidyl chromane arylsulfonamide Nav1.7 inhibitors was discovered.  Early optimization focused on improvement of potency through refinement of the low energy ligand conformation and mitigation of high in vivo clearance.  An in vitro hepatotoxicity hazard was identified and resolved through optimization of lipophilicity and LLE to arrive at GNE-616 (24(I)), a highly potent, metabolically stable, subtype selective inhibitor of Nav1.7.  I showed a robust PK/PD response in a Nav1.7 dependent mouse model and site-directed mutagenesis was used to identify residues crit. for the isoform selectivity profile of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw_A7qQl172bVg90H21EOLACvtfcHk0ljgTLFho8qVKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmslSgsLk%253D&md5=b8bd9e3d9f7debf6e4168e605dd837dc</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00141%26sid%3Dliteratum%253Aachs%26aulast%3DMcKerrall%26aufirst%3DS.%2BJ.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DLai%26aufirst%3DK.%2BW.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DDiPasquale%26aufirst%3DA.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChernov-Rogan%26aufirst%3DT.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DMaher%26aufirst%3DJ.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPayandeh%26aufirst%3DJ.%26aulast%3DProctor%26aufirst%3DW.%2BR.%26aulast%3DShields%26aufirst%3DS.%2BD.%26aulast%3DVogt%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBallini%26aufirst%3DE.%26aulast%3DSchumann%26aufirst%3DL.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DHasan%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26atitle%3DStructure-%2520and%2520ligand-based%2520discovery%2520of%2520chromane%2520arylsulfonamide%2520NaV1.7%2520inhibitors%2520for%2520the%2520treatment%2520of%2520chronic%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D4091%26epage%3D4109%26doi%3D10.1021%2Facs.jmedchem.9b00141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venables, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of morpholine-based aryl sulfonamides as Na<sub>V</sub>1.7 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">958</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.01.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2018.01.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=29439904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFCmtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=958-962&author=Y.+Wuauthor=J.+Guernonauthor=A.+McClureauthor=B.+Venablesauthor=R.+Rajamaniauthor=K.+J.+Robbinsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+L.+Pieschlauthor=J.+Herringtonauthor=L.+J.+Bristowauthor=N.+A.+Meanwellauthor=R.+Olsonauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Discovery+of+morpholine-based+aryl+sulfonamides+as+NaV1.7+inhibitors&doi=10.1016%2Fj.bmcl.2018.01.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of morpholine-based aryl sulfonamides as Nav1.7 inhibitors</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; McClure, Andrea; Venables, Brian; Rajamani, Ramkumar; Robbins, Kevin J.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick L.; Herrington, James; Bristow, Linda J.; Meanwell, Nicholas A.; Olson, Richard; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">958-962</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Replacement of the piperidine ring in the lead benzenesulfonamide Nav1.7 inhibitor I with a weakly basic morpholine core resulted in a significant redn. in Nav1.7 inhibitory activity, but the activity was restored by shortening the linkage from methyleneoxy to oxygen.  These efforts led to a series of morpholine-based aryl sulfonamides as isoform-selective Nav1.7 inhibitors.  This report describes the synthesis and SAR of these analogs.  Discovery of morpholine-based aryl sulfonamides as Nav1.7 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojgiZrOTuKrbVg90H21EOLACvtfcHk0ljgTLFho8qVKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFCmtLc%253D&md5=7d9f583e76737c61f2b7c386ed661619</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.01.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.01.035%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DVenables%26aufirst%3DB.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DRobbins%26aufirst%3DK.%2BJ.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%2BL.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520morpholine-based%2520aryl%2520sulfonamides%2520as%2520NaV1.7%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D958%26epage%3D962%26doi%3D10.1016%2Fj.bmcl.2018.01.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ditta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post-Munson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graef, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newberry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Development of new benzenesulfonamides as potent and selective Na<sub>V</sub>1.7 inhibitors for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2513</span>– <span class="NLM_lpage">2525</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01918</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01918" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVCmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2513-2525&author=Y.+Wuauthor=J.+Guernonauthor=J.+Shiauthor=J.+Dittaauthor=K.+J.+Robbinsauthor=R.+Rajamaniauthor=A.+Eastonauthor=A.+Newtonauthor=C.+Bourinauthor=K.+Mosureauthor=M.+G.+Soarsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+L.+Pieschlauthor=D.+J.+Post-Munsonauthor=S.+Wangauthor=J.+Herringtonauthor=J.+Graefauthor=K.+Newberryauthor=L.+J.+Bristowauthor=N.+A.+Meanwellauthor=R.+Olsonauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Development+of+new+benzenesulfonamides+as+potent+and+selective+NaV1.7+inhibitors+for+the+treatment+of+pain&doi=10.1021%2Facs.jmedchem.6b01918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Development of New Benzenesulfonamides As Potent and Selective Nav1.7 Inhibitors for the Treatment of Pain</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; Shi, Jianliang; Ditta, Jonathan; Robbins, Kevin J.; Rajamani, Ramkumar; Easton, Amy; Newton, Amy; Bourin, Clotilde; Mosure, Kathleen; Soars, Matthew G.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick L.; Post-Munson, Debra J.; Wang, Shuya; Herrington, James; Graef, John; Newberry, Kimberly; Bristow, Linda J.; Meanwell, Nicholas A.; Olson, Richard; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2513-2525</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By taking advantage of certain features in piperidine (I), the authors developed a novel series of cyclohexylamine- and piperidine-based benzenesulfonamides as potent and selective Nav1.7 inhibitors.  However, 4-((((1S,4S)-4-aminocydohexyl)methyl)amino)-5-chloro-2-fluoro-N-(thiazol-2-yl)benzenesulfonamide (24), one of the early analogs, failed to reduce phase 2 flinching in the mouse formalin test even at a dose of 100 mpk PO due to insufficient DRG exposure attributed to poor membrane permeability.  Two analogs with improved membrane permeability showed much increased DRG concns. at doses of 30 mpk PO but, confoundingly, only one of these was effective in the formalin test.  More data are needed to understand the disconnect between efficacy and exposure relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVESOC2ks88bVg90H21EOLACvtfcHk0ljseHpE_iMliw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVCmtrs%253D&md5=d320dedb1d61794445680d94dc2c7e48</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01918%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DDitta%26aufirst%3DJ.%26aulast%3DRobbins%26aufirst%3DK.%2BJ.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DEaston%26aufirst%3DA.%26aulast%3DNewton%26aufirst%3DA.%26aulast%3DBourin%26aufirst%3DC.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%2BL.%26aulast%3DPost-Munson%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DGraef%26aufirst%3DJ.%26aulast%3DNewberry%26aufirst%3DK.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520new%2520benzenesulfonamides%2520as%2520potent%2520and%2520selective%2520NaV1.7%2520inhibitors%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2513%26epage%3D2525%26doi%3D10.1021%2Facs.jmedchem.6b01918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit20c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnaby, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivarao, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of non-zwitterionic aryl sulfonamides as Na<sub>V</sub>1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5490</span>– <span class="NLM_lpage">5505</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmc.2017.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=28818462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlegsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=5490-5505&author=Y.-J.+Wuauthor=J.+Guernonauthor=A.+McClureauthor=G.+Luoauthor=R.+Rajamaniauthor=A.+Ngauthor=A.+Eastonauthor=A.+Newtonauthor=C.+Bourinauthor=D.+Parkerauthor=K.+Mosureauthor=O.+Barnabyauthor=M.+G.+Soarsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+Pieschlauthor=J.+Herringtonauthor=P.+Chenauthor=D.+V.+Sivaraoauthor=L.+J.+Bristowauthor=N.+A.+Meanwellauthor=J.+Bronsonauthor=R.+Olsonauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Discovery+of+non-zwitterionic+aryl+sulfonamides+as+NaV1.7+inhibitors+with+efficacy+in+preclinical+behavioral+models+and+translational+measures+of+nociceptive+neuron+activation&doi=10.1016%2Fj.bmc.2017.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20cR"><div class="casContent"><span class="casTitleNuber">20c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of non-zwitterionic aryl sulfonamides as Nav1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; McClure, Andrea; Luo, Guanglin; Rajamani, Ramkumar; Ng, Alicia; Easton, Amy; Newton, Amy; Bourin, Clotilde; Parker, Dawn; Mosure, Kathleen; Barnaby, Omar; Soars, Matthew G.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick; Herrington, James; Chen, Ping; Sivarao, D. V.; Bristow, Linda J.; Meanwell, Nicholas A.; Bronson, Joanne; Olson, Richard; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5490-5505</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Since zwitterionic benzenesulfonamide Nav1.7 inhibitors suffer from poor membrane permeability, the authors sought to eliminate this characteristic by replacing the basic moiety with non-basic bicyclic acetals and monocyclic ethers.  These efforts led to the discovery of the non-zwitterionic aryl sulfonamide 49 ((R)-5-chloro-2-fluoro-4-(((tetrahydro-2H-pyran-3-yl)methyl)amino)-N-(thiazol-2-yl)benzenesulfonamide) as a selective Nav1.7 inhibitor with improved membrane permeability.  Despite its moderate cellular activity, 49 exhibited robust efficacy in mouse models of neuropathic and inflammatory pain and modulated translational electromyogram measures assocd. with activation of nociceptive neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDfNtc0Dv967Vg90H21EOLACvtfcHk0ljseHpE_iMliw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlegsL%252FE&md5=d8426c3423ce37ddfb45f1ea31f89d16</span></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.-J.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DEaston%26aufirst%3DA.%26aulast%3DNewton%26aufirst%3DA.%26aulast%3DBourin%26aufirst%3DC.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DBarnaby%26aufirst%3DO.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DSivarao%26aufirst%3DD.%2BV.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DBronson%26aufirst%3DJ.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520non-zwitterionic%2520aryl%2520sulfonamides%2520as%2520NaV1.7%2520inhibitors%2520with%2520efficacy%2520in%2520preclinical%2520behavioral%2520models%2520and%2520translational%2520measures%2520of%2520nociceptive%2520neuron%2520activation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D5490%26epage%3D5505%26doi%3D10.1016%2Fj.bmc.2017.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span> <span> </span><span class="NLM_article-title">The discovery of tetrahydropyridine analogs as hNa<sub>V</sub>1.7 selective inhibitors for analgesia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2210</span>– <span class="NLM_lpage">2215</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2017.03.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=28385504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslarsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2210-2215&author=W.+Wuauthor=Z.+Liauthor=G.+Yangauthor=M.+Tengauthor=J.+Qinauthor=Z.+Huauthor=L.+Houauthor=L.+Shenauthor=H.+Dongauthor=Y.+Zhangauthor=J.+Liauthor=S.+Chenauthor=J.+Tianauthor=J.+Zhangauthor=L.+Ye&title=The+discovery+of+tetrahydropyridine+analogs+as+hNaV1.7+selective+inhibitors+for+analgesia&doi=10.1016%2Fj.bmcl.2017.03.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of tetrahydropyridine analogs as hNav1.7 selective inhibitors for analgesia</span></div><div class="casAuthors">Wu, Wentao; Li, Zhixiang; Yang, Guangwen; Teng, Mingxing; Qin, Jian; Hu, Zhijing; Hou, Lijuan; Shen, Liang; Dong, Haiheng; Zhang, Yang; Li, Jian; Chen, Shuhui; Tian, Jingwei; Zhang, Jianzhao; Ye, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2210-2215</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HNav1.7 small mol. inhibitors have attracted lots of attention by its unique analgesic effect.  Herein, the design and synthesis of a novel series of tetrahydropyridine analogs as hNav1.7 inhibitors for analgesia is reported.  Detail structural-activity relationship (SAR) studies were undertaken towards improving hNav1.7 activity, in vitro ADME, and in vivo PK profiles.  These efforts resulted in the identification of compd. (-)-I, a highly potent and selective hNav1.7 inhibitor with good ADME and PK profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP6xx5fd4NYrVg90H21EOLACvtfcHk0li6eXlntpxpSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslarsb8%253D&md5=ed0b99fa7611354124394c07bbf259ac</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.043%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DTeng%26aufirst%3DM.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DHou%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DL.%26atitle%3DThe%2520discovery%2520of%2520tetrahydropyridine%2520analogs%2520as%2520hNaV1.7%2520selective%2520inhibitors%2520for%2520analgesia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2210%26epage%3D2215%26doi%3D10.1016%2Fj.bmcl.2017.03.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of aminocyclohexene analogues as selective and orally bioavailable hNa<sub>V</sub>1.7 inhibitors for analgesia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_fpage">4979</span>– <span class="NLM_lpage">4984</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2017.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=29037948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gksb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=4979-4984&author=M.+Tengauthor=W.+Wuauthor=Z.+Liauthor=G.+Yangauthor=J.+Qinauthor=Y.+Wangauthor=Z.+Huauthor=H.+Dongauthor=L.+Houauthor=G.+Huauthor=L.+Shenauthor=Y.+Zhangauthor=J.+Liauthor=S.+Chenauthor=J.+Tianauthor=L.+Yeauthor=J.+Zhangauthor=H.+Wang&title=Discovery+of+aminocyclohexene+analogues+as+selective+and+orally+bioavailable+hNaV1.7+inhibitors+for+analgesia&doi=10.1016%2Fj.bmcl.2017.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of aminocyclohexene analogues as selective and orally bioavailable hNav1.7 inhibitors for analgesia</span></div><div class="casAuthors">Teng, Mingxing; Wu, Wentao; Li, Zhixiang; Yang, Guangwen; Qin, Jian; Wang, Yikai; Hu, Zhijing; Dong, Haiheng; Hou, Lijuan; Hu, Guoping; Shen, Liang; Zhang, Yang; Li, Jian; Chen, Shuhui; Tian, Jingwei; Ye, Liang; Zhang, Jianzhao; Wang, Hongbo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4979-4984</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HNav1.7 receives a lot of attention owing to its attractive mechanism of action in pain processing pathway.  The authors have previously reported the design of a novel series of tetrahydropyridine analogs towards hNav1.7 selective inhibitors.  Herein, the authors disclose further efforts to the optimization of hit compd. (-)-6, which led to the identification of aminocyclohexene analogs (-)-9 and (-)-17 with good potency, high selectivity, and minimal CYP inhibition.  Both compds. (-)-9 and (-)-17 demonstrated improved pharmacokinetic profiles in rats, and robust efficacy in rat formalin-induced nociception and spinal nerve ligation (SNL) models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqawNCRE6H6rVg90H21EOLACvtfcHk0li6eXlntpxpSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gksb7J&md5=922146ec3e1c272e02af031be78dc06d</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DHou%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520aminocyclohexene%2520analogues%2520as%2520selective%2520and%2520orally%2520bioavailable%2520hNaV1.7%2520inhibitors%2520for%2520analgesia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26spage%3D4979%26epage%3D4984%26doi%3D10.1016%2Fj.bmcl.2017.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sawynok, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, A.</span></span> <span> </span><span class="NLM_article-title">Caffeine inhibits anti-nociception by acetaminophen in the formalin test by inhibiting spinal adenosine A1 receptors</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>674</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2011.10.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.ejphar.2011.10.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=22085758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1Kitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=674&publication_year=2012&pages=248-254&author=J.+Sawynokauthor=A.+Reid&title=Caffeine+inhibits+anti-nociception+by+acetaminophen+in+the+formalin+test+by+inhibiting+spinal+adenosine+A1+receptors&doi=10.1016%2Fj.ejphar.2011.10.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine inhibits antinociception by acetaminophen in the formalin test by inhibiting spinal adenosine A1 receptors</span></div><div class="casAuthors">Sawynok, Jana; Reid, Allison R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">674</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">248-254</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study examd. effects of caffeine on antinociception by acetaminophen in the formalin test in mice.  It demonstrates that caffeine 10 mg/kg inhibits antinociception produced by acetaminophen 300 mg/kg i.p. against phase 2 flinches.  Chronic administration of caffeine in the drinking water (0.1, 0.3 g/l) for 8 days also inhibits the action of acetaminophen.  The selective adenosine A1 receptor antagonist DPCPX 1 mg/kg i.p. mimics the action of caffeine, but the selective adenosine A2A receptor antagonist SCH58261 3 mg/kg i.p. does not.  While acetaminophen produced the same effect in mice that were +/+, +/-, and -/- for adenosine A1 receptors, inhibition of antinociception by caffeine was seen only in +/+ and +/- mice.  A higher dose of caffeine, 40 mg/kg, produced an intrinsic antinociception against formalin-evoked flinches, an effect also seen when caffeine was administered intrathecally.  SCH58261 30 nmol, but not DPCPX 10 nmol, also produced antinociception when administered intrathecally indicating involvement of adenosine A2A receptors in spinal antinociception.  Caffeine reversal of acetaminophen results from actions in the spinal cord, as intrathecal DPCPX 10 nmol inhibited antinociception by systemic acetaminophen; this was also obsd. in +/+ but not in -/- adenosine A1 receptor mice.  We propose that spinal adenosine A1 receptors contribute to the action of acetaminophen secondarily to involvement of descending serotonin pathways and release of adenosine within the spinal cord.  Inhibition of acetaminophen antinociception by doses of caffeine relevant to dietary human intake levels suggests a more detailed consideration of acetaminophen-caffeine interactions in humans is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlaONeW1abErVg90H21EOLACvtfcHk0li6eXlntpxpSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1Kitw%253D%253D&md5=c05e2e48def5461fcf7be9873c33d6c0</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2011.10.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2011.10.036%26sid%3Dliteratum%253Aachs%26aulast%3DSawynok%26aufirst%3DJ.%26aulast%3DReid%26aufirst%3DA.%26atitle%3DCaffeine%2520inhibits%2520anti-nociception%2520by%2520acetaminophen%2520in%2520the%2520formalin%2520test%2520by%2520inhibiting%2520spinal%2520adenosine%2520A1%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D674%26spage%3D248%26epage%3D254%26doi%3D10.1016%2Fj.ejphar.2011.10.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shields, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavanaugh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basbaum, A.</span></span> <span> </span><span class="NLM_article-title">Pain behavior in the formalin test persists after ablation of the great majority of C-fiber nociceptors</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2010.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.pain.2010.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=20832171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A280%3ADC%252BC3cfpsVyitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2010&pages=422-429&author=S.+Shieldsauthor=D.+Cavanaughauthor=H.+Leeauthor=D.+Andersonauthor=A.+Basbaum&title=Pain+behavior+in+the+formalin+test+persists+after+ablation+of+the+great+majority+of+C-fiber+nociceptors&doi=10.1016%2Fj.pain.2010.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Pain behavior in the formalin test persists after ablation of the great majority of C-fiber nociceptors</span></div><div class="casAuthors">Shields Shannon D; Cavanaugh Daniel J; Lee Hyosang; Anderson David J; Basbaum Allan I</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">422-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although the formalin test is a widely used model of persistent pain, the primary afferent fiber types that underlie the cellular and behavioral responses to formalin injection are largely unknown.  Here we used a combined genetic and pharmacological approach to investigate the effect of ablating subsets of primary afferent nociceptors on formalin-induced nocifensive behaviors and spinal cord Fos protein expression.  Intrathecal capsaicin-induced ablation of the central terminals of TRPV1+neurons greatly reduced the behavioral responses and Fos elicited by low-dose (0.5%) formalin.  In contrast, genetic ablation of the MrgprD-expressing subset of non-peptidergic unmyelinated afferents, which constitute a largely non-overlapping population, altered neither the behavior nor the Fos induced by low-dose formalin.  Remarkably, nocifensive behavior following high-dose (2%) formalin was unchanged in mice lacking either afferent population, or even in mice lacking both populations, which together make up the great majority of C-fiber nociceptors.  Thus, at high doses, which are routinely used in the formalin test, formalin-induced "pain" behavior persists in the absence of the vast majority of C-fiber nociceptors, which points to a contribution of a large spectrum of afferents secondary to non-specific formalin-induced tissue and nerve damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQxSXCbJPqGTwWRJ3OJdH_qfW6udTcc2eaJJWkEZES-mbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfpsVyitQ%253D%253D&md5=5cfd5f8deb05329879ed0a39954f69dd</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2010.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2010.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DShields%26aufirst%3DS.%26aulast%3DCavanaugh%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DAnderson%26aufirst%3DD.%26aulast%3DBasbaum%26aufirst%3DA.%26atitle%3DPain%2520behavior%2520in%2520the%2520formalin%2520test%2520persists%2520after%2520ablation%2520of%2520the%2520great%2520majority%2520of%2520C-fiber%2520nociceptors%26jtitle%3DPain%26date%3D2010%26volume%3D151%26spage%3D422%26epage%3D429%26doi%3D10.1016%2Fj.pain.2010.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mogil, J.</span>; <span class="NLM_string-name">Wilson, S.</span>; <span class="NLM_string-name">Wan, Y.</span></span> <span> </span><span class="NLM_article-title">Assessing Nociception in Murine Subjects</span>. In  <i>Methods in Pain Research</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, L.</span></span>, Ed.; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, Florida</span>, <span class="NLM_year">2001</span>; pp  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">39</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1201%2F9781420042566-c2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=11-39&author=J.+Mogil&author=S.+Wilson&author=Y.+Wanauthor=L.+Kruger&title=Methods+in+Pain+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1201%2F9781420042566-c2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1201%252F9781420042566-c2%26sid%3Dliteratum%253Aachs%26aulast%3DMogil%26aufirst%3DJ.%26atitle%3DAssessing%2520Nociception%2520in%2520Murine%2520Subjects%26btitle%3DMethods%2520in%2520Pain%2520Research%26aulast%3DKruger%26aufirst%3DL.%26pub%3DCRC%2520Press%26date%3D2001%26spage%3D11%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okauchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuramoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, M.</span></span> <span> </span><span class="NLM_article-title">Facile preparation of aryl sulfides using palladium catalysis under mild conditions</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2010</i></span>,  <span class="NLM_fpage">2891</span>– <span class="NLM_lpage">2894</span>, <span class="refDoi"> DOI: 10.1055/s-0030-1259012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1055%2Fs-0030-1259012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2010&publication_year=2010&pages=2891-2894&author=T.+Okauchiauthor=K.+Kuramotoauthor=M.+Kitamura&title=Facile+preparation+of+aryl+sulfides+using+palladium+catalysis+under+mild+conditions&doi=10.1055%2Fs-0030-1259012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1055%2Fs-0030-1259012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0030-1259012%26sid%3Dliteratum%253Aachs%26aulast%3DOkauchi%26aufirst%3DT.%26aulast%3DKuramoto%26aufirst%3DK.%26aulast%3DKitamura%26aufirst%3DM.%26atitle%3DFacile%2520preparation%2520of%2520aryl%2520sulfides%2520using%2520palladium%2520catalysis%2520under%2520mild%2520conditions%26jtitle%3DSynlett%26date%3D2010%26volume%3D2010%26spage%3D2891%26epage%3D2894%26doi%3D10.1055%2Fs-0030-1259012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Barluenga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomas-Gamasa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aznar, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdes, C.</span></span> <span> </span><span class="NLM_article-title">Pd-Catalyzed cross-coupling reactions with carbonyls: application in a very efficient synthesis of 4-aryltetrahydropyridines</span>. <i>Chem.–Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4792</span>– <span class="NLM_lpage">4795</span>, <span class="refDoi"> DOI: 10.1002/chem.200800390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1002%2Fchem.200800390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=18412167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnslOjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=4792-4795&author=J.+Barluengaauthor=M.+Tomas-Gamasaauthor=P.+Morielauthor=F.+Aznarauthor=C.+Valdes&title=Pd-Catalyzed+cross-coupling+reactions+with+carbonyls%3A+application+in+a+very+efficient+synthesis+of+4-aryltetrahydropyridines&doi=10.1002%2Fchem.200800390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Pd-catalyzed cross-coupling reactions with carbonyls: application in a very efficient synthesis of 4-aryltetrahydropyridines</span></div><div class="casAuthors">Barluenga, Jose; Tomas-Gamasa, Maria; Moriel, Patricia; Aznar, Fernando; Valdes, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4792-4795</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Readily available 4-piperidones are directly employed in a very efficient Pd-catalyzed synthesis of 4-aryltetrahydropyridines, which are important scaffolds in medicinal chem.  The actual coupling partner, a tosylhydrazone, is generated in situ from the piperidone and tosylhydrazine.  The reaction can be applied to other ketones and aldehydes, providing polysubstituted olefins directly from carbonyls by a very simple and efficient procedure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9Kd_hYIu017Vg90H21EOLACvtfcHk0lhM3rezuv6RGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnslOjsbg%253D&md5=f78fc7c74a15e804866d1e17024a37c5</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1002%2Fchem.200800390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200800390%26sid%3Dliteratum%253Aachs%26aulast%3DBarluenga%26aufirst%3DJ.%26aulast%3DTomas-Gamasa%26aufirst%3DM.%26aulast%3DMoriel%26aufirst%3DP.%26aulast%3DAznar%26aufirst%3DF.%26aulast%3DValdes%26aufirst%3DC.%26atitle%3DPd-Catalyzed%2520cross-coupling%2520reactions%2520with%2520carbonyls%253A%2520application%2520in%2520a%2520very%2520efficient%2520synthesis%2520of%25204-aryltetrahydropyridines%26jtitle%3DChem.%25E2%2580%2593Eur.%2520J.%26date%3D2008%26volume%3D14%26spage%3D4792%26epage%3D4795%26doi%3D10.1002%2Fchem.200800390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Barluenga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escribano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aznar, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valde′s, C.</span></span> <span> </span><span class="NLM_article-title">Arylation of α-chiral ketones by palladium-catalyzed cross-coupling reactions of tosylhydrazones with aryl halides</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6856</span>– <span class="NLM_lpage">6859</span>, <span class="refDoi"> DOI: 10.1002/anie.201003450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1002%2Fanie.201003450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGntr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6856-6859&author=J.+Barluengaauthor=M.+Escribanoauthor=F.+Aznarauthor=C.+Valde%E2%80%B2s&title=Arylation+of+%CE%B1-chiral+ketones+by+palladium-catalyzed+cross-coupling+reactions+of+tosylhydrazones+with+aryl+halides&doi=10.1002%2Fanie.201003450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Arylation of α-Chiral Ketones by Palladium-Catalyzed Cross-Coupling Reactions of Tosylhydrazones with Aryl Halides</span></div><div class="casAuthors">Barluenga, Jose; Escribano, Maria; Aznar, Fernando; Valdes, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">6856-6859, S6856/1-S6856/62</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">It is disclosed that palladium-catalyzed cross-coupling between tosylhydrazones and aryl halides is a powerful methodol. for the manipulation of α-chiral ketones with total preservation the stereochem. of the α carbon.  We have synthesized that aryl-substituted chiral cyclohexenes from α-chiral cyclohexanones, and chiral allylamines from Me ketones that were easily obtained from α-amino acids.  Taking into consideration the wide availability, but also the configurational instability, of α-chiral ketones, this catalytic process may represent a very useful transformation in org. synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvuKVciXDWebVg90H21EOLACvtfcHk0liivBir46uKHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGntr7J&md5=9d9371cab4d1012e567a9a84a24f09df</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1002%2Fanie.201003450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201003450%26sid%3Dliteratum%253Aachs%26aulast%3DBarluenga%26aufirst%3DJ.%26aulast%3DEscribano%26aufirst%3DM.%26aulast%3DAznar%26aufirst%3DF.%26aulast%3DValde%25E2%2580%25B2s%26aufirst%3DC.%26atitle%3DArylation%2520of%2520%25CE%25B1-chiral%2520ketones%2520by%2520palladium-catalyzed%2520cross-coupling%2520reactions%2520of%2520tosylhydrazones%2520with%2520aryl%2520halides%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D6856%26epage%3D6859%26doi%3D10.1002%2Fanie.201003450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit25c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renmao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youchu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhilong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthew, J. F.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed coupling of sulfonylhydrazones with heteroaromatic 2-amino-halides (Barluenga reaction): exploring the electronics of the sulfonylhydrazone</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1044</span>– <span class="NLM_lpage">1048</span>, <span class="refDoi"> DOI: 10.1021/acs.oprd.5b00211</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.oprd.5b00211" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12ks7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2015&pages=1044-1048&author=H.+Tanauthor=H.+Ioannisauthor=L.+Renmaoauthor=W.+Youchuauthor=C.+Zhilongauthor=J.+F.+Matthew&title=Palladium-catalyzed+coupling+of+sulfonylhydrazones+with+heteroaromatic+2-amino-halides+%28Barluenga+reaction%29%3A+exploring+the+electronics+of+the+sulfonylhydrazone&doi=10.1021%2Facs.oprd.5b00211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25cR"><div class="casContent"><span class="casTitleNuber">25c</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Coupling of Sulfonylhydrazones with Heteroaromatic 2-Amino-Halides (Barluenga Reaction): Exploring the Electronics of the Sulfonylhydrazone</span></div><div class="casAuthors">Tan, Hongyu; Houpis, Ioannis; Liu, Renmao; Wang, Youchu; Chen, Zhilong; Fleming, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1044-1048</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes a new reactivity of the Pd-catalyzed coupling of 2-amino-3-bromo-arom. and heteroarom. compds. with sulfonylhydrazones (Barluenga reaction).The new catalyst system and modulation of the electronic nature of hydrazone that were needed for successful reaction are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOEayrtVlGNbVg90H21EOLACvtfcHk0liivBir46uKHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12ks7fP&md5=4d55eb510f0ae40d6a5f9c1b76b25f81</span></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=10.1021%2Facs.oprd.5b00211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.oprd.5b00211%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DH.%26aulast%3DIoannis%26aufirst%3DH.%26aulast%3DRenmao%26aufirst%3DL.%26aulast%3DYouchu%26aufirst%3DW.%26aulast%3DZhilong%26aufirst%3DC.%26aulast%3DMatthew%26aufirst%3DJ.%2BF.%26atitle%3DPalladium-catalyzed%2520coupling%2520of%2520sulfonylhydrazones%2520with%2520heteroaromatic%25202-amino-halides%2520%2528Barluenga%2520reaction%2529%253A%2520exploring%2520the%2520electronics%2520of%2520the%2520sulfonylhydrazone%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2015%26volume%3D19%26spage%3D1044%26epage%3D1048%26doi%3D10.1021%2Facs.oprd.5b00211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avitabile, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judd, D. B.</span></span> <span> </span><span class="NLM_article-title">Pentafluorophenyl sulfonate ester as a protecting group for the preparation of biaryl- and heterobiaryl sulfonate esters</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">843</span>– <span class="NLM_lpage">846</span>, <span class="refDoi"> DOI: 10.1021/ol047422o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol047422o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVantbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=843-846&author=B.+G.+Avitabileauthor=C.+A.+Smithauthor=D.+B.+Judd&title=Pentafluorophenyl+sulfonate+ester+as+a+protecting+group+for+the+preparation+of+biaryl-+and+heterobiaryl+sulfonate+esters&doi=10.1021%2Fol047422o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Pentafluorophenyl Sulfonate Ester as a Protecting Group for the Preparation of Biaryl- and Heterobiaryl Sulfonate Esters</span></div><div class="casAuthors">Avitabile, Barbara G.; Smith, Clive A.; Judd, Duncan B.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">843-846</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of the pentafluorophenyl (PFP) group as a sulfonic acid protecting group has allowed the synthesis of new biaryl- and heterobiaryl-PFP-sulfonate esters by use of the Suzuki-Miyaura reaction.  E.g., PdCl2(PPh3)2 catalyzed the Suzuki-Miyaura reaction of ROSO2C6H4Br-4 (R = pentafluorophenyl) with p-tolylboronic acid to give 68% 4-ROSO2C6H4C6H4Me-4.  The successful employment of a novel inorg. base, anhyd. sodium tetraborate, was crucial to give the products in excellent yields.  The PFP-sulfonate ester has been previously shown to be an excellent alternative to sulfonyl chlorides in the synthesis of sulfonamides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHLaqCV7_T57Vg90H21EOLACvtfcHk0liivBir46uKHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVantbw%253D&md5=beacf53dff4f3144821b03d5817b150f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fol047422o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol047422o%26sid%3Dliteratum%253Aachs%26aulast%3DAvitabile%26aufirst%3DB.%2BG.%26aulast%3DSmith%26aufirst%3DC.%2BA.%26aulast%3DJudd%26aufirst%3DD.%2BB.%26atitle%3DPentafluorophenyl%2520sulfonate%2520ester%2520as%2520a%2520protecting%2520group%2520for%2520the%2520preparation%2520of%2520biaryl-%2520and%2520heterobiaryl%2520sulfonate%2520esters%26jtitle%3DOrg.%2520Lett.%26date%3D2005%26volume%3D7%26spage%3D843%26epage%3D846%26doi%3D10.1021%2Fol047422o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4a','cit4b'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b','cit9c','cit9d'],'ref10':['cit10a','cit10b','cit10c'],'ref11':['cit11a','cit11b','cit11c','cit11d'],'ref12':['cit12a','cit12b','cit12c','cit12d'],'ref13':['cit13a','cit13b','cit13c','cit13d','cit13e','cit13f'],'ref14':['cit14'],'ref15':['cit15a','cit15b'],'ref16':['cit16a','cit16b','cit16c','cit16d'],'ref17':['cit17a','cit17b','cit17c','cit17d','cit17e'],'ref18':['cit18a','cit18b'],'ref19':['cit19a','cit19b','cit19c'],'ref20':['cit20a','cit20b','cit20c'],'ref21':['cit21a','cit21b'],'ref22':['cit22a','cit22b'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25a','cit25b','cit25c'],'ref26':['cit26']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a NaV 1.7 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Synfacts</span><span> <strong>2020,</strong>,, 1020. <a href="https://doi.org/10.1055/s-0040-1705864" title="DOI URL">https://doi.org/10.1055/s-0040-1705864</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/s-0040-1705864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fs-0040-1705864%26sid%3Dliteratum%253Aachs%26jtitle%3DSynfacts%26atitle%3DSynthesis%252Bof%252Ba%252BNaV%252B1.7%252Binhibitor%26date%3D2020%26date%3D2020%26volume%3D16%26issue%3D09%26spage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of selected aryl sulfonamide Na<sub>V</sub>1.7 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Central bicyclic core switch from benzoxazine to chroman for multiparameter optimization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overall SAR summary of the chroman series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of compound <b>13</b> in different pain models in mice; (a) dose-response effect at 3, 10, and 30 mpk, p.o. on veratridine-induced nociceptive behaviors; (b) dose-response effect at 3, 10, and 30 mpk, p.o. on phases I and II of formalin-induced nociceptive behaviors. Results are presented as the mean ± standard error of the mean (SEM) response (<i>n</i> = 8–10/group) and were analyzed by one-way analysis of variance (ANOVA) followed by Dunnett’s post hoc tests; **<i>P</i> < 0.01, ***<i>P</i> < 0.001, compared to the respective vehicle group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effect of compound <b>51</b> in different pain models in mice; (a) dose-response effect at 3, 10, and 30 mpk, p.o. on veratridine-induced nociceptive behaviors; (b) dose-response effect at 3, 10, and 30 mpk, p.o. on phases I and II of formalin-induced nociceptive behaviors; (c) response of compound <b>51</b> at 100 mpk, p.o. in CCI-induced allodynia. Gabapentine (60 mpk, ip) was used as the positive control. Results are presented as the mean ± SEM response (<i>n</i> = 10–13/group) and were analyzed by one-way ANOVA followed by Dunnett’s post hoc tests; **<i>P</i> < 0.01, ***<i>P</i> < 0.001, compared to the respective vehicle group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>1</b>, <b>4</b>, <b>13</b>–<b>20</b>, and <b>25</b>–<b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) BnSH, Pd<sub>2</sub>(dba)<sub>3</sub>, (<i><sup>i</sup></i>Pr)<sub>2</sub>NEt, 80 °C, 1 h, 60%; (b) tosylhydrazide, MeOH, 80 °C, 16 h, 94%; (c) Na<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub>(dppf)·DCM, dioxane-H<sub>2</sub>O (85:15), 100 °C, 5–8 h 47–76%; (d) (i) SO<sub>2</sub>Cl<sub>2</sub>, AcOH, cat. H<sub>2</sub>O, dichloromethane (DCM), −5 °C, 1 h; (ii) pentafluorophenol, Et<sub>3</sub>N, DCM, 0 °C, 1 h, 60–71%; (e) H<sub>2</sub> (3 atm), 10% Pd-C, EtOAc, 4–6 h, room temperature (rt), 83–94%; (f) (i) HetArNH<sub>2</sub>, LiHMDS (1 M in tetrahydrofuran (THF)), 0 °C to rt, 1–2 h; (ii) chiral separation, 9–44%.</p></p></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>2–3</b>, <b>5–12</b>, <b>21–24</b>, <b>29</b>–<b>31</b>, and <b>36</b>–<b>50</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) NCS, AcOH-H<sub>2</sub>O (4:1), 0 °C to rt, 45 min; (ii) pentafluorophenol, Et<sub>3</sub>N, DCM, 0 °C, 45 min, 65%; (b) tosylhydrazide, MeOH, 80 °C, 16 h, 94%; (c) Na<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub>(dppf)·DCM, dioxane-H<sub>2</sub>O (85:15), 100 °C, 1–2 h, 38–61%; (d) H<sub>2</sub> (3 atm), 10% Pd-C, EtOAc, 4–6 h, rt, 50–90%; (e) (i) HetArNH<sub>2</sub>, LiHMDS (1 M in THF), 0 °C to rt, 1–2 h, 9–69%; (ii) chiral separation; (f) HCHO, AcOH cat., NaBH(OAc)<sub>3</sub>, 16 h, 79%.</p></p></figure><figure data-id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of Compounds <b>32</b>–<b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) [(<i>t</i>-Bu)<sub>3</sub>PH]BF<sub>4</sub>, PdCl<sub>2</sub>(dppf)·DCM, 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, dioxane, 100 °C, 2 h, 91%; (b) HetArNH<sub>2</sub>, LiHMDS (1 M in THF), 0 °C to rt, 1–2 h, 9–78%.</p></p></figure><figure data-id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/medium/jm0c00361_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Compounds <b>51</b>–<b>54</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-11/acs.jmedchem.0c00361/20200604/images/large/jm0c00361_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00361&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) tosylhydrazide, MeOH, 80 °C, 16 h, 90%; (b) Na<sub>2</sub>CO<sub>3</sub>, PdCl<sub>2</sub>(dppf)·DCM, dioxane-H<sub>2</sub>O (85:15), 100 °C, 4–6 h, 51–58%; (c) (i) NCS, AcOH-H<sub>2</sub>O (4:1), 0 °C to rt, 45 min; (ii) pentafluorophenol, Et<sub>3</sub>N, DCM, 0 °C, 45 min, 53–55%; (d) H<sub>2</sub> (1 atm), 10% Pd-C, EtOAc, rt, 16 h, 87–91%; (e) <i>N</i>-(2,4-dimethoxybenzyl)pyrimidin-2-amine (for <b>68a</b>) or pyrimidin-2-amine (for <b>68b</b>) LiHMDS (1 M in THF), 0 °C to rt, 1–2 h, 35–55%; chiral separation for <b>54</b>; (f) (i) [(<i>t</i>-Bu)<sub>3</sub>PH]BF<sub>4</sub>, PdCl<sub>2</sub>(dppf)·DCM, heteroarylboronic acid, dioxane, 100 °C, 1–2 h; (ii) trifluoroacetic acid (TFA), DCM, rt; (iii) chiral separation, 23–39%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i133">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80680" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80680" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 26 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ragsdale, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPhee, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheuer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catterall, W. A.</span></span> <span> </span><span class="NLM_article-title">Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na<sup>+</sup> channels</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">9270</span>– <span class="NLM_lpage">9275</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.17.9270</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1073%2Fpnas.93.17.9270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=8799190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADyaK28Xlt1Cnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=9270-9275&author=D.+S.+Ragsdaleauthor=J.+C.+McPheeauthor=T.+Scheuerauthor=W.+A.+Catterall&title=Common+molecular+determinants+of+local+anesthetic%2C+antiarrhythmic%2C+and+anticonvulsant+block+of+voltage-gated+Na%2B+channels&doi=10.1073%2Fpnas.93.17.9270"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels</span></div><div class="casAuthors">Ragsdale, David S.; McPhee, Jancy C.; Scheuer, Todd; Catterall, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9270-9275</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Voltage-gated Na+ channels are the mol. targets of local anesthetics, class I antiarrhythmic drugs, and some anticonvulsants.  These chem. diverse drugs inhibit Na+ channels with complex voltage- and frequency-dependent properties that reflect preferential drug binding to open and inactivated channel states.  The site-directed mutations F1764A and Y1771A in transmembrane segment IVS6 of type IIA Na+ channel α subunits dramatically reduce the affinity of inactivated channels for the local anesthetic etidocaine.  In this study, we show that these mutations also greatly reduce the sensitivity of Na+ channels to state-dependent block by the class Ib antiarrhythmic drug lidocaine and the anticonvulsant phenytoin and, to a lesser extent, reduce the sensitivity to block by the class Ia and Ic antiarrhythmic drugs quinidine and flecainide.  For lidocaine and phenytoin, which bind preferentially to inactivated Na+ channels, the mutation F1764A reduced the affinity for binding to the inactivated state 24.5-fold and 8.3-fold, resp., while Y1771A had smaller effects.  For quinidine and flecainide, which bind preferentially to the open Na+ channels, the mutations F1764A and Y1771A reduced the affinity for binding to the open state 2- to 3-fold.  Thus, F1764 and Y1771 are common mol. determinants of state-dependent binding of diverse drugs including lidocaine, phenytoin, flecainide, and quinidine, suggesting that these drugs interact with a common receptor site.  However, the different magnitude of the effects of these mutations on binding of the individual drugs indicates that they interact in an overlapping, but nonidentical, manner with a common receptor site.  These results further define the contributions of F1764 and Y1771 to a complex drug receptor site in the pore of Na+ channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRIXUvm8DEQLVg90H21EOLACvtfcHk0li_AiYdWtOWtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xlt1Cnur0%253D&md5=6df1987234a739a47ed5e3b12059245d</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.17.9270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.17.9270%26sid%3Dliteratum%253Aachs%26aulast%3DRagsdale%26aufirst%3DD.%2BS.%26aulast%3DMcPhee%26aufirst%3DJ.%2BC.%26aulast%3DScheuer%26aufirst%3DT.%26aulast%3DCatterall%26aufirst%3DW.%2BA.%26atitle%3DCommon%2520molecular%2520determinants%2520of%2520local%2520anesthetic%252C%2520antiarrhythmic%252C%2520and%2520anticonvulsant%2520block%2520of%2520voltage-gated%2520Na%252B%2520channels%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D9270%26epage%3D9275%26doi%3D10.1073%2Fpnas.93.17.9270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lampert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberhardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">Altered sodium channel gating as molecular basis for pain: contribution of activation, inactivation, and resurgent currents</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>221</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1007%2F978-3-642-41588-3_5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=24737233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFOiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=2014&pages=91-110&author=A.+Lampertauthor=M.+Eberhardtauthor=S.+G.+Waxman&title=Altered+sodium+channel+gating+as+molecular+basis+for+pain%3A+contribution+of+activation%2C+inactivation%2C+and+resurgent+currents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Altered sodium channel gating as molecular basis for pain: Contribution of activation, inactivation, and resurgent currents</span></div><div class="casAuthors">Lampert, Angelika; Eberhardt, Mirjam; Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue">Voltage Gated Sodium Channels</span>),
    <span class="NLM_cas:pages">91-110</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Mutations in voltage-gated sodium channels, esp. Nav1.7, can cause the genetic pain syndromes inherited erythromelalgia, small fiber neuropathy, paroxysmal extreme pain disorder, and chronic insensitivity to pain.  Functional anal. of these mutations offers the possibility of understanding the potential pathomechanisms of these disease patterns and also may help to explicate the mol. mechanisms underlying pain in normal conditions.  The mutations are distributed over the whole channel protein, but nevertheless induce similar changes for each pain syndrome.  In this review we focus on their impact on sodium channel gating, which may be conferred via modulation of (1) conformation (affecting all gating characteristics); (2) the amt. of voltage-sensing charges (affecting mainly activation); (3) interaction within the protein (e.g., binding of the inactivation linker); and (4) interaction with other proteins (e.g., for generation of resurgent currents).  Understanding the mol. basis for each gating mode and its impact on cellular excitability and nociception in each disease type may provide a basis for development of more specific and effective therapeutic tools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5dw1Yz0s5Y7Vg90H21EOLACvtfcHk0lhpF16hfbWkYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFOiurw%253D&md5=ba7b1e27b05d13a6d47ace1a80f5483b</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-41588-3_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-642-41588-3_5%26sid%3Dliteratum%253Aachs%26aulast%3DLampert%26aufirst%3DA.%26aulast%3DEberhardt%26aufirst%3DM.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DAltered%2520sodium%2520channel%2520gating%2520as%2520molecular%2520basis%2520for%2520pain%253A%2520contribution%2520of%2520activation%252C%2520inactivation%252C%2520and%2520resurgent%2520currents%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2014%26volume%3D221%26spage%3D91%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">England, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D.</span></span> <span> </span><span class="NLM_article-title">Isoform-selective voltage-gated Na<sup>+</sup> channel modulators as next-generation analgesics</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">790</span>, <span class="refDoi"> DOI: 10.4155/fmc.10.26</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.4155%2Ffmc.10.26" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=21426202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslamtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=775-790&author=S.+Englandauthor=D.+Rawson&title=Isoform-selective+voltage-gated+Na%2B+channel+modulators+as+next-generation+analgesics&doi=10.4155%2Ffmc.10.26"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform-selective voltage-gated Na+ channel modulators as next-generation analgesics</span></div><div class="casAuthors">England, Steve; Rawson, David</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">775-790</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  For many patients the current therapies for controlling chronic pain are inadequate.  This has driven the search for analgesics with improved efficacy and side effect profiles.  Some anticonvulsants have voltage-gated Na+ channels (VGSCs) as their mol. targets and are used to treat pain, but the efficacy seen is marginal and the drugs are generally poorly tolerated.  The clin. used VGSC-modulating analgesics show no isoform selectivity, which probably limits their use.  Thus, focus has fallen on VGSCs expressed selectively by primary afferent neurons and the search for isoform-selective drugs.  In this review, we describe developments in our understanding of the biol. of VGSCs, screening technologies and the pharmacol. properties of VGSC modulators with promise as analgesics.  Also highlighted are the challenges assocd. with targeting isoform-selective VGSCs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHZcFRT0qRdbVg90H21EOLACvtfcHk0lhpF16hfbWkYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslamtLo%253D&md5=06b147bfe9141a4742ff4dcd2642b86c</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.4155%2Ffmc.10.26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.10.26%26sid%3Dliteratum%253Aachs%26aulast%3DEngland%26aufirst%3DS.%26aulast%3DRawson%26aufirst%3DD.%26atitle%3DIsoform-selective%2520voltage-gated%2520Na%252B%2520channel%2520modulators%2520as%2520next-generation%2520analgesics%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2010%26volume%3D2%26spage%3D775%26epage%3D790%26doi%3D10.4155%2Ffmc.10.26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ogata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, S.</span></span> <span> </span><span class="NLM_article-title">New perspectives on the structure and function of the Na<sup>+</sup> channel multigene family</span>. <i>Curr. Med. Chem.: Cent. Nerv. Syst. Agents</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.2174/1568015024606637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.2174%2F1568015024606637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Oltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=59-81&author=N.+Ogataauthor=S.+Yoshida&title=New+perspectives+on+the+structure+and+function+of+the+Na%2B+channel+multigene+family&doi=10.2174%2F1568015024606637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">New perspectives on the structure and function of the Na+ channel multigene family</span></div><div class="casAuthors">Ogata, Nobukuni; Yoshida, Shigeru</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry: Central Nervous System Agents</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-81</span>CODEN:
                <span class="NLM_cas:coden">CMCCCO</span>;
        ISSN:<span class="NLM_cas:issn">1568-0150</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent studies on the voltage-gated Na+ channel (VGSC) have revealed several excellent discoveries regarding its structure and function.  This article summarizes recent findings on VGSCs, and presents our views on the subject.  Based on the multi-pore 3D model of the VGSC, we propose a "twist-sprinkler" model: (i) twisting and untwisting of the central cavity corresponds to the closed and open states of the channel, and (ii) cytoplasmic outlet pores sprinkle Na+ ions laterally over the inner surface of the plasma membrane to effect a rapid depolarization.  VGSCs can be classified into two major categories.  Category-I isoforms currently comprise nine highly homologous clones (Nav1.1-Nav1.9), most of which have been functionally expressed.  In contrast, the category-II isoform consists of one clone (Nax), which has not been successfully expressed in an exogenous system.  It is considerably different from the category-I isoforms, esp. in the S4 segment, and shows little voltage dependence.  The main function of the category-I isoforms is to form an action potential upstroke.  However, Nav1.6 can also influence subthreshold elec. activity in neurons through the "persistent" and "resurgent" Na+ currents, indicating that the VGSC itself can modulate overall neuronal firing behavior.  Nav1.8 and Nav1.9 are preferentially expressed in peripheral nociceptive neurons and contain a structure common to tetrodotoxin (TTX)-resistant Na+ channels.  Both Nav1.8 and Nav1.9 play a pivotal role in pain sensation.  The category-II isoform Nax (x = unknown function) is a "concn.-sensitive" but not "voltage-sensitive" Na+ channel.  It is involved in regulation of salt intake behavior by sensing an increase in [Na+]o, and it should be renamed as Nac (c = concn.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmFQ0MDmvtlLVg90H21EOLACvtfcHk0liFA81PXQaskA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Oltrg%253D&md5=7aa71ed0cbe1d0478a7eebd85f055d16</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.2174%2F1568015024606637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568015024606637%26sid%3Dliteratum%253Aachs%26aulast%3DOgata%26aufirst%3DN.%26aulast%3DYoshida%26aufirst%3DS.%26atitle%3DNew%2520perspectives%2520on%2520the%2520structure%2520and%2520function%2520of%2520the%2520Na%252B%2520channel%2520multigene%2520family%26jtitle%3DCurr.%2520Med.%2520Chem.%253A%2520Cent.%2520Nerv.%2520Syst.%2520Agents%26date%3D2002%26volume%3D2%26spage%3D59%26epage%3D81%26doi%3D10.2174%2F1568015024606637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boorman, J.</span></span> <span> </span><span class="NLM_article-title">Voltage-gated sodium channel blockers; target validation and therapeutic potential</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.2174/1568026054367584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.2174%2F1568026054367584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=16022675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsVKltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=529-537&author=J.+N.+Woodauthor=J.+Boorman&title=Voltage-gated+sodium+channel+blockers%3B+target+validation+and+therapeutic+potential&doi=10.2174%2F1568026054367584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-gated sodium channel blockers; target validation and therapeutic potential</span></div><div class="casAuthors">Wood, John N.; Boorman, James</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">529-537</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium channels are encoded by a family of 10 structurally-related genes that are expressed in spatially and temporally distinct patterns, mainly in excitable tissues.  They underlie elec. signalling in nerve and muscle.  It has long been known that sodium channel blockers are anesthetics as well as powerful analgesics when delivered at low concns.  In addn., cardiac arrhythmias and epileptic activity can be treated with sodium channel blockers.  As we have learned more about the subtypes of sodium channels and their distribution, new therapeutic opportunities have suggested themselves.  There are indications that sodium channel blockers may also be useful in affective disorders and schizophrenia.  The prodn. of tissue-specific and eventually inducible knock out mice as well as genetic studies has proved useful in understanding the specialized role of individual types of sodium channels.  The development of subtype-specific blockers has proved slower than anticipated, although the properties of naturally occurring toxin blockers suggest that subtype-specific blockers of sodium channels could be very useful clin. in the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro0_4sFMQybrVg90H21EOLACvtfcHk0liFA81PXQaskA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsVKltro%253D&md5=1ed688405bc9f975b23d61fc2ada387c</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.2174%2F1568026054367584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054367584%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DBoorman%26aufirst%3DJ.%26atitle%3DVoltage-gated%2520sodium%2520channel%2520blockers%253B%2520target%2520validation%2520and%2520therapeutic%2520potential%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D529%26epage%3D537%26doi%3D10.2174%2F1568026054367584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eijkelkamp, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linley, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minett, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cregg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werdehausen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rugiero, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span> <span> </span><span class="NLM_article-title">Neurological perspectives on voltage-gated sodium channels</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">2585</span>– <span class="NLM_lpage">2612</span>, <span class="refDoi"> DOI: 10.1093/brain/aws225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1093%2Fbrain%2Faws225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=22961543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A280%3ADC%252BC38bltlymug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2012&pages=2585-2612&author=N.+Eijkelkampauthor=J.+E.+Linleyauthor=M.+D.+Bakerauthor=M.+S.+Minettauthor=R.+Creggauthor=R.+Werdehausenauthor=F.+Rugieroauthor=J.+N.+Wood&title=Neurological+perspectives+on+voltage-gated+sodium+channels&doi=10.1093%2Fbrain%2Faws225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Neurological perspectives on voltage-gated sodium channels</span></div><div class="casAuthors">Eijkelkamp Niels; Linley John E; Baker Mark D; Minett Michael S; Cregg Roman; Werdehausen Robert; Rugiero Francois; Wood John N</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">Pt 9</span>),
    <span class="NLM_cas:pages">2585-612</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The activity of voltage-gated sodium channels has long been linked to disorders of neuronal excitability such as epilepsy and chronic pain.  Recent genetic studies have now expanded the role of sodium channels in health and disease, to include autism, migraine, multiple sclerosis, cancer as well as muscle and immune system disorders.  Transgenic mouse models have proved useful in understanding the physiological role of individual sodium channels, and there has been significant progress in the development of subtype selective inhibitors of sodium channels.  This review will outline the functions and roles of specific sodium channels in electrical signalling and disease, focusing on neurological aspects.  We also discuss recent advances in the development of selective sodium channel inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMaWmHsTCoQ3l8icjszYl0fW6udTcc2eY_ncpp6Hz5gbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bltlymug%253D%253D&md5=6f9b33df722a3c5831b8860d3fad1af2</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Faws225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Faws225%26sid%3Dliteratum%253Aachs%26aulast%3DEijkelkamp%26aufirst%3DN.%26aulast%3DLinley%26aufirst%3DJ.%2BE.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DMinett%26aufirst%3DM.%2BS.%26aulast%3DCregg%26aufirst%3DR.%26aulast%3DWerdehausen%26aufirst%3DR.%26aulast%3DRugiero%26aufirst%3DF.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26atitle%3DNeurological%2520perspectives%2520on%2520voltage-gated%2520sodium%2520channels%26jtitle%3DBrain%26date%3D2012%26volume%3D135%26spage%3D2585%26epage%3D2612%26doi%3D10.1093%2Fbrain%2Faws225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">de Lera Ruiz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span> <span> </span><span class="NLM_article-title">Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7093</span>– <span class="NLM_lpage">7118</span>, <span class="refDoi"> DOI: 10.1021/jm501981g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501981g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7093-7118&author=M.+de+Lera+Ruizauthor=R.+L.+Kraus&title=Voltage-gated+sodium+channels%3A+structure%2C+function%2C+pharmacology%2C+and+clinical+indications&doi=10.1021%2Fjm501981g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications</span></div><div class="casAuthors">de Lera Ruiz, Manuel; Kraus, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7093-7118</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The tremendous therapeutic potential of voltage-gated sodium channels (Navs) has been the subject of many studies in the past and is of intense interest today.  Nav1.7 channels in particular have received much attention recently because of strong genetic validation of their involvement in nociception.  Here we summarize the current status of research in the Nav field and present the most relevant recent developments with respect to the mol. structure, general physiol., and pharmacol. of distinct Nav channel subtypes.  We discuss Nav channel ligands such as small mols., toxins isolated from animal venoms, and the recently identified Nav1.7-selective antibody.  Furthermore, we review eight characterized ligand binding sites on the Nav channel α subunit.  Finally, we examine possible therapeutic applications of Nav ligands and provide an update on current clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn2idyYye8oLVg90H21EOLACvtfcHk0lhf4trmpszu-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnsFemu7c%253D&md5=a816fdf5b46e2e5727669bf17e2e4fd4</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1021%2Fjm501981g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501981g%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BLera%2BRuiz%26aufirst%3DM.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26atitle%3DVoltage-gated%2520sodium%2520channels%253A%2520structure%252C%2520function%252C%2520pharmacology%252C%2520and%2520clinical%2520indications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7093%26epage%3D7118%26doi%3D10.1021%2Fjm501981g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">The Na(V)1.7 sodium channel: from molecule to man</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">62</span>, <span class="refDoi"> DOI: 10.1038/nrn3404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1038%2Fnrn3404" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=23232607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=49-62&author=S.+D.+Dib-Hajjauthor=Y.+Yangauthor=J.+A.+Blackauthor=S.+G.+Waxman&title=The+Na%28V%291.7+sodium+channel%3A+from+molecule+to+man&doi=10.1038%2Fnrn3404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">The NaV1.7 sodium channel: from molecule to man</span></div><div class="casAuthors">Dib-Hajj, Sulayman D.; Yang, Yang; Black, Joel A.; Waxman, Stephen G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-62</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The voltage-gated sodium channel NaV1.7 is preferentially expressed in peripheral somatic and visceral sensory neurons, olfactory sensory neurons and sympathetic ganglion neurons.  NaV1.7 accumulates at nerve fiber endings and amplifies small subthreshold depolarizations, poising it to act as a threshold channel that regulates excitability.  Genetic and functional studies have added to the evidence that NaV1.7 is a major contributor to pain signaling in humans, and homol. modeling based on crystal structures of ion channels suggests an at.-level structural basis for the altered gating of mutant NaV1.7 that causes pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC4lZH1L7XWLVg90H21EOLACvtfcHk0lhf4trmpszu-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVaisrrJ&md5=0e075d2c82d98774da1d316f4409d3eb</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1038%2Fnrn3404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3404%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBlack%26aufirst%3DJ.%2BA.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DThe%2520Na%2528V%25291.7%2520sodium%2520channel%253A%2520from%2520molecule%2520to%2520man%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D49%26epage%3D62%26doi%3D10.1038%2Fnrn3404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rush, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hisama, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrrell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">Gain-of-function mutation in Na<sub>V</sub>1.7 in familial erythromelalgia induces bursting of sensory neurons</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">1847</span>– <span class="NLM_lpage">1854</span>, <span class="refDoi"> DOI: 10.1093/brain/awh514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1093%2Fbrain%2Fawh514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=15958509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A280%3ADC%252BD2MzntF2mtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2005&pages=1847-1854&author=S.+D.+Dib-Hajjauthor=A.+M.+Rushauthor=T.+R.+Cumminsauthor=F.+M.+Hisamaauthor=S.+Novellaauthor=L.+Tyrrellauthor=L.+Marshallauthor=S.+G.+Waxman&title=Gain-of-function+mutation+in+NaV1.7+in+familial+erythromelalgia+induces+bursting+of+sensory+neurons&doi=10.1093%2Fbrain%2Fawh514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons</span></div><div class="casAuthors">Dib-Hajj S D; Rush A M; Cummins T R; Hisama F M; Novella S; Tyrrell L; Marshall L; Waxman S G</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">Pt 8</span>),
    <span class="NLM_cas:pages">1847-54</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Erythromelalgia is an autosomal dominant disorder characterized by burning pain in response to warm stimuli or moderate exercise.  We describe a novel mutation in a family with erythromelalgia in SCN9A, the gene that encodes the Na(v)1.7 sodium channel.  Na(v)1.7 produces threshold currents and is selectively expressed within sensory neurons including nociceptors.  We demonstrate that this mutation, which produces a hyperpolarizing shift in activation and a depolarizing shift in steady-state inactivation, lowers thresholds for single action potentials and high frequency firing in dorsal root ganglion neurons.  Erythromelalgia is the first inherited pain disorder in which it is possible to link a mutation with an abnormality in ion channel function and with altered firing of pain signalling neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7l6KFKSfqfGPgL4LrC-0VfW6udTcc2eYHZC9vNrxBd7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzntF2mtw%253D%253D&md5=6befcde7de47dd574901a333c2f14909</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawh514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawh514%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DRush%26aufirst%3DA.%2BM.%26aulast%3DCummins%26aufirst%3DT.%2BR.%26aulast%3DHisama%26aufirst%3DF.%2BM.%26aulast%3DNovella%26aufirst%3DS.%26aulast%3DTyrrell%26aufirst%3DL.%26aulast%3DMarshall%26aufirst%3DL.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DGain-of-function%2520mutation%2520in%2520NaV1.7%2520in%2520familial%2520erythromelalgia%2520induces%2520bursting%2520of%2520sensory%2520neurons%26jtitle%3DBrain%26date%3D2005%26volume%3D128%26spage%3D1847%26epage%3D1854%26doi%3D10.1093%2Fbrain%2Fawh514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rush, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span> <span> </span><span class="NLM_article-title">Mutation in the sodium channel Na<sub>V</sub>1.7 underlie inherited erythromelalgia</span>. <i>Drug Discovery Today: Dis. Mech.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">350</span>, <span class="refDoi"> DOI: 10.1016/j.ddmec.2006.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.ddmec.2006.09.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=343-350&author=S.+D.+Dib-Hajjauthor=A.+M.+Rushauthor=T.+R.+Cumminsauthor=S.+G.+Waxman&title=Mutation+in+the+sodium+channel+NaV1.7+underlie+inherited+erythromelalgia&doi=10.1016%2Fj.ddmec.2006.09.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2Fj.ddmec.2006.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddmec.2006.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DRush%26aufirst%3DA.%2BM.%26aulast%3DCummins%26aufirst%3DT.%2BR.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26atitle%3DMutation%2520in%2520the%2520sodium%2520channel%2520NaV1.7%2520underlie%2520inherited%2520erythromelalgia%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Dis.%2520Mech.%26date%3D2006%26volume%3D3%26spage%3D343%26epage%3D350%26doi%3D10.1016%2Fj.ddmec.2006.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fertleman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffatt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmslie, F. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrahamsen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klugbauer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, M.</span></span> <span> </span><span class="NLM_article-title">SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2006.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.neuron.2006.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=17145499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCgu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2006&pages=767-774&author=C.+R.+Fertlemanauthor=M.+D.+Bakerauthor=K.+A.+Parkerauthor=S.+Moffattauthor=F.+V.+Elmslieauthor=B.+Abrahamsenauthor=J.+Ostmanauthor=N.+Klugbauerauthor=J.+N.+Woodauthor=R.+M.+Gardinerauthor=M.+Rees&title=SCN9A+mutations+in+paroxysmal+extreme+pain+disorder%3A+allelic+variants+underlie+distinct+channel+defects+and+phenotypes&doi=10.1016%2Fj.neuron.2006.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">SCN9A mutations in paroxysmal clinical study extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes</span></div><div class="casAuthors">Fertleman, Caroline R.; Baker, Mark D.; Parker, Keith A.; Moffatt, Sarah; Elmslie, Frances V.; Abrahamsen, Bjarke; Ostman, Johan; Klugbauer, Norbert; Wood, John N.; Gardiner, R. Mark; Rees, Michele</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">767-774</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Paroxysmal extreme pain disorder (PEPD), previously known as familial rectal pain (FRP, or OMIM 167400), is an inherited condition characterized by paroxysms of rectal, ocular, or submandibular pain with flushing.  A genome-wide linkage search followed by mutational anal. of the candidate gene SCN9A, which encodes hNav1.7, identified eight missense mutations in 11 families and 2 sporadic cases.  Functional anal. in vitro of three of these mutant Nav1.7 channels revealed a redn. in fast inactivation, leading to persistent sodium current.  Other mutations in SCN9A assocd. with more neg. activation thresholds are known to cause primary erythermalgia (PE).  Carbamazepine, a drug that is effective in PEPD, but not PE, showed selective block of persistent current assocd. with PEPD mutants, but did not affect the neg. activation threshold of a PE mutant.  PEPD and PE are allelic variants with distinct underlying biophys. mechanisms and represent a sep. class of peripheral neuronal sodium channelopathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi2qhSqNNAvLVg90H21EOLACvtfcHk0lg2T1GcJ0326A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCgu7fJ&md5=2f52e4722b3046d2bb0dc7af0901e952</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2006.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2006.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DFertleman%26aufirst%3DC.%2BR.%26aulast%3DBaker%26aufirst%3DM.%2BD.%26aulast%3DParker%26aufirst%3DK.%2BA.%26aulast%3DMoffatt%26aufirst%3DS.%26aulast%3DElmslie%26aufirst%3DF.%2BV.%26aulast%3DAbrahamsen%26aufirst%3DB.%26aulast%3DOstman%26aufirst%3DJ.%26aulast%3DKlugbauer%26aufirst%3DN.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DGardiner%26aufirst%3DR.%2BM.%26aulast%3DRees%26aufirst%3DM.%26atitle%3DSCN9A%2520mutations%2520in%2520paroxysmal%2520extreme%2520pain%2520disorder%253A%2520allelic%2520variants%2520underlie%2520distinct%2520channel%2520defects%2520and%2520phenotypes%26jtitle%3DNeuron%26date%3D2006%26volume%3D52%26spage%3D767%26epage%3D774%26doi%3D10.1016%2Fj.neuron.2006.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faber, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoeijmakers, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estacion, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauria, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoutte, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerrits, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drenth, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merkies, I. S.</span></span> <span> </span><span class="NLM_article-title">Gain of function Na<sub>V</sub>1.7 mutations in idiopathic small fiber neuropathy</span>. <i>Ann. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1002/ana.22485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1002%2Fana.22485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=21698661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=26-39&author=C.+G.+Faberauthor=J.+G.+Hoeijmakersauthor=H.+S.+Ahnauthor=X.+Chengauthor=C.+Hanauthor=J.+S.+Choiauthor=M.+Estacionauthor=G.+Lauriaauthor=E.+K.+Vanhoutteauthor=M.+M.+Gerritsauthor=S.+Dib-Hajjauthor=J.+P.+Drenthauthor=S.+G.+Waxmanauthor=I.+S.+Merkies&title=Gain+of+function+NaV1.7+mutations+in+idiopathic+small+fiber+neuropathy&doi=10.1002%2Fana.22485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy</span></div><div class="casAuthors">Faber, Catharina G.; Hoeijmakers, Janneke G. J.; Ahn, Hye-Sook; Cheng, Xiaoyang; Han, Chongyang; Choi, Jin-Sung; Estacion, Mark; Lauria, Giuseppe; Vanhoutte, Els K.; Gerrits, Monique M.; Dib-Hajj, Sulayman; Drenth, Joost P. H.; Waxman, Stephen G.; Merkies, Ingemar S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-39</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective: : Small nerve fiber neuropathy (SFN) often occurs without apparent cause, but no systematic genetic studies have been performed in patients with idiopathic SFN (I-SFN).  We sought to identify a genetic basis for I-SFN by screening patients with biopsy-confirmed idiopathic SFN for mutations in the SCN9A gene, encoding voltage-gated sodium channel NaV1.7, which is preferentially expressed in small diam. peripheral axons.  Methods: : Patients referred with possible I-SFN, who met the criteria of ≥2 SFN-related symptoms, normal strength, tendon reflexes, vibration sense, and nerve conduction studies, and reduced intraepidermal nerve fiber d. (IENFD) plus abnormal quant. sensory testing (QST) and no underlying etiol. for SFN, were assessed clin. and by screening of SCN9A for mutations and functional analyses.  Results: : Twenty-eight patients who met stringent criteria for I-SFN including abnormal IENFD and QST underwent SCN9A gene analyses.  Of these 28 patients with biopsy-confirmed I-SFN, 8 were found to carry novel mutations in SCN9A.  Functional anal. revealed multiple gain of function changes in the mutant channels; each of the mutations rendered dorsal root ganglion neurons hyperexcitable.  Interpretation: : We show for the first time that gain of function mutations in sodium channel NaV1.7, which render dorsal root ganglion neurons hyperexcitable, are present in a substantial proportion (28.6%; 8 of 28) of patients meeting strict criteria for I-SFN.  These results point to a broader role of NaV1.7 mutations in neurol. disease than previously considered from studies on rare genetic syndromes, and suggest an etiol. basis for I-SFN, whereby expression of gain of function mutant sodium channels in small diam. peripheral axons may cause these fibers to degenerate.  ANN NEUROL 2012;71:26-39.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI5yt6a_BN-rVg90H21EOLACvtfcHk0lg2T1GcJ0326A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCqtr4%253D&md5=ea551234a6635b3fd70e3ea4bd68f96c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fana.22485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.22485%26sid%3Dliteratum%253Aachs%26aulast%3DFaber%26aufirst%3DC.%2BG.%26aulast%3DHoeijmakers%26aufirst%3DJ.%2BG.%26aulast%3DAhn%26aufirst%3DH.%2BS.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DC.%26aulast%3DChoi%26aufirst%3DJ.%2BS.%26aulast%3DEstacion%26aufirst%3DM.%26aulast%3DLauria%26aufirst%3DG.%26aulast%3DVanhoutte%26aufirst%3DE.%2BK.%26aulast%3DGerrits%26aufirst%3DM.%2BM.%26aulast%3DDib-Hajj%26aufirst%3DS.%26aulast%3DDrenth%26aufirst%3DJ.%2BP.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26aulast%3DMerkies%26aufirst%3DI.%2BS.%26atitle%3DGain%2520of%2520function%2520NaV1.7%2520mutations%2520in%2520idiopathic%2520small%2520fiber%2520neuropathy%26jtitle%3DAnn.%2520Neurol.%26date%3D2012%26volume%3D71%26spage%3D26%26epage%3D39%26doi%3D10.1002%2Fana.22485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karbani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jafri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raashid, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gazali, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamamy, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHale, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gribble, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C. G.</span></span> <span> </span><span class="NLM_article-title">An SCN9A channelopathy causes congenital inability to experience pain</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>444</i></span>,  <span class="NLM_fpage">894</span>– <span class="NLM_lpage">898</span>, <span class="refDoi"> DOI: 10.1038/nature05413</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1038%2Fnature05413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=17167479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2006&pages=894-898&author=J.+J.+Coxauthor=F.+Reimannauthor=A.+K.+Nicolasauthor=G.+Thorntonauthor=E.+Robertsauthor=K.+Springellauthor=G.+Karbaniauthor=H.+Jafriauthor=J.+Mannanauthor=Y.+Raashidauthor=L.+Al-Gazaliauthor=H.+Hamamyauthor=E.+M.+Valenteauthor=S.+Gormanauthor=R.+Williamsauthor=D.+P.+McHaleauthor=J.+N.+Woodauthor=F.+M.+Gribbleauthor=C.+G.+Woods&title=An+SCN9A+channelopathy+causes+congenital+inability+to+experience+pain&doi=10.1038%2Fnature05413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">An SCN9A channelopathy causes congenital inability to experience pain</span></div><div class="casAuthors">Cox, James J.; Reimann, Frank; Nicholas, Adeline K.; Thornton, Gemma; Roberts, Emma; Springell, Kelly; Karbani, Gulshan; Jafri, Hussain; Mannan, Jovaria; Raashid, Yasmin; Al-Gazali, Lihadh; Hamamy, Henan; Valente, Enza Maria; Gorman, Shaun; Williams, Richard; McHale, Duncan P.; Wood, John N.; Gribble, Fiona M.; Woods, C. Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">444</span>
        (<span class="NLM_cas:issue">7121</span>),
    <span class="NLM_cas:pages">894-898</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The complete inability to sense pain in an otherwise healthy individual is a very rare phenotype.  In three consanguineous families from northern Pakistan, we mapped the condition as an autosomal-recessive trait to chromosome 2q24.3.  This region contains the gene SCN9A, encoding the α-subunit of the voltage-gated sodium channel, Nav1.7, which is strongly expressed in nociceptive neurons.  Sequence anal. of SCN9A in affected individuals revealed three distinct homozygous nonsense mutations (S459X, I767X and W897X).  We show that these mutations cause loss of function of Nav1.7 by co-expression of wild-type or mutant human Nav1.7 with sodium channel β1 and β2 subunits in HEK293 cells.  In cells expressing mutant Nav1.7, the currents were no greater than background.  Our data suggest that SCN9A is an essential and non-redundant requirement for nociception in humans.  These findings should stimulate the search for novel analgesics that selectively target this sodium channel subunit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWD3rCKSQEurVg90H21EOLACvtfcHk0lg2SVwA4AGNHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlShtrzM&md5=461e3a6abd6d3f4f8f7d896d8f62d882</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature05413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05413%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DJ.%2BJ.%26aulast%3DReimann%26aufirst%3DF.%26aulast%3DNicolas%26aufirst%3DA.%2BK.%26aulast%3DThornton%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DE.%26aulast%3DSpringell%26aufirst%3DK.%26aulast%3DKarbani%26aufirst%3DG.%26aulast%3DJafri%26aufirst%3DH.%26aulast%3DMannan%26aufirst%3DJ.%26aulast%3DRaashid%26aufirst%3DY.%26aulast%3DAl-Gazali%26aufirst%3DL.%26aulast%3DHamamy%26aufirst%3DH.%26aulast%3DValente%26aufirst%3DE.%2BM.%26aulast%3DGorman%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DMcHale%26aufirst%3DD.%2BP.%26aulast%3DWood%26aufirst%3DJ.%2BN.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26aulast%3DWoods%26aufirst%3DC.%2BG.%26atitle%3DAn%2520SCN9A%2520channelopathy%2520causes%2520congenital%2520inability%2520to%2520experience%2520pain%26jtitle%3DNature%26date%3D2006%26volume%3D444%26spage%3D894%26epage%3D898%26doi%3D10.1038%2Fnature05413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacFarlane, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattice, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hossain, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pape, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radomski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donaldson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oves, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younghusband, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boltshauser, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grinspan, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimon, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andria, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toscano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerdraon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowsher, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pimstone, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuels, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherrington, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, M. R.</span></span> <span> </span><span class="NLM_article-title">Loss-of-function mutations in the Na<sub>V</sub>1.7 gene underlie congenital indifference to pain in multiple human populations</span>. <i>Clin. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">319</span>, <span class="refDoi"> DOI: 10.1111/j.1399-0004.2007.00790.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1111%2Fj.1399-0004.2007.00790.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=17470132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=311-319&author=Y.+P.+Goldbergauthor=J.+MacFarlaneauthor=M.+L.+MacDonaldauthor=J.+Thompsonauthor=M.-P.+Dubeauthor=M.+Matticeauthor=R.+Fraserauthor=C.+Youngauthor=S.+Hossainauthor=T.+Papeauthor=B.+Payneauthor=C.+Radomskiauthor=G.+Donaldsonauthor=E.+Ovesauthor=J.+Coxauthor=H.+B.+Younghusbandauthor=R.+Greenauthor=A.+Duffauthor=E.+Boltshauserauthor=G.+A.+Grinspanauthor=J.+H.+Dimonauthor=B.+G.+Sibleyauthor=G.+Andriaauthor=E.+Toscanoauthor=J.+Kerdraonauthor=D.+Bowsherauthor=S.+N.+Pimstoneauthor=M.+E.+Samuelsauthor=R.+Sherringtonauthor=M.+R.+Hayden&title=Loss-of-function+mutations+in+the+NaV1.7+gene+underlie+congenital+indifference+to+pain+in+multiple+human+populations&doi=10.1111%2Fj.1399-0004.2007.00790.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations</span></div><div class="casAuthors">Goldberg Y P; MacFarlane J; MacDonald M L; Thompson J; Dube M-P; Mattice M; Fraser R; Young C; Hossain S; Pape T; Payne B; Radomski C; Donaldson G; Ives E; Cox J; Younghusband H B; Green R; Duff A; Boltshauser E; Grinspan G A; Dimon J H; Sibley B G; Andria G; Toscano E; Kerdraon J; Bowsher D; Pimstone S N; Samuels M E; Sherrington R; Hayden M R</div><div class="citationInfo"><span class="NLM_cas:title">Clinical genetics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-9</span>
        ISSN:<span class="NLM_cas:issn">0009-9163</span>.
    </div><div class="casAbstract">Congenital indifference to pain (CIP) is a rare condition in which patients have severely impaired pain perception, but are otherwise essentially normal.  We identified and collected DNA from individuals from nine families of seven different nationalities in which the affected individuals meet the diagnostic criteria for CIP.  Using homozygosity mapping and haplotype sharing methods, we narrowed the CIP locus to chromosome 2q24-q31, a region known to contain a cluster of voltage-gated sodium channel genes.  From these prioritized candidate sodium channels, we identified 10 mutations in the SCN9A gene encoding the sodium channel protein Nav1.7.  The mutations completely co-segregated with the disease phenotype, and nine of these SCN9A mutations resulted in truncation and loss-of-function of the Nav1.7 channel.  These genetic data further support the evidence that Nav1.7 plays an essential role in mediating pain in humans, and that SCN9A mutations identified in multiple different populations underlie CIP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgEhjb_1oWGHqj_yg7twvpfW6udTcc2ea3j-hAi_Sjb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3mtFSqsg%253D%253D&md5=02ae3943bc678b3407d492e4a6298b74</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-0004.2007.00790.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-0004.2007.00790.x%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DY.%2BP.%26aulast%3DMacFarlane%26aufirst%3DJ.%26aulast%3DMacDonald%26aufirst%3DM.%2BL.%26aulast%3DThompson%26aufirst%3DJ.%26aulast%3DDube%26aufirst%3DM.-P.%26aulast%3DMattice%26aufirst%3DM.%26aulast%3DFraser%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DHossain%26aufirst%3DS.%26aulast%3DPape%26aufirst%3DT.%26aulast%3DPayne%26aufirst%3DB.%26aulast%3DRadomski%26aufirst%3DC.%26aulast%3DDonaldson%26aufirst%3DG.%26aulast%3DOves%26aufirst%3DE.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DYounghusband%26aufirst%3DH.%2BB.%26aulast%3DGreen%26aufirst%3DR.%26aulast%3DDuff%26aufirst%3DA.%26aulast%3DBoltshauser%26aufirst%3DE.%26aulast%3DGrinspan%26aufirst%3DG.%2BA.%26aulast%3DDimon%26aufirst%3DJ.%2BH.%26aulast%3DSibley%26aufirst%3DB.%2BG.%26aulast%3DAndria%26aufirst%3DG.%26aulast%3DToscano%26aufirst%3DE.%26aulast%3DKerdraon%26aufirst%3DJ.%26aulast%3DBowsher%26aufirst%3DD.%26aulast%3DPimstone%26aufirst%3DS.%2BN.%26aulast%3DSamuels%26aufirst%3DM.%2BE.%26aulast%3DSherrington%26aufirst%3DR.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26atitle%3DLoss-of-function%2520mutations%2520in%2520the%2520NaV1.7%2520gene%2520underlie%2520congenital%2520indifference%2520to%2520pain%2520in%2520multiple%2520human%2520populations%26jtitle%3DClin.%2520Genet.%26date%3D2007%26volume%3D71%26spage%3D311%26epage%3D319%26doi%3D10.1111%2Fj.1399-0004.2007.00790.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gingras, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nye, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couture, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feric, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottman, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beiler, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmberg, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, S. I.</span></span> <span> </span><span class="NLM_article-title">Global Na<sub>V</sub>1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e105895</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0105895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1371%2Fjournal.pone.0105895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=25188265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslaqt73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=J.+Gingrasauthor=S.+Smithauthor=D.+J.+Matsonauthor=D.+Johnsonauthor=K.+Nyeauthor=L.+Coutureauthor=E.+Fericauthor=R.+Yinauthor=B.+D.+Moyerauthor=M.+L.+Petersonauthor=J.+B.+Rottmanauthor=R.+J.+Beilerauthor=A.+B.+Malmbergauthor=S.+I.+McDonough&title=Global+NaV1.7+knockout+mice+recapitulate+the+phenotype+of+human+congenital+indifference+to+pain&doi=10.1371%2Fjournal.pone.0105895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain</span></div><div class="casAuthors">Gingras, Jacinthe; Smith, Sarah; Matson, David J.; Johnson, Danielle; Nye, Kim; Couture, Lauren; Feric, Elma; Yin, Ruoyuan; Moyer, Bryan D.; Peterson, Matthew L.; Rottman, James B.; Beiler, Rudolph J.; Malmberg, Annika B.; McDonough, Stefan I.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e105895/1-e105895/14, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Clin. genetic studies have shown that loss of Nav1.7 function leads to the complete loss of acute pain perception.  The global deletion is reported lethal in mice, however, and studies of mice with promoter-specific deletions of Nav1.7 have suggested that the role of Nav1.7 in pain transduction depends on the precise form of pain.  We developed genetic and animal husbandry strategies that overcame the neonatal-lethal phenotype and enabled construction of a global Nav1.7 knockout mouse.  Knockouts were anatomically normal, reached adulthood, and had phenotype wholly analogous to human congenital indifference to pain (CIP): compared to littermates, knockouts showed no defects in mech. sensitivity or overall movement yet were completely insensitive to painful tactile, thermal, and chem. stimuli and were anosmic.  Knockouts also showed no painful behaviors resulting from peripheral injection of nonselective sodium channel activators, did not develop complete Freund's adjuvant-induced thermal hyperalgesia, and were insensitive to intra-dermal histamine injection.  Tetrodotoxin-sensitive sodium current recorded from cell bodies of isolated sensory neurons and the mech.-evoked spiking of C-fibers in a skin-nerve prepn. each were reduced but not eliminated in tissue from knockouts compared to littermates.  Results support a role for Nav1.7 that is conserved between rodents and humans and suggest several possibly translatable biomarkers for the study of Nav1.7-targeted therapeutics.  Results further suggest that Nav1.7 may retain its key role in persistent as well as acute forms of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAzxB508dD1LVg90H21EOLACvtfcHk0ljwnoHj2nyynA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslaqt73O&md5=6a1acb0c6e4e38ac89b1ab38d67b538e</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0105895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0105895%26sid%3Dliteratum%253Aachs%26aulast%3DGingras%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DMatson%26aufirst%3DD.%2BJ.%26aulast%3DJohnson%26aufirst%3DD.%26aulast%3DNye%26aufirst%3DK.%26aulast%3DCouture%26aufirst%3DL.%26aulast%3DFeric%26aufirst%3DE.%26aulast%3DYin%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26aulast%3DRottman%26aufirst%3DJ.%2BB.%26aulast%3DBeiler%26aufirst%3DR.%2BJ.%26aulast%3DMalmberg%26aufirst%3DA.%2BB.%26aulast%3DMcDonough%26aufirst%3DS.%2BI.%26atitle%3DGlobal%2520NaV1.7%2520knockout%2520mice%2520recapitulate%2520the%2520phenotype%2520of%2520human%2520congenital%2520indifference%2520to%2520pain%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0105895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Gingras, J.</span>; <span class="NLM_string-name">McDonough, S. I.</span></span> <span> </span><span class="NLM_article-title">Na<sub>V</sub>1.7 Knockout Mouse and Uses Thereof</span>. <span class="NLM_patent">WO2012/099983A1</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=J.+Gingras&author=S.+I.+McDonough&title=NaV1.7+Knockout+Mouse+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGingras%26aufirst%3DJ.%26atitle%3DNaV1.7%2520Knockout%2520Mouse%2520and%2520Uses%2520Thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Theile, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, T. R.</span></span> <span> </span><span class="NLM_article-title">Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes</span>. <i>Front Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.3389/fphar.2011.00054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.3389%2Ffphar.2011.00054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=21779246" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=1-14&author=J.+W.+Theileauthor=T.+R.+Cummins&title=Recent+developments+regarding+voltage-gated+sodium+channel+blockers+for+the+treatment+of+inherited+and+acquired+neuropathic+pain+syndromes&doi=10.3389%2Ffphar.2011.00054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2011.00054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2011.00054%26sid%3Dliteratum%253Aachs%26aulast%3DTheile%26aufirst%3DJ.%2BW.%26aulast%3DCummins%26aufirst%3DT.%2BR.%26atitle%3DRecent%2520developments%2520regarding%2520voltage-gated%2520sodium%2520channel%2520blockers%2520for%2520the%2520treatment%2520of%2520inherited%2520and%2520acquired%2520neuropathic%2520pain%2520syndromes%26jtitle%3DFront%2520Pharmacol.%26date%3D2011%26volume%3D2%26spage%3D1%26epage%3D14%26doi%3D10.3389%2Ffphar.2011.00054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandrou, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mis, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilbrey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutteridge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castle, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krafte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estacion, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dib-Hajj, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waxman, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hounshell, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randall, A.</span></span> <span> </span><span class="NLM_article-title">Subtype-selective small molecule inhibitors reveal a fundamental role for Na<sub>V</sub>1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e0152405</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0152405</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1371%2Fjournal.pone.0152405" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=27050761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1KqtL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&author=A.+J.+Alexandrouauthor=A.+R.+Brownauthor=J.+Turnerauthor=M.+A.+Misauthor=A.+Wilbreyauthor=E.+C.+Payneauthor=A.+Gutteridgeauthor=P.+J.+Coxauthor=R.+P.+Buttauthor=E.+B.+Stevensauthor=M.+L.+Chapmanauthor=D.+Printzenhoffauthor=Z.+Linauthor=B.+E.+Marronauthor=C.+Westauthor=N.+A.+Castleauthor=D.+Krafteauthor=M.+Estacionauthor=S.+D.+Dib-Hajjauthor=S.+G.+Waxmanauthor=R.+Doyleauthor=N.+A.+Swainauthor=R.+I.+Storerauthor=P.+A.+Stuppleauthor=J.+A.+Hounshellauthor=M.+Rivaraauthor=M.+K.+Patelauthor=A.+Randall&title=Subtype-selective+small+molecule+inhibitors+reveal+a+fundamental+role+for+NaV1.7+in+nociceptor+electrogenesis%2C+axonal+conduction+and+presynaptic+release&doi=10.1371%2Fjournal.pone.0152405"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9dR"><div class="casContent"><span class="casTitleNuber">9d</span><div class="casTitle"><span class="NLM_cas:atitle">Subtype-selective small molecule inhibitors reveal a fundamental role for Nav1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release</span></div><div class="casAuthors">Alexandrou, Aristos J.; Brown, Adam R.; Chapman, Mark L.; Estacion, Mark; Turner, Jamie; Mis, Malgorzata A.; Wilbrey, Anna; Payne, Elizabeth C.; Gutteridge, Alex; Cox, Peter J.; Doyle, Rachel; Printzenhoff, David; Lin, Zhixin; Marron, Brian E.; West, Christopher; Swain, Nigel A.; Storer, R. Ian; Stupple, Paul A.; Castle, Neil A.; Hounshell, James A.; Rivara, Mirko; Randall, Andrew; Dib-Hajj, Sulayman D.; Krafte, Douglas; Waxman, Stephen G.; Patel, Manoj K.; Butt, Richard P.; Stevens, Edward B.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e0152405/1-e0152405/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Human genetic studies show that the voltage gated sodium channel 1.7 (Nav1.7) is a key mol. determinant of pain sensation.  However, defining the Nav1.7 contribution to nociceptive signalling has been hampered by a lack of selective inhibitors.  Here we report two potent and selective arylsulfonamide Nav1.7 inhibitors; PF-05198007 and PF-05089771, which we have used to directly interrogate Nav1.7's role in nociceptor physiol.  We report that Nav1.7 is the predominant functional TTX-sensitive Nav in mouse and human nociceptors and contributes to the initiation and the upstroke phase of the nociceptor action potential.  Moreover, we confirm a role for Nav1.7 in influencing synaptic transmission in the dorsal horn of the spinal cord as well as peripheral neuropeptide release in the skin.  These findings demonstrate multiple contributions of Nav1.7 to nociceptor signalling and shed new light on the relative functional contribution of this channel to peripheral and central noxious signal transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx6L5QNhpEg7Vg90H21EOLACvtfcHk0ljwnoHj2nyynA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1KqtL3M&md5=41505ac1108ad830dec78c052655f6b0</span></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0152405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0152405%26sid%3Dliteratum%253Aachs%26aulast%3DAlexandrou%26aufirst%3DA.%2BJ.%26aulast%3DBrown%26aufirst%3DA.%2BR.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DMis%26aufirst%3DM.%2BA.%26aulast%3DWilbrey%26aufirst%3DA.%26aulast%3DPayne%26aufirst%3DE.%2BC.%26aulast%3DGutteridge%26aufirst%3DA.%26aulast%3DCox%26aufirst%3DP.%2BJ.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DStevens%26aufirst%3DE.%2BB.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DWest%26aufirst%3DC.%26aulast%3DCastle%26aufirst%3DN.%2BA.%26aulast%3DKrafte%26aufirst%3DD.%26aulast%3DEstacion%26aufirst%3DM.%26aulast%3DDib-Hajj%26aufirst%3DS.%2BD.%26aulast%3DWaxman%26aufirst%3DS.%2BG.%26aulast%3DDoyle%26aufirst%3DR.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DHounshell%26aufirst%3DJ.%2BA.%26aulast%3DRivara%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DM.%2BK.%26aulast%3DRandall%26aufirst%3DA.%26atitle%3DSubtype-selective%2520small%2520molecule%2520inhibitors%2520reveal%2520a%2520fundamental%2520role%2520for%2520NaV1.7%2520in%2520nociceptor%2520electrogenesis%252C%2520axonal%2520conduction%2520and%2520presynaptic%2520release%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26doi%3D10.1371%2Fjournal.pone.0152405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mulroy, M. F.</span></span> <span> </span><span class="NLM_article-title">Systemic toxicity and cardiotoxicity from local anesthetics: incidence and preventive measures</span>. <i>Reg. Anesth. Pain Med.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">556</span>– <span class="NLM_lpage">561</span>, <span class="refDoi"> DOI: 10.1097/00115550-200211000-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1097%2F00115550-200211000-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=12430104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1Kns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=556-561&author=M.+F.+Mulroy&title=Systemic+toxicity+and+cardiotoxicity+from+local+anesthetics%3A+incidence+and+preventive+measures&doi=10.1097%2F00115550-200211000-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic toxicity and cardiotoxicity from local anesthetics: incidence and preventive measures</span></div><div class="casAuthors">Mulroy, Michael F.</div><div class="citationInfo"><span class="NLM_cas:title">Regional Anesthesia and Pain Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">556-561</span>CODEN:
                <span class="NLM_cas:coden">RAPMFX</span>;
        ISSN:<span class="NLM_cas:issn">1098-7339</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">A review.  Central nervous system toxicity from unintentionally high blood levels has been a significant concern and risk with local anesthetics since their discovery.  Cardiotoxicity assocd. with toxic blood levels of long-acting local anesthetics has heightened concern about systemic blood levels in the last 20 yr.  This review will discuss the apparent incidence of systemic toxicity, the situations in which it occurs, some of the other risks of regional anesthesia, and appropriate safety steps to reduce the frequency of both systemic reactions and cardiotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoMkLHgF6vjrVg90H21EOLACvtfcHk0liimlqNp7JSVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1Kns7o%253D&md5=6ddb4d2bbba7485049e85a3f8df71038</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1097%2F00115550-200211000-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00115550-200211000-00003%26sid%3Dliteratum%253Aachs%26aulast%3DMulroy%26aufirst%3DM.%2BF.%26atitle%3DSystemic%2520toxicity%2520and%2520cardiotoxicity%2520from%2520local%2520anesthetics%253A%2520incidence%2520and%2520preventive%2520measures%26jtitle%3DReg.%2520Anesth.%2520Pain%2520Med.%26date%3D2002%26volume%3D27%26spage%3D556%26epage%3D561%26doi%3D10.1097%2F00115550-200211000-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Walia, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raza, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, Y. N.</span></span> <span> </span><span class="NLM_article-title">Side effects of antiepileptics-a review</span>. <i>Pain Pract.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1111/j.1533-2500.2004.04304.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1111%2Fj.1533-2500.2004.04304.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=17173601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A280%3ADC%252BD28jjs1Gkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=194-203&author=K.+S.+Waliaauthor=E.+A.+Khanauthor=D.+H.+Koauthor=S.+S.+Razaauthor=Y.+N.+Khan&title=Side+effects+of+antiepileptics-a+review&doi=10.1111%2Fj.1533-2500.2004.04304.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Side effects of antiepileptics--a review</span></div><div class="casAuthors">Walia Kulbir S; Khan Elizabeth A; Ko Dong H; Raza Shariq S; Khan Yasin N</div><div class="citationInfo"><span class="NLM_cas:title">Pain practice : the official journal of World Institute of Pain</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">194-203</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Older generation antiepileptic drugs like Phenobarbital (Luminal), carbamazepine (Tegretol), phenytoin (Dilantin), and valproic acid (Depakote) have several shortcomings such as suboptimal response rates, significant adverse effects, several drug interactions, and a narrow therapeutic index.  New antiepileptic drugs have been developed in the last decade to overcome some of these problems.  These newer generation antiepileptics like felbamate (Felbatol), gabapentin (Neurontin), lamotrigine (Lamictal), levetiracetam (Keppra), oxcarbazepine (Trileptal), tiagabine (Gabitril), topiramate (Topamax), and zonisamide (Zonegran) have better tolerability profiles, low interaction potential, and significantly less enzyme inducing or inhibiting properties.  As the use of antiepileptic drugs has expanded to include treatment of neuropathic pain, newer side effects have been reported.  In addition to the common side effects of antiepileptic drugs, like dizziness, drowsiness, and mental slowing; other side effects like weight gain, metabolic acidosis, nephrolithiasis, angle closure glaucoma, skin rash, hepatotoxicity, colitis, and movement and behavioral disorders, to name a few, have been brought to our attention.  This review is an attempt to highlight the features and incidences of some of these side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSq8w-gtiU7_bYtC3U5jeOifW6udTcc2eaIu4LVBQZf27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jjs1Gkug%253D%253D&md5=0bd5221a573a26194b0ea14116d9ce7c</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1111%2Fj.1533-2500.2004.04304.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1533-2500.2004.04304.x%26sid%3Dliteratum%253Aachs%26aulast%3DWalia%26aufirst%3DK.%2BS.%26aulast%3DKhan%26aufirst%3DE.%2BA.%26aulast%3DKo%26aufirst%3DD.%2BH.%26aulast%3DRaza%26aufirst%3DS.%2BS.%26aulast%3DKhan%26aufirst%3DY.%2BN.%26atitle%3DSide%2520effects%2520of%2520antiepileptics-a%2520review%26jtitle%3DPain%2520Pract.%26date%3D2004%26volume%3D4%26spage%3D194%26epage%3D203%26doi%3D10.1111%2Fj.1533-2500.2004.04304.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dworkin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backonja, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrar, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finnerup, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalso, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loeser, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miaskowski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nurmikko, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portenoy, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stacey, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treede, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, M. S.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic management of neuropathic pain: evidence-based recommendations</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">251</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2007.08.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.pain.2007.08.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=17920770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1yls7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2007&pages=237-251&author=R.+H.+Dworkinauthor=A.+B.+O%E2%80%99Connorauthor=M.+Backonjaauthor=J.+T.+Farrarauthor=N.+B.+Finnerupauthor=T.+S.+Jensenauthor=E.+A.+Kalsoauthor=J.+D.+Loeserauthor=C.+Miaskowskiauthor=T.+J.+Nurmikkoauthor=R.+K.+Portenoyauthor=A.+S.+Riceauthor=B.+R.+Staceyauthor=R.+D.+Treedeauthor=D.+C.+Turkauthor=M.+S.+Wallace&title=Pharmacologic+management+of+neuropathic+pain%3A+evidence-based+recommendations&doi=10.1016%2Fj.pain.2007.08.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic management of neuropathic pain: Evidence-based recommendations</span></div><div class="casAuthors">Dworkin, Robert H.; O'Connor, Alec B.; Backonja, Miroslav; Farrar, John T.; Finnerup, Nanna B.; Jensen, Troels S.; Kalso, Eija A.; Loeser, John D.; Miaskowski, Christine; Nurmikko, Turo J.; Portenoy, Russell K.; Rice, Andrew S. C.; Stacey, Brett R.; Treede, Rolf-Detlef; Turk, Dennis C.; Wallace, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">237-251</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Patients with neuropathic pain (NP) are challenging to manage and evidence-based clin. recommendations for pharmacol. management are needed.  Systematic literature reviews, randomized clin. trials, and existing guidelines were evaluated at a consensus meeting.  Medications were considered for recommendation if their efficacy was supported by at least one methodol.-sound, randomized clin. trial (RCT) demonstrating superiority to placebo or a relevant comparison treatment.  Recommendations were based on the amt. and consistency of evidence, degree of efficacy, safety, and clin. experience of the authors.  Available RCTs typically evaluated chronic NP of moderate to severe intensity.  Recommended first-line treatments include certain antidepressants (i.e., tricyclic antidepressants and dual reuptake inhibitors of both serotonin and norepinephrine), calcium channel α2-δ ligands (i.e., gabapentin and pregabalin), and topical lidocaine.  Opioid analgesics and tramadol are recommended as generally second-line treatments that can be considered for first-line use in select clin. circumstances.  Other medications that would generally be used as third-line treatments but that could also be used as second-line treatments in some circumstances include certain antiepileptic and antidepressant medications, mexiletine, N-methyl-D-aspartate receptor antagonists, and topical capsaicin.  Medication selection should be individualized, considering side effects, potential beneficial or deleterious effects on comorbidities, and whether prompt onset of pain relief is necessary.  To date, no medications have demonstrated efficacy in lumbosacral radiculopathy, which is probably the most common type of NP.  Long-term studies, head-to-head comparisons between medications, studies involving combinations of medications, and RCTs examg. treatment of central NP are lacking and should be a priority for future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNM2xlrhF4ZrVg90H21EOLACvtfcHk0liimlqNp7JSVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1yls7nN&md5=dfa9749c8bb2a828419a7d0cfd62c9b4</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2007.08.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2007.08.033%26sid%3Dliteratum%253Aachs%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DA.%2BB.%26aulast%3DBackonja%26aufirst%3DM.%26aulast%3DFarrar%26aufirst%3DJ.%2BT.%26aulast%3DFinnerup%26aufirst%3DN.%2BB.%26aulast%3DJensen%26aufirst%3DT.%2BS.%26aulast%3DKalso%26aufirst%3DE.%2BA.%26aulast%3DLoeser%26aufirst%3DJ.%2BD.%26aulast%3DMiaskowski%26aufirst%3DC.%26aulast%3DNurmikko%26aufirst%3DT.%2BJ.%26aulast%3DPortenoy%26aufirst%3DR.%2BK.%26aulast%3DRice%26aufirst%3DA.%2BS.%26aulast%3DStacey%26aufirst%3DB.%2BR.%26aulast%3DTreede%26aufirst%3DR.%2BD.%26aulast%3DTurk%26aufirst%3DD.%2BC.%26aulast%3DWallace%26aufirst%3DM.%2BS.%26atitle%3DPharmacologic%2520management%2520of%2520neuropathic%2520pain%253A%2520evidence-based%2520recommendations%26jtitle%3DPain%26date%3D2007%26volume%3D132%26spage%3D237%26epage%3D251%26doi%3D10.1016%2Fj.pain.2007.08.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertrampf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kless, A.</span></span> <span> </span><span class="NLM_article-title">Advances in targeting voltage-gated sodium channels with small molecules</span>. <i>Chem. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1712</span>– <span class="NLM_lpage">1740</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200298</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1002%2Fcmdc.201200298" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=22945552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1yks7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1712-1740&author=A.+Nardiauthor=N.+Damannauthor=T.+Hertrampfauthor=A.+Kless&title=Advances+in+targeting+voltage-gated+sodium+channels+with+small+molecules&doi=10.1002%2Fcmdc.201200298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in Targeting Voltage-Gated Sodium Channels with Small Molecules</span></div><div class="casAuthors">Nardi, Antonio; Damann, Nils; Hertrampf, Torsten; Kless, Achim</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1712-1740</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Blockade of voltage-gated sodium channels (VGSCs) has been used successfully in the clinic to enable control of pathol. firing patterns that occur in conditions as diverse as chronic pain, epilepsy, and arrhythmias.  Herein we review the state of the art in marketed sodium channel inhibitors, including a brief compendium of their binding sites and of the cellular and mol. biol. of sodium channels.  Despite the preferential action of this drug class toward over-excited cells, which significantly limits potential undesired side effects on other cells, the need to develop a second generation of sodium channel inhibitors to overcome their crit. clin. shortcomings is apparent.  Current approaches in drug discovery to deliver novel and truly innovative sodium channel inhibitors is next presented by surveying the most recent medicinal chem. breakthroughs in the field of small mols. and developments in automated patch-clamp platforms.  Various strategies aimed at identifying small mols. that target either particular isoforms of sodium channels involved in specific diseases or anomalous sodium channel currents, irresp. of the isoform by which they have been generated, are critically discussed and revised.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq25xI9xQpdebVg90H21EOLACvtfcHk0lgqKCg74bjb1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1yks7nN&md5=a4072539ac2084d994eb4a2143844d3c</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200298%26sid%3Dliteratum%253Aachs%26aulast%3DNardi%26aufirst%3DA.%26aulast%3DDamann%26aufirst%3DN.%26aulast%3DHertrampf%26aufirst%3DT.%26aulast%3DKless%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520targeting%2520voltage-gated%2520sodium%2520channels%2520with%2520small%2520molecules%26jtitle%3DChem.%2520Med.%2520Chem.%26date%3D2012%26volume%3D7%26spage%3D1712%26epage%3D1740%26doi%3D10.1002%2Fcmdc.201200298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prime, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span> <span> </span><span class="NLM_article-title">Recent progress in sodium channel modulators for pain</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3690</span>– <span class="NLM_lpage">3699</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.06.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2014.06.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=25060923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Wls7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3690-3699&author=S.+K.+Bagalauthor=M.+L.+Chapmanauthor=B.+E.+Marronauthor=R.+Primeauthor=R.+I.+Storerauthor=N.+A.+Swain&title=Recent+progress+in+sodium+channel+modulators+for+pain&doi=10.1016%2Fj.bmcl.2014.06.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in sodium channel modulators for pain</span></div><div class="casAuthors">Bagal, Sharan K.; Chapman, Mark L.; Marron, Brian E.; Prime, Rebecca; Storer, R. Ian; Swain, Nigel A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3690-3699</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium channels (Navs) are an important family of transmembrane ion channel proteins and Nav drug discovery is an exciting field.  Pharmaceutical investment in Navs for pain therapeutics has expanded exponentially due to genetic data such as SCN10A mutations and an improved ability to establish an effective screen sequence for example IonWorks Barracuda, Synchropatch and Qube.  Moreover, emerging clin. data (AZD-3161, XEN402, CNV1014802, PF-05089771, PF-04531083) combined with recent breakthroughs in Nav structural biol. pave the way for a future of fruitful prospective Nav drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbT6en4xkVxLVg90H21EOLACvtfcHk0lgqKCg74bjb1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Wls7vL&md5=c8bae40b70509e2aa3dce106e2c41677</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.038%26sid%3Dliteratum%253Aachs%26aulast%3DBagal%26aufirst%3DS.%2BK.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DPrime%26aufirst%3DR.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26atitle%3DRecent%2520progress%2520in%2520sodium%2520channel%2520modulators%2520for%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3690%26epage%3D3699%26doi%3D10.1016%2Fj.bmcl.2014.06.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rivara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuliani, V.</span></span> <span> </span><span class="NLM_article-title">Novel sodium channel antagonists in the treatment of neuropathic pain</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1517/13543784.2016.1121992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1517%2F13543784.2016.1121992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=26576738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVSrt7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=215-226&author=M.+Rivaraauthor=V.+Zuliani&title=Novel+sodium+channel+antagonists+in+the+treatment+of+neuropathic+pain&doi=10.1517%2F13543784.2016.1121992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Novel sodium channel antagonists in the treatment of neuropathic pain</span></div><div class="casAuthors">Rivara, Mirko; Zuliani, Valentina</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-226</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Effective and safe drugs for the treatment of neuropathic pain are still an unmet clin. need.  Neuropathic pain, caused by a lesion or disease that affects the somatosensory system, is a debilitating and hampering condition that has a great economic cost and, above all, a tremendous impact on the quality of life.  Sodium channels are one of the major players in generating and propagating action potentials.  They represent an appealing target for researchers involved in the development of new and safer drugs useful in the treatment of neuropathic pain.  The actual goal for researchers is to target sodium channels selectively to stop the abnormal signaling that characterizes neuropathic pain while leaving normal somatosensory functions intact.: This review covers the most recent publications regarding sodium channel blockers and their development as new treatments for neuropathic pain.  The main areas discussed are the natural sources of new blockers, such as venom exts. and the recent efforts from many pharmaceutical companies in the field.: There have been serious efforts by both the pharmaceutical industry and academia to develop new and safer therapeutic options for neuropathic pain.  A no. of different strategies have been undertaken; the main efforts directed towards the identification of selective blockers starting from both natural products or screening chem. libraries.  At this time, researchers have identified and characterized selective compds. against NaV1.7 or NaV1.8 voltage-gated sodium channels but only time will tell if they reach the market.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl3PzyBSNxFbVg90H21EOLACvtfcHk0lgqKCg74bjb1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVSrt7rK&md5=f0280383c1361e07d6c5378b0dda6373</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1517%2F13543784.2016.1121992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2016.1121992%26sid%3Dliteratum%253Aachs%26aulast%3DRivara%26aufirst%3DM.%26aulast%3DZuliani%26aufirst%3DV.%26atitle%3DNovel%2520sodium%2520channel%2520antagonists%2520in%2520the%2520treatment%2520of%2520neuropathic%2520pain%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2016%26volume%3D25%26spage%3D215%26epage%3D226%26doi%3D10.1517%2F13543784.2016.1121992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Vetter, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuis, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starobova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rash, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobli, M.</span></span> <span> </span><span class="NLM_article-title">Na<sub>V</sub>1.7 as a pain target – From gene to pharmacology</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">73</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2016.11.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.pharmthera.2016.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=27916648" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislClsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2017&pages=73-100&author=I.+Vetterauthor=J.+R.+Deuisauthor=A.+Muellerauthor=M.+R.+Israelauthor=H.+Starobovaauthor=A.+Zhangauthor=L.+D.+Rashauthor=M.+Mobli&title=NaV1.7+as+a+pain+target+%E2%80%93+From+gene+to+pharmacology&doi=10.1016%2Fj.pharmthera.2016.11.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11dR"><div class="casContent"><span class="casTitleNuber">11d</span><div class="casTitle"><span class="NLM_cas:atitle">NaV1.7 as a pain target - From gene to pharmacology</span></div><div class="casAuthors">Vetter, Irina; Deuis, Jennifer R.; Mueller, Alexander; Israel, Mathilde R.; Starobova, Hana; Zhang, Alan; Rash, Lachlan D.; Mobli, Mehdi</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">73-100</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">NaV1.7, a subtype of the voltage-gated sodium channel family that is highly expressed in peripheral sensory neurons, remains one of the most promising targets for the treatment of pain.  However, despite compelling genetic evidence supporting a key role for NaV1.7 in regulating excitability of peripheral sensory neurons, the development of truly subtype-selective inhibitors has been challenging.  Here, we discuss complexities surrounding targeting NaV1.7 pharmacol. for treatment of pain and explore future opportunities for development of effective analgesic NaV1.7 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgpB1bBe31X7Vg90H21EOLACvtfcHk0lhAkZTUUlEYog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislClsg%253D%253D&md5=78a0e17dfccd84b511491b6c5d83fd94</span></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2016.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2016.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DVetter%26aufirst%3DI.%26aulast%3DDeuis%26aufirst%3DJ.%2BR.%26aulast%3DMueller%26aufirst%3DA.%26aulast%3DIsrael%26aufirst%3DM.%2BR.%26aulast%3DStarobova%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DA.%26aulast%3DRash%26aufirst%3DL.%2BD.%26aulast%3DMobli%26aufirst%3DM.%26atitle%3DNaV1.7%2520as%2520a%2520pain%2520target%2520%25E2%2580%2593%2520From%2520gene%2520to%2520pharmacology%26jtitle%3DPharmacol.%2520Ther.%26date%3D2017%26volume%3D172%26spage%3D73%26epage%3D100%26doi%3D10.1016%2Fj.pharmthera.2016.11.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asghari-Roodsari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H. L.</span></span> <span> </span><span class="NLM_article-title">Cardiac sodium channelopathies</span>. <i>Pfluegers Arch. - Eur. J. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>460</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1007/s00424-009-0761-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1007%2Fs00424-009-0761-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=20091048" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=460&publication_year=2010&pages=223-237&author=A.+S.+Aminauthor=A.+Asghari-Roodsariauthor=H.+L.+Tan&title=Cardiac+sodium+channelopathies&doi=10.1007%2Fs00424-009-0761-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1007%2Fs00424-009-0761-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00424-009-0761-0%26sid%3Dliteratum%253Aachs%26aulast%3DAmin%26aufirst%3DA.%2BS.%26aulast%3DAsghari-Roodsari%26aufirst%3DA.%26aulast%3DTan%26aufirst%3DH.%2BL.%26atitle%3DCardiac%2520sodium%2520channelopathies%26jtitle%3DPfluegers%2520Arch.%2520-%2520Eur.%2520J.%2520Physiol.%26date%3D2010%26volume%3D460%26spage%3D223%26epage%3D237%26doi%3D10.1007%2Fs00424-009-0761-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Schott, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alshinawi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyndt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Probst, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoorntje, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulsbeek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilde, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escande, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannens, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Marec, H.</span></span> <span> </span><span class="NLM_article-title">Cardiac conduction defects associate with mutations in SCN5A</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1038/12618</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1038%2F12618" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10471492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFWhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1999&pages=20-21&author=J.+J.+Schottauthor=C.+Alshinawiauthor=F.+Kyndtauthor=V.+Probstauthor=T.+M.+Hoorntjeauthor=M.+Hulsbeekauthor=A.+A.+Wildeauthor=D.+Escandeauthor=M.+M.+Mannensauthor=H.+Le+Marec&title=Cardiac+conduction+defects+associate+with+mutations+in+SCN5A&doi=10.1038%2F12618"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiac conduction defects associate with mutations in SCN5A</span></div><div class="casAuthors">Schott, Jean-Jacques; Alshinawi, Connie; Kyndt, Florence; Probst, Vincent; Hoorntje, Theo M.; Hulsbeek, Miriam; Wilde, Arthur A. M.; Escande, Denis; Mannens, Marcel M. A. M.; Le Marec, Herve</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-21</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">Progressive cardiac conduction defect (PCCD) also called Lenegre or Lev disease, is one of the most common cardiac conduction disturbances.  Here, the authors report a mutation in the gene encoding the cardiac-specific sodium channel (SCN5A) that segregates with PCCD in an autosomal dominant manner in a large French family.  The authors also studied a Dutch family in which the proband presented after birth with asymptomatic first-degree atrio-ventricular block assocd. with right bundle branch block.  Sequencing the entire SCN5A coding region in the French family identified a T→C substitution in the highly conserved +2 donor splicing site of intron 22.  The abnormal transcript predicts in-frame skipping of exon 22 and an impaired gene product lacking the voltage-sensitive DIIIS4 segment.  SCN5A was directly sequenced in the Dutch family.  A deletion of a single nucleotide (G) at position 5280 resulting in a frameshift predicting a premature stop codon was identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsWjnnnqL4MbVg90H21EOLACvtfcHk0lhAkZTUUlEYog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFWhs7k%253D&md5=7cb11c78625c8e2fd7f21caa876de2ff</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1038%2F12618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F12618%26sid%3Dliteratum%253Aachs%26aulast%3DSchott%26aufirst%3DJ.%2BJ.%26aulast%3DAlshinawi%26aufirst%3DC.%26aulast%3DKyndt%26aufirst%3DF.%26aulast%3DProbst%26aufirst%3DV.%26aulast%3DHoorntje%26aufirst%3DT.%2BM.%26aulast%3DHulsbeek%26aufirst%3DM.%26aulast%3DWilde%26aufirst%3DA.%2BA.%26aulast%3DEscande%26aufirst%3DD.%26aulast%3DMannens%26aufirst%3DM.%2BM.%26aulast%3DLe%2BMarec%26aufirst%3DH.%26atitle%3DCardiac%2520conduction%2520defects%2520associate%2520with%2520mutations%2520in%2520SCN5A%26jtitle%3DNat.%2520Genet.%26date%3D1999%26volume%3D23%26spage%3D20%26epage%3D21%26doi%3D10.1038%2F12618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tfelt-Hansen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkel, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunnet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jespersen, T.</span></span> <span> </span><span class="NLM_article-title">Inherited cardiac diseases caused by mutations in the Na<sub>V</sub>1.5 sodium channel</span>. <i>J. Cardiovasc. Electrophysiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1111/j.1540-8167.2009.01633.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1111%2Fj.1540-8167.2009.01633.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=19845816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A280%3ADC%252BC3czkvVOksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=107-115&author=J.+Tfelt-Hansenauthor=B.+G.+Winkelauthor=M.+Grunnetauthor=T.+Jespersen&title=Inherited+cardiac+diseases+caused+by+mutations+in+the+NaV1.5+sodium+channel&doi=10.1111%2Fj.1540-8167.2009.01633.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">Inherited cardiac diseases caused by mutations in the Nav1.5 sodium channel</span></div><div class="casAuthors">Tfelt-Hansen Jacob; Winkel Bo Gregers; Grunnet Morten; Jespersen Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cardiovascular electrophysiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">107-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A prerequisite for a normal cardiac function is a proper generation and propagation of electrical impulses.  Contraction of the heart is obtained through a delicate matched transmission of the electrical impulses.  A pivotal element of the impulse propagation is the depolarizing sodium current, responsible for the initial depolarization of the cardiomyocytes.  Recent research has shown that mutations in the SCN5A gene, encoding the cardiac sodium channel Nav1.5, are associated with both rare forms of ventricular arrhythmia, as well as the most frequent form of arrhythmia, atrial fibrillation (AF).  In this comprehensive review, we describe the functional role of Nav1.5 and its associated proteins in propagation and depolarization both in a normal- and in a pathophysiological setting.  Furthermore, several of the arrhythmogenic diseases, such as long-QT syndrome, Brugada syndrome, and AF, reported to be associated with mutations in SCN5A, are thoroughly described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRQrZacCEoQ64hLSh9fo81bfW6udTcc2ebQ5g6cKUBCdbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czkvVOksQ%253D%253D&md5=f232be7a17114e5ef7f275c6cce32c6e</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1111%2Fj.1540-8167.2009.01633.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1540-8167.2009.01633.x%26sid%3Dliteratum%253Aachs%26aulast%3DTfelt-Hansen%26aufirst%3DJ.%26aulast%3DWinkel%26aufirst%3DB.%2BG.%26aulast%3DGrunnet%26aufirst%3DM.%26aulast%3DJespersen%26aufirst%3DT.%26atitle%3DInherited%2520cardiac%2520diseases%2520caused%2520by%2520mutations%2520in%2520the%2520NaV1.5%2520sodium%2520channel%26jtitle%3DJ.%2520Cardiovasc.%2520Electrophysiol.%26date%3D2010%26volume%3D21%26spage%3D107%26epage%3D115%26doi%3D10.1111%2Fj.1540-8167.2009.01633.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Erdemli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penland, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, P. K.</span></span> <span> </span><span class="NLM_article-title">Cardiac safety implications of hNa<sub>V</sub>1.5 blockade and a framework for pre-clinical evaluation</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.3389/fphar.2012.00006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.3389%2Ffphar.2012.00006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=22291651" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1-9&author=G.+Erdemliauthor=A.+M.+Kimauthor=H.+Juauthor=C.+Springerauthor=R.+C.+Penlandauthor=P.+K.+Hoffmann&title=Cardiac+safety+implications+of+hNaV1.5+blockade+and+a+framework+for+pre-clinical+evaluation&doi=10.3389%2Ffphar.2012.00006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12d&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2012.00006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2012.00006%26sid%3Dliteratum%253Aachs%26aulast%3DErdemli%26aufirst%3DG.%26aulast%3DKim%26aufirst%3DA.%2BM.%26aulast%3DJu%26aufirst%3DH.%26aulast%3DSpringer%26aufirst%3DC.%26aulast%3DPenland%26aufirst%3DR.%2BC.%26aulast%3DHoffmann%26aufirst%3DP.%2BK.%26atitle%3DCardiac%2520safety%2520implications%2520of%2520hNaV1.5%2520blockade%2520and%2520a%2520framework%2520for%2520pre-clinical%2520evaluation%26jtitle%3DFront.%2520Pharmacol.%26date%3D2012%26volume%3D3%26spage%3D1%26epage%3D9%26doi%3D10.3389%2Ffphar.2012.00006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of voltage-gated sodium channel Na<sub>V</sub>1.7: patent applications since 2010</span>. <i>Pharm. Pat. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">509</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.4155/ppa.14.39</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.4155%2Fppa.14.39" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=25374320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVKrs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=509-521&author=S.+Sunauthor=C.+J.+Cohenauthor=C.+M.+Dehnhardt&title=Inhibitors+of+voltage-gated+sodium+channel+NaV1.7%3A+patent+applications+since+2010&doi=10.4155%2Fppa.14.39"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010</span></div><div class="casAuthors">Sun, Shaoyi; Cohen, Charles J.; Dehnhardt, Christoph M.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Patent Analyst</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">509-521</span>CODEN:
                <span class="NLM_cas:coden">PPAHCN</span>;
        ISSN:<span class="NLM_cas:issn">2046-8954</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  There has been intense interest in developing inhibitors of the sodium channel Nav1.7 because genetic studies have established very strong validation for the efficacy to alleviate both inflammatory and neuropathic pain.  This review summarizes patent applications targeting Nav1.7 since 2010 until May, 2014.  We have classified the patents into three categories as follows: small mols. with well-defined mol. selectivity among sodium channel isoforms; biologicals with well-defined mol. selectivity; and, small mols. that inhibit Nav1.7 with unknown mol. selectivity.  Most of the review is dedicated to small mol. selective compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE50bQQ3wiFLVg90H21EOLACvtfcHk0lgOIXou8TCcFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKrs7rL&md5=6986fe156f608706204b483207d2201c</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.4155%2Fppa.14.39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Fppa.14.39%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26atitle%3DInhibitors%2520of%2520voltage-gated%2520sodium%2520channel%2520NaV1.7%253A%2520patent%2520applications%2520since%25202010%26jtitle%3DPharm.%2520Pat.%2520Anal.%26date%3D2014%26volume%3D3%26spage%3D509%26epage%3D521%26doi%3D10.4155%2Fppa.14.39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batchelor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudoin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechle, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galan, S. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulier, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greener, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markworth, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransley, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reister, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate 4-[2-(5-amino-1Hpyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-<i>N</i>-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): design and optimization of diary ether aryl sulfonamides as selective inhibitors of Na<sub>V</sub>1.7</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7029</span>– <span class="NLM_lpage">7042</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFagu7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7029-7042&author=N.+A.+Swainauthor=D.+Batchelorauthor=S.+Beaudoinauthor=B.+M.+Bechleauthor=P.+A.+Bradleyauthor=A.+D.+Brownauthor=B.+Brownauthor=K.+J.+Butcherauthor=R.+P.+Buttauthor=M.+L.+Chapmanauthor=S.+Dentonauthor=D.+Ellisauthor=S.+R.+G.+Galanauthor=S.+M.+Gaulierauthor=B.+S.+Greenerauthor=M.+J.+de+Grootauthor=M.+S.+Glossopauthor=I.+K.+Gurrellauthor=J.+Hannamauthor=M.+S.+Johnsonauthor=Z.+Linauthor=C.+J.+Markworthauthor=B.+E.+Marronauthor=D.+S.+Millanauthor=S.+Nakagawaauthor=A.+Pikeauthor=D.+Printzenhoffauthor=D.+J.+Rawsonauthor=S.+J.+Ransleyauthor=S.+M.+Reisterauthor=K.+Sasakiauthor=R.+I.+Storerauthor=P.+A.+Stuppleauthor=C.+W.+West&title=Discovery+of+clinical+candidate+4-%5B2-%285-amino-1Hpyrazol-4-yl%29-4-chlorophenoxy%5D-5-chloro-2-fluoro-N-1%2C3-thiazol-4-ylbenzenesulfonamide+%28PF-05089771%29%3A+design+and+optimization+of+diary+ether+aryl+sulfonamides+as+selective+inhibitors+of+NaV1.7&doi=10.1021%2Facs.jmedchem.7b00598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7</span></div><div class="casAuthors">Swain, Nigel. A.; Batchelor, Dave; Beaudoin, Serge; Bechle, Bruce M.; Bradley, Paul A.; Brown, Alan D.; Brown, Bruce; Butcher, Ken J.; Butt, Richard P.; Chapman, Mark L.; Denton, Stephen; Ellis, David; Galan, Sebastien R. G.; Gaulier, Steven M.; Greener, Ben S.; de Groot, Marcel J.; Glossop, Mel S.; Gurrell, Ian K.; Hannam, Jo; Johnson, Matthew S.; Lin, Zhixin; Markworth, Christopher J.; Marron, Brian E.; Millan, David S.; Nakagawa, Shoko; Pike, Andy; Printzenhoff, David; Rawson, David J.; Ransley, Sarah J.; Reister, Steven M.; Sasaki, Kosuke; Storer, R. Ian; Stupple, Paul A.; West, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7029-7042</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of acidic diaryl ether heterocyclic sulfonamides that are potent and sub-type selective NaV1.7 inhibitors is described.  Optimization of early lead matter focused on removal of structural alerts, improving metabolic stability and reducing cytochrome P 450 inhibition driven drug-drug interaction concerns to deliver the desired balance of preclin. in vitro properties.  Concerns over non-metabolic routes of clearance, variable clearance in pre-clin. species and subsequent low confidence human pharmacokinetic predictions led to the decision to conduct a human microdose study to det. clin. pharmacokinetics.  The design strategies and results from pre-clin. PK and clin. human microdose PK data are described leading to the discovery of the first sub-type selective NaV1.7 inhibitor clin. candidate PF-05089771 (34) which binds to a site in the voltage sensing domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpST6i8wDUALbVg90H21EOLACvtfcHk0lgOIXou8TCcFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFagu7jM&md5=93761c8e8e16cea4db2c9cff6e315e57</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00598%26sid%3Dliteratum%253Aachs%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DBatchelor%26aufirst%3DD.%26aulast%3DBeaudoin%26aufirst%3DS.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DBradley%26aufirst%3DP.%2BA.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DButcher%26aufirst%3DK.%2BJ.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DDenton%26aufirst%3DS.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DGalan%26aufirst%3DS.%2BR.%2BG.%26aulast%3DGaulier%26aufirst%3DS.%2BM.%26aulast%3DGreener%26aufirst%3DB.%2BS.%26aulast%3Dde%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DGlossop%26aufirst%3DM.%2BS.%26aulast%3DGurrell%26aufirst%3DI.%2BK.%26aulast%3DHannam%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DRawson%26aufirst%3DD.%2BJ.%26aulast%3DRansley%26aufirst%3DS.%2BJ.%26aulast%3DReister%26aufirst%3DS.%2BM.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWest%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25204-%255B2-%25285-amino-1Hpyrazol-4-yl%2529-4-chlorophenoxy%255D-5-chloro-2-fluoro-N-1%252C3-thiazol-4-ylbenzenesulfonamide%2520%2528PF-05089771%2529%253A%2520design%2520and%2520optimization%2520of%2520diary%2520ether%2520aryl%2520sulfonamides%2520as%2520selective%2520inhibitors%2520of%2520NaV1.7%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7029%26epage%3D7042%26doi%3D10.1021%2Facs.jmedchem.7b00598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojic, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milgram, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescourio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparling, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stellwagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaida, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: Optimizing potency, pharmacokinetics, and metabolic properties to obtain atropisomeric quinolinone (AM-0466) that affords robust in vivo activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5990</span>– <span class="NLM_lpage">6017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5990-6017&author=R.+F.+Graceffaauthor=A.+A.+Boezioauthor=J.+Ableauthor=S.+Altmannauthor=L.+M.+Berryauthor=C.+Boezioauthor=J.+R.+Butlerauthor=M.+Chu-Moyerauthor=M.+Cookeauthor=E.+F.+DiMauroauthor=T.+A.+Dineenauthor=E.+F.+Bojicauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=A.+Guzman-Perezauthor=H.+Gaoauthor=H.+Gunaydinauthor=H.+Huangauthor=L.+Huangauthor=C.+Ilchauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=B.+C.+Milgramauthor=M.+J.+Linauthor=I.+E.+Marxauthor=H.+N.+Nguyenauthor=E.+A.+Petersonauthor=G.+Rescourioauthor=J.+Robertsauthor=L.+Schenkelauthor=R.+Shimanovichauthor=B.+A.+Sparlingauthor=J.+Stellwagenauthor=K.+Tabornauthor=K.+R.+Vaidaauthor=J.+Wangauthor=J.+Yeomanauthor=V.+Yuauthor=D.+Zhuauthor=B.+D.+Moyerauthor=M.+M.+Weiss&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+Optimizing+potency%2C+pharmacokinetics%2C+and+metabolic+properties+to+obtain+atropisomeric+quinolinone+%28AM-0466%29+that+affords+robust+in+vivo+activity&doi=10.1021%2Facs.jmedchem.6b01850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13cR"><div class="casContent"><span class="casTitleNuber">13c</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity</span></div><div class="casAuthors">Graceffa, Russell F.; Boezio, Alessandro A.; Able, Jessica; Altmann, Steven; Berry, Loren M.; Boezio, Christiane; Butler, John R.; Chu-Moyer, Margaret; Cooke, Melanie; DiMauro, Erin F.; Dineen, Thomas A.; Feric Bojic, Elma; Foti, Robert S.; Fremeau, Robert T.; Guzman-Perez, Angel; Gao, Hua; Gunaydin, Hakan; Huang, Hongbing; Huang, Liyue; Ilch, Christopher; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Milgram, Benjamin C.; Lin, Min-Hwa Jasmine; Marx, Isaac E.; Nguyen, Hanh N.; Peterson, Emily A.; Rescourio, Gwen; Roberts, John; Schenkel, Laurie; Shimanovich, Roman; Sparling, Brian A.; Stellwagen, John; Taborn, Kristin; Vaida, Karina R.; Wang, Jean; Yeoman, John; Yu, Violeta; Zhu, Dawn; Moyer, Bryan D.; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5990-6017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of its strong genetic validation, NaV1.7 has attracted significant interest as a target for the treatment of pain.  We have previously reported on a no. of structurally distinct bicyclic heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  Herein, we report the discovery and optimization of a series of atropisomeric quinolinone sulfonamide inhibitors [Bicyclic sulfonamide compds. as sodium channel inhibitors and their prepn. WO 2014201206, 2014] of NaV1.7, which demonstrate nanomolar inhibition of NaV1.7 and exhibit high levels of selectivity over other sodium channel isoforms.  After optimization of metabolic and pharmacokinetic properties, including PXR activation, CYP2C9 inhibition, and CYP3A4 TDI, several compds. were advanced into in vivo target engagement and efficacy models.  When tested in mice, compd. 39 (AM-0466) demonstrated robust pharmacodynamic activity in a NaV1.7-dependent model of histamine-induced pruritus (itch) and addnl. in a capsaicin-induced nociception model of pain without any confounding effect in open-field activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ofeMhgMFqbVg90H21EOLACvtfcHk0lhvyW9YZFrrIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D&md5=5b48afe24a97290ea5e44a71deaa0303</span></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01850%26sid%3Dliteratum%253Aachs%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DBoezio%26aufirst%3DC.%26aulast%3DButler%26aufirst%3DJ.%2BR.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DBojic%26aufirst%3DE.%2BF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DIlch%26aufirst%3DC.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DMilgram%26aufirst%3DB.%2BC.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRescourio%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DSchenkel%26aufirst%3DL.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DSparling%26aufirst%3DB.%2BA.%26aulast%3DStellwagen%26aufirst%3DJ.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DVaida%26aufirst%3DK.%2BR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYeoman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520Optimizing%2520potency%252C%2520pharmacokinetics%252C%2520and%2520metabolic%2520properties%2520to%2520obtain%2520atropisomeric%2520quinolinone%2520%2528AM-0466%2529%2520that%2520affords%2520robust%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5990%26epage%3D6017%26doi%3D10.1021%2Facs.jmedchem.6b01850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shields, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post-Munson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graef, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newberry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivarao, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senapati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linda J. Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of indole- and indazole-acylsulfonamides as potent and selective Na<sub>V</sub>1.7 inhibitors for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">831</span>– <span class="NLM_lpage">856</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01550</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01550" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFyhurvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=831-856&author=G.+Luoauthor=L.+Chenauthor=A.+Eastonauthor=A.+Newtonauthor=C.+Bourinauthor=E.+Shieldsauthor=K.+Mosureauthor=M.+G.+Soarsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+L.+Pieschlauthor=D.+J.+Post-Munsonauthor=S.+Wangauthor=J.+Herringtonauthor=J.+Graefauthor=K.+Newberryauthor=D.+V.+Sivaraoauthor=A.+Senapatiauthor=L.+J.+Linda+J.+Bristowauthor=N.+A.+Meanwellauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Discovery+of+indole-+and+indazole-acylsulfonamides+as+potent+and+selective+NaV1.7+inhibitors+for+the+treatment+of+pain&doi=10.1021%2Facs.jmedchem.8b01550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13dR"><div class="casContent"><span class="casTitleNuber">13d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain</span></div><div class="casAuthors">Luo, Guanglin; Chen, Ling; Easton, Amy; Newton, Amy; Bourin, Clotilde; Shields, Eric; Mosure, Kathy; Soars, Matthew G.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick L.; Post-Munson, Debra J.; Wang, Shuya; Herrington, James; Graef, John; Newberry, Kimberly; Sivarao, Digavalli V.; Senapati, Arun; Bristow, Linda J.; Meanwell, Nicholas A.; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">831-856</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Aryl-indole and 3-aryl-indazole derivs. were identified as potent and selective Nav1.7 inhibitors.  Compd. I was shown to be efficacious in the mouse formalin assay and also reduced complete Freund's adjuvant (CFA)-induced thermal hyperalgesia and chronic constriction injury (CCI) induced cold allodynia and models of inflammatory and neuropathic pain, resp., following i.p. (IP) doses of 30 mg/kg.  The obsd. efficacy could be correlated with the mouse dorsal root ganglion exposure and NaV1.7 potency assocd. with I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfhO7JA5f8M7Vg90H21EOLACvtfcHk0lhvyW9YZFrrIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFyhurvJ&md5=e9fbe2bca698914994f5f008a918d935</span></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01550%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DEaston%26aufirst%3DA.%26aulast%3DNewton%26aufirst%3DA.%26aulast%3DBourin%26aufirst%3DC.%26aulast%3DShields%26aufirst%3DE.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%2BL.%26aulast%3DPost-Munson%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DGraef%26aufirst%3DJ.%26aulast%3DNewberry%26aufirst%3DK.%26aulast%3DSivarao%26aufirst%3DD.%2BV.%26aulast%3DSenapati%26aufirst%3DA.%26aulast%3DLinda%2BJ.%2BBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520indole-%2520and%2520indazole-acylsulfonamides%2520as%2520potent%2520and%2520selective%2520NaV1.7%2520inhibitors%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D831%26epage%3D856%26doi%3D10.1021%2Facs.jmedchem.8b01550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenova, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrez, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemeon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelkenbrecher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPasquale, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sojo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindgren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldbrook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinette, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span> <span> </span><span class="NLM_article-title">Identification of selective acyl sulfonamide–cycloalkylether inhibitors of the voltage-gated sodium channel (Na<sub>V</sub>) 1.7 with potent analgesic activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">908</span>– <span class="NLM_lpage">927</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01621</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01621" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlylsLzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=908-927&author=S.+Sunauthor=Q.+Jiaauthor=A.+Y.+Zenovaauthor=M.+S.+Wilsonauthor=S.+Chowdhuryauthor=T.+Fockenauthor=J.+Liauthor=S.+Deckerauthor=M.+E.+Grimwoodauthor=J.-C.+Andrezauthor=I.+Hemeonauthor=T.+Shengauthor=C.-A.+Chenauthor=A.+Whiteauthor=D.+H.+Hackosauthor=L.+Dengauthor=G.+Bankarauthor=K.+Khakhauthor=E.+Changauthor=R.+Kwanauthor=S.+Linauthor=K.+Nelkenbrecherauthor=B.+D.+Sellersauthor=A.+G.+DiPasqualeauthor=J.+Changauthor=J.+Pangauthor=L.+Sojoauthor=A.+Lindgrenauthor=M.+Waldbrookauthor=Z.+Xieauthor=C.+Youngauthor=J.+P.+Johnsonauthor=C.+L.+Robinetteauthor=C.+J.+Cohenauthor=B.+S.+Safinaauthor=D.+P.+Sutherlinauthor=D.+F.+Ortwineauthor=C.+M.+Dehnhardt&title=Identification+of+selective+acyl+sulfonamide%E2%80%93cycloalkylether+inhibitors+of+the+voltage-gated+sodium+channel+%28NaV%29+1.7+with+potent+analgesic+activity&doi=10.1021%2Facs.jmedchem.8b01621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13eR"><div class="casContent"><span class="casTitleNuber">13e</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Selective Acyl Sulfonamide-Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (Nav) 1.7 with Potent Analgesic Activity</span></div><div class="casAuthors">Sun, Shaoyi; Jia, Qi; Zenova, Alla Y.; Wilson, Michael S.; Chowdhury, Sultan; Focken, Thilo; Li, Jun; Decker, Shannon; Grimwood, Michael E.; Andrez, Jean-Christophe; Hemeon, Ivan; Sheng, Tao; Chen, Chien-An; White, Andy; Hackos, David H.; Deng, Lunbin; Bankar, Girish; Khakh, Kuldip; Chang, Elaine; Kwan, Rainbow; Lin, Sophia; Nelkenbrecher, Karen; Sellers, Benjamin D.; DiPasquale, Antonio G.; Chang, Jae; Pang, Jodie; Sojo, Luis; Lindgren, Andrea; Waldbrook, Matthew; Xie, Zhiwei; Young, Clint; Johnson, James P.; Robinette, C. Lee; Cohen, Charles J.; Safina, Brian S.; Sutherlin, Daniel P.; Ortwine, Daniel F.; Dehnhardt, Christoph M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">908-927</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, the authors report the discovery and optimization of a series of orally bioavailable acyl sulfonamide Nav1.7 inhibitors that are selective for Nav1.7 over Nav1.5 and highly efficacious in in vivo models of pain and hNav1.7 target engagement.  An anal. of the physicochem. properties of literature Nav1.7 inhibitors suggested that acyl sulfonamides with high fsp3 could overcome some of the pharmacokinetic (PK) and efficacy challenges seen with existing series.  Parallel library syntheses lead to the identification of analog 7, which exhibited moderate potency against Nav1.7 and an acceptable PK profile in rodents, but relatively poor stability in human liver microsomes.  Further, design strategy then focused on the optimization of potency against hNav1.7 and improvement of human metabolic stability, using induced fit docking in the authors' previously disclosed x-ray cocrystal of the Nav1.7 voltage sensing domain.  These studies culminated in the discovery of tool compd. 33(I), one of the most potent and efficacious Nav1.7 inhibitors reported to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ73dSmnXyarVg90H21EOLACvtfcHk0ljqojFizQtdLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlylsLzF&md5=f098e8182d290e4c1233b7d74887a4d0</span></div><a href="/servlet/linkout?suffix=cit13e&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01621%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DQ.%26aulast%3DZenova%26aufirst%3DA.%2BY.%26aulast%3DWilson%26aufirst%3DM.%2BS.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DDecker%26aufirst%3DS.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DAndrez%26aufirst%3DJ.-C.%26aulast%3DHemeon%26aufirst%3DI.%26aulast%3DSheng%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DC.-A.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DE.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DNelkenbrecher%26aufirst%3DK.%26aulast%3DSellers%26aufirst%3DB.%2BD.%26aulast%3DDiPasquale%26aufirst%3DA.%2BG.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DSojo%26aufirst%3DL.%26aulast%3DLindgren%26aufirst%3DA.%26aulast%3DWaldbrook%26aufirst%3DM.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DRobinette%26aufirst%3DC.%2BL.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26atitle%3DIdentification%2520of%2520selective%2520acyl%2520sulfonamide%25E2%2580%2593cycloalkylether%2520inhibitors%2520of%2520the%2520voltage-gated%2520sodium%2520channel%2520%2528NaV%2529%25201.7%2520with%2520potent%2520analgesic%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D908%26epage%3D927%26doi%3D10.1021%2Facs.jmedchem.8b01621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit13f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrall, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPasquale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chernov-Rogan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payandeh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proctor, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shields, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span> <span> </span><span class="NLM_article-title">Structure and ligand-based discovery of chromane arylsulfonamide Na<sub>V</sub>1.7 inhibitors for the treatment of chronic pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4091</span>– <span class="NLM_lpage">4109</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00141</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00141" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmslSgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=4091-4109&author=S.+J.+McKerrallauthor=T.+Nguyenauthor=K.+W.+Laiauthor=P.+Bergeronauthor=L.+Dengauthor=A.+DiPasqualeauthor=J.+H.+Changauthor=J.+Chenauthor=T.+Chernov-Roganauthor=D.+H.+Hackosauthor=J.+Maherauthor=D.+F.+Ortwineauthor=J.+Pangauthor=J.+Payandehauthor=W.+R.+Proctorauthor=S.+D.+Shieldsauthor=J.+Vogtauthor=P.+Jiauthor=W.+Liuauthor=E.+Balliniauthor=L.+Schumannauthor=G.+Tarozzoauthor=G.+Bankarauthor=S.+Chowdhuryauthor=A.+Hasanauthor=J.+P.+Johnsonauthor=K.+Khakhauthor=S.+Linauthor=C.+J.+Cohenauthor=C.+M.+Dehnhardtauthor=B.+S.+Safinaauthor=D.+P.+Sutherlin&title=Structure+and+ligand-based+discovery+of+chromane+arylsulfonamide+NaV1.7+inhibitors+for+the+treatment+of+chronic+pain&doi=10.1021%2Facs.jmedchem.9b00141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13fR"><div class="casContent"><span class="casTitleNuber">13f</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Nav1.7 Inhibitors for the Treatment of Chronic Pain</span></div><div class="casAuthors">McKerrall, Steven J.; Nguyen, Teresa; Lai, Kwong Wah; Bergeron, Philippe; Deng, Lunbin; DiPasquale, Antonio; Chang, Jae H.; Chen, Jun; Chernov-Rogan, Tania; Hackos, David H.; Maher, Jonathan; Ortwine, Daniel F.; Pang, Jodie; Payandeh, Jian; Proctor, William R.; Shields, Shannon D.; Vogt, Jennifer; Ji, Pengfei; Liu, Wenfeng; Ballini, Elisa; Schumann, Lilia; Tarozzo, Glauco; Bankar, Girish; Chowdhury, Sultan; Hasan, Abid; Johnson, J. P.; Khakh, Kuldip; Lin, Sophia; Cohen, Charles J.; Dehnhardt, Christoph M.; Safina, Brian S.; Sutherlin, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4091-4109</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using structure- and ligand-based design principles, a novel series of piperidyl chromane arylsulfonamide Nav1.7 inhibitors was discovered.  Early optimization focused on improvement of potency through refinement of the low energy ligand conformation and mitigation of high in vivo clearance.  An in vitro hepatotoxicity hazard was identified and resolved through optimization of lipophilicity and LLE to arrive at GNE-616 (24(I)), a highly potent, metabolically stable, subtype selective inhibitor of Nav1.7.  I showed a robust PK/PD response in a Nav1.7 dependent mouse model and site-directed mutagenesis was used to identify residues crit. for the isoform selectivity profile of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw_A7qQl172bVg90H21EOLACvtfcHk0ljqojFizQtdLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmslSgsLk%253D&md5=b8bd9e3d9f7debf6e4168e605dd837dc</span></div><a href="/servlet/linkout?suffix=cit13f&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00141%26sid%3Dliteratum%253Aachs%26aulast%3DMcKerrall%26aufirst%3DS.%2BJ.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DLai%26aufirst%3DK.%2BW.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DDiPasquale%26aufirst%3DA.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChernov-Rogan%26aufirst%3DT.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DMaher%26aufirst%3DJ.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPayandeh%26aufirst%3DJ.%26aulast%3DProctor%26aufirst%3DW.%2BR.%26aulast%3DShields%26aufirst%3DS.%2BD.%26aulast%3DVogt%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBallini%26aufirst%3DE.%26aulast%3DSchumann%26aufirst%3DL.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DHasan%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26atitle%3DStructure%2520and%2520ligand-based%2520discovery%2520of%2520chromane%2520arylsulfonamide%2520NaV1.7%2520inhibitors%2520for%2520the%2520treatment%2520of%2520chronic%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D4091%26epage%3D4109%26doi%3D10.1021%2Facs.jmedchem.9b00141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahuja, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukundl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shriverl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coons, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brillantes, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estevez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verschoof, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrez, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starovasnik, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koth, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payandeh, J.</span></span> <span> </span><span class="NLM_article-title">Structural basis of Na<sub>V</sub>1.7 inhibition by an isoform-selective small molecule antagonist</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>350</i></span>, <span class="NLM_elocation-id">aac5464</span> <span class="refDoi"> DOI: 10.1126/science.aac5464</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1126%2Fscience.aac5464" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=26680203" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2015&author=S.+Ahujaauthor=S.+Mukundlauthor=L.+Dengauthor=K.+Khakhauthor=E.+Changauthor=H.+Hoauthor=S.+Shriverlauthor=C.+Youngauthor=S.+Linauthor=J.+P.+Johnsonauthor=P.+Wuauthor=J.+Liauthor=M.+Coonsauthor=C.+Tamauthor=B.+Brillantesauthor=H.+Sampangauthor=K.+Mortaraauthor=K.+K.+Bowmanauthor=K.+R.+Clarkauthor=A.+Estevezauthor=Z.+Xieauthor=H.+Verschoofauthor=M.+Grimwoodauthor=C.+Dehnhardtauthor=J.-C.+Andrezauthor=T.+Fockenauthor=D.+P.+Sutherlinauthor=B.+S.+Safinaauthor=M.+A.+Starovasnikauthor=D.+F.+Ortwineauthor=Y.+Frankeauthor=C.+J.+Cohenauthor=D.+H.+Hackosauthor=C.+M.+Kothauthor=J.+Payandeh&title=Structural+basis+of+NaV1.7+inhibition+by+an+isoform-selective+small+molecule+antagonist&doi=10.1126%2Fscience.aac5464"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1126%2Fscience.aac5464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aac5464%26sid%3Dliteratum%253Aachs%26aulast%3DAhuja%26aufirst%3DS.%26aulast%3DMukundl%26aufirst%3DS.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DE.%26aulast%3DHo%26aufirst%3DH.%26aulast%3DShriverl%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DCoons%26aufirst%3DM.%26aulast%3DTam%26aufirst%3DC.%26aulast%3DBrillantes%26aufirst%3DB.%26aulast%3DSampang%26aufirst%3DH.%26aulast%3DMortara%26aufirst%3DK.%26aulast%3DBowman%26aufirst%3DK.%2BK.%26aulast%3DClark%26aufirst%3DK.%2BR.%26aulast%3DEstevez%26aufirst%3DA.%26aulast%3DXie%26aufirst%3DZ.%26aulast%3DVerschoof%26aufirst%3DH.%26aulast%3DGrimwood%26aufirst%3DM.%26aulast%3DDehnhardt%26aufirst%3DC.%26aulast%3DAndrez%26aufirst%3DJ.-C.%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DStarovasnik%26aufirst%3DM.%2BA.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DFranke%26aufirst%3DY.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DKoth%26aufirst%3DC.%2BM.%26aulast%3DPayandeh%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520of%2520NaV1.7%2520inhibition%2520by%2520an%2520isoform-selective%2520small%2520molecule%2520antagonist%26jtitle%3DScience%26date%3D2015%26volume%3D350%26doi%3D10.1126%2Fscience.aac5464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrall, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span> <span> </span><span class="NLM_article-title">Na<sub>V</sub>1.7 inhibitors for the treatment of chronic pain</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3141</span>– <span class="NLM_lpage">3149</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2018.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=30139550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFCrtrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=3141-3149&author=S.+J.+McKerrallauthor=D.+P.+Sutherlin&title=NaV1.7+inhibitors+for+the+treatment+of+chronic+pain&doi=10.1016%2Fj.bmcl.2018.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Nav1.7 inhibitors for the treatment of chronic pain</span></div><div class="casAuthors">McKerrall, Steven J.; Sutherlin, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">3141-3149</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage gated sodium channel Nav1.7 plays an essential role in the transmission of pain signals.  Strong human genetic validation has motivated extensive efforts to discover potent, selective, and efficacious Nav1.7 inhibitors for the treatment of chronic pain.  This digest will introduce the structure and function of Nav1.7 and highlight the wealth of recent developments on a diverse array of Nav1.7 inhibitors, including optimization of their potency, selectivity, and PK/PD relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV0q99YDMCULVg90H21EOLACvtfcHk0lg41H7BlF9U1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFCrtrzO&md5=7242d16b121ee8d18f769e220e5a51ef</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DMcKerrall%26aufirst%3DS.%2BJ.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26atitle%3DNaV1.7%2520inhibitors%2520for%2520the%2520treatment%2520of%2520chronic%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D3141%26epage%3D3149%26doi%3D10.1016%2Fj.bmcl.2018.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="note"><p class="first last">and references cited therein.</p></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mulcahy, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajouhesh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beckley, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delwig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du Bois, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, J. C.</span></span> <span> </span><span class="NLM_article-title">Challenges and opportunities for therapeutics targeting the voltage-gated sodium channel isoform Na<sub>V</sub>1.7</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">8695</span>– <span class="NLM_lpage">8710</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01906</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01906" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvFCiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=8695-8710&author=J.+V.+Mulcahyauthor=H.+Pajouheshauthor=J.+T.+Beckleyauthor=A.+Delwigauthor=J.+Du+Boisauthor=J.+C.+Hunter&title=Challenges+and+opportunities+for+therapeutics+targeting+the+voltage-gated+sodium+channel+isoform+NaV1.7&doi=10.1021%2Facs.jmedchem.8b01906"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform NaV1.7</span></div><div class="casAuthors">Mulcahy, John V.; Pajouhesh, Hassan; Beckley, Jacob T.; Delwig, Anton; Du Bois, J.; Hunter, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8695-8710</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Voltage-gated sodium ion channel subtype 1.7 (NaV1.7) is a high interest target for the discovery of non-opioid analgesics.  Compelling evidence from human genetic data, particularly the finding that persons lacking functional NaV1.7 are insensitive to pain, has spurred considerable effort to develop selective inhibitors of this Na+ ion channel target as analgesic medicines.  Recent clin. setbacks and disappointing performance of preclin. compds. in animal pain models, however, have led to skepticism around the potential of selective NaV1.7 inhibitors as human therapeutics.  In this Perspective, we discuss the attributes and limitations of recently disclosed investigational drugs targeting NaV1.7, and review evidence that, by better understanding the requirements for selectivity and target engagement, the opportunity to deliver effective analgesic medicines targeting NaV1.7 endures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLRid0FL5Uk7Vg90H21EOLACvtfcHk0lg41H7BlF9U1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvFCiurw%253D&md5=414a1a2ba5f68684ae8a6fbba812b1f5</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01906%26sid%3Dliteratum%253Aachs%26aulast%3DMulcahy%26aufirst%3DJ.%2BV.%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DBeckley%26aufirst%3DJ.%2BT.%26aulast%3DDelwig%26aufirst%3DA.%26aulast%3DDu%2BBois%26aufirst%3DJ.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26atitle%3DChallenges%2520and%2520opportunities%2520for%2520therapeutics%2520targeting%2520the%2520voltage-gated%2520sodium%2520channel%2520isoform%2520NaV1.7%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D8695%26epage%3D8710%26doi%3D10.1021%2Facs.jmedchem.8b01906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">and reference cited therein.</p></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzygiel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hay, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luckwell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearce, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phipps, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segelbacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speed, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, K.</span></span> <span> </span><span class="NLM_article-title">Clinical micro-dose studies to explore the human pharmacokinetics of four selective inhibitors of human Na<sub>V</sub>1.7 voltage-dependent sodium channels</span>. <i>Clin. Pharmacokinet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">875</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1007/s40262-015-0365-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1007%2Fs40262-015-0365-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=26895021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=875-887&author=H.+M.+Jonesauthor=R.+P.+Buttauthor=R.+W.+Websterauthor=I.+Gurrellauthor=P.+Dzygielauthor=N.+Flanaganauthor=D.+Fraierauthor=T.+Hayauthor=L.+E.+Iavaroneauthor=J.+Luckwellauthor=H.+Pearceauthor=A.+Phippsauthor=J.+Segelbacherauthor=B.+Speedauthor=K.+Beaumont&title=Clinical+micro-dose+studies+to+explore+the+human+pharmacokinetics+of+four+selective+inhibitors+of+human+NaV1.7+voltage-dependent+sodium+channels&doi=10.1007%2Fs40262-015-0365-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels</span></div><div class="casAuthors">Jones, Hannah M.; Butt, Richard P.; Webster, Rob W.; Gurrell, Ian; Dzygiel, Pawel; Flanagan, Neil; Fraier, Daniela; Hay, Tanya; Iavarone, Laura Else; Luckwell, Jacquelynn; Pearce, Hannah; Phipps, Alex; Segelbacher, Jill; Speed, Bill; Beaumont, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacokinetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">875-887</span>CODEN:
                <span class="NLM_cas:coden">CPKNDH</span>;
        ISSN:<span class="NLM_cas:issn">0312-5963</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Background: The emergence of genetic data linking Nav1.7 sodium channel over- and under- expression to human pain signalling has led to an interest in the treatment of chronic pain through inhibition of Nav1.7 channels.  Objective: We describe the pharmacokinetic (PK) results of a clin. microdose study performed with four potent and selective Nav1.7 inhibitors and the subsequent modeling resulting in the selection of a single compd. to explore Nav1.7 pharmacol. at higher doses.  Methods: A clin. microdose study to investigate the i.v. and oral PK of four compds. (PF-05089771, PF-05150122, PF-05186462 and PF-05241328) was performed in healthy volunteers.  PK parameters were derived via noncompartmental anal.  A physiol.-based PK (PBPK) model was used to predict exposure and multiples of Nav1.7 50 % inhibitory concn. (IC50) for each compd. at higher doses.  Results: Plasma clearance, vol. of distribution and bioavailability ranged from 45 to 392 mL/min/kg, 13 to 36 L/kg and 38 to 110 %, resp.  The PBPK model for PF-05089771 predicted a 1 g oral dose would be required to achieve exposures of approx. 12× Nav1.7 IC50 at max. concn. (Cmax), and approx. 3× IC50 after 12 h (min. concn. [Cmin] for a twice-daily regimen).  Lower multiples of Nav1.7 IC50 were predicted with the same oral doses of PF-05150122, PF-05186462, and PF-05241328.  In a subsequent single ascending oral dose clin. study, the predictions for PF-05089771 compared well with obsd. data.  Conclusion: Based on the human PK data obtained from the microdose study and subsequent modeling, PF-05089771 provided the best opportunity to explore Nav1.7 blockade for the treatment of acute or chronic pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUEQTEvITzd7Vg90H21EOLACvtfcHk0lj5lnPdnh45Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtlKjtb4%253D&md5=bf8dbccbbbbf25f52bf13f28bc995c18</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1007%2Fs40262-015-0365-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40262-015-0365-0%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DWebster%26aufirst%3DR.%2BW.%26aulast%3DGurrell%26aufirst%3DI.%26aulast%3DDzygiel%26aufirst%3DP.%26aulast%3DFlanagan%26aufirst%3DN.%26aulast%3DFraier%26aufirst%3DD.%26aulast%3DHay%26aufirst%3DT.%26aulast%3DIavarone%26aufirst%3DL.%2BE.%26aulast%3DLuckwell%26aufirst%3DJ.%26aulast%3DPearce%26aufirst%3DH.%26aulast%3DPhipps%26aufirst%3DA.%26aulast%3DSegelbacher%26aufirst%3DJ.%26aulast%3DSpeed%26aufirst%3DB.%26aulast%3DBeaumont%26aufirst%3DK.%26atitle%3DClinical%2520micro-dose%2520studies%2520to%2520explore%2520the%2520human%2520pharmacokinetics%2520of%2520four%2520selective%2520inhibitors%2520of%2520human%2520NaV1.7%2520voltage-dependent%2520sodium%2520channels%26jtitle%3DClin.%2520Pharmacokinet.%26date%3D2016%26volume%3D55%26spage%3D875%26epage%3D887%26doi%3D10.1007%2Fs40262-015-0365-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batchelor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudoin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechle, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galan, S. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulier, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greener, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markworth, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransley, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reister, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate 4-[2-(5-amino-1Hpyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-<i>N</i>-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): design and optimization of diary ether aryl sulfonamides as selective inhibitors of Na<sub>V</sub>1.7</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7029</span>– <span class="NLM_lpage">7042</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFagu7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7029-7042&author=N.+A.+Swainauthor=D.+Batchelorauthor=S.+Beaudoinauthor=B.+M.+Bechleauthor=P.+A.+Bradleyauthor=A.+D.+Brownauthor=B.+Brownauthor=K.+J.+Butcherauthor=R.+P.+Buttauthor=M.+L.+Chapmanauthor=S.+Dentonauthor=D.+Ellisauthor=S.+R.+G.+Galanauthor=S.+M.+Gaulierauthor=B.+S.+Greenerauthor=M.+J.+de+Grootauthor=M.+S.+Glossopauthor=I.+K.+Gurrellauthor=J.+Hannamauthor=M.+S.+Johnsonauthor=Z.+Linauthor=C.+J.+Markworthauthor=B.+E.+Marronauthor=D.+S.+Millanauthor=S.+Nakagawaauthor=A.+Pikeauthor=D.+Printzenhoffauthor=D.+J.+Rawsonauthor=S.+J.+Ransleyauthor=S.+M.+Reisterauthor=K.+Sasakiauthor=R.+I.+Storerauthor=P.+A.+Stuppleauthor=C.+W.+West&title=Discovery+of+clinical+candidate+4-%5B2-%285-amino-1Hpyrazol-4-yl%29-4-chlorophenoxy%5D-5-chloro-2-fluoro-N-1%2C3-thiazol-4-ylbenzenesulfonamide+%28PF-05089771%29%3A+design+and+optimization+of+diary+ether+aryl+sulfonamides+as+selective+inhibitors+of+NaV1.7&doi=10.1021%2Facs.jmedchem.7b00598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7</span></div><div class="casAuthors">Swain, Nigel. A.; Batchelor, Dave; Beaudoin, Serge; Bechle, Bruce M.; Bradley, Paul A.; Brown, Alan D.; Brown, Bruce; Butcher, Ken J.; Butt, Richard P.; Chapman, Mark L.; Denton, Stephen; Ellis, David; Galan, Sebastien R. G.; Gaulier, Steven M.; Greener, Ben S.; de Groot, Marcel J.; Glossop, Mel S.; Gurrell, Ian K.; Hannam, Jo; Johnson, Matthew S.; Lin, Zhixin; Markworth, Christopher J.; Marron, Brian E.; Millan, David S.; Nakagawa, Shoko; Pike, Andy; Printzenhoff, David; Rawson, David J.; Ransley, Sarah J.; Reister, Steven M.; Sasaki, Kosuke; Storer, R. Ian; Stupple, Paul A.; West, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7029-7042</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of acidic diaryl ether heterocyclic sulfonamides that are potent and sub-type selective NaV1.7 inhibitors is described.  Optimization of early lead matter focused on removal of structural alerts, improving metabolic stability and reducing cytochrome P 450 inhibition driven drug-drug interaction concerns to deliver the desired balance of preclin. in vitro properties.  Concerns over non-metabolic routes of clearance, variable clearance in pre-clin. species and subsequent low confidence human pharmacokinetic predictions led to the decision to conduct a human microdose study to det. clin. pharmacokinetics.  The design strategies and results from pre-clin. PK and clin. human microdose PK data are described leading to the discovery of the first sub-type selective NaV1.7 inhibitor clin. candidate PF-05089771 (34) which binds to a site in the voltage sensing domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpST6i8wDUALbVg90H21EOLACvtfcHk0lj5lnPdnh45Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFagu7jM&md5=93761c8e8e16cea4db2c9cff6e315e57</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00598%26sid%3Dliteratum%253Aachs%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DBatchelor%26aufirst%3DD.%26aulast%3DBeaudoin%26aufirst%3DS.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DBradley%26aufirst%3DP.%2BA.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DButcher%26aufirst%3DK.%2BJ.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DDenton%26aufirst%3DS.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DGalan%26aufirst%3DS.%2BR.%2BG.%26aulast%3DGaulier%26aufirst%3DS.%2BM.%26aulast%3DGreener%26aufirst%3DB.%2BS.%26aulast%3Dde%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DGlossop%26aufirst%3DM.%2BS.%26aulast%3DGurrell%26aufirst%3DI.%2BK.%26aulast%3DHannam%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DRawson%26aufirst%3DD.%2BJ.%26aulast%3DRansley%26aufirst%3DS.%2BJ.%26aulast%3DReister%26aufirst%3DS.%2BM.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWest%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25204-%255B2-%25285-amino-1Hpyrazol-4-yl%2529-4-chlorophenoxy%255D-5-chloro-2-fluoro-N-1%252C3-thiazol-4-ylbenzenesulfonamide%2520%2528PF-05089771%2529%253A%2520design%2520and%2520optimization%2520of%2520diary%2520ether%2520aryl%2520sulfonamides%2520as%2520selective%2520inhibitors%2520of%2520NaV1.7%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7029%26epage%3D7042%26doi%3D10.1021%2Facs.jmedchem.7b00598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit16c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandrou, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechle, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakemore, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castle, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbett, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fengas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckmans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theile, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torella, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmus, J. S.</span></span> <span> </span><span class="NLM_article-title">Highly potent and selective Na<sub>V</sub>1.7 inhibitors for use as intravenous agents and chemical probes</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">4805</span>– <span class="NLM_lpage">4811</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.09.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2017.09.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=29029933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gmur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4805-4811&author=R.+I.+Storerauthor=A.+Pikeauthor=N.+A.+Swainauthor=A.+J.+Alexandrouauthor=B.+M.+Bechleauthor=D.+C.+Blakemoreauthor=A.+D.+Brownauthor=N.+A.+Castleauthor=M.+S.+Corbettauthor=N.+J.+Flanaganauthor=D.+Fengasauthor=M.+S.+Johnsonauthor=L.+H.+Jonesauthor=B.+E.+Marronauthor=C.+E.+Payneauthor=D.+Printzenhoffauthor=D.+J.+Rawsonauthor=C.+R.+Roseauthor=T.+Ryckmansauthor=J.+Sunauthor=J.+W.+Theileauthor=R.+Torellaauthor=E.+Tsengauthor=J.+S.+Warmus&title=Highly+potent+and+selective+NaV1.7+inhibitors+for+use+as+intravenous+agents+and+chemical+probes&doi=10.1016%2Fj.bmcl.2017.09.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16cR"><div class="casContent"><span class="casTitleNuber">16c</span><div class="casTitle"><span class="NLM_cas:atitle">Highly potent and selective NaV1.7 inhibitors for use as intravenous agents and chemical probes</span></div><div class="casAuthors">Storer, R. Ian; Pike, Andy; Swain, Nigel A.; Alexandrou, Aristos J.; Bechle, Bruce M.; Blakemore, David C.; Brown, Alan D.; Castle, Neil A.; Corbett, Matthew S.; Flanagan, Neil J.; Fengas, David; Johnson, M. Scott; Jones, Lyn H.; Marron, Brian E.; Payne, C. Elizabeth; Printzenhoff, David; Rawson, David J.; Rose, Colin R.; Ryckmans, Thomas; Sun, Jianmin; Theile, Jonathan W.; Torella, Rubben; Tseng, Elaine; Warmus, Joseph S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4805-4811</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and selection of a highly potent and selective NaV1.7 inhibitor PF-06456384, designed specifically for i.v. infusion, is disclosed.  Extensive in vitro pharmacol. and ADME profiling followed by in vivo preclin. PK and efficacy model data are discussed.  A proposed protein-ligand binding mode for this compd. is also provided to rationalize the high levels of potency and selectivity over inhibition of related sodium channels.  To further support the proposed binding mode, potent conjugates are described which illustrate the potential for development of chem. probes to enable further target evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA-67HTehcGLVg90H21EOLACvtfcHk0lh6e3ywlKrw3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gmur3L&md5=5be8e615ad061aa7cf06056de8b8682c</span></div><a href="/servlet/linkout?suffix=cit16c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.09.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.09.056%26sid%3Dliteratum%253Aachs%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DAlexandrou%26aufirst%3DA.%2BJ.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DBlakemore%26aufirst%3DD.%2BC.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DCastle%26aufirst%3DN.%2BA.%26aulast%3DCorbett%26aufirst%3DM.%2BS.%26aulast%3DFlanagan%26aufirst%3DN.%2BJ.%26aulast%3DFengas%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DJones%26aufirst%3DL.%2BH.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DPayne%26aufirst%3DC.%2BE.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DRawson%26aufirst%3DD.%2BJ.%26aulast%3DRose%26aufirst%3DC.%2BR.%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DTheile%26aufirst%3DJ.%2BW.%26aulast%3DTorella%26aufirst%3DR.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DWarmus%26aufirst%3DJ.%2BS.%26atitle%3DHighly%2520potent%2520and%2520selective%2520NaV1.7%2520inhibitors%2520for%2520use%2520as%2520intravenous%2520agents%2520and%2520chemical%2520probes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D4805%26epage%3D4811%26doi%3D10.1016%2Fj.bmcl.2017.09.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit16d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">McDonnell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surujbally, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span> <span> </span><span class="NLM_article-title">Efficacy of the Na<sub>V</sub>1.7 blocker PF-05089771 in a randomized, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">1465</span>– <span class="NLM_lpage">1476</span>, <span class="refDoi"> DOI: 10.1097/j.pain.0000000000001227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1097%2Fj.pain.0000000000001227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=29578944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlelu7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2018&pages=1465-1476&author=A.+McDonnellauthor=S.+Collinsauthor=Z.+Aliauthor=L.+Iavaroneauthor=R.+Surujballyauthor=S.+Kirbyauthor=R.+P.+Butt&title=Efficacy+of+the+NaV1.7+blocker+PF-05089771+in+a+randomized%2C+placebo-controlled%2C+double-blind+clinical+study+in+subjects+with+painful+diabetic+peripheral+neuropathy&doi=10.1097%2Fj.pain.0000000000001227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16dR"><div class="casContent"><span class="casTitleNuber">16d</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy</span></div><div class="casAuthors">McDonnell, Aoibhinn; Collins, Susie; Ali, Zahid; Iavarone, Laura; Surujbally, Raulin; Kirby, Simon; Butt, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1465-1476</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The effect of PF-05089771, a selective, peripherally restricted Nav1.7 sodium channel blocker on pain due to diabetic peripheral neuropathy was investigated in a randomised, placebo and active-controlled parallel group clin. trial (NCT02215252).  A 1-wk placebo-run in the period was followed by a 4-wk treatment period and a 1-wk placebo run-out/taper-down period.  Single-blind placebo was administered throughout run-in and run-out periods.  Subjects were randomised to receive either PF-05089771 150 mg twice daily, pregabalin 150 mg twice daily, or placebo during the 4-wk treatment period.  One hundred thirty-five subjects were randomised.  The primary endpoint was the av. pain score derived from subjects' Numerical Rating Scale scores over the past 7 days of week 4 of the double-blind treatment period.  Predefined efficacy criteria for the trial were the effect of PF-05089771 being >0.5 units better than placebo at interim anal. after completion of the first part of the study.  Although a trend for a redn. in the weekly av. pain score in the PF-05089771 treatment group was obsd., this was not statistically significant when compared with placebo at week 4, with a mean posterior difference of -0.41 (90% credible interval: -1.00 to 0.17).  The effect of PF-05089771 was smaller than that seen with pregabalin, which was statistically significant when compared with placebo at week 4, with a mean posterior difference of -0.53 (90% credible interval: -0.91 to -0.20).  As predefined efficacy criteria were not met, the study did not proceed to the second part.  PF-05089771 was well tolerated.  Possible reasons for the modest efficacy obsd. with PF-05089771 are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKiEsCT64-q7Vg90H21EOLACvtfcHk0lh6e3ywlKrw3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlelu7fM&md5=61d83a34d992b85b828cea56f0a4f7b9</span></div><a href="/servlet/linkout?suffix=cit16d&amp;dbid=16384&amp;doi=10.1097%2Fj.pain.0000000000001227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252Fj.pain.0000000000001227%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonnell%26aufirst%3DA.%26aulast%3DCollins%26aufirst%3DS.%26aulast%3DAli%26aufirst%3DZ.%26aulast%3DIavarone%26aufirst%3DL.%26aulast%3DSurujbally%26aufirst%3DR.%26aulast%3DKirby%26aufirst%3DS.%26aulast%3DButt%26aufirst%3DR.%2BP.%26atitle%3DEfficacy%2520of%2520the%2520NaV1.7%2520blocker%2520PF-05089771%2520in%2520a%2520randomized%252C%2520placebo-controlled%252C%2520double-blind%2520clinical%2520study%2520in%2520subjects%2520with%2520painful%2520diabetic%2520peripheral%2520neuropathy%26jtitle%3DPain%26date%3D2018%26volume%3D159%26spage%3D1465%26epage%3D1476%26doi%3D10.1097%2Fj.pain.0000000000001227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojic, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortuno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkel, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Application of a parallel synthetic strategy in the discovery of biaryl acyl sulfonamides as efficient and selective Na<sub>V</sub>1.7 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7818</span>– <span class="NLM_lpage">7839</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00425</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00425" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1SktLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7818-7839&author=E.+F.+DiMauroauthor=S.+Altmannauthor=L.+M.+Berryauthor=H.+Bregmanauthor=N.+Chakkaauthor=M.+Chu-Moyerauthor=E.+F.+Bojicauthor=R.+S.+Fotiauthor=R.+Fremeauauthor=H.+Gaoauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=B.+E.+Hallauthor=H.+Huangauthor=M.+Jaroshauthor=T.+Kornecookauthor=J.+Leeauthor=J.+Liguttiauthor=D.+Liuauthor=B.+D.+Moyerauthor=D.+Ortunoauthor=P.+E.+Roseauthor=L.+B.+Schenkelauthor=K.+Tabornauthor=J.+Wangauthor=Y.+Wangauthor=V.+Yuauthor=M.+M.+Weiss&title=Application+of+a+parallel+synthetic+strategy+in+the+discovery+of+biaryl+acyl+sulfonamides+as+efficient+and+selective+NaV1.7+inhibitors&doi=10.1021%2Facs.jmedchem.6b00425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors</span></div><div class="casAuthors">DiMauro, Erin F.; Altmann, Stephen; Berry, Loren M.; Bregman, Howard; Chakka, Nagasree; Chu-Moyer, Margaret; Bojic, Elma Feric; Foti, Robert S.; Fremeau, Robert; Gao, Hua; Gunaydin, Hakan; Guzman-Perez, Angel; Hall, Brian E.; Huang, Hongbing; Jarosh, Michael; Kornecook, Thomas; Lee, Josie; Ligutti, Joseph; Liu, Dong; Moyer, Bryan D.; Ortuno, Daniel; Rose, Paul E.; Schenkel, Laurie B.; Taborn, Kristin; Wang, Jean; Wang, Yan; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7818-7839</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of potent and selective hNaV1.7 inhibitors possess common pharmacophoric features that include a heteroaryl sulfonamide headgroup and a lipophilic arom. tail group.  Recently, reports of similar arom. tail groups in combination with an acyl sulfonamide headgroup have emerged, with the acyl sulfonamide bestowing levels of selectivity over hNaV1.5 comparable to the heteroaryl sulfonamide.  Beginning with com. available carboxylic acids that met selected pharmacophoric requirements in the lipophilic tail, a parallel synthetic approach was applied to rapidly generate the derived acyl sulfonamides.  A biaryl acyl sulfonamide hit from this library was elaborated, optimizing for potency and selectivity with attention to physicochem. properties.  The resulting novel leads are potent, ligand and lipophilic efficient, and selective over hNaV1.5.  Representative lead I demonstrates selectivity over other human NaV isoforms and good pharmacokinetics in rodents.  The biaryl acyl sulfonamides reported herein may also offer ADME advantages over known heteroaryl sulfonamide inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxffPzH1T1T7Vg90H21EOLACvtfcHk0lh6e3ywlKrw3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1SktLjK&md5=8afa7437928f0d43a1327662674978ed</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00425%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DBojic%26aufirst%3DE.%2BF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DHall%26aufirst%3DB.%2BE.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DOrtuno%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DSchenkel%26aufirst%3DL.%2BB.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DApplication%2520of%2520a%2520parallel%2520synthetic%2520strategy%2520in%2520the%2520discovery%2520of%2520biaryl%2520acyl%2520sulfonamides%2520as%2520efficient%2520and%2520selective%2520NaV1.7%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7818%26epage%3D7839%26doi%3D10.1021%2Facs.jmedchem.6b00425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: optimizing potency and pharmacokinetics to enable in vivo target engagement</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1062</span>– <span class="NLM_lpage">1067</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00243</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00243" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFCmsr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1062-1067&author=I.+E.+Marxauthor=T.+A.+Dineenauthor=J.+Ableauthor=C.+Bodeauthor=H.+Bregmanauthor=M.+Chu-Moyerauthor=E.+F.+DiMauroauthor=B.+Duauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=H.+Gaoauthor=H.+Gunaydinauthor=B.+E.+Hallauthor=L.+Huangauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=M.+J.+Linauthor=D.+Liuauthor=J.+S.+McDermottauthor=B.+D.+Moyerauthor=E.+A.+Petersonauthor=J.+T.+Robertsauthor=P.+Roseauthor=J.+Wangauthor=B.+D.+Youngbloodauthor=V.+Yuauthor=M.+M.+Weiss&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+optimizing+potency+and+pharmacokinetics+to+enable+in+vivo+target+engagement&doi=10.1021%2Facsmedchemlett.6b00243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement</span></div><div class="casAuthors">Marx, Isaac E.; Dineen, Thomas A.; Able, Jessica; Bode, Christiane; Bregman, Howard; Chu-Moyer, Margaret; DiMauro, Erin F.; Du, Bingfan; Foti, Robert S.; Fremeau, Robert T.; Gao, Hua; Gunaydin, Hakan; Hall, Brian E.; Huang, Liyue; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Lin, Min-Hwa Jasmine; Liu, Dong; McDermott, Jeff S.; Moyer, Bryan D.; Peterson, Emily A.; Roberts, Jonathan T.; Rose, Paul; Wang, Jean; Youngblood, Beth D.; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1062-1067</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human genetic evidence has identified the voltage-gated sodium channel NaV1.7 as an attractive target for the treatment of pain.  The authors initially identified naphthalene sulfonamide 5-(2-(1-methyl-1H-pyrazol-5-yl)-4-(trifluoromethyl)phenyl)-N-(1,2,4-thiadiazol-5-yl)naphthalene-2-sulfonamide (compd. 3) as a potent and selective inhibitor of NaV1.7.  Optimization to reduce biliary clearance by balancing hydrophilicity and hydrophobicity (Log D) while maintaining NaV1.7 potency led to the identification of quinazoline 16 (AM-2099).  Compd. 16 demonstrated a favorable pharmacokinetic profile in rat and dog and demonstrated dose-dependent redn. of histamine-induced scratching bouts in a mouse behavioral model following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosNi8X2t0EULVg90H21EOLACvtfcHk0lhH3xBgflnCcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFCmsr%252FE&md5=43c2ae357af90d6c6f56245c3114c016</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00243%26sid%3Dliteratum%253Aachs%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDu%26aufirst%3DB.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHall%26aufirst%3DB.%2BE.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRoberts%26aufirst%3DJ.%2BT.%26aulast%3DRose%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYoungblood%26aufirst%3DB.%2BD.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520optimizing%2520potency%2520and%2520pharmacokinetics%2520to%2520enable%2520in%2520vivo%2520target%2520engagement%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D1062%26epage%3D1067%26doi%3D10.1021%2Facsmedchemlett.6b00243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojic, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youngblood, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: optimizing potency and pharmacokinetics while mitigating metabolic liabilities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5969</span>– <span class="NLM_lpage">5989</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01851</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01851" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFOmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5969-5989&author=M.+M.+Weissauthor=T.+A.+Dineenauthor=I.+E.+Marxauthor=S.+Altmannauthor=A.+A.+Boezioauthor=H.+Bregmanauthor=M.+Chu-Moyerauthor=E.+F.+DiMauroauthor=E.+F.+Bojicauthor=R.+S.+Fotiauthor=H.+Gaoauthor=R.+F.+Graceffaauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=H.+Huangauthor=L.+Huangauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=J.+Liguttiauthor=D.+S.+Laauthor=M.+J.+Linauthor=D.+Liuauthor=B.+D.+Moyerauthor=H.+N.+Nguyenauthor=E.+A.+Petersonauthor=P.+E.+Roseauthor=K.+Tabornauthor=B.+D.+Youngbloodauthor=V.+Yuauthor=R.+T.+Fremeau&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+optimizing+potency+and+pharmacokinetics+while+mitigating+metabolic+liabilities&doi=10.1021%2Facs.jmedchem.6b01851"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17cR"><div class="casContent"><span class="casTitleNuber">17c</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities</span></div><div class="casAuthors">Weiss, Matthew M.; Dineen, Thomas A.; Marx, Isaac E.; Altmann, Steven; Boezio, Alessandro; Bregman, Howard; Chu-Moyer, Margaret; DiMauro, Erin F.; Feric Bojic, Elma; Foti, Robert S.; Gao, Hua; Graceffa, Russell; Gunaydin, Hakan; Guzman-Perez, Angel; Huang, Hongbing; Huang, Liyue; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; Ligutti, Joseph; La, Daniel S.; Lin, Min-Hwa Jasmine; Liu, Dong; Moyer, Bryan D.; Nguyen, Hanh N.; Peterson, Emily A.; Rose, Paul E.; Taborn, Kristin; Youngblood, Beth D.; Yu, Violeta; Fremeau, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5969-5989</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several reports have recently emerged regarding the identification of heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  The optimization of a series of internal NaV1.7 leads that address a no. of metabolic liabilities including bioactivation, PXR activation, as well as CYP3A4 induction and inhibition led to the identification of potent and selective inhibitors that demonstrated favorable pharmacokinetic profiles and were devoid of the aforementioned liabilities.  The key to achieving this within a series prone to transporter-mediated clearance was the identification of a small range of optimal cLogD values and the discovery of subtle PXR SAR that was not lipophilicity dependent.  This enabled the identification of compd. 20, which was advanced into a target engagement pharmacodynamic model where it exhibited robust reversal of histamine-induced scratching bouts in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovsPC2UZpxsbVg90H21EOLACvtfcHk0lhH3xBgflnCcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFOmtbw%253D&md5=6333a6b936e48f9d18cf9df10ea12853</span></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01851%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DBojic%26aufirst%3DE.%2BF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DYoungblood%26aufirst%3DB.%2BD.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520optimizing%2520potency%2520and%2520pharmacokinetics%2520while%2520mitigating%2520metabolic%2520liabilities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5969%26epage%3D5989%26doi%3D10.1021%2Facs.jmedchem.6b01851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit17d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojic, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foti, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R. T.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarosh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milgram, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rescourio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenkel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparling, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stellwagen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaida, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">Sulfonamides as selective Na<sub>V</sub>1.7 inhibitors: optimizing potency, pharmacokinetics, and metabolic properties to obtain atropisomeric quinolinone (AM-0466) that affords robust in vivo activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5990</span>– <span class="NLM_lpage">6017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5990-6017&author=R.+F.+Graceffaauthor=A.+A.+Boezioauthor=J.+Ableauthor=S.+Altmannauthor=L.+M.+Berryauthor=C.+Boezioauthor=J.+R.+Butlerauthor=M.+Chu-Moyerauthor=M.+Cookeauthor=E.+F.+DiMauroauthor=T.+A.+Dineenauthor=E.+F.+Bojicauthor=R.+S.+Fotiauthor=R.+T.+Fremeauauthor=A.+Guzman-Perezauthor=H.+Gaoauthor=H.+Gunaydinauthor=H.+Huangauthor=L.+Huangauthor=C.+Ilchauthor=M.+Jaroshauthor=T.+Kornecookauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=J.+Liguttiauthor=B.+C.+Milgramauthor=M.+J.+Linauthor=I.+E.+Marxauthor=H.+N.+Nguyenauthor=E.+A.+Petersonauthor=G.+Rescourioauthor=J.+Robertsauthor=L.+Schenkelauthor=R.+Shimanovichauthor=B.+A.+Sparlingauthor=J.+Stellwagenauthor=K.+Tabornauthor=K.+R.+Vaidaauthor=J.+Wangauthor=J.+Yeomanauthor=V.+Yuauthor=D.+Zhuauthor=B.+D.+Moyerauthor=M.+M.+Weiss&title=Sulfonamides+as+selective+NaV1.7+inhibitors%3A+optimizing+potency%2C+pharmacokinetics%2C+and+metabolic+properties+to+obtain+atropisomeric+quinolinone+%28AM-0466%29+that+affords+robust+in+vivo+activity&doi=10.1021%2Facs.jmedchem.6b01850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17dR"><div class="casContent"><span class="casTitleNuber">17d</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity</span></div><div class="casAuthors">Graceffa, Russell F.; Boezio, Alessandro A.; Able, Jessica; Altmann, Steven; Berry, Loren M.; Boezio, Christiane; Butler, John R.; Chu-Moyer, Margaret; Cooke, Melanie; DiMauro, Erin F.; Dineen, Thomas A.; Feric Bojic, Elma; Foti, Robert S.; Fremeau, Robert T.; Guzman-Perez, Angel; Gao, Hua; Gunaydin, Hakan; Huang, Hongbing; Huang, Liyue; Ilch, Christopher; Jarosh, Michael; Kornecook, Thomas; Kreiman, Charles R.; La, Daniel S.; Ligutti, Joseph; Milgram, Benjamin C.; Lin, Min-Hwa Jasmine; Marx, Isaac E.; Nguyen, Hanh N.; Peterson, Emily A.; Rescourio, Gwen; Roberts, John; Schenkel, Laurie; Shimanovich, Roman; Sparling, Brian A.; Stellwagen, John; Taborn, Kristin; Vaida, Karina R.; Wang, Jean; Yeoman, John; Yu, Violeta; Zhu, Dawn; Moyer, Bryan D.; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5990-6017</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Because of its strong genetic validation, NaV1.7 has attracted significant interest as a target for the treatment of pain.  We have previously reported on a no. of structurally distinct bicyclic heteroarylsulfonamides as NaV1.7 inhibitors that demonstrate high levels of selectivity over other NaV isoforms.  Herein, we report the discovery and optimization of a series of atropisomeric quinolinone sulfonamide inhibitors [Bicyclic sulfonamide compds. as sodium channel inhibitors and their prepn. WO 2014201206, 2014] of NaV1.7, which demonstrate nanomolar inhibition of NaV1.7 and exhibit high levels of selectivity over other sodium channel isoforms.  After optimization of metabolic and pharmacokinetic properties, including PXR activation, CYP2C9 inhibition, and CYP3A4 TDI, several compds. were advanced into in vivo target engagement and efficacy models.  When tested in mice, compd. 39 (AM-0466) demonstrated robust pharmacodynamic activity in a NaV1.7-dependent model of histamine-induced pruritus (itch) and addnl. in a capsaicin-induced nociception model of pain without any confounding effect in open-field activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ofeMhgMFqbVg90H21EOLACvtfcHk0lidFrmhQrPLmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslKltr4%253D&md5=5b48afe24a97290ea5e44a71deaa0303</span></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01850%26sid%3Dliteratum%253Aachs%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DAltmann%26aufirst%3DS.%26aulast%3DBerry%26aufirst%3DL.%2BM.%26aulast%3DBoezio%26aufirst%3DC.%26aulast%3DButler%26aufirst%3DJ.%2BR.%26aulast%3DChu-Moyer%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DM.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DBojic%26aufirst%3DE.%2BF.%26aulast%3DFoti%26aufirst%3DR.%2BS.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DIlch%26aufirst%3DC.%26aulast%3DJarosh%26aufirst%3DM.%26aulast%3DKornecook%26aufirst%3DT.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DMilgram%26aufirst%3DB.%2BC.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DMarx%26aufirst%3DI.%2BE.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DRescourio%26aufirst%3DG.%26aulast%3DRoberts%26aufirst%3DJ.%26aulast%3DSchenkel%26aufirst%3DL.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DSparling%26aufirst%3DB.%2BA.%26aulast%3DStellwagen%26aufirst%3DJ.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DVaida%26aufirst%3DK.%2BR.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYeoman%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DSulfonamides%2520as%2520selective%2520NaV1.7%2520inhibitors%253A%2520optimizing%2520potency%252C%2520pharmacokinetics%252C%2520and%2520metabolic%2520properties%2520to%2520obtain%2520atropisomeric%2520quinolinone%2520%2528AM-0466%2529%2520that%2520affords%2520robust%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5990%26epage%3D6017%26doi%3D10.1021%2Facs.jmedchem.6b01850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit17e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">La, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu-Moyer, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coats, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dineen, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graceffa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeau, R.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornecook, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreiman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ligutti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDermott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taborn, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. M.</span></span> <span> </span><span class="NLM_article-title">The discovery of benzoxazine sulfonamide inhibitors of Na<sub>V</sub>1.7: tools that bridge efficacy and target engagement</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">3477</span>– <span class="NLM_lpage">3485</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.05.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2017.05.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=28629594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVeqsb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=3477-3485&author=D.+S.+Laauthor=E.+A.+Petersonauthor=C.+Bodeauthor=A.+A.+Boezioauthor=H.+Bregmanauthor=M.+Y.+Chu-Moyerauthor=J.+Coatsauthor=E.+F.+DiMauroauthor=T.+A.+Dineenauthor=B.+Duauthor=H.+Gaoauthor=R.+Graceffaauthor=H.+Gunaydinauthor=A.+Guzman-Perezauthor=R.+Fremeauauthor=X.+Huangauthor=C.+Ilchauthor=T.+J.+Kornecookauthor=C.+Kreimanauthor=J.+Liguttiauthor=M.+J.+Linauthor=J.+S.+McDermottauthor=I.+Marxauthor=D.+J.+Matsonauthor=S.+I.+McDonoughauthor=B.+D.+Moyerauthor=H.+N.+Nguyenauthor=K.+Tabornauthor=V.+Yuauthor=M.+M.+Weiss&title=The+discovery+of+benzoxazine+sulfonamide+inhibitors+of+NaV1.7%3A+tools+that+bridge+efficacy+and+target+engagement&doi=10.1016%2Fj.bmcl.2017.05.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17eR"><div class="casContent"><span class="casTitleNuber">17e</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of benzoxazine sulfonamide inhibitors of NaV1.7: Tools that bridge efficacy and target engagement</span></div><div class="casAuthors">La, Daniel S.; Peterson, Emily A.; Bode, Christiane; Boezio, Alessandro A.; Bregman, Howard; Chu-Moyer, Margaret Y.; Coats, James; Di Mauro, Erin F.; Dineen, Thomas A.; Du, Bingfan; Gao, Hua; Graceffa, Russell; Gunaydin, Hakan; Guzman-Perez, Angel; Fremeau, Robert, Jr.; Huang, Xin; Ilch, Christopher; Kornecook, Thomas J.; Kreiman, Charles; Ligutti, Joseph; Jasmine Lin, Min-Hwa; McDermott, Jeff S.; Marx, Isaac; Matson, David J.; McDonough, Stefan I.; Moyer, Bryan D.; Nho Nguyen, Hanh; Taborn, Kristin; Yu, Violeta; Weiss, Matthew M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3477-3485</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage-gated sodium channel NaV1.7 has received much attention from the scientific community due to compelling human genetic data linking gain- and loss-of-function mutations to pain phenotypes.  Despite this genetic validation of NaV1.7 as a target for pain, high quality pharmacol. tools facilitate further understanding of target biol., establishment of target coverage requirements and subsequent progression into the clinic.  Within the sulfonamide class of inhibitors, reduced potency on rat NaV1.7 vs. human NaV1.7 was obsd., rendering in vivo rat pharmacol. studies challenging.  Herein, the authors report the discovery and optimization of novel benzoxazine sulfonamide inhibitors of human, rat and mouse NaV1.7 which enabled pharmacol. assessment in traditional behavioral rodent models of pain and in turn, established a connection between formalin-induced pain and histamine-induced pruritus in mice.  The latter represents a simple and efficient means of measuring target engagement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrephmJ2EoOv7Vg90H21EOLACvtfcHk0ljJtxUZI7d1Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVeqsb7K&md5=680ffa374194c12fd3705a7003bd572e</span></div><a href="/servlet/linkout?suffix=cit17e&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.05.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.05.070%26sid%3Dliteratum%253Aachs%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChu-Moyer%26aufirst%3DM.%2BY.%26aulast%3DCoats%26aufirst%3DJ.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DDu%26aufirst%3DB.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DFremeau%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DIlch%26aufirst%3DC.%26aulast%3DKornecook%26aufirst%3DT.%2BJ.%26aulast%3DKreiman%26aufirst%3DC.%26aulast%3DLigutti%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DM.%2BJ.%26aulast%3DMcDermott%26aufirst%3DJ.%2BS.%26aulast%3DMarx%26aufirst%3DI.%26aulast%3DMatson%26aufirst%3DD.%2BJ.%26aulast%3DMcDonough%26aufirst%3DS.%2BI.%26aulast%3DMoyer%26aufirst%3DB.%2BD.%26aulast%3DNguyen%26aufirst%3DH.%2BN.%26aulast%3DTaborn%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26atitle%3DThe%2520discovery%2520of%2520benzoxazine%2520sulfonamide%2520inhibitors%2520of%2520NaV1.7%253A%2520tools%2520that%2520bridge%2520efficacy%2520and%2520target%2520engagement%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D3477%26epage%3D3485%26doi%3D10.1016%2Fj.bmcl.2017.05.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Roecker, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egbertson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K. L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koser, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majercak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarelli, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of selective, orally bioavailable, N-linked arylsulfonamide Na<sub>V</sub>1.7 inhibitors with pain efficacy in mice</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2087</span>– <span class="NLM_lpage">2093</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2017.03.085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=28389149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslOgur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2087-2093&author=A.+J.+Roeckerauthor=M.+Egbertsonauthor=K.+L.+G.+Jonesauthor=R.+Gomezauthor=R.+L.+Krausauthor=Y.+Liauthor=A.+J.+Koserauthor=M.+O.+Urbanauthor=R.+Kleinauthor=M.+Clementsauthor=J.+Panigelauthor=C.+Daleyauthor=J.+Wangauthor=E.+N.+Fingerauthor=J.+Majercakauthor=V.+Santarelliauthor=I.+Greganauthor=M.+Catoauthor=T.+Filzenauthor=A.+Jovanovskaauthor=Y.+Wangauthor=D.+Wangauthor=L.+A.+Joyceauthor=E.+C.+Shererauthor=X.+Pengauthor=X.+Wangauthor=H.+Sunauthor=P.+J.+Colemanauthor=A.+K.+Houghtonauthor=M.+E.+Layton&title=Discovery+of+selective%2C+orally+bioavailable%2C+N-linked+arylsulfonamide+NaV1.7+inhibitors+with+pain+efficacy+in+mice&doi=10.1016%2Fj.bmcl.2017.03.085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nav1.7 inhibitors with pain efficacy in mice</span></div><div class="casAuthors">Roecker, Anthony J.; Egbertson, Melissa; Jones, Kristen L. G.; Gomez, Robert; Kraus, Richard L.; Li, Yuxing; Koser, Amy Jo; Urban, Mark O.; Klein, Rebecca; Clements, Michelle; Panigel, Jacqueline; Daley, Christopher; Wang, Jixin; Finger, Eleftheria N.; Majercak, John; Santarelli, Vincent; Gregan, Irene; Cato, Matthew; Filzen, Tracey; Jovanovska, Aneta; Wang, Ying-Hong; Wang, Deping; Joyce, Leo A.; Sherer, Edward C.; Peng, Xuanjia; Wang, Xiu; Sun, Haiyan; Coleman, Paul J.; Houghton, Andrea K.; Layton, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2087-2093</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage-gated sodium channel Nav1.7 is a genetically validated target for the treatment of pain with gain-of-function mutations in man eliciting a variety of painful disorders and loss-of-function mutations affording insensitivity to pain.  Unfortunately, drugs thought to garner efficacy via Nav1 inhibition have undesirable side effect profiles due to their lack of selectivity over channel isoforms.  Herein we report the discovery of a novel series of orally bioavailable arylsulfonamide Nav1.7 inhibitors with high levels of selectivity over Nav1.5, the Nav isoform responsible for cardiovascular side effects, through judicious use of parallel medicinal chem. and physicochem. property optimization.  This effort produced inhibitors such as compd. 5 with excellent potency, selectivity, behavioral efficacy in a rodent pain model, and efficacy in a mouse itch model suggestive of target modulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNDA0s8NB86LVg90H21EOLACvtfcHk0ljJtxUZI7d1Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslOgur0%253D&md5=5729efef8e3df4afe3f89c25472c9268</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.085%26sid%3Dliteratum%253Aachs%26aulast%3DRoecker%26aufirst%3DA.%2BJ.%26aulast%3DEgbertson%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DK.%2BL.%2BG.%26aulast%3DGomez%26aufirst%3DR.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKoser%26aufirst%3DA.%2BJ.%26aulast%3DUrban%26aufirst%3DM.%2BO.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DClements%26aufirst%3DM.%26aulast%3DPanigel%26aufirst%3DJ.%26aulast%3DDaley%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DMajercak%26aufirst%3DJ.%26aulast%3DSantarelli%26aufirst%3DV.%26aulast%3DGregan%26aufirst%3DI.%26aulast%3DCato%26aufirst%3DM.%26aulast%3DFilzen%26aufirst%3DT.%26aulast%3DJovanovska%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DJoyce%26aufirst%3DL.%2BA.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DHoughton%26aufirst%3DA.%2BK.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26atitle%3DDiscovery%2520of%2520selective%252C%2520orally%2520bioavailable%252C%2520N-linked%2520arylsulfonamide%2520NaV1.7%2520inhibitors%2520with%2520pain%2520efficacy%2520in%2520mice%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2087%26epage%3D2093%26doi%3D10.1016%2Fj.bmcl.2017.03.085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pero, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehman, H. D. G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulhearn, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolkenberg, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cato, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daley, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filzen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henze, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovanovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majercak, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layton, M. E.</span></span> <span> </span><span class="NLM_article-title">Benzoxazolinone aryl sulfonamides as potent, selective Na<sub>V</sub>1.7 inhibitors with in vivo efficacy in a preclinical pain model</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2683</span>– <span class="NLM_lpage">2688</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.04.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2017.04.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=28465103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvFSmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2683-2688&author=J.+E.+Peroauthor=M.+A.+Rossiauthor=H.+D.+G.+F.+Lehmanauthor=M.+J.+Kellyauthor=J.+J.+Mulhearnauthor=S.+E.+Wolkenbergauthor=M.+J.+Catoauthor=M.+K.+Clementsauthor=C.+J.+Daleyauthor=T.+Filzenauthor=E.+N.+Fingerauthor=Y.+Greganauthor=D.+A.+Henzeauthor=A.+Jovanovskaauthor=R.+Kleinauthor=R.+L.+Krausauthor=Y.+Liauthor=A.+Liangauthor=J.+M.+Majercakauthor=J.+Panigelauthor=M.+O.+Urbanauthor=J.+Wangauthor=Y.+Wangauthor=A.+K.+Houghtonauthor=M.+E.+Layton&title=Benzoxazolinone+aryl+sulfonamides+as+potent%2C+selective+NaV1.7+inhibitors+with+in+vivo+efficacy+in+a+preclinical+pain+model&doi=10.1016%2Fj.bmcl.2017.04.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model</span></div><div class="casAuthors">Pero, Joseph E.; Rossi, Michael A.; Lehman, Hannah D. G. F.; Kelly, Michael J., III; Mulhearn, James J.; Wolkenberg, Scott E.; Cato, Matthew J.; Clements, Michelle K.; Daley, Christopher J.; Filzen, Tracey; Finger, Eleftheria N.; Gregan, Yun; Henze, Darrell A.; Jovanovska, Aneta; Klein, Rebecca; Kraus, Richard L.; Li, Yuxing; Liang, Annie; Majercak, John M.; Panigel, Jacqueline; Urban, Mark O.; Wang, Jixin; Wang, Ying-Hong; Houghton, Andrea K.; Layton, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2683-2688</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Studies on human genetics have suggested that inhibitors of the Nav1.7 voltage-gated sodium channel hold considerable promise as therapies for the treatment of chronic pain syndromes.  Herein, we report novel, peripherally-restricted benzoxazolinone aryl sulfonamides as potent Nav1.7 inhibitors with excellent selectivity against the Nav1.5 isoform, which is expressed in the heart muscle.  Elaboration of initial lead compd. 3d afforded exemplar 13, which featured attractive physicochem. properties, outstanding lipophilic ligand efficiency and pharmacol. selectivity against Nav1.5 exceeding 1000-fold.  Key structure-activity relationships assocd. with oral bioavailability were leveraged to discover compd. 17, which exhibited a comparable potency/selectivity profile as well as full efficacy following oral administration in a preclin. model indicative of antinociceptive behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGCg6OCYoM57Vg90H21EOLACvtfcHk0liMsZf1xQxOOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvFSmt70%253D&md5=9ea2c021a2c76ffe0bb8c623d1eb7427</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.04.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.04.040%26sid%3Dliteratum%253Aachs%26aulast%3DPero%26aufirst%3DJ.%2BE.%26aulast%3DRossi%26aufirst%3DM.%2BA.%26aulast%3DLehman%26aufirst%3DH.%2BD.%2BG.%2BF.%26aulast%3DKelly%26aufirst%3DM.%2BJ.%26aulast%3DMulhearn%26aufirst%3DJ.%2BJ.%26aulast%3DWolkenberg%26aufirst%3DS.%2BE.%26aulast%3DCato%26aufirst%3DM.%2BJ.%26aulast%3DClements%26aufirst%3DM.%2BK.%26aulast%3DDaley%26aufirst%3DC.%2BJ.%26aulast%3DFilzen%26aufirst%3DT.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DGregan%26aufirst%3DY.%26aulast%3DHenze%26aufirst%3DD.%2BA.%26aulast%3DJovanovska%26aufirst%3DA.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DKraus%26aufirst%3DR.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DA.%26aulast%3DMajercak%26aufirst%3DJ.%2BM.%26aulast%3DPanigel%26aufirst%3DJ.%26aulast%3DUrban%26aufirst%3DM.%2BO.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHoughton%26aufirst%3DA.%2BK.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26atitle%3DBenzoxazolinone%2520aryl%2520sulfonamides%2520as%2520potent%252C%2520selective%2520NaV1.7%2520inhibitors%2520with%2520in%2520vivo%2520efficacy%2520in%2520a%2520preclinical%2520pain%2520model%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2683%26epage%3D2688%26doi%3D10.1016%2Fj.bmcl.2017.04.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zenova, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chafeev, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span> <span> </span><span class="NLM_article-title">The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na<sub>V</sub>1.7</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4397</span>– <span class="NLM_lpage">4401</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.08.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2014.08.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=25176194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWqsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4397-4401&author=S.+Sunauthor=Q.+Jiaauthor=A.+Y.+Zenovaauthor=M.+Chafeevauthor=Z.+Zhangauthor=S.+Linauthor=R.+Kwanauthor=M.+E.+Grimwoodauthor=S.+Chowdhuryauthor=C.+Youngauthor=C.+J.+Cohenauthor=R.+M.+Oballa&title=The+discovery+of+benzenesulfonamide-based+potent+and+selective+inhibitors+of+voltage-gated+sodium+channel+NaV1.7&doi=10.1016%2Fj.bmcl.2014.08.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Nav1.7</span></div><div class="casAuthors">Sun, Shaoyi; Jia, Qi; Zenova, Alla Y.; Chafeev, Mikhail; Zhang, Zaihui; Lin, Sophia; Kwan, Rainbow; Grimwood, Mike E.; Chowdhury, Sultan; Young, Clint; Cohen, Charles J.; Oballa, Renata M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4397-4401</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The voltage gated sodium channel Nav1.7 represents an interesting target for the treatment of pain.  Human genetic studies have identified the crucial role of Nav1.7 in pain signaling.  Herein, we report the design and synthesis of a novel series of benzenesulfonamide-based Nav1.7 inhibitors.  Structural-activity relationship (SAR) studies were undertaken towards improving Nav1.7 activity and minimizing CYP inhibition.  These efforts resulted in the identification of compd. I, a highly potent Nav1.7 inhibitor with a thousand-fold selectivity over Nav1.5 and negligible CYP inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjReDfVWQ9BbVg90H21EOLACvtfcHk0liMsZf1xQxOOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWqsrfJ&md5=ac2bc2156d5bce18e8eb6027088edf27</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.08.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.08.017%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DQ.%26aulast%3DZenova%26aufirst%3DA.%2BY.%26aulast%3DChafeev%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26atitle%3DThe%2520discovery%2520of%2520benzenesulfonamide-based%2520potent%2520and%2520selective%2520inhibitors%2520of%2520voltage-gated%2520sodium%2520channel%2520NaV1.7%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4397%26epage%3D4401%26doi%3D10.1016%2Fj.bmcl.2014.08.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Focken, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chahal, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauphinais, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemeon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bichler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogucki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldbrook, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sojo, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuart, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oballa, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinette, C. L.</span></span> <span> </span><span class="NLM_article-title">Discovery of aryl sulfonamides as isoform-selective inhibitors of Na<sub>V</sub>1.7 with efficacy in rodent pain models</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">282</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00447</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00447" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=277-282&author=T.+Fockenauthor=S.+Liuauthor=N.+Chahalauthor=M.+Dauphinaisauthor=M.+E.+Grimwoodauthor=S.+Chowdhuryauthor=I.+Hemeonauthor=P.+Bichlerauthor=D.+Boguckiauthor=M.+Waldbrookauthor=G.+Bankarauthor=L.+E.+Sojoauthor=C.+Youngauthor=S.+Linauthor=N.+Shuartauthor=R.+Kwanauthor=J.+Pangauthor=J.+H.+Changauthor=B.+S.+Safinaauthor=D.+P.+Sutherlinauthor=J.+P.+Johnsonauthor=C.+M.+Dehnhardtauthor=T.+S.+Mansourauthor=R.+M.+Oballaauthor=C.+J.+Cohenauthor=C.+L.+Robinette&title=Discovery+of+aryl+sulfonamides+as+isoform-selective+inhibitors+of+NaV1.7+with+efficacy+in+rodent+pain+models&doi=10.1021%2Facsmedchemlett.5b00447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of NaV1.7 with Efficacy in Rodent Pain Models</span></div><div class="casAuthors">Focken, Thilo; Liu, Shifeng; Chahal, Navjot; Dauphinais, Maxim; Grimwood, Michael E.; Chowdhury, Sultan; Hemeon, Ivan; Bichler, Paul; Bogucki, David; Waldbrook, Matthew; Bankar, Girish; Sojo, Luis E.; Young, Clint; Lin, Sophia; Shuart, Noah; Kwan, Rainbow; Pang, Jodie; Chang, Jae H.; Safina, Brian S.; Sutherlin, Daniel P.; Johnson, J. P., Jr.; Dehnhardt, Christoph M.; Mansour, Tarek S.; Oballa, Renata M.; Cohen, Charles J.; Robinette, C. Lee</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-282</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report on a novel series of aryl sulfonamides that act as nanomolar potent, isoform-selective inhibitors of the human sodium channel hNaV1.7.  The optimization of these inhibitors is described.  The authors aimed to improve potency against hNaV1.7 while minimizing off-target safety concerns and generated compd. I.  This agent displayed significant analgesic effects in rodent models of acute and inflammatory pain and demonstrated that binding to the voltage sensor domain 4 site of NaV1.7 leads to an analgesic effect in vivo.  The findings corroborate the importance of hNaV1.7 as a drug target for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpIxiu3ixqRLVg90H21EOLACvtfcHk0liMsZf1xQxOOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKksrk%253D&md5=ae05f2c1ef6cf51d69a67a7b1ee7f8fa</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00447%26sid%3Dliteratum%253Aachs%26aulast%3DFocken%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DChahal%26aufirst%3DN.%26aulast%3DDauphinais%26aufirst%3DM.%26aulast%3DGrimwood%26aufirst%3DM.%2BE.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DHemeon%26aufirst%3DI.%26aulast%3DBichler%26aufirst%3DP.%26aulast%3DBogucki%26aufirst%3DD.%26aulast%3DWaldbrook%26aufirst%3DM.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DSojo%26aufirst%3DL.%2BE.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DShuart%26aufirst%3DN.%26aulast%3DKwan%26aufirst%3DR.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DRobinette%26aufirst%3DC.%2BL.%26atitle%3DDiscovery%2520of%2520aryl%2520sulfonamides%2520as%2520isoform-selective%2520inhibitors%2520of%2520NaV1.7%2520with%2520efficacy%2520in%2520rodent%2520pain%2520models%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D277%26epage%3D282%26doi%3D10.1021%2Facsmedchemlett.5b00447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">McKerrall, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiPasquale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chernov-Rogan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payandeh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proctor, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shields, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schumann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. P.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khakh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Safina, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherlin, D. P.</span></span> <span> </span><span class="NLM_article-title">Structure- and ligand-based discovery of chromane arylsulfonamide Na<sub>V</sub>1.7 inhibitors for the treatment of chronic pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4091</span>– <span class="NLM_lpage">4109</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00141</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00141" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmslSgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=4091-4109&author=S.+J.+McKerrallauthor=T.+Nguyenauthor=K.+W.+Laiauthor=P.+Bergeronauthor=L.+Dengauthor=A.+DiPasqualeauthor=J.+H.+Changauthor=J.+Chenauthor=T.+Chernov-Roganauthor=D.+H.+Hackosauthor=J.+Maherauthor=D.+F.+Ortwineauthor=J.+Pangauthor=J.+Payandehauthor=W.+R.+Proctorauthor=S.+D.+Shieldsauthor=J.+Vogtauthor=P.+Jiauthor=W.+Liuauthor=E.+Balliniauthor=L.+Schumannauthor=G.+Tarozzoauthor=G.+Bankarauthor=S.+Chowdhuryauthor=A.+Hasanauthor=J.+P.+Johnsonauthor=K.+Khakhauthor=S.+Linauthor=C.+J.+Cohenauthor=C.+M.+Dehnhardtauthor=B.+S.+Safinaauthor=D.+P.+Sutherlin&title=Structure-+and+ligand-based+discovery+of+chromane+arylsulfonamide+NaV1.7+inhibitors+for+the+treatment+of+chronic+pain&doi=10.1021%2Facs.jmedchem.9b00141"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Nav1.7 Inhibitors for the Treatment of Chronic Pain</span></div><div class="casAuthors">McKerrall, Steven J.; Nguyen, Teresa; Lai, Kwong Wah; Bergeron, Philippe; Deng, Lunbin; DiPasquale, Antonio; Chang, Jae H.; Chen, Jun; Chernov-Rogan, Tania; Hackos, David H.; Maher, Jonathan; Ortwine, Daniel F.; Pang, Jodie; Payandeh, Jian; Proctor, William R.; Shields, Shannon D.; Vogt, Jennifer; Ji, Pengfei; Liu, Wenfeng; Ballini, Elisa; Schumann, Lilia; Tarozzo, Glauco; Bankar, Girish; Chowdhury, Sultan; Hasan, Abid; Johnson, J. P.; Khakh, Kuldip; Lin, Sophia; Cohen, Charles J.; Dehnhardt, Christoph M.; Safina, Brian S.; Sutherlin, Daniel P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4091-4109</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using structure- and ligand-based design principles, a novel series of piperidyl chromane arylsulfonamide Nav1.7 inhibitors was discovered.  Early optimization focused on improvement of potency through refinement of the low energy ligand conformation and mitigation of high in vivo clearance.  An in vitro hepatotoxicity hazard was identified and resolved through optimization of lipophilicity and LLE to arrive at GNE-616 (24(I)), a highly potent, metabolically stable, subtype selective inhibitor of Nav1.7.  I showed a robust PK/PD response in a Nav1.7 dependent mouse model and site-directed mutagenesis was used to identify residues crit. for the isoform selectivity profile of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw_A7qQl172bVg90H21EOLACvtfcHk0ljoH2MMl5MacA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmslSgsLk%253D&md5=b8bd9e3d9f7debf6e4168e605dd837dc</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00141%26sid%3Dliteratum%253Aachs%26aulast%3DMcKerrall%26aufirst%3DS.%2BJ.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DLai%26aufirst%3DK.%2BW.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DDiPasquale%26aufirst%3DA.%26aulast%3DChang%26aufirst%3DJ.%2BH.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChernov-Rogan%26aufirst%3DT.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DMaher%26aufirst%3DJ.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPayandeh%26aufirst%3DJ.%26aulast%3DProctor%26aufirst%3DW.%2BR.%26aulast%3DShields%26aufirst%3DS.%2BD.%26aulast%3DVogt%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBallini%26aufirst%3DE.%26aulast%3DSchumann%26aufirst%3DL.%26aulast%3DTarozzo%26aufirst%3DG.%26aulast%3DBankar%26aufirst%3DG.%26aulast%3DChowdhury%26aufirst%3DS.%26aulast%3DHasan%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DJ.%2BP.%26aulast%3DKhakh%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DCohen%26aufirst%3DC.%2BJ.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DSafina%26aufirst%3DB.%2BS.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26atitle%3DStructure-%2520and%2520ligand-based%2520discovery%2520of%2520chromane%2520arylsulfonamide%2520NaV1.7%2520inhibitors%2520for%2520the%2520treatment%2520of%2520chronic%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D4091%26epage%3D4109%26doi%3D10.1021%2Facs.jmedchem.9b00141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venables, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of morpholine-based aryl sulfonamides as Na<sub>V</sub>1.7 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">958</span>– <span class="NLM_lpage">962</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.01.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2018.01.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=29439904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFCmtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=958-962&author=Y.+Wuauthor=J.+Guernonauthor=A.+McClureauthor=B.+Venablesauthor=R.+Rajamaniauthor=K.+J.+Robbinsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+L.+Pieschlauthor=J.+Herringtonauthor=L.+J.+Bristowauthor=N.+A.+Meanwellauthor=R.+Olsonauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Discovery+of+morpholine-based+aryl+sulfonamides+as+NaV1.7+inhibitors&doi=10.1016%2Fj.bmcl.2018.01.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of morpholine-based aryl sulfonamides as Nav1.7 inhibitors</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; McClure, Andrea; Venables, Brian; Rajamani, Ramkumar; Robbins, Kevin J.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick L.; Herrington, James; Bristow, Linda J.; Meanwell, Nicholas A.; Olson, Richard; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">958-962</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Replacement of the piperidine ring in the lead benzenesulfonamide Nav1.7 inhibitor I with a weakly basic morpholine core resulted in a significant redn. in Nav1.7 inhibitory activity, but the activity was restored by shortening the linkage from methyleneoxy to oxygen.  These efforts led to a series of morpholine-based aryl sulfonamides as isoform-selective Nav1.7 inhibitors.  This report describes the synthesis and SAR of these analogs.  Discovery of morpholine-based aryl sulfonamides as Nav1.7 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojgiZrOTuKrbVg90H21EOLACvtfcHk0ljoH2MMl5MacA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFCmtLc%253D&md5=7d9f583e76737c61f2b7c386ed661619</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.01.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.01.035%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DVenables%26aufirst%3DB.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DRobbins%26aufirst%3DK.%2BJ.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%2BL.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520morpholine-based%2520aryl%2520sulfonamides%2520as%2520NaV1.7%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D958%26epage%3D962%26doi%3D10.1016%2Fj.bmcl.2018.01.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ditta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post-Munson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graef, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newberry, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Development of new benzenesulfonamides as potent and selective Na<sub>V</sub>1.7 inhibitors for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2513</span>– <span class="NLM_lpage">2525</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01918</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01918" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVCmtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2513-2525&author=Y.+Wuauthor=J.+Guernonauthor=J.+Shiauthor=J.+Dittaauthor=K.+J.+Robbinsauthor=R.+Rajamaniauthor=A.+Eastonauthor=A.+Newtonauthor=C.+Bourinauthor=K.+Mosureauthor=M.+G.+Soarsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+L.+Pieschlauthor=D.+J.+Post-Munsonauthor=S.+Wangauthor=J.+Herringtonauthor=J.+Graefauthor=K.+Newberryauthor=L.+J.+Bristowauthor=N.+A.+Meanwellauthor=R.+Olsonauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Development+of+new+benzenesulfonamides+as+potent+and+selective+NaV1.7+inhibitors+for+the+treatment+of+pain&doi=10.1021%2Facs.jmedchem.6b01918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Development of New Benzenesulfonamides As Potent and Selective Nav1.7 Inhibitors for the Treatment of Pain</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; Shi, Jianliang; Ditta, Jonathan; Robbins, Kevin J.; Rajamani, Ramkumar; Easton, Amy; Newton, Amy; Bourin, Clotilde; Mosure, Kathleen; Soars, Matthew G.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick L.; Post-Munson, Debra J.; Wang, Shuya; Herrington, James; Graef, John; Newberry, Kimberly; Bristow, Linda J.; Meanwell, Nicholas A.; Olson, Richard; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2513-2525</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By taking advantage of certain features in piperidine (I), the authors developed a novel series of cyclohexylamine- and piperidine-based benzenesulfonamides as potent and selective Nav1.7 inhibitors.  However, 4-((((1S,4S)-4-aminocydohexyl)methyl)amino)-5-chloro-2-fluoro-N-(thiazol-2-yl)benzenesulfonamide (24), one of the early analogs, failed to reduce phase 2 flinching in the mouse formalin test even at a dose of 100 mpk PO due to insufficient DRG exposure attributed to poor membrane permeability.  Two analogs with improved membrane permeability showed much increased DRG concns. at doses of 30 mpk PO but, confoundingly, only one of these was effective in the formalin test.  More data are needed to understand the disconnect between efficacy and exposure relationships.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVESOC2ks88bVg90H21EOLACvtfcHk0ljMcws9kCr21Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVCmtrs%253D&md5=d320dedb1d61794445680d94dc2c7e48</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01918%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DDitta%26aufirst%3DJ.%26aulast%3DRobbins%26aufirst%3DK.%2BJ.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DEaston%26aufirst%3DA.%26aulast%3DNewton%26aufirst%3DA.%26aulast%3DBourin%26aufirst%3DC.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%2BL.%26aulast%3DPost-Munson%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DGraef%26aufirst%3DJ.%26aulast%3DNewberry%26aufirst%3DK.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520new%2520benzenesulfonamides%2520as%2520potent%2520and%2520selective%2520NaV1.7%2520inhibitors%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2513%26epage%3D2525%26doi%3D10.1021%2Facs.jmedchem.6b01918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit20c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guernon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnaby, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matchett, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieschl, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivarao, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bristow, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzierba, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of non-zwitterionic aryl sulfonamides as Na<sub>V</sub>1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5490</span>– <span class="NLM_lpage">5505</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmc.2017.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=28818462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlegsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=5490-5505&author=Y.-J.+Wuauthor=J.+Guernonauthor=A.+McClureauthor=G.+Luoauthor=R.+Rajamaniauthor=A.+Ngauthor=A.+Eastonauthor=A.+Newtonauthor=C.+Bourinauthor=D.+Parkerauthor=K.+Mosureauthor=O.+Barnabyauthor=M.+G.+Soarsauthor=R.+J.+Knoxauthor=M.+Matchettauthor=R.+Pieschlauthor=J.+Herringtonauthor=P.+Chenauthor=D.+V.+Sivaraoauthor=L.+J.+Bristowauthor=N.+A.+Meanwellauthor=J.+Bronsonauthor=R.+Olsonauthor=L.+A.+Thompsonauthor=C.+Dzierba&title=Discovery+of+non-zwitterionic+aryl+sulfonamides+as+NaV1.7+inhibitors+with+efficacy+in+preclinical+behavioral+models+and+translational+measures+of+nociceptive+neuron+activation&doi=10.1016%2Fj.bmc.2017.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20cR"><div class="casContent"><span class="casTitleNuber">20c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of non-zwitterionic aryl sulfonamides as Nav1.7 inhibitors with efficacy in preclinical behavioral models and translational measures of nociceptive neuron activation</span></div><div class="casAuthors">Wu, Yong-Jin; Guernon, Jason; McClure, Andrea; Luo, Guanglin; Rajamani, Ramkumar; Ng, Alicia; Easton, Amy; Newton, Amy; Bourin, Clotilde; Parker, Dawn; Mosure, Kathleen; Barnaby, Omar; Soars, Matthew G.; Knox, Ronald J.; Matchett, Michele; Pieschl, Rick; Herrington, James; Chen, Ping; Sivarao, D. V.; Bristow, Linda J.; Meanwell, Nicholas A.; Bronson, Joanne; Olson, Richard; Thompson, Lorin A.; Dzierba, Carolyn</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5490-5505</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Since zwitterionic benzenesulfonamide Nav1.7 inhibitors suffer from poor membrane permeability, the authors sought to eliminate this characteristic by replacing the basic moiety with non-basic bicyclic acetals and monocyclic ethers.  These efforts led to the discovery of the non-zwitterionic aryl sulfonamide 49 ((R)-5-chloro-2-fluoro-4-(((tetrahydro-2H-pyran-3-yl)methyl)amino)-N-(thiazol-2-yl)benzenesulfonamide) as a selective Nav1.7 inhibitor with improved membrane permeability.  Despite its moderate cellular activity, 49 exhibited robust efficacy in mouse models of neuropathic and inflammatory pain and modulated translational electromyogram measures assocd. with activation of nociceptive neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDfNtc0Dv967Vg90H21EOLACvtfcHk0ljMcws9kCr21Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlegsL%252FE&md5=d8426c3423ce37ddfb45f1ea31f89d16</span></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.-J.%26aulast%3DGuernon%26aufirst%3DJ.%26aulast%3DMcClure%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DEaston%26aufirst%3DA.%26aulast%3DNewton%26aufirst%3DA.%26aulast%3DBourin%26aufirst%3DC.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DBarnaby%26aufirst%3DO.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DMatchett%26aufirst%3DM.%26aulast%3DPieschl%26aufirst%3DR.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DSivarao%26aufirst%3DD.%2BV.%26aulast%3DBristow%26aufirst%3DL.%2BJ.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DBronson%26aufirst%3DJ.%26aulast%3DOlson%26aufirst%3DR.%26aulast%3DThompson%26aufirst%3DL.%2BA.%26aulast%3DDzierba%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520non-zwitterionic%2520aryl%2520sulfonamides%2520as%2520NaV1.7%2520inhibitors%2520with%2520efficacy%2520in%2520preclinical%2520behavioral%2520models%2520and%2520translational%2520measures%2520of%2520nociceptive%2520neuron%2520activation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D5490%26epage%3D5505%26doi%3D10.1016%2Fj.bmc.2017.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span> <span> </span><span class="NLM_article-title">The discovery of tetrahydropyridine analogs as hNa<sub>V</sub>1.7 selective inhibitors for analgesia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">2210</span>– <span class="NLM_lpage">2215</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.03.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2017.03.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=28385504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlslarsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=2210-2215&author=W.+Wuauthor=Z.+Liauthor=G.+Yangauthor=M.+Tengauthor=J.+Qinauthor=Z.+Huauthor=L.+Houauthor=L.+Shenauthor=H.+Dongauthor=Y.+Zhangauthor=J.+Liauthor=S.+Chenauthor=J.+Tianauthor=J.+Zhangauthor=L.+Ye&title=The+discovery+of+tetrahydropyridine+analogs+as+hNaV1.7+selective+inhibitors+for+analgesia&doi=10.1016%2Fj.bmcl.2017.03.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of tetrahydropyridine analogs as hNav1.7 selective inhibitors for analgesia</span></div><div class="casAuthors">Wu, Wentao; Li, Zhixiang; Yang, Guangwen; Teng, Mingxing; Qin, Jian; Hu, Zhijing; Hou, Lijuan; Shen, Liang; Dong, Haiheng; Zhang, Yang; Li, Jian; Chen, Shuhui; Tian, Jingwei; Zhang, Jianzhao; Ye, Liang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2210-2215</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HNav1.7 small mol. inhibitors have attracted lots of attention by its unique analgesic effect.  Herein, the design and synthesis of a novel series of tetrahydropyridine analogs as hNav1.7 inhibitors for analgesia is reported.  Detail structural-activity relationship (SAR) studies were undertaken towards improving hNav1.7 activity, in vitro ADME, and in vivo PK profiles.  These efforts resulted in the identification of compd. (-)-I, a highly potent and selective hNav1.7 inhibitor with good ADME and PK profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoP6xx5fd4NYrVg90H21EOLACvtfcHk0lizIrBKccryEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlslarsb8%253D&md5=ed0b99fa7611354124394c07bbf259ac</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.03.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.03.043%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DTeng%26aufirst%3DM.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DHou%26aufirst%3DL.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DL.%26atitle%3DThe%2520discovery%2520of%2520tetrahydropyridine%2520analogs%2520as%2520hNaV1.7%2520selective%2520inhibitors%2520for%2520analgesia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D2210%26epage%3D2215%26doi%3D10.1016%2Fj.bmcl.2017.03.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of aminocyclohexene analogues as selective and orally bioavailable hNa<sub>V</sub>1.7 inhibitors for analgesia</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_fpage">4979</span>– <span class="NLM_lpage">4984</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.bmcl.2017.10.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=29037948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gksb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=4979-4984&author=M.+Tengauthor=W.+Wuauthor=Z.+Liauthor=G.+Yangauthor=J.+Qinauthor=Y.+Wangauthor=Z.+Huauthor=H.+Dongauthor=L.+Houauthor=G.+Huauthor=L.+Shenauthor=Y.+Zhangauthor=J.+Liauthor=S.+Chenauthor=J.+Tianauthor=L.+Yeauthor=J.+Zhangauthor=H.+Wang&title=Discovery+of+aminocyclohexene+analogues+as+selective+and+orally+bioavailable+hNaV1.7+inhibitors+for+analgesia&doi=10.1016%2Fj.bmcl.2017.10.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of aminocyclohexene analogues as selective and orally bioavailable hNav1.7 inhibitors for analgesia</span></div><div class="casAuthors">Teng, Mingxing; Wu, Wentao; Li, Zhixiang; Yang, Guangwen; Qin, Jian; Wang, Yikai; Hu, Zhijing; Dong, Haiheng; Hou, Lijuan; Hu, Guoping; Shen, Liang; Zhang, Yang; Li, Jian; Chen, Shuhui; Tian, Jingwei; Ye, Liang; Zhang, Jianzhao; Wang, Hongbo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4979-4984</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HNav1.7 receives a lot of attention owing to its attractive mechanism of action in pain processing pathway.  The authors have previously reported the design of a novel series of tetrahydropyridine analogs towards hNav1.7 selective inhibitors.  Herein, the authors disclose further efforts to the optimization of hit compd. (-)-6, which led to the identification of aminocyclohexene analogs (-)-9 and (-)-17 with good potency, high selectivity, and minimal CYP inhibition.  Both compds. (-)-9 and (-)-17 demonstrated improved pharmacokinetic profiles in rats, and robust efficacy in rat formalin-induced nociception and spinal nerve ligation (SNL) models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqawNCRE6H6rVg90H21EOLACvtfcHk0lizIrBKccryEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gksb7J&md5=922146ec3e1c272e02af031be78dc06d</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.010%26sid%3Dliteratum%253Aachs%26aulast%3DTeng%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DHou%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520aminocyclohexene%2520analogues%2520as%2520selective%2520and%2520orally%2520bioavailable%2520hNaV1.7%2520inhibitors%2520for%2520analgesia%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26spage%3D4979%26epage%3D4984%26doi%3D10.1016%2Fj.bmcl.2017.10.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sawynok, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, A.</span></span> <span> </span><span class="NLM_article-title">Caffeine inhibits anti-nociception by acetaminophen in the formalin test by inhibiting spinal adenosine A1 receptors</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>674</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2011.10.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.ejphar.2011.10.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=22085758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1Kitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=674&publication_year=2012&pages=248-254&author=J.+Sawynokauthor=A.+Reid&title=Caffeine+inhibits+anti-nociception+by+acetaminophen+in+the+formalin+test+by+inhibiting+spinal+adenosine+A1+receptors&doi=10.1016%2Fj.ejphar.2011.10.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeine inhibits antinociception by acetaminophen in the formalin test by inhibiting spinal adenosine A1 receptors</span></div><div class="casAuthors">Sawynok, Jana; Reid, Allison R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">674</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">248-254</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The present study examd. effects of caffeine on antinociception by acetaminophen in the formalin test in mice.  It demonstrates that caffeine 10 mg/kg inhibits antinociception produced by acetaminophen 300 mg/kg i.p. against phase 2 flinches.  Chronic administration of caffeine in the drinking water (0.1, 0.3 g/l) for 8 days also inhibits the action of acetaminophen.  The selective adenosine A1 receptor antagonist DPCPX 1 mg/kg i.p. mimics the action of caffeine, but the selective adenosine A2A receptor antagonist SCH58261 3 mg/kg i.p. does not.  While acetaminophen produced the same effect in mice that were +/+, +/-, and -/- for adenosine A1 receptors, inhibition of antinociception by caffeine was seen only in +/+ and +/- mice.  A higher dose of caffeine, 40 mg/kg, produced an intrinsic antinociception against formalin-evoked flinches, an effect also seen when caffeine was administered intrathecally.  SCH58261 30 nmol, but not DPCPX 10 nmol, also produced antinociception when administered intrathecally indicating involvement of adenosine A2A receptors in spinal antinociception.  Caffeine reversal of acetaminophen results from actions in the spinal cord, as intrathecal DPCPX 10 nmol inhibited antinociception by systemic acetaminophen; this was also obsd. in +/+ but not in -/- adenosine A1 receptor mice.  We propose that spinal adenosine A1 receptors contribute to the action of acetaminophen secondarily to involvement of descending serotonin pathways and release of adenosine within the spinal cord.  Inhibition of acetaminophen antinociception by doses of caffeine relevant to dietary human intake levels suggests a more detailed consideration of acetaminophen-caffeine interactions in humans is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlaONeW1abErVg90H21EOLACvtfcHk0lizIrBKccryEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1Kitw%253D%253D&md5=c05e2e48def5461fcf7be9873c33d6c0</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2011.10.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2011.10.036%26sid%3Dliteratum%253Aachs%26aulast%3DSawynok%26aufirst%3DJ.%26aulast%3DReid%26aufirst%3DA.%26atitle%3DCaffeine%2520inhibits%2520anti-nociception%2520by%2520acetaminophen%2520in%2520the%2520formalin%2520test%2520by%2520inhibiting%2520spinal%2520adenosine%2520A1%2520receptors%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D674%26spage%3D248%26epage%3D254%26doi%3D10.1016%2Fj.ejphar.2011.10.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shields, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavanaugh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basbaum, A.</span></span> <span> </span><span class="NLM_article-title">Pain behavior in the formalin test persists after ablation of the great majority of C-fiber nociceptors</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2010.08.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1016%2Fj.pain.2010.08.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=20832171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A280%3ADC%252BC3cfpsVyitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2010&pages=422-429&author=S.+Shieldsauthor=D.+Cavanaughauthor=H.+Leeauthor=D.+Andersonauthor=A.+Basbaum&title=Pain+behavior+in+the+formalin+test+persists+after+ablation+of+the+great+majority+of+C-fiber+nociceptors&doi=10.1016%2Fj.pain.2010.08.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Pain behavior in the formalin test persists after ablation of the great majority of C-fiber nociceptors</span></div><div class="casAuthors">Shields Shannon D; Cavanaugh Daniel J; Lee Hyosang; Anderson David J; Basbaum Allan I</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">422-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although the formalin test is a widely used model of persistent pain, the primary afferent fiber types that underlie the cellular and behavioral responses to formalin injection are largely unknown.  Here we used a combined genetic and pharmacological approach to investigate the effect of ablating subsets of primary afferent nociceptors on formalin-induced nocifensive behaviors and spinal cord Fos protein expression.  Intrathecal capsaicin-induced ablation of the central terminals of TRPV1+neurons greatly reduced the behavioral responses and Fos elicited by low-dose (0.5%) formalin.  In contrast, genetic ablation of the MrgprD-expressing subset of non-peptidergic unmyelinated afferents, which constitute a largely non-overlapping population, altered neither the behavior nor the Fos induced by low-dose formalin.  Remarkably, nocifensive behavior following high-dose (2%) formalin was unchanged in mice lacking either afferent population, or even in mice lacking both populations, which together make up the great majority of C-fiber nociceptors.  Thus, at high doses, which are routinely used in the formalin test, formalin-induced "pain" behavior persists in the absence of the vast majority of C-fiber nociceptors, which points to a contribution of a large spectrum of afferents secondary to non-specific formalin-induced tissue and nerve damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQxSXCbJPqGTwWRJ3OJdH_qfW6udTcc2ebzZgmulqJbgrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfpsVyitQ%253D%253D&md5=5cfd5f8deb05329879ed0a39954f69dd</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2010.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2010.08.001%26sid%3Dliteratum%253Aachs%26aulast%3DShields%26aufirst%3DS.%26aulast%3DCavanaugh%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DAnderson%26aufirst%3DD.%26aulast%3DBasbaum%26aufirst%3DA.%26atitle%3DPain%2520behavior%2520in%2520the%2520formalin%2520test%2520persists%2520after%2520ablation%2520of%2520the%2520great%2520majority%2520of%2520C-fiber%2520nociceptors%26jtitle%3DPain%26date%3D2010%26volume%3D151%26spage%3D422%26epage%3D429%26doi%3D10.1016%2Fj.pain.2010.08.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mogil, J.</span>; <span class="NLM_string-name">Wilson, S.</span>; <span class="NLM_string-name">Wan, Y.</span></span> <span> </span><span class="NLM_article-title">Assessing Nociception in Murine Subjects</span>. In  <i>Methods in Pain Research</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, L.</span></span>, Ed.; <span class="NLM_publisher-name">CRC Press</span>: <span class="NLM_publisher-loc">Boca Raton, Florida</span>, <span class="NLM_year">2001</span>; pp  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">39</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1201%2F9781420042566-c2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=11-39&author=J.+Mogil&author=S.+Wilson&author=Y.+Wanauthor=L.+Kruger&title=Methods+in+Pain+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1201%2F9781420042566-c2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1201%252F9781420042566-c2%26sid%3Dliteratum%253Aachs%26aulast%3DMogil%26aufirst%3DJ.%26atitle%3DAssessing%2520Nociception%2520in%2520Murine%2520Subjects%26btitle%3DMethods%2520in%2520Pain%2520Research%26aulast%3DKruger%26aufirst%3DL.%26pub%3DCRC%2520Press%26date%3D2001%26spage%3D11%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okauchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuramoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, M.</span></span> <span> </span><span class="NLM_article-title">Facile preparation of aryl sulfides using palladium catalysis under mild conditions</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2010</i></span>,  <span class="NLM_fpage">2891</span>– <span class="NLM_lpage">2894</span>, <span class="refDoi"> DOI: 10.1055/s-0030-1259012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1055%2Fs-0030-1259012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2010&publication_year=2010&pages=2891-2894&author=T.+Okauchiauthor=K.+Kuramotoauthor=M.+Kitamura&title=Facile+preparation+of+aryl+sulfides+using+palladium+catalysis+under+mild+conditions&doi=10.1055%2Fs-0030-1259012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1055%2Fs-0030-1259012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0030-1259012%26sid%3Dliteratum%253Aachs%26aulast%3DOkauchi%26aufirst%3DT.%26aulast%3DKuramoto%26aufirst%3DK.%26aulast%3DKitamura%26aufirst%3DM.%26atitle%3DFacile%2520preparation%2520of%2520aryl%2520sulfides%2520using%2520palladium%2520catalysis%2520under%2520mild%2520conditions%26jtitle%3DSynlett%26date%3D2010%26volume%3D2010%26spage%3D2891%26epage%3D2894%26doi%3D10.1055%2Fs-0030-1259012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Barluenga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomas-Gamasa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aznar, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdes, C.</span></span> <span> </span><span class="NLM_article-title">Pd-Catalyzed cross-coupling reactions with carbonyls: application in a very efficient synthesis of 4-aryltetrahydropyridines</span>. <i>Chem.–Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4792</span>– <span class="NLM_lpage">4795</span>, <span class="refDoi"> DOI: 10.1002/chem.200800390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1002%2Fchem.200800390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=18412167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnslOjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=4792-4795&author=J.+Barluengaauthor=M.+Tomas-Gamasaauthor=P.+Morielauthor=F.+Aznarauthor=C.+Valdes&title=Pd-Catalyzed+cross-coupling+reactions+with+carbonyls%3A+application+in+a+very+efficient+synthesis+of+4-aryltetrahydropyridines&doi=10.1002%2Fchem.200800390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Pd-catalyzed cross-coupling reactions with carbonyls: application in a very efficient synthesis of 4-aryltetrahydropyridines</span></div><div class="casAuthors">Barluenga, Jose; Tomas-Gamasa, Maria; Moriel, Patricia; Aznar, Fernando; Valdes, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4792-4795</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Readily available 4-piperidones are directly employed in a very efficient Pd-catalyzed synthesis of 4-aryltetrahydropyridines, which are important scaffolds in medicinal chem.  The actual coupling partner, a tosylhydrazone, is generated in situ from the piperidone and tosylhydrazine.  The reaction can be applied to other ketones and aldehydes, providing polysubstituted olefins directly from carbonyls by a very simple and efficient procedure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9Kd_hYIu017Vg90H21EOLACvtfcHk0lhYjcOScttj7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnslOjsbg%253D&md5=f78fc7c74a15e804866d1e17024a37c5</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1002%2Fchem.200800390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200800390%26sid%3Dliteratum%253Aachs%26aulast%3DBarluenga%26aufirst%3DJ.%26aulast%3DTomas-Gamasa%26aufirst%3DM.%26aulast%3DMoriel%26aufirst%3DP.%26aulast%3DAznar%26aufirst%3DF.%26aulast%3DValdes%26aufirst%3DC.%26atitle%3DPd-Catalyzed%2520cross-coupling%2520reactions%2520with%2520carbonyls%253A%2520application%2520in%2520a%2520very%2520efficient%2520synthesis%2520of%25204-aryltetrahydropyridines%26jtitle%3DChem.%25E2%2580%2593Eur.%2520J.%26date%3D2008%26volume%3D14%26spage%3D4792%26epage%3D4795%26doi%3D10.1002%2Fchem.200800390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Barluenga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escribano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aznar, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valde′s, C.</span></span> <span> </span><span class="NLM_article-title">Arylation of α-chiral ketones by palladium-catalyzed cross-coupling reactions of tosylhydrazones with aryl halides</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6856</span>– <span class="NLM_lpage">6859</span>, <span class="refDoi"> DOI: 10.1002/anie.201003450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=10.1002%2Fanie.201003450" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGntr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6856-6859&author=J.+Barluengaauthor=M.+Escribanoauthor=F.+Aznarauthor=C.+Valde%E2%80%B2s&title=Arylation+of+%CE%B1-chiral+ketones+by+palladium-catalyzed+cross-coupling+reactions+of+tosylhydrazones+with+aryl+halides&doi=10.1002%2Fanie.201003450"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Arylation of α-Chiral Ketones by Palladium-Catalyzed Cross-Coupling Reactions of Tosylhydrazones with Aryl Halides</span></div><div class="casAuthors">Barluenga, Jose; Escribano, Maria; Aznar, Fernando; Valdes, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">6856-6859, S6856/1-S6856/62</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">It is disclosed that palladium-catalyzed cross-coupling between tosylhydrazones and aryl halides is a powerful methodol. for the manipulation of α-chiral ketones with total preservation the stereochem. of the α carbon.  We have synthesized that aryl-substituted chiral cyclohexenes from α-chiral cyclohexanones, and chiral allylamines from Me ketones that were easily obtained from α-amino acids.  Taking into consideration the wide availability, but also the configurational instability, of α-chiral ketones, this catalytic process may represent a very useful transformation in org. synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvuKVciXDWebVg90H21EOLACvtfcHk0li9JrcBwUUKyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGntr7J&md5=9d9371cab4d1012e567a9a84a24f09df</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1002%2Fanie.201003450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201003450%26sid%3Dliteratum%253Aachs%26aulast%3DBarluenga%26aufirst%3DJ.%26aulast%3DEscribano%26aufirst%3DM.%26aulast%3DAznar%26aufirst%3DF.%26aulast%3DValde%25E2%2580%25B2s%26aufirst%3DC.%26atitle%3DArylation%2520of%2520%25CE%25B1-chiral%2520ketones%2520by%2520palladium-catalyzed%2520cross-coupling%2520reactions%2520of%2520tosylhydrazones%2520with%2520aryl%2520halides%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D6856%26epage%3D6859%26doi%3D10.1002%2Fanie.201003450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit25c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioannis, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renmao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youchu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhilong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthew, J. F.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed coupling of sulfonylhydrazones with heteroaromatic 2-amino-halides (Barluenga reaction): exploring the electronics of the sulfonylhydrazone</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1044</span>– <span class="NLM_lpage">1048</span>, <span class="refDoi"> DOI: 10.1021/acs.oprd.5b00211</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.oprd.5b00211" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12ks7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2015&pages=1044-1048&author=H.+Tanauthor=H.+Ioannisauthor=L.+Renmaoauthor=W.+Youchuauthor=C.+Zhilongauthor=J.+F.+Matthew&title=Palladium-catalyzed+coupling+of+sulfonylhydrazones+with+heteroaromatic+2-amino-halides+%28Barluenga+reaction%29%3A+exploring+the+electronics+of+the+sulfonylhydrazone&doi=10.1021%2Facs.oprd.5b00211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25cR"><div class="casContent"><span class="casTitleNuber">25c</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Coupling of Sulfonylhydrazones with Heteroaromatic 2-Amino-Halides (Barluenga Reaction): Exploring the Electronics of the Sulfonylhydrazone</span></div><div class="casAuthors">Tan, Hongyu; Houpis, Ioannis; Liu, Renmao; Wang, Youchu; Chen, Zhilong; Fleming, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1044-1048</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes a new reactivity of the Pd-catalyzed coupling of 2-amino-3-bromo-arom. and heteroarom. compds. with sulfonylhydrazones (Barluenga reaction).The new catalyst system and modulation of the electronic nature of hydrazone that were needed for successful reaction are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOEayrtVlGNbVg90H21EOLACvtfcHk0li9JrcBwUUKyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12ks7fP&md5=4d55eb510f0ae40d6a5f9c1b76b25f81</span></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=10.1021%2Facs.oprd.5b00211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.oprd.5b00211%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DH.%26aulast%3DIoannis%26aufirst%3DH.%26aulast%3DRenmao%26aufirst%3DL.%26aulast%3DYouchu%26aufirst%3DW.%26aulast%3DZhilong%26aufirst%3DC.%26aulast%3DMatthew%26aufirst%3DJ.%2BF.%26atitle%3DPalladium-catalyzed%2520coupling%2520of%2520sulfonylhydrazones%2520with%2520heteroaromatic%25202-amino-halides%2520%2528Barluenga%2520reaction%2529%253A%2520exploring%2520the%2520electronics%2520of%2520the%2520sulfonylhydrazone%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2015%26volume%3D19%26spage%3D1044%26epage%3D1048%26doi%3D10.1021%2Facs.oprd.5b00211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Avitabile, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judd, D. B.</span></span> <span> </span><span class="NLM_article-title">Pentafluorophenyl sulfonate ester as a protecting group for the preparation of biaryl- and heterobiaryl sulfonate esters</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">843</span>– <span class="NLM_lpage">846</span>, <span class="refDoi"> DOI: 10.1021/ol047422o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol047422o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVantbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=843-846&author=B.+G.+Avitabileauthor=C.+A.+Smithauthor=D.+B.+Judd&title=Pentafluorophenyl+sulfonate+ester+as+a+protecting+group+for+the+preparation+of+biaryl-+and+heterobiaryl+sulfonate+esters&doi=10.1021%2Fol047422o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Pentafluorophenyl Sulfonate Ester as a Protecting Group for the Preparation of Biaryl- and Heterobiaryl Sulfonate Esters</span></div><div class="casAuthors">Avitabile, Barbara G.; Smith, Clive A.; Judd, Duncan B.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">843-846</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of the pentafluorophenyl (PFP) group as a sulfonic acid protecting group has allowed the synthesis of new biaryl- and heterobiaryl-PFP-sulfonate esters by use of the Suzuki-Miyaura reaction.  E.g., PdCl2(PPh3)2 catalyzed the Suzuki-Miyaura reaction of ROSO2C6H4Br-4 (R = pentafluorophenyl) with p-tolylboronic acid to give 68% 4-ROSO2C6H4C6H4Me-4.  The successful employment of a novel inorg. base, anhyd. sodium tetraborate, was crucial to give the products in excellent yields.  The PFP-sulfonate ester has been previously shown to be an excellent alternative to sulfonyl chlorides in the synthesis of sulfonamides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHLaqCV7_T57Vg90H21EOLACvtfcHk0li9JrcBwUUKyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVantbw%253D&md5=beacf53dff4f3144821b03d5817b150f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fol047422o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol047422o%26sid%3Dliteratum%253Aachs%26aulast%3DAvitabile%26aufirst%3DB.%2BG.%26aulast%3DSmith%26aufirst%3DC.%2BA.%26aulast%3DJudd%26aufirst%3DD.%2BB.%26atitle%3DPentafluorophenyl%2520sulfonate%2520ester%2520as%2520a%2520protecting%2520group%2520for%2520the%2520preparation%2520of%2520biaryl-%2520and%2520heterobiaryl%2520sulfonate%2520esters%26jtitle%3DOrg.%2520Lett.%26date%3D2005%26volume%3D7%26spage%3D843%26epage%3D846%26doi%3D10.1021%2Fol047422o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i129"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00361">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_25044"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00361?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00361</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">SMILES strrings for the compounds that are the subject of this publication (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00361/suppl_file/jm0c00361_si_001.csv">CSV</a>)</p></li><li><p class="inline">Confirmation of absolute configuration of active isomer; synthesis of intermediates <b>58a–m</b> and analytical data; methods and conditions for separation of enantiomers by preparative chiral HPLC (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00361/suppl_file/jm0c00361_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00361/suppl_file/jm0c00361_si_001.csv">jm0c00361_si_001.csv (5.71 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00361/suppl_file/jm0c00361_si_002.pdf">jm0c00361_si_002.pdf (3.33 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00361&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00361%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-11" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00361" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c695ebb03c4c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
